data_2fm4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fm4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 391' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 121.468 0.652 . . . . 0.0 110.551 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.465 HG12 ' N ' ' A' ' 392' ' ' ILE . 25.4 t -41.01 143.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.326 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.619 ' CG1' ' N ' ' A' ' 393' ' ' GLY . 2.5 pt -87.72 -55.06 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.635 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.619 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -153.98 -157.13 7.97 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.4 p -164.51 108.47 0.93 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -84.84 -146.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 42.0 mt -96.79 139.99 21.89 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.92 93.07 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.61 0 C-N-CA 121.294 1.329 . . . . 0.0 111.303 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.02 -69.85 0.25 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.715 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 57.0 m -133.24 139.25 33.6 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.756 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.31 100.83 0.07 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.895 1.064 . . . . 0.0 110.406 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.616 ' C ' ' SG ' ' A' ' 466' ' ' CYS . . . -152.03 162.36 29.73 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.639 -1.743 . . . . 0.0 112.116 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -141.43 128.44 20.73 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.65 160.58 43.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.019 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -138.77 107.9 6.06 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.023 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.07 30.35 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.051 -1.547 . . . . 0.0 111.307 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . 0.467 ' HE3' ' CD2' ' A' ' 495' ' ' TYR . 3.7 mttp -85.98 137.93 32.36 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.936 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.54 ' O ' ' CG ' ' A' ' 408' ' ' TYR . 49.6 t -55.44 148.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.986 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 407' ' ' VAL . 17.8 m-85 -170.98 139.9 1.48 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.653 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.762 ' CB ' ' HZ2' ' A' ' 481' ' ' LYS . 4.1 m-85 -113.79 42.43 2.01 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.313 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.462 ' OG1' ' OE1' ' A' ' 413' ' ' GLU . 1.0 OUTLIER -159.36 145.0 16.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.886 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -76.83 -18.23 58.51 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.787 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -74.16 -39.93 62.91 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.69 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . 0.462 ' OE1' ' OG1' ' A' ' 410' ' ' THR . 41.8 mt-10 -66.78 -26.76 67.12 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.6 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 418' ' ' HIS . . . -72.5 -38.27 68.17 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.54 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -43.1 86.42 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.876 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.57 -49.58 52.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.842 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -58.77 -62.11 2.11 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.083 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 414' ' ' ALA . 24.8 t-80 -41.53 -30.58 0.21 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.663 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -89.53 -22.02 22.62 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.575 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 417' ' ' ALA . 0.0 OUTLIER -94.91 -49.2 5.67 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.521 -0.871 . . . . 0.0 112.842 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 422' ' ' GLU . . . -153.74 -10.64 0.07 OUTLIER Glycine 0 N--CA 1.497 2.737 0 C-N-CA 118.763 -1.684 . . . . 0.0 112.03 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . 0.446 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 3.0 mt-10 64.24 -145.89 0.28 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 49.87 65.89 1.29 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.614 -1.234 . . . . 0.0 108.352 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.47 154.92 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.702 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.459 HG21 ' H ' ' A' ' 426' ' ' LEU . 18.9 mm -118.75 160.9 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.406 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.459 ' H ' HG21 ' A' ' 425' ' ' ILE . 1.4 tp -134.58 125.56 27.47 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.183 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.496 ' HB ' ' CZ ' ' A' ' 409' ' ' PHE . 38.2 t -114.14 127.16 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.75 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ARG . . . . . 0.477 ' H ' HG21 ' A' ' 447' ' ' THR . 0.0 OUTLIER -152.48 146.69 25.47 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.122 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 12.03 2.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.566 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 428' ' ' ARG . 67.2 tt0 -176.4 139.76 0.35 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.1 p -106.14 153.49 22.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.271 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.32 158.67 63.39 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.715 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.9 Cg_endo -65.79 -69.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.903 1.736 . . . . 0.0 112.394 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -35.23 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.568 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.624 ' OD1' ' SD ' ' A' ' 439' ' ' MET . 0.6 OUTLIER -62.83 -8.41 6.88 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.622 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 439' ' ' MET . 0.3 OUTLIER -32.68 -58.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.462 ' N ' HG21 ' A' ' 436' ' ' ILE . 53.2 mt-10 -47.93 -41.19 24.15 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 117.961 -1.496 . . . . 0.0 109.086 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -71.91 -25.85 73.92 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' MET . . . . . 0.624 ' SD ' ' OD1' ' A' ' 435' ' ' ASP . 40.5 mtp -70.65 -46.93 62.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.444 ' CE1' ' SD ' ' A' ' 463' ' ' MET . 85.9 m-70 -58.26 -61.66 2.41 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 118.267 -1.373 . . . . 0.0 109.546 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -49.25 -32.15 10.18 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.096 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . 0.652 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -98.04 71.45 2.15 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.544 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.18 3.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.239 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.652 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -144.32 145.17 14.46 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 49.8 mt -148.01 118.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.091 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.444 HD11 ' CG1' ' A' ' 468' ' ' VAL . 4.6 tp -115.55 97.96 6.45 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' THR . . . . . 0.477 HG21 ' H ' ' A' ' 428' ' ' ARG . 4.4 p -106.16 160.94 14.95 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.901 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 56.6 t -86.47 -20.62 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.157 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 470' ' ' GLY . 2.0 tpt85 -99.54 -136.04 0.29 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.615 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.522 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 73.14 -170.47 52.05 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.62 -170.34 40.54 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.897 -1.62 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 13.9 ttt -46.95 -37.97 9.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.91 129.26 5.91 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.182 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.1 m -174.29 -178.29 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' HIS . . . . . 0.479 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 34.4 m80 -45.63 -38.3 6.52 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.952 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -59.51 -51.27 70.58 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.694 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -78.19 -52.09 9.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 3.4 t -47.85 -50.49 9.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.284 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 65.9 t -63.99 -39.27 84.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 464' ' ' GLY . . . -65.51 -50.59 64.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.381 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -53.96 -29.07 41.15 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.422 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.15 -35.33 27.4 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' MET . . . . . 0.444 ' SD ' ' CE1' ' A' ' 440' ' ' HIS . 16.2 mmt -97.49 6.43 48.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.727 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 460' ' ' ALA . . . 48.78 24.72 4.4 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.953 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 94.3 m -84.11 146.4 27.91 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.831 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' CYS . . . . . 0.616 ' SG ' ' C ' ' A' ' 401' ' ' GLY . 17.0 t -76.1 129.5 36.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 80.0 m -151.54 146.98 26.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.822 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . 0.529 HG11 ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.69 160.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.393 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' SER . . . . . 0.529 ' N ' HG11 ' A' ' 468' ' ' VAL . 7.0 t -151.04 148.15 27.99 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.596 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 52.0 92.39 0.01 OUTLIER Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . 0.434 ' SG ' HD11 ' A' ' 474' ' ' ILE . 7.9 m -100.69 -159.39 0.73 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.643 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.72 -99.0 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.959 -1.591 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -133.92 43.87 2.8 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.416 0.627 . . . . 0.0 109.34 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.434 HD11 ' SG ' ' A' ' 471' ' ' CYS . 5.0 mt -39.09 110.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.846 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -94.3 121.96 36.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.36 131.13 35.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 117.829 -1.548 . . . . 0.0 112.795 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -104.39 119.45 38.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.552 ' C ' ' N ' ' A' ' 480' ' ' ALA . 1.5 mp0 -62.65 -10.69 13.26 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.598 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -45.51 -20.18 0.06 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 118.236 -1.386 . . . . 0.0 108.518 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.552 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.68 -103.67 0.01 OUTLIER 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . 0.762 ' HZ2' ' CB ' ' A' ' 409' ' ' PHE . 11.2 mmmm -155.96 65.87 0.59 Allowed 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.482 ' CB ' ' HA ' ' A' ' 491' ' ' ALA . 4.8 p -98.43 -179.5 4.36 Favored 'General case' 0 C--O 1.201 -1.475 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.783 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 483' ' ' PHE . 0.5 OUTLIER -150.78 117.23 5.72 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.043 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.17 118.48 28.9 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.839 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.479 HD13 ' H ' ' A' ' 486' ' ' GLY . 61.6 tp -143.53 154.79 43.98 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.775 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' GLY . . . . . 0.479 ' H ' HD13 ' A' ' 485' ' ' LEU . . . 56.89 -114.59 5.48 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.484 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.85 3.91 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.11 152.19 33.04 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 88.3 m -107.79 112.03 24.49 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.946 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 483' ' ' PHE . 5.6 m-30 -89.45 110.93 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.061 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -98.23 149.01 23.02 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.865 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.485 ' O ' ' CG ' ' A' ' 492' ' ' GLU . 1.9 tm-20 -67.29 69.49 0.09 Allowed 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -173.96 22.47 0.06 OUTLIER Glycine 0 C--N 1.269 -3.139 0 C-N-CA 119.206 -1.473 . . . . 0.0 109.765 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 495' ' ' TYR . 2.4 t0 -140.69 -173.94 3.83 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.655 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . 0.467 ' CD2' ' HE3' ' A' ' 406' ' ' LYS . 0.2 OUTLIER -116.41 129.64 56.34 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.587 ' C ' ' CD1' ' A' ' 496' ' ' ILE . 0.6 OUTLIER -138.37 160.5 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.554 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' SER . . . . . 0.464 ' N ' HD11 ' A' ' 496' ' ' ILE . 17.3 m -125.05 112.11 16.15 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.76 141.25 41.03 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.539 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.12 161.7 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.037 0.922 . . . . 0.0 112.531 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' GLY . . . . . 0.603 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -150.65 94.73 0.15 Allowed Glycine 0 C--N 1.287 -2.189 0 N-CA-C 106.737 -2.545 . . . . 0.0 106.737 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' SER . . . . . 0.469 ' C ' ' OG1' ' A' ' 502' ' ' THR . 0.3 OUTLIER 174.31 1.55 0.0 OUTLIER 'General case' 1 C--N 1.241 -4.122 0 CA-C-N 112.995 -1.602 . . . . 0.0 108.161 179.797 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' THR . . . . . 0.469 ' OG1' ' C ' ' A' ' 501' ' ' SER . 0.6 OUTLIER -168.66 -21.03 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.019 -1.9 . . . . 0.0 107.844 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.19 72.97 1.28 Allowed Glycine 0 N--CA 1.484 1.865 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.46 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -139.88 112.74 8.06 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.348 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 5.8 mt -89.46 149.05 4.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.286 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 507' ' ' LYS . 46.4 t80 -147.66 161.44 41.18 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.412 ' O ' ' CE2' ' A' ' 506' ' ' TYR . 15.7 tttt -116.89 160.61 20.61 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.965 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.605 179.952 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.832 0.349 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.572 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 24.3 t -96.59 135.18 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.4 pt -90.75 -31.6 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 164.65 -176.34 40.5 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.075 -1.536 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.8 p -141.5 151.47 43.34 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.184 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -142.46 -152.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.344 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.718 ' N ' ' CD2' ' A' ' 396' ' ' LEU . 0.1 OUTLIER -63.45 115.51 18.77 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.323 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.79 100.52 0.83 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.023 1.149 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -59.89 -76.03 0.05 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.094 -1.043 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.3 t -137.85 151.38 70.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.732 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.08 104.04 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.447 1.431 . . . . 0.0 110.822 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.62 163.24 30.29 Favored Glycine 0 N--CA 1.503 3.152 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.87 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -137.81 123.41 19.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.48 161.16 43.06 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.703 -1.599 . . . . 0.0 114.12 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -148.5 107.11 3.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.001 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.47 31.81 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 118.905 -1.617 . . . . 0.0 112.151 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . 0.637 ' HZ3' ' CB ' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -84.5 132.51 34.53 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.522 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.419 HG11 ' N ' ' A' ' 408' ' ' TYR . 40.8 t -69.49 158.59 5.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.028 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.577 ' CD1' ' CD ' ' A' ' 413' ' ' GLU . 3.8 m-85 -151.8 -170.62 3.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.463 ' CZ ' HG13 ' A' ' 427' ' ' VAL . 2.3 m-85 -142.27 6.43 1.71 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.798 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.0 p -141.64 142.25 33.41 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -67.25 -12.17 59.41 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.661 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -73.12 -42.86 62.45 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . 0.577 ' CD ' ' CD1' ' A' ' 408' ' ' TYR . 49.9 mt-10 -63.92 -37.9 89.12 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.873 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.42 68.37 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.773 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -69.93 -38.42 76.19 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.271 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.53 -13.29 34.91 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.206 -0.997 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -90.2 -52.43 4.94 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.83 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -47.79 -21.58 0.42 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.328 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.9 OUTLIER -83.75 -68.68 0.69 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.205 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -93.2 -24.35 18.24 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.761 -0.776 . . . . 0.0 112.342 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -89.27 -51.87 2.85 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.027 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 417' ' ' ALA . 3.6 mt-10 62.38 165.65 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.022 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 422' ' ' GLU . 12.6 mpt_? 45.0 80.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.535 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 425' ' ' ILE . 4.2 t -130.21 161.4 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.984 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.414 ' N ' HG11 ' A' ' 424' ' ' VAL . 7.2 mm -133.42 160.81 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.653 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.448 ' HG ' ' N ' ' A' ' 427' ' ' VAL . 9.8 tp -131.65 151.69 51.42 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.613 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.463 HG13 ' CZ ' ' A' ' 409' ' ' PHE . 6.2 t -131.45 126.28 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ARG . . . . . 0.502 ' O ' ' CG2' ' A' ' 447' ' ' THR . 90.4 mtt180 -151.89 150.77 30.44 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.354 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 429' ' ' LEU . 7.0 mt -59.55 -44.09 93.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.646 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.62 -178.16 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.81 -178.07 6.83 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.927 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.78 122.42 0.81 Allowed Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.6 -33.6 93.34 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.036 1.157 . . . . 0.0 111.779 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -73.81 -9.4 58.62 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.1 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -87.26 -8.33 56.91 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.565 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 7.9 tp -39.91 -50.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.5 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.643 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 27.3 mt-10 -61.19 -31.53 71.28 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 117.877 -1.529 . . . . 0.0 108.387 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.16 -28.09 60.88 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 75.0 mtp -66.91 -42.65 85.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.191 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -67.46 -58.88 3.94 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.198 -1.401 . . . . 0.0 108.924 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -49.36 -36.07 20.51 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.392 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . 0.699 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -94.19 81.59 4.07 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.158 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.95 21.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.113 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.699 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -165.97 149.57 15.86 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.4 HG23 ' SG ' ' A' ' 467' ' ' CYS . 0.2 OUTLIER -149.39 131.56 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.97 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.72 108.66 12.77 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.06 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 428' ' ' ARG . 3.4 p -121.83 160.23 25.12 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.538 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.09 -25.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.406 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -121.13 -142.22 0.34 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.197 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 81.13 -143.9 24.36 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.137 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . 0.608 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 55.67 -140.87 40.05 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.204 -1.474 . . . . 0.0 110.122 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.48 ' C ' ' HG1' ' A' ' 453' ' ' THR . 24.9 mtm 43.82 38.95 2.3 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.487 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' THR . . . . . 0.48 ' HG1' ' C ' ' A' ' 452' ' ' MET . 56.2 p 42.43 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.575 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 45.5 p -160.06 -164.64 1.33 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.168 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' HIS . . . . . 0.49 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 69.0 m80 -43.9 -51.36 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.211 -0.995 . . . . 0.0 110.593 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -42.34 -55.33 3.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.764 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.48 6.31 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.667 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 50.3 t -47.02 -40.83 5.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.49 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 43.4 t -74.36 -42.13 50.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.26 -35.89 81.57 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -68.46 -40.34 81.07 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.456 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -61.12 -36.52 92.48 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.388 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.78 -15.65 29.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.989 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 61.91 57.88 15.4 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.644 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 161.24 17.4 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 401' ' ' GLY . 19.0 t -81.11 91.7 6.16 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.481 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.4 ' SG ' HG23 ' A' ' 445' ' ' ILE . 4.2 t -129.34 158.8 38.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.397 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -136.62 162.71 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.055 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' SER . . . . . 0.608 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 32.1 t -143.59 160.17 41.13 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.669 -1.213 . . . . 0.0 113.093 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 47.35 75.18 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.434 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . 0.481 ' SG ' ' CD1' ' A' ' 485' ' ' LEU . 1.8 t -84.75 -171.67 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.215 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -50.25 -90.83 0.01 OUTLIER Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.672 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -155.67 66.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 0.0 OUTLIER -62.79 107.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.41 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -89.91 123.28 33.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.58 126.58 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.565 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -97.39 113.63 25.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.731 ' C ' ' H ' ' A' ' 480' ' ' ALA . 0.8 OUTLIER -67.87 -6.12 20.1 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.416 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -52.92 -7.43 0.07 Allowed 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.551 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.731 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -179.72 -82.3 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 112.527 -2.124 . . . . 0.0 105.487 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . 0.483 ' HB3' ' CG ' ' A' ' 492' ' ' GLU . 4.5 mttt 169.17 89.18 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.099 0.952 . . . . 0.0 109.772 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 491' ' ' ALA . 1.4 p -151.29 138.78 19.53 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.301 -1.772 . . . . 0.0 111.885 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' PHE . . . . . 0.446 ' HB2' ' CG2' ' A' ' 474' ' ' ILE . 16.0 p90 -97.83 152.0 19.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -119.33 116.28 25.9 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.198 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.481 ' CD1' ' SG ' ' A' ' 471' ' ' CYS . 6.2 tt -150.5 152.87 34.86 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 69.04 -108.35 2.44 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 118.828 -1.653 . . . . 0.0 110.286 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . 0.614 ' C ' ' CD2' ' A' ' 488' ' ' HIS . . . -137.34 27.21 2.89 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.194 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' HIS . . . . . 0.614 ' CD2' ' C ' ' A' ' 487' ' ' GLY . 26.7 m-70 -150.68 152.51 34.06 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.829 -1.149 . . . . 0.0 111.286 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.9 m -119.83 97.12 5.47 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.12 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 490' ' ' PHE . 39.0 p90 -155.48 155.31 33.26 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.98 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 482' ' ' THR . . . -152.1 -124.31 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.483 ' CG ' ' HB3' ' A' ' 481' ' ' LYS . 1.1 pt-20 -67.9 49.03 0.05 Allowed 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -138.51 2.63 2.83 Favored Glycine 0 C--N 1.283 -2.37 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -167.56 -173.97 2.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.477 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -122.94 141.94 51.36 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.742 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 496' ' ' ILE . 0.6 OUTLIER -121.47 160.06 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.944 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 506' ' ' TYR . 6.3 m -115.37 99.46 7.4 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -100.48 140.83 34.18 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.219 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.486 ' N ' HD13 ' A' ' 498' ' ' LEU . 21.7 t70 -93.42 160.64 14.72 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-O 122.018 0.913 . . . . 0.0 111.896 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -148.27 95.14 0.16 Allowed Glycine 0 C--N 1.272 -3.026 0 N-CA-C 106.508 -2.637 . . . . 0.0 106.508 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 2.0 t 171.15 4.47 0.0 OUTLIER 'General case' 0 C--N 1.244 -3.981 0 CA-C-N 112.177 -2.012 . . . . 0.0 107.065 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.38 -22.79 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.516 -2.129 . . . . 0.0 107.496 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 96.93 -7.86 65.08 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.882 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 154.74 9.8 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.914 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 2.1 mp -135.04 146.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.295 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' TYR . . . . . 0.572 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 14.0 m-85 -133.79 161.96 33.3 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -127.74 153.86 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.209 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.209 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.773 0.32 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.657 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 65.1 t -46.3 156.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.289 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.422 ' N ' ' CG1' ' A' ' 391' ' ' VAL . 34.3 pt -128.29 -11.8 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.363 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -175.25 -167.41 34.37 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.896 -1.621 . . . . 0.0 111.481 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.2 p 177.12 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.327 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.36 -151.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.74 127.16 76.12 Favored Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.601 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.08 97.32 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -60.39 -59.37 5.51 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.946 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.01 133.72 12.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.91 98.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 120.791 0.994 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -153.43 159.58 28.7 Favored Glycine 0 N--CA 1.504 3.169 0 C-N-CA 118.876 -1.63 . . . . 0.0 111.882 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.756 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -133.13 132.05 41.2 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.711 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.39 161.38 42.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.184 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.14 110.94 6.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.231 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -153.16 167.69 31.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.812 -1.661 . . . . 0.0 111.774 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -83.89 156.46 22.39 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.179 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.579 ' HB ' ' H ' ' A' ' 492' ' ' GLU . 0.0 OUTLIER -78.79 165.23 3.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.639 -0.825 . . . . 0.0 113.072 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.59 ' CE1' ' OE1' ' A' ' 413' ' ' GLU . 3.6 m-85 -170.37 170.0 7.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.993 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.48 ' CG ' ' HD2' ' A' ' 481' ' ' LYS . 14.2 m-85 -137.36 23.21 2.97 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.805 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 12.6 p -146.95 142.0 27.09 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.25 -12.28 61.37 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -78.22 -36.47 47.12 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.451 -0.899 . . . . 0.0 109.718 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . 0.59 ' OE1' ' CE1' ' A' ' 408' ' ' TYR . 62.0 mm-40 -65.58 -40.38 92.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.63 85.19 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.345 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -56.48 -34.25 66.74 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.762 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.62 -50.82 5.71 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.717 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -55.17 -48.02 74.35 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.28 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' HIS . . . . . 0.594 ' ND1' ' OE1' ' A' ' 419' ' ' GLU . 17.9 t-80 -43.76 -41.01 4.66 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.045 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.594 ' OE1' ' ND1' ' A' ' 418' ' ' HIS . 0.6 OUTLIER -91.92 -25.6 18.83 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.457 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 420' ' ' LYS . 7.6 mtpm? -92.69 -52.8 4.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.63 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -101.3 -31.6 5.52 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.148 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . 0.461 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 0.9 OUTLIER 65.96 148.6 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.396 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 55.89 95.01 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.879 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.54 162.45 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.484 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.406 ' CD1' ' HA3' ' A' ' 444' ' ' GLY . 16.8 mm -121.69 159.93 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 6.6 tp -136.15 134.52 38.34 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.345 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' ' 483' ' ' PHE . 8.7 t -117.72 121.73 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.714 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ARG . . . . . 0.494 ' O ' ' CG2' ' A' ' 447' ' ' THR . 47.8 mtt180 -151.29 161.64 42.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -66.5 0.53 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.62 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -109.3 -165.53 1.02 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 432' ' ' SER . 0.1 OUTLIER -99.0 -163.97 1.09 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.32 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.517 ' N ' ' OG1' ' A' ' 431' ' ' THR . 1.4 t -175.61 137.16 0.51 Allowed Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.557 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.5 Cg_endo -62.27 -77.59 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.388 1.392 . . . . 0.0 112.126 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -44.01 -18.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 439' ' ' MET . 11.0 m-20 -82.53 -9.0 59.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.39 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.751 ' CG2' ' H ' ' A' ' 437' ' ' GLU . 6.1 tp -46.78 -63.54 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.579 -0.849 . . . . 0.0 111.145 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.751 ' H ' ' CG2' ' A' ' 436' ' ' ILE . 5.4 mt-10 -52.27 -26.98 13.34 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.414 -1.315 . . . . 0.0 108.59 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -81.17 -24.67 56.9 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 435' ' ' ASP . 53.3 mtt -77.64 -41.97 36.47 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.861 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.589 ' NE2' ' CD1' ' A' ' 436' ' ' ILE . 28.1 m170 -65.14 -49.04 71.41 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.813 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -48.38 -20.83 0.45 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . 0.536 ' N ' ' C ' ' A' ' 440' ' ' HIS . . . -116.57 61.77 0.72 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.53 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.641 ' H ' ' CD ' ' A' ' 443' ' ' GLU . 1.4 pm0 -26.03 -58.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.875 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.406 ' HA3' ' CD1' ' A' ' 425' ' ' ILE . . . -81.48 145.2 25.01 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 118.494 -1.812 . . . . 0.0 109.009 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 41.0 mt -147.81 112.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 118.449 -1.301 . . . . 0.0 112.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.425 ' CD2' HD23 ' A' ' 498' ' ' LEU . 1.3 mm? -100.35 137.63 38.51 Favored 'General case' 0 C--O 1.187 -2.217 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 428' ' ' ARG . 0.3 OUTLIER -149.64 151.44 33.76 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.019 -1.473 . . . . 0.0 111.896 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.429 ' HA ' ' SG ' ' A' ' 471' ' ' CYS . 18.8 t -77.02 -24.29 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.805 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 10.7 ttt-85 -108.13 -143.66 0.38 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.225 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.508 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 73.93 -162.69 54.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . 0.702 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 77.21 -41.92 1.85 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.159 -1.496 . . . . 0.0 110.392 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.461 ' C ' ' CG2' ' A' ' 453' ' ' THR . 53.7 mtt -64.86 19.09 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' THR . . . . . 0.702 ' H ' ' C ' ' A' ' 451' ' ' GLY . 1.0 OUTLIER 62.84 114.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.874 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.7 t -173.28 -155.54 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' HIS . . . . . 0.473 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 45.8 t60 -57.67 -36.8 72.4 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . 0.418 ' HB3' ' CG2' ' A' ' 431' ' ' THR . . . -63.23 -44.67 94.59 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.0 -57.43 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.648 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.67 -41.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.7 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 51.5 t -65.95 -53.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.11 73.48 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -69.33 -24.0 63.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.606 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.05 -48.3 5.8 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.642 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 56.7 mmm -78.41 -40.81 34.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.982 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.35 22.0 30.68 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.574 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' THR . . . . . 0.481 ' CG2' ' H ' ' A' ' 466' ' ' CYS . 7.3 m -76.03 -170.51 1.41 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' CYS . . . . . 0.756 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.1 120.32 39.29 Favored 'General case' 0 C--O 1.202 -1.414 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.667 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 23.4 t -151.29 147.24 26.72 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.055 -1.458 . . . . 0.0 112.005 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.89 162.71 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.747 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' SER . . . . . 0.508 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 28.8 t -147.79 160.58 42.58 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.995 -1.082 . . . . 0.0 112.62 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 46.94 72.92 0.35 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.184 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . 0.445 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.5 OUTLIER -83.43 -158.82 0.32 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.878 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -67.69 -101.71 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.31 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -135.33 54.57 1.92 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.861 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.445 HD12 ' SG ' ' A' ' 471' ' ' CYS . 5.1 mt -45.67 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.921 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -89.37 121.39 31.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.01 122.44 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.929 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . 0.431 ' C ' ' H ' ' A' ' 479' ' ' GLU . 5.0 m120 -99.46 111.97 24.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.904 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.784 ' C ' ' H ' ' A' ' 480' ' ' ALA . 35.9 mt-10 -60.54 0.29 0.21 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.286 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 480' ' ' ALA . 47.4 mt-10 -64.24 17.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.254 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.784 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 155.2 -71.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . 0.48 ' HD2' ' CG ' ' A' ' 409' ' ' PHE . 2.1 mmtt 158.51 79.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.492 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 491' ' ' ALA . 6.7 p -132.28 143.76 50.12 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.681 -0.807 . . . . 0.0 112.325 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' PHE . . . . . 0.627 ' H ' ' HB1' ' A' ' 491' ' ' ALA . 10.8 p90 -98.96 143.51 29.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.201 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 485' ' ' LEU . 5.1 tp10 -101.54 111.24 23.42 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.196 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 487' ' ' GLY . 0.8 OUTLIER -134.6 117.83 16.55 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.002 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 485' ' ' LEU . . . 21.3 -74.15 0.0 OUTLIER Glycine 0 N--CA 1.51 3.593 0 O-C-N 124.486 1.116 . . . . 0.0 114.439 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 485' ' ' LEU . . . -51.76 -67.92 1.78 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.543 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 26.6 m80 -154.44 163.53 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.156 -1.418 . . . . 0.0 112.869 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' THR . . . . . 0.474 ' OG1' ' CD ' ' A' ' 484' ' ' GLU . 9.2 m -93.6 99.29 11.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.554 ' CG ' ' NZ ' ' A' ' 507' ' ' LYS . 40.3 p90 -153.22 154.13 34.07 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 118.455 -1.298 . . . . 0.0 113.825 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.627 ' HB1' ' H ' ' A' ' 483' ' ' PHE . . . 170.94 172.52 0.07 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 113.767 -1.561 . . . . 0.0 108.678 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.579 ' H ' ' HB ' ' A' ' 407' ' ' VAL . 19.7 tt0 26.06 41.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 O-C-N 124.266 0.979 . . . . 0.0 109.978 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -167.61 1.43 0.04 OUTLIER Glycine 0 C--N 1.281 -2.505 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 495' ' ' TYR . 2.9 m-20 -156.96 -152.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . 0.424 ' H ' ' HB3' ' A' ' 494' ' ' ASP . 1.5 p90 -154.32 140.52 18.51 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.433 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.487 ' H ' ' CD1' ' A' ' 496' ' ' ILE . 0.2 OUTLIER -122.99 160.6 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.569 -0.852 . . . . 0.0 113.073 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 506' ' ' TYR . 1.8 p -115.29 98.37 6.72 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -93.39 142.31 27.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.893 -1.123 . . . . 0.0 113.012 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.466 ' N ' HD13 ' A' ' 498' ' ' LEU . 0.9 OUTLIER -106.52 161.54 14.52 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.479 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -156.28 95.41 0.15 Allowed Glycine 0 C--N 1.277 -2.707 0 N-CA-C 106.836 -2.505 . . . . 0.0 106.836 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 77.7 p -178.03 6.68 0.01 OUTLIER 'General case' 1 C--N 1.241 -4.142 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.33 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.35 -19.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 112.822 -1.99 . . . . 0.0 107.72 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 86.77 74.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.558 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 499' ' ' ASP . 19.8 mttp -155.45 115.16 3.68 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.258 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' ILE . . . . . 0.548 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.1 tt -93.91 160.45 2.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.687 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' TYR . . . . . 0.657 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 18.8 m-85 -141.82 161.44 37.95 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.771 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.554 ' NZ ' ' CG ' ' A' ' 490' ' ' PHE . 47.6 tttt -107.67 154.36 21.57 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.695 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.567 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--O 1.215 -0.731 0 CA-C-O 120.822 0.344 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.486 HG23 ' CE1' ' A' ' 506' ' ' TYR . 0.4 OUTLIER -83.79 137.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.707 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.503 HG13 ' N ' ' A' ' 393' ' ' GLY . 28.2 pt -77.48 -39.38 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.571 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.503 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -178.56 -162.33 27.97 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.499 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 121.11 0.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.615 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . 0.431 ' HB2' ' SG ' ' A' ' 471' ' ' CYS . . . -94.86 -142.69 0.25 Allowed 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.913 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.77 128.34 48.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.328 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.73 98.2 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 121.076 1.184 . . . . 0.0 111.756 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . 0.433 ' HB1' ' SG ' ' A' ' 467' ' ' CYS . . . -62.93 -74.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.26 146.24 60.07 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.946 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -52.27 100.4 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.762 1.642 . . . . 0.0 111.078 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.65 161.22 29.74 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 117.9 -2.095 . . . . 0.0 112.989 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -150.48 117.23 5.83 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.135 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.49 161.57 42.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.652 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.35 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.746 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.16 166.64 31.09 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.337 -1.887 . . . . 0.0 112.338 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -85.24 134.29 34.14 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.567 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 408' ' ' TYR . 2.2 p -66.21 138.24 23.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.998 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.658 ' CE1' ' OE2' ' A' ' 413' ' ' GLU . 1.5 m-85 -153.08 146.16 24.63 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.584 ' CD2' ' CD ' ' A' ' 481' ' ' LYS . 4.2 m-85 -110.94 41.53 1.8 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.531 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.95 143.65 12.72 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -78.11 -13.36 59.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.606 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.61 -41.04 24.61 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.06 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . 0.658 ' OE2' ' CE1' ' A' ' 408' ' ' TYR . 6.0 mm-40 -64.38 -40.6 96.14 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.966 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.07 97.99 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.46 -38.28 90.54 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -82.01 -16.96 48.52 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.56 -52.4 4.91 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.183 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.51 -19.06 55.78 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.563 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 421' ' ' GLY . 0.7 OUTLIER -64.6 -48.24 75.67 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.877 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -1.07 0.08 Allowed 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 77.82 64.86 1.98 Allowed Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.08 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . 0.67 ' C ' ' HE ' ' A' ' 423' ' ' ARG . 7.2 mt-10 -146.43 -166.53 2.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.414 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . 0.725 ' N ' ' HE ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER -115.69 148.36 39.82 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.632 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.419 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 1.7 t -148.97 162.1 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.075 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 6.2 mm -123.81 160.74 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.24 121.14 30.39 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.432 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 409' ' ' PHE . 24.8 t -111.31 117.27 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.246 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ARG . . . . . 0.523 ' H ' HG22 ' A' ' 447' ' ' THR . 17.0 mtp85 -152.43 155.52 37.7 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.76 ' H ' ' CD2' ' A' ' 429' ' ' LEU . 0.7 OUTLIER -106.32 28.71 7.48 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.571 1.177 . . . . 0.0 109.649 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.39 121.17 2.96 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 456' ' ' ALA . 0.8 OUTLIER -76.08 179.56 5.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.97 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 2.9 t -177.24 139.5 0.44 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.068 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.91 -72.9 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.617 1.545 . . . . 0.0 111.871 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 435' ' ' ASP . 7.4 pt-20 -39.48 -32.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.659 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 438' ' ' GLY . 4.0 m-20 -62.14 -8.6 5.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.727 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.505 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 6.7 tp -48.54 -43.4 13.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.878 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.505 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 23.2 mt-10 -62.66 -27.19 69.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 117.769 -1.572 . . . . 0.0 107.957 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -78.88 -26.93 57.58 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 27.8 mtt -66.49 -39.22 88.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.756 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -74.54 -39.72 62.16 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.336 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.756 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -55.76 -28.77 57.71 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.782 -1.167 . . . . 0.0 107.91 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . 0.619 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -112.84 89.47 3.09 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.118 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.36 37.23 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.862 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -171.58 140.52 5.9 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.9 mm -139.24 132.17 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.913 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.418 HD11 ' CG1' ' A' ' 468' ' ' VAL . 1.4 tp -135.96 95.98 3.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' THR . . . . . 0.533 ' H ' ' HG1' ' A' ' 447' ' ' THR . 2.2 p -109.14 161.44 15.21 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.804 -0.758 . . . . 0.0 112.768 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 37.0 t -85.23 -21.0 8.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.971 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 470' ' ' GLY . 19.1 mmm-85 -105.97 -148.11 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.626 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 89.08 -136.58 13.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . 0.578 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 82.59 163.69 33.76 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 16.8 tpp 46.64 13.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.482 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 451' ' ' GLY . 0.3 OUTLIER 66.97 131.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.592 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 455' ' ' HIS . 9.0 t -163.58 -169.97 2.08 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.957 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' HIS . . . . . 0.492 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 4.6 m80 -43.41 -46.04 6.47 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . 0.424 ' HB3' ' CG2' ' A' ' 431' ' ' THR . . . -61.39 -48.12 82.68 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.663 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -74.66 -55.02 6.33 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.534 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 2.2 t -50.25 -53.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.548 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 88.6 t -54.08 -44.1 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.527 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.461 ' HB1' ' SG ' ' A' ' 467' ' ' CYS . . . -61.22 -55.17 35.15 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -55.38 -28.69 55.64 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.534 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.11 66.14 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.602 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 463' ' ' MET . 1.1 tpt -91.46 -41.66 10.72 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.03 83.94 1.64 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.523 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' THR . . . . . 0.598 ' CG2' ' N ' ' A' ' 466' ' ' CYS . 1.9 m -162.36 171.93 16.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.8 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' CYS . . . . . 0.598 ' N ' ' CG2' ' A' ' 465' ' ' THR . 12.8 t -78.1 126.47 30.87 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.958 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.461 ' SG ' ' HB1' ' A' ' 460' ' ' ALA . 0.5 OUTLIER -151.2 148.36 28.15 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.89 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.01 160.78 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.67 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' SER . . . . . 0.578 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 6.9 t -150.85 152.6 33.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.443 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 44.16 87.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.431 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . 0.451 ' SG ' HD13 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -99.63 -174.78 2.8 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.45 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -47.22 -84.29 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -158.15 66.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.95 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.462 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.3 mt -61.96 102.71 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.604 -0.839 . . . . 0.0 112.45 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.69 120.29 29.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 477' ' ' ASN . 52.9 mt -88.76 137.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.327 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . 0.529 ' CB ' ' OG1' ' A' ' 482' ' ' THR . 0.3 OUTLIER -107.42 123.15 47.96 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.682 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.604 ' C ' ' N ' ' A' ' 480' ' ' ALA . 20.3 mm-40 -54.58 -7.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 478' ' ' GLU . 0.1 OUTLIER -46.46 -18.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.239 -1.384 . . . . 0.0 108.311 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.604 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . 177.56 -97.37 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 112.283 -2.235 . . . . 0.0 105.43 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . 0.584 ' CD ' ' CD2' ' A' ' 409' ' ' PHE . 3.6 mmpp? -148.55 40.49 0.92 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.529 ' OG1' ' CB ' ' A' ' 477' ' ' ASN . 44.5 p -68.94 172.94 5.88 Favored 'General case' 0 C--O 1.197 -1.708 0 CA-C-N 113.975 -1.466 . . . . 0.0 114.384 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 483' ' ' PHE . 0.1 OUTLIER -151.5 147.94 27.45 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.812 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' GLU . . . . . 0.495 ' C ' ' CD ' ' A' ' 484' ' ' GLU . 3.1 tp10 -131.72 113.89 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.372 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.469 ' CD2' ' C ' ' A' ' 485' ' ' LEU . 0.3 OUTLIER -151.08 161.73 42.18 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.786 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.21 -115.41 7.97 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.036 -1.554 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . 0.454 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -130.17 29.53 3.67 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.38 -1.391 . . . . 0.0 110.804 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 15.3 m170 -151.21 148.77 28.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.68 -1.208 . . . . 0.0 111.41 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' THR . . . . . 0.434 ' OG1' ' OE1' ' A' ' 484' ' ' GLU . 3.3 m -116.71 99.14 6.92 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.169 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.49 ' CZ ' ' HG3' ' A' ' 507' ' ' LYS . 38.3 m-85 -90.06 160.6 16.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 482' ' ' THR . . . -126.5 126.27 43.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.116 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.477 ' H ' ' HA ' ' A' ' 482' ' ' THR . 2.6 tm-20 -45.05 103.12 0.03 OUTLIER 'General case' 0 CA--C 1.478 -1.794 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.402 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 159.01 14.26 0.04 OUTLIER Glycine 0 C--N 1.261 -3.613 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' ASP . . . . . 0.594 ' CG ' ' N ' ' A' ' 495' ' ' TYR . 0.4 OUTLIER -138.44 -153.31 0.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.139 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . 0.594 ' N ' ' CG ' ' A' ' 494' ' ' ASP . 2.5 p90 -152.55 139.79 19.39 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.597 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -127.38 161.34 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.528 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 506' ' ' TYR . 3.3 t -104.61 102.88 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' LEU . . . . . 0.482 HD11 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -102.28 134.29 45.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.642 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.482 ' N ' HD11 ' A' ' 498' ' ' LEU . 0.1 OUTLIER -121.03 142.38 49.86 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.481 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -147.8 90.4 0.15 Allowed Glycine 0 C--O 1.197 -2.188 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 7.4 p -160.74 8.34 0.08 Allowed 'General case' 0 C--N 1.252 -3.642 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.41 -16.48 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 111.67 -2.514 . . . . 0.0 106.863 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 86.3 85.45 1.06 Allowed Glycine 0 N--CA 1.484 1.835 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.194 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -158.04 102.82 1.82 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 3.5 mt -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.391 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 497' ' ' SER . 75.5 m-85 -123.01 161.81 23.55 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.902 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.49 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 10.7 tmtt? -108.76 152.82 24.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . 0.438 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . . . . . . 0 N--CA 1.484 1.84 0 C-N-CA 119.057 -1.545 . . . . 0.0 110.243 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 2.3 t -50.13 132.21 9.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.564 ' CG1' ' N ' ' A' ' 393' ' ' GLY . 3.4 pt -78.03 -52.49 15.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . 170.84 -170.92 43.54 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.7 p -143.2 142.11 31.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.769 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.09 -145.75 0.4 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 6.8 mt -77.17 125.28 86.8 Favored Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.768 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.82 102.36 0.63 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.982 1.122 . . . . 0.0 111.26 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.77 -62.15 1.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.356 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.8 t -146.73 140.88 15.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.975 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.29 103.36 0.15 Allowed 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.078 1.185 . . . . 0.0 111.072 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -151.25 161.68 29.22 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.772 -1.68 . . . . 0.0 112.28 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -134.93 124.6 25.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -149.76 160.89 43.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.143 -1.423 . . . . 0.0 112.595 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.16 110.11 5.87 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.017 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.12 165.92 30.89 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.957 -1.592 . . . . 0.0 111.292 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -85.18 147.14 26.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 492' ' ' GLU . 2.0 m -78.72 142.7 13.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.473 -1.291 . . . . 0.0 113.228 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -146.87 146.47 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.892 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.502 ' CD2' ' HD2' ' A' ' 481' ' ' LYS . 4.9 m-85 -105.84 37.41 2.25 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.439 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 21.5 p -155.85 141.45 17.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 -12.8 59.89 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.278 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.47 -43.62 59.81 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.672 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.15 -42.62 86.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.674 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -61.29 -39.67 91.31 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.523 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -58.86 -30.15 67.51 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.985 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -88.6 -38.74 14.62 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.537 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -69.04 -61.01 1.97 Allowed 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.114 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 417' ' ' ALA . 19.5 t-80 -43.4 -26.52 0.2 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.811 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.435 ' N ' ' C ' ' A' ' 417' ' ' ALA . 30.1 tt0 -91.17 -33.92 15.22 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.375 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 417' ' ' ALA . 29.4 mtmt -131.74 49.9 2.28 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.813 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -178.38 -48.24 0.07 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . 0.469 ' O ' ' NE ' ' A' ' 423' ' ' ARG . 2.5 mt-10 48.96 71.23 0.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.167 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . 0.469 ' NE ' ' O ' ' A' ' 422' ' ' GLU . 6.3 mtm180 164.04 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 0.2 OUTLIER -147.51 160.34 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.698 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 43.2 mm -121.25 160.66 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.102 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 13.1 tp -127.31 118.55 24.4 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.83 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 409' ' ' PHE . 1.5 t -104.66 130.82 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.038 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ARG . . . . . 0.549 ' O ' ' CG2' ' A' ' 447' ' ' THR . 1.6 mtp85 -153.01 145.94 24.51 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.471 ' H ' HD13 ' A' ' 429' ' ' LEU . 5.8 mp -56.61 -60.72 3.13 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.816 -1.553 . . . . 0.0 109.698 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.9 -175.09 2.59 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.611 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.17 176.61 6.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.183 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.2 t -173.09 128.35 0.52 Allowed Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.357 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.0 Cg_endo -61.41 -56.37 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.107 1.205 . . . . 0.0 111.501 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -45.71 -13.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.968 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 433' ' ' PRO . 13.4 t70 -90.31 -8.3 51.2 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.557 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.717 ' CG2' ' H ' ' A' ' 437' ' ' GLU . 4.9 tp -41.85 -60.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.174 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.717 ' H ' ' CG2' ' A' ' 436' ' ' ILE . 19.3 mm-40 -49.11 -33.75 12.51 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.419 -1.312 . . . . 0.0 109.189 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.46 -24.18 68.66 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 436' ' ' ILE . 26.8 mtt -72.71 -34.37 67.08 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.71 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -75.74 -45.6 35.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 118.113 -1.435 . . . . 0.0 109.622 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.629 ' N ' ' CG ' ' A' ' 440' ' ' HIS . . . -47.41 -36.39 9.73 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.426 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . 0.695 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -106.86 93.07 4.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.501 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.79 28.22 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.597 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.695 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -160.28 132.01 2.82 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.2 mm -127.97 142.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.001 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.428 HD13 ' CG1' ' A' ' 468' ' ' VAL . 4.7 tp -150.1 97.32 2.55 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.261 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' THR . . . . . 0.549 ' CG2' ' O ' ' A' ' 428' ' ' ARG . 0.9 OUTLIER -108.72 160.33 16.04 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.874 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.0 t -75.76 -45.05 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.829 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 470' ' ' GLY . 8.1 mtt180 -94.08 -150.15 0.29 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.458 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 77.46 128.29 0.39 Allowed Glycine 0 N--CA 1.482 1.759 0 C-N-CA 119.145 -1.502 . . . . 0.0 109.4 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 453' ' ' THR . . . 175.62 -163.43 33.19 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 53.9 mtp 44.04 19.58 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.084 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 67.16 122.87 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.66 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' SER . . . . . 0.492 ' H ' ' HB1' ' A' ' 457' ' ' ALA . 69.9 p -166.64 -156.2 0.23 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.318 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' HIS . . . . . 0.485 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 26.3 m80 -51.88 -51.1 59.16 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.971 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -52.55 -42.4 64.4 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.533 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 454' ' ' SER . . . -84.55 -51.02 7.2 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.519 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 454' ' ' SER . 79.0 t -55.28 -44.82 76.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.748 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 47.2 t -67.16 -55.2 18.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.066 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.27 -28.96 65.43 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.289 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -65.35 -45.62 83.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -67.15 -24.29 73.28 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.147 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -21.31 31.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.815 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 63.02 21.12 63.32 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.675 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' THR . . . . . 0.553 ' CG2' ' H ' ' A' ' 466' ' ' CYS . 14.4 m -93.08 -168.89 2.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' CYS . . . . . 0.553 ' H ' ' CG2' ' A' ' 465' ' ' THR . 8.9 t -97.44 122.6 40.68 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 1.7 t -151.18 149.2 29.18 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.351 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . 0.499 HG11 ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -127.37 160.89 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.393 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' SER . . . . . 0.499 ' N ' HG11 ' A' ' 468' ' ' VAL . 6.2 t -150.43 155.68 40.01 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.34 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 450' ' ' GLY . . . 53.72 75.46 0.23 Allowed Glycine 0 N--CA 1.497 2.747 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . 0.495 ' SG ' ' CD2' ' A' ' 485' ' ' LEU . 0.6 OUTLIER -82.93 -179.58 7.48 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.919 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -57.82 -96.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -140.38 58.52 1.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.433 HD12 ' SG ' ' A' ' 471' ' ' CYS . 11.3 mt -53.36 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.637 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.26 115.3 26.65 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.443 HG23 ' N ' ' A' ' 477' ' ' ASN . 11.1 mt -88.18 136.6 22.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.129 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . 0.451 ' H ' ' HG1' ' A' ' 482' ' ' THR . 4.9 m120 -114.63 127.2 55.64 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.18 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' A' ' 480' ' ' ALA . 10.3 pt-20 -62.85 -5.44 2.83 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.048 -0.978 . . . . 0.0 113.227 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 478' ' ' GLU . 5.2 mm-40 -46.13 -19.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.437 -1.305 . . . . 0.0 108.45 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -175.14 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . 0.502 ' HD2' ' CD2' ' A' ' 409' ' ' PHE . 0.8 OUTLIER -153.5 56.78 0.75 Allowed 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.481 ' CB ' ' HA ' ' A' ' 491' ' ' ALA . 1.6 p -86.6 175.37 8.34 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 483' ' ' PHE . 0.3 OUTLIER -151.93 120.86 6.61 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.762 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -91.95 114.42 26.95 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.533 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.495 ' CD2' ' SG ' ' A' ' 471' ' ' CYS . 63.6 tp -138.3 155.69 48.35 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.843 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' GLY . . . . . 0.461 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.66 -107.92 1.86 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -139.11 28.87 2.58 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.065 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.24 160.56 43.6 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.781 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.4 m -113.82 107.96 16.42 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.19 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.494 ' HB2' ' CE2' ' A' ' 483' ' ' PHE . 10.0 m-30 -89.55 119.44 29.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.505 -0.878 . . . . 0.0 108.859 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -100.24 136.78 39.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.155 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.486 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.9 tm-20 -50.05 95.12 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.949 0 C-N-CA 118.438 -1.305 . . . . 0.0 108.742 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 161.44 17.87 0.03 OUTLIER Glycine 0 C--N 1.267 -3.3 0 C-N-CA 118.313 -1.899 . . . . 0.0 109.624 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -128.69 -161.33 1.1 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.08 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 496' ' ' ILE . 1.8 t80 -137.64 132.7 33.37 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.484 ' N ' ' CD1' ' A' ' 495' ' ' TYR . 0.6 OUTLIER -136.81 162.35 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.818 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 28.9 p -130.17 113.21 14.18 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.684 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.13 152.61 24.87 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.716 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -99.42 160.39 14.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.027 0.918 . . . . 0.0 112.847 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -155.64 96.46 0.16 Allowed Glycine 0 C--N 1.289 -2.032 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 502' ' ' THR . 3.6 t 175.06 5.38 0.0 OUTLIER 'General case' 1 C--N 1.242 -4.071 0 CA-C-N 112.911 -1.644 . . . . 0.0 107.779 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 501' ' ' SER . 0.4 OUTLIER -175.0 -23.26 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.542 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 96.26 85.52 1.74 Allowed Glycine 0 N--CA 1.479 1.506 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -151.38 101.78 2.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.465 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 4.7 mt -89.05 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.286 -0.965 . . . . 0.0 110.749 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 12.2 t80 -148.96 161.7 41.38 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.59 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 1.8 ttpt -125.74 156.36 39.53 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.598 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.249 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.686 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 19.9 t -112.66 140.41 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.388 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.06 -25.32 5.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.215 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 162.78 -172.65 38.87 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.04 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.95 129.76 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.764 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.48 -146.22 0.24 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.274 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.7 140.79 33.51 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.94 96.94 0.46 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.227 1.285 . . . . 0.0 111.65 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -75.14 -73.14 0.26 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.351 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.9 p -136.88 144.16 45.46 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.347 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.89 101.66 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.983 1.122 . . . . 0.0 110.344 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.54 162.45 29.93 Favored Glycine 0 N--CA 1.51 3.624 0 C-N-CA 117.685 -2.198 . . . . 0.0 113.658 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.752 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -136.53 119.76 16.71 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.71 161.77 41.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.936 -1.506 . . . . 0.0 113.802 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -144.92 112.59 6.25 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 113.904 -1.498 . . . . 0.0 107.708 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.85 168.03 31.7 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.848 -1.644 . . . . 0.0 112.124 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 142.67 29.96 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.149 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.444 HG21 ' N ' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -78.46 148.15 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.7 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.546 ' C ' ' H ' ' A' ' 410' ' ' THR . 0.4 OUTLIER -159.97 99.61 1.38 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.769 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 481' ' ' LYS . 7.8 m-85 -57.12 -0.32 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.846 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 408' ' ' TYR . 3.2 p -106.39 140.91 38.57 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.99 26.12 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.515 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -70.7 -38.09 73.63 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.167 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 417' ' ' ALA . 68.9 mm-40 -62.81 -51.42 67.14 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -54.67 -31.71 58.13 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.982 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -71.27 -47.36 57.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.59 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -86.19 -9.35 56.75 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.03 -55.11 3.75 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -56.8 -28.03 60.77 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.863 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 421' ' ' GLY . 1.6 tt0 -55.58 -45.48 77.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.189 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 420' ' ' LYS . 0.8 OUTLIER -59.33 -6.12 0.92 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.493 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 82.92 49.02 5.23 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.467 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -133.33 154.21 50.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.679 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 423' ' ' ARG . 0.4 OUTLIER -79.12 146.46 33.19 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.775 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.21 160.84 15.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.637 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.462 HG23 ' H ' ' A' ' 426' ' ' LEU . 41.5 mm -125.83 160.55 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.731 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.462 ' H ' HG23 ' A' ' 425' ' ' ILE . 3.4 tp -132.17 121.19 23.32 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.042 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.484 ' CG1' ' CZ ' ' A' ' 409' ' ' PHE . 7.2 t -110.57 121.03 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.36 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ARG . . . . . 0.493 ' O ' ' CG2' ' A' ' 447' ' ' THR . 0.1 OUTLIER -150.9 148.67 28.72 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.02 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' A' ' 449' ' ' ARG . 5.7 mt -53.43 -49.64 66.91 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.199 -1.401 . . . . 0.0 109.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -135.82 167.82 20.46 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.65 161.66 14.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.317 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.94 160.92 32.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.64 -31.51 94.45 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.99 1.793 . . . . 0.0 112.329 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.46 -12.91 61.64 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 439' ' ' MET . 15.0 m-20 -90.85 -9.05 47.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.919 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.644 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -35.78 -56.12 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.644 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 32.9 mt-10 -61.07 -38.69 87.12 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.341 -1.344 . . . . 0.0 109.052 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -72.83 -21.77 79.52 Favored Glycine 0 C--N 1.3 -1.45 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 435' ' ' ASP . 70.9 mtp -79.22 -46.41 17.92 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.336 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.773 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.1 OUTLIER -71.84 -34.79 69.58 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.398 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.773 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -56.45 -23.74 40.88 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.647 -1.221 . . . . 0.0 107.979 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . 0.655 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -117.11 85.4 2.32 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.969 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.428 ' HA ' ' CG2' ' A' ' 465' ' ' THR . 11.8 pt-20 -52.41 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.591 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -136.24 139.66 10.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.406 ' HB ' ' SG ' ' A' ' 467' ' ' CYS . 67.8 mt -141.36 142.8 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.689 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.427 HD11 ' CG1' ' A' ' 468' ' ' VAL . 4.6 tp -140.24 98.95 3.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 428' ' ' ARG . 2.6 p -111.53 161.27 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.42 -24.45 12.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 470' ' ' GLY . 14.0 mmt180 -100.87 -121.88 0.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.324 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.497 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 68.43 144.6 0.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -131.16 179.87 16.68 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.22 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 86.9 mtp -43.72 -28.83 0.45 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.091 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 453' ' ' THR . 6.7 t -160.59 132.28 5.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.325 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.3 p 179.05 -176.85 0.26 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.53 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' HIS . . . . . 0.487 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 68.0 m80 -42.98 -49.52 5.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.336 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -48.44 -48.64 37.28 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.819 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.567 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 2.6 t -45.13 -45.58 3.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 24.2 t -70.42 -40.27 77.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.575 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -68.66 -32.77 72.85 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.595 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -67.7 -36.95 81.59 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -75.28 -33.67 53.09 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.534 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 6.7 mmt -94.27 0.32 55.56 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.96 60.53 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' THR . . . . . 0.428 ' CG2' ' HA ' ' A' ' 443' ' ' GLU . 0.2 OUTLIER -95.31 156.1 16.46 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.0 OUTLIER -89.43 129.88 35.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.692 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.406 ' SG ' ' HB ' ' A' ' 445' ' ' ILE . 99.5 m -152.86 157.42 40.68 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.062 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -126.15 162.28 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.263 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' SER . . . . . 0.525 ' N ' HG12 ' A' ' 468' ' ' VAL . 7.9 t -150.3 147.71 27.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.278 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 57.23 90.45 0.01 OUTLIER Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.349 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.85 170.18 8.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.569 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -44.77 -82.02 0.03 OUTLIER Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.614 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -156.06 68.06 0.62 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.037 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 17.4 mt -66.47 102.64 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.081 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -88.72 120.03 29.74 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.68 132.32 33.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.77 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . 0.416 ' CB ' ' HG1' ' A' ' 482' ' ' THR . 0.5 OUTLIER -107.22 122.13 45.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.898 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.609 ' C ' ' N ' ' A' ' 480' ' ' ALA . 0.4 OUTLIER -53.06 -9.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.338 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -44.92 -18.45 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.401 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.609 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -177.88 -102.29 0.0 OUTLIER 'General case' 0 C--N 1.263 -3.176 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 409' ' ' PHE . 10.9 mmmt -150.61 43.39 0.83 Allowed 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.479 ' HA ' ' H ' ' A' ' 492' ' ' GLU . 52.1 p -69.06 174.35 4.64 Favored 'General case' 0 C--O 1.194 -1.857 0 CA-C-N 113.23 -1.805 . . . . 0.0 114.41 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 483' ' ' PHE . 0.7 OUTLIER -152.04 132.18 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.809 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' GLU . . . . . 0.407 ' HG2' ' HG1' ' A' ' 489' ' ' THR . 6.4 tm-20 -112.59 116.53 30.34 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.031 -0.667 . . . . 0.0 111.146 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.459 ' CD2' ' C ' ' A' ' 485' ' ' LEU . 0.3 OUTLIER -150.63 161.89 41.72 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.903 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.55 -113.01 5.47 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -132.21 26.15 3.77 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 2.7 m-70 -150.16 153.23 35.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' THR . . . . . 0.407 ' HG1' ' HG2' ' A' ' 484' ' ' GLU . 58.4 m -115.06 100.23 8.02 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.481 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.54 ' CZ ' ' NZ ' ' A' ' 507' ' ' LYS . 7.6 m-85 -89.78 158.37 17.53 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -126.43 128.21 46.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.323 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.479 ' H ' ' HA ' ' A' ' 482' ' ' THR . 0.0 OUTLIER -47.4 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.472 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 168.53 14.32 0.02 OUTLIER Glycine 0 C--N 1.266 -3.311 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 495' ' ' TYR . 57.2 m-20 -142.64 -153.57 0.47 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.887 -0.657 . . . . 0.0 109.76 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -147.99 155.39 41.47 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.849 -1.141 . . . . 0.0 111.841 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 39.9 pt -136.99 162.31 34.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.833 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 30.7 t -127.76 108.84 11.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' LEU . . . . . 0.608 ' CD2' ' H ' ' A' ' 498' ' ' LEU . 1.7 pt? -117.03 159.35 22.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.723 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 500' ' ' GLY . 50.5 t0 -94.95 161.44 14.14 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.272 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -144.73 93.69 0.17 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 53.6 p 175.22 -7.32 0.0 OUTLIER 'General case' 0 C--N 1.25 -3.754 0 CA-C-N 111.66 -2.27 . . . . 0.0 106.08 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.8 -28.02 0.13 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.045 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 100.52 -11.44 59.67 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.638 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -50.38 125.81 13.56 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 6.9 mt -113.88 135.04 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.397 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' TYR . . . . . 0.686 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 0.5 OUTLIER -128.21 159.89 33.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.566 ' HE3' ' H ' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -119.29 161.01 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.186 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 C-N-CA 119.376 -1.392 . . . . 0.0 110.991 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.067 0.46 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.716 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 45.5 t -66.57 150.18 11.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.645 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.504 ' CG1' ' N ' ' A' ' 393' ' ' GLY . 5.2 pt -117.22 -48.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.694 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -159.14 -157.54 8.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.554 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.5 p -171.41 116.1 0.41 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.78 -145.87 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 96.4 mt -87.44 134.3 36.46 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.674 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.51 86.44 0.44 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.016 1.144 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -60.89 -60.83 3.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.084 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.3 p -143.77 145.87 32.58 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.217 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.35 119.36 6.24 Favored 'Trans proline' 0 C--N 1.326 -0.642 0 C-N-CA 121.085 1.19 . . . . 0.0 109.916 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.48 162.88 30.11 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.524 -2.274 . . . . 0.0 114.556 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -151.85 107.17 3.3 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.4 161.39 42.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 117.968 -1.493 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.23 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.013 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.97 167.58 31.15 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.649 -1.262 . . . . 0.0 111.134 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -82.72 161.76 21.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.305 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 492' ' ' GLU . 1.5 m -97.79 149.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.639 ' CE2' ' CD1' ' A' ' 426' ' ' LEU . 33.1 p90 -153.44 174.75 13.98 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.035 -1.438 . . . . 0.0 107.536 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 481' ' ' LYS . 2.7 m-85 -129.76 -19.32 3.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.203 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 38.8 p -100.51 135.6 41.7 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.47 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.82 -23.1 67.11 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.837 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -68.68 -41.36 79.34 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.098 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.92 -40.91 90.51 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.076 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -57.69 -37.55 73.67 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.394 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.19 -35.45 80.83 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.433 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.53 -13.52 37.17 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.59 -55.51 3.55 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.74 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 418' ' ' HIS . 0.3 OUTLIER -61.21 -21.1 63.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.846 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.486 ' CA ' ' OE1' ' A' ' 419' ' ' GLU . 0.6 OUTLIER -69.65 -38.08 76.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.588 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -64.53 -1.87 2.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 73.12 44.14 36.89 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.665 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -137.12 136.37 38.24 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . 0.41 ' C ' ' CG2' ' A' ' 424' ' ' VAL . 11.4 mmt180 -56.23 155.62 6.55 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.311 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 408' ' ' TYR . 2.0 t -147.64 158.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.988 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.434 ' O ' ' CD1' ' A' ' 408' ' ' TYR . 6.3 mm -126.24 158.58 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.618 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 5.3 tp -127.61 142.97 51.21 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.511 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.438 ' N ' ' HG ' ' A' ' 426' ' ' LEU . 25.1 t -128.04 120.13 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.268 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ARG . . . . . 0.496 ' O ' ' CG2' ' A' ' 447' ' ' THR . 0.1 OUTLIER -151.37 149.42 29.3 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.093 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 449' ' ' ARG . 3.5 mp -48.04 -57.04 6.32 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.366 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 431' ' ' THR . 1.0 OUTLIER -130.4 165.18 23.11 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.467 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' THR . . . . . 0.459 ' H ' ' HG3' ' A' ' 430' ' ' GLU . 0.4 OUTLIER -101.17 -179.63 4.1 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.383 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 27.2 p -163.98 151.73 10.81 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.564 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.8 Cg_endo -61.59 -53.07 2.51 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.467 1.445 . . . . 0.0 112.036 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -45.08 -18.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.8 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.8 m-20 -87.2 -6.35 58.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.656 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.616 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 10.4 tp -33.63 -51.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.667 ' CD ' ' H ' ' A' ' 438' ' ' GLY . 3.0 pm0 -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.074 -1.45 . . . . 0.0 108.448 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.667 ' H ' ' CD ' ' A' ' 437' ' ' GLU . . . -66.49 -30.82 77.15 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -62.4 -44.01 97.45 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.959 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -62.29 -56.88 14.16 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -46.73 -33.2 4.14 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.56 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . 0.715 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -96.2 81.01 3.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.069 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.76 17.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.715 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.72 143.93 9.15 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.447 HG22 ' SG ' ' A' ' 467' ' ' CYS . 0.6 OUTLIER -135.3 133.95 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.316 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.43 HD13 ' CG1' ' A' ' 468' ' ' VAL . 3.5 tp -135.8 98.12 3.82 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.105 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 428' ' ' ARG . 2.1 p -116.24 161.84 18.37 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.67 -23.18 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.72 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' ARG . . . . . 0.435 HH22 ' CE ' ' A' ' 452' ' ' MET . 1.3 mmp_? -112.44 -128.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.861 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.69 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 62.52 -170.97 11.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . 0.6 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 61.51 -20.97 0.05 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.69 ' H ' ' C ' ' A' ' 450' ' ' GLY . 7.5 mmt -68.92 42.72 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' THR . . . . . 0.6 ' H ' ' C ' ' A' ' 451' ' ' GLY . 39.1 p 45.66 90.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.1 t -173.32 -155.66 0.08 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.122 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' HIS . . . . . 0.682 ' H ' ' HD1' ' A' ' 455' ' ' HIS . 8.5 p-80 -55.24 -41.69 72.46 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.44 50.98 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.366 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.46 -28.41 52.34 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.903 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.51 -54.31 12.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.573 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 455' ' ' HIS . 92.1 t -56.49 -40.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.115 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.64 55.15 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.78 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -65.96 -14.78 62.2 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.814 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.46 -35.61 19.54 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.489 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 7.3 mmt -91.75 -9.72 42.61 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 62.06 24.42 65.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 466' ' ' CYS . 14.3 t -87.7 -166.86 1.7 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' CYS . . . . . 0.44 ' SG ' ' HA3' ' A' ' 401' ' ' GLY . 8.9 t -98.98 123.26 43.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.424 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.447 ' SG ' HG22 ' A' ' 445' ' ' ILE . 1.4 t -152.06 139.91 19.97 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 118.018 -1.473 . . . . 0.0 112.708 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.99 161.27 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' SER . . . . . 0.64 ' HG ' ' N ' ' A' ' 470' ' ' GLY . 9.0 t -151.46 151.8 32.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.971 -1.491 . . . . 0.0 113.86 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.64 ' N ' ' HG ' ' A' ' 469' ' ' SER . . . 48.2 90.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.146 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 96.7 m -98.42 -160.53 0.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.834 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.75 -95.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.63 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' GLU . . . . . 0.555 ' N ' ' CD ' ' A' ' 473' ' ' GLU . 1.6 pm0 -142.07 58.94 1.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.1 mt -43.17 102.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.775 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -88.86 113.76 24.75 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.409 HG23 ' HZ3' ' A' ' 481' ' ' LYS . 9.5 mt -88.69 134.37 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 118.602 -1.239 . . . . 0.0 112.38 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.5 123.47 50.29 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.385 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' A' ' 480' ' ' ALA . 1.2 tt0 -63.6 -3.43 2.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.442 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -47.71 -16.56 0.07 Allowed 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 118.194 -1.402 . . . . 0.0 108.296 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.627 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -174.8 -100.38 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.0 OUTLIER -158.05 65.91 0.46 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.488 ' CB ' ' HA ' ' A' ' 491' ' ' ALA . 1.4 p -97.51 178.34 5.22 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 483' ' ' PHE . 0.2 OUTLIER -151.56 129.69 11.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.471 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -99.61 116.46 31.78 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.665 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 486' ' ' GLY . 3.2 tt -136.51 156.25 48.85 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.012 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 485' ' ' LEU . . . 44.65 -117.43 2.11 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.283 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -124.42 37.15 2.71 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.532 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' HIS . . . . . 0.506 ' CG ' ' CZ ' ' A' ' 490' ' ' PHE . 0.3 OUTLIER -150.68 129.65 12.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.404 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 83.5 m -102.98 115.07 29.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.59 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.506 ' CZ ' ' CG ' ' A' ' 488' ' ' HIS . 22.8 m-85 -112.43 130.94 55.81 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.751 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -99.18 156.84 16.75 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.469 ' O ' ' CG ' ' A' ' 492' ' ' GLU . 1.5 tm-20 -65.46 63.67 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.602 -1.239 . . . . 0.0 108.566 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -160.43 25.45 0.29 Allowed Glycine 0 C--N 1.263 -3.512 0 C-N-CA 119.263 -1.446 . . . . 0.0 109.838 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -146.26 -164.62 2.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.046 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -128.23 137.58 52.08 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.215 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 2.0 pt -131.93 160.14 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.089 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 506' ' ' TYR . 48.3 m -123.46 110.98 15.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.348 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 498' ' ' LEU . 0.1 OUTLIER -105.57 136.92 44.27 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.418 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.633 ' N ' ' OD1' ' A' ' 499' ' ' ASP . 0.5 OUTLIER -108.6 160.58 15.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.027 0.917 . . . . 0.0 112.244 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -142.11 94.2 0.18 Allowed Glycine 0 C--N 1.285 -2.299 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 4.6 m -171.42 -3.01 0.01 OUTLIER 'General case' 0 C--N 1.244 -3.98 0 CA-C-N 112.577 -1.812 . . . . 0.0 107.398 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.09 -16.68 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.555 -2.111 . . . . 0.0 107.276 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.46 40.13 8.58 Favored Glycine 0 N--CA 1.482 1.725 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.371 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -115.37 119.97 38.03 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' ILE . . . . . 0.541 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.5 tt -97.57 160.23 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.425 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' TYR . . . . . 0.716 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 17.8 m-85 -135.15 162.09 33.5 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.178 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.504 ' HD2' ' CE1' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -136.71 142.93 43.12 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.779 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . 0.468 ' N ' ' HD3' ' A' ' 507' ' ' LYS . . . . . . . . 0 N--CA 1.493 2.461 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.758 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.57 142.76 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.539 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 1.9 pt -94.42 -33.53 5.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.757 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 179.67 -167.49 37.39 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.87 -1.633 . . . . 0.0 111.314 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 31.1 t -154.79 120.78 5.21 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.583 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . 0.436 ' HB3' ' SG ' ' A' ' 471' ' ' CYS . . . -93.09 -144.06 0.22 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.076 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 51.2 mt -93.42 128.69 41.48 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . 0.552 ' HG3' ' O ' ' A' ' 502' ' ' THR . 7.7 Cg_endo -68.37 89.35 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.142 1.228 . . . . 0.0 111.565 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -55.37 -54.73 40.06 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.506 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' SER . . . . . 0.403 ' HG ' ' N ' ' A' ' 400' ' ' PRO . 1.1 t -150.45 141.85 15.1 Favored Pre-proline 0 C--N 1.307 -1.281 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.177 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.403 ' N ' ' HG ' ' A' ' 399' ' ' SER . 5.8 Cg_exo -54.34 101.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.121 1.214 . . . . 0.0 110.569 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -151.46 161.81 29.33 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.544 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.564 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -139.21 114.87 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -138.39 160.73 38.77 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.862 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.454 ' HB2' ' HH ' ' A' ' 495' ' ' TYR . . . -142.17 110.62 6.07 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.709 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.07 167.92 31.24 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.923 -1.608 . . . . 0.0 111.268 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -82.82 137.11 34.43 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.571 ' CG1' ' C ' ' A' ' 491' ' ' ALA . 1.0 OUTLIER -83.37 151.68 3.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 C-N-CA 118.925 -1.11 . . . . 0.0 113.374 -179.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -149.86 -152.79 0.45 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.924 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.466 ' CD2' ' HE2' ' A' ' 481' ' ' LYS . 10.5 m-85 -146.31 -47.71 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.058 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' THR . . . . . 0.426 ' OG1' ' OE1' ' A' ' 413' ' ' GLU . 37.4 p -86.03 143.36 28.15 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.235 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -69.47 -10.91 60.07 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.503 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 412' ' ' ASP . 10.2 m-20 -74.26 -42.55 59.46 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.775 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 413' ' ' GLU . 2.1 mp0 -66.88 -42.47 85.52 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.568 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.7 66.28 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.88 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -73.68 -38.63 64.85 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.396 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.58 -12.2 37.74 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.84 -43.58 9.95 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.837 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' HIS . . . . . 0.463 ' O ' ' CD2' ' A' ' 418' ' ' HIS . 8.8 t60 -69.88 -29.42 66.63 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.219 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.68 -21.89 61.0 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 -5.93 42.86 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.797 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 89.99 45.44 4.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -147.44 131.87 17.63 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.812 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -58.58 157.09 9.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.432 ' N ' ' OE2' ' A' ' 443' ' ' GLU . 2.4 t -148.27 160.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.931 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 7.5 mm -130.63 160.97 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.911 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 4.3 tp -139.42 144.6 38.16 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.594 -1.242 . . . . 0.0 112.851 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 81.6 t -118.46 130.21 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.557 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ARG . . . . . 0.552 ' C ' ' H ' ' A' ' 430' ' ' GLU . 0.0 OUTLIER -151.79 135.26 16.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.59 -1.244 . . . . 0.0 112.06 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.11 17.87 0.12 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.552 ' H ' ' C ' ' A' ' 428' ' ' ARG . 5.9 pt-20 175.86 147.46 0.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' THR . . . . . 0.425 ' HG1' ' HB2' ' A' ' 455' ' ' HIS . 0.1 OUTLIER -87.77 177.39 7.02 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.89 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.2 m -161.6 131.08 3.23 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.712 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.03 -31.61 91.32 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 121.183 1.255 . . . . 0.0 111.807 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -75.46 -16.41 60.32 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.191 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.1 t70 -90.41 -9.24 48.27 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.723 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.679 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -39.3 -52.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.861 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.679 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 26.9 mt-10 -58.23 -35.77 72.18 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.925 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.22 -22.44 73.55 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 2.1 mmt -74.75 -42.02 58.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.433 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.794 ' HD1' ' N ' ' A' ' 441' ' ' ALA . 0.2 OUTLIER -70.7 -32.98 70.38 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.332 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.794 ' N ' ' HD1' ' A' ' 440' ' ' HIS . . . -50.09 -29.04 8.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . 0.642 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -109.38 92.02 3.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.679 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 443' ' ' GLU . 1.4 pm0 -53.0 0.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.949 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.642 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -142.01 144.47 14.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.446 ' HB ' ' SG ' ' A' ' 467' ' ' CYS . 38.8 mt -145.73 135.45 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.459 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.445 HD11 ' CG1' ' A' ' 468' ' ' VAL . 5.8 tp -131.05 98.23 4.52 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.004 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' THR . . . . . 0.458 HG21 ' N ' ' A' ' 428' ' ' ARG . 1.5 p -107.9 161.49 14.87 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.7 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 4.9 t -85.28 -20.11 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.969 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -106.6 -152.05 0.47 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.755 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.445 ' HA3' ' HG ' ' A' ' 469' ' ' SER . . . 81.28 -151.39 31.31 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . 0.653 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 76.78 -50.99 3.03 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.548 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.485 ' O ' ' CB ' ' A' ' 453' ' ' THR . 70.7 mmm -64.45 11.97 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.413 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' THR . . . . . 0.653 ' H ' ' C ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.31 108.27 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.019 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 455' ' ' HIS . 30.2 t -158.41 -173.16 4.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.841 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' HIS . . . . . 0.552 ' N ' ' OG ' ' A' ' 454' ' ' SER . 60.4 m80 -50.34 -35.3 27.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -53.7 -58.71 6.23 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.322 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.63 -52.21 9.37 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.347 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 13.3 t -44.76 -43.42 2.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.675 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 97.5 t -69.38 -43.55 80.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.201 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.94 -41.08 87.59 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.84 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -66.35 -27.71 68.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -90.0 -26.7 23.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.671 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 11.2 mmt -94.07 -23.11 18.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.302 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.69 -21.25 30.66 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.966 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 60.2 m -44.22 160.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -87.25 129.1 35.11 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.937 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.446 ' SG ' ' HB ' ' A' ' 445' ' ' ILE . 1.8 m -153.3 153.1 31.96 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.434 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . 0.542 HG11 ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -124.38 161.16 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 108.995 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 28.1 t -150.27 155.31 39.46 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.7 -1.2 . . . . 0.0 112.213 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 42.63 82.98 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . 0.462 ' HG ' HD13 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -90.07 -160.4 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.272 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -61.13 -99.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.542 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 474' ' ' ILE . 1.4 mm-40 -145.07 41.25 1.27 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.417 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 0.0 OUTLIER -38.81 107.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.901 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -89.71 123.99 34.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.205 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 3.0 mt -86.41 119.59 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.191 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . 0.408 HD22 ' HG3' ' A' ' 479' ' ' GLU . 53.1 t-20 -89.24 110.83 21.55 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.163 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.636 ' H ' ' CD ' ' A' ' 478' ' ' GLU . 1.4 pm0 -67.67 -9.33 42.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.525 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 478' ' ' GLU . 11.4 mm-40 -46.3 -19.87 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.342 -1.343 . . . . 0.0 107.661 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.607 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -163.64 -107.21 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.412 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . 0.466 ' HE2' ' CD2' ' A' ' 409' ' ' PHE . 20.2 mmmt -159.47 70.94 0.48 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.606 ' HA ' ' CB ' ' A' ' 491' ' ' ALA . 1.2 p -138.63 148.46 44.11 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.867 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' PHE . . . . . 0.539 ' H ' ' HB3' ' A' ' 491' ' ' ALA . 6.2 p90 -104.74 156.53 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.895 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.44 103.57 12.22 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.287 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 486' ' ' GLY . 1.4 tt -126.61 139.72 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' GLY . . . . . 0.478 ' N ' ' CD2' ' A' ' 485' ' ' LEU . . . 57.06 -110.59 2.28 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.128 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -128.82 36.76 2.36 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.372 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 24.4 m170 -150.35 126.15 10.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.482 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.2 m -99.38 97.36 8.41 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.971 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.621 ' CB ' ' HZ2' ' A' ' 507' ' ' LYS . 35.6 p90 -155.3 158.18 38.37 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.036 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.606 ' CB ' ' HA ' ' A' ' 482' ' ' THR . . . -170.09 -136.08 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.177 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.464 ' N ' HG11 ' A' ' 407' ' ' VAL . 57.6 tt0 -49.63 94.18 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 117.964 -1.494 . . . . 0.0 109.39 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 152.02 17.7 0.06 OUTLIER Glycine 0 C--N 1.297 -1.611 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -156.25 -152.62 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.435 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . 0.454 ' HH ' ' HB2' ' A' ' 404' ' ' ALA . 6.8 t80 -149.71 126.77 11.25 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.284 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.96 161.59 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.49 106.16 11.54 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.3 OUTLIER -92.48 134.77 34.64 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.169 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.506 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.4 OUTLIER -89.48 159.25 17.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.424 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -155.65 95.17 0.15 Allowed Glycine 0 C--N 1.282 -2.453 0 N-CA-C 106.923 -2.471 . . . . 0.0 106.923 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 3.3 t 172.86 7.28 0.0 OUTLIER 'General case' 0 C--N 1.245 -3.956 0 CA-C-N 112.507 -1.846 . . . . 0.0 106.943 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' THR . . . . . 0.552 ' O ' ' HG3' ' A' ' 397' ' ' PRO . 0.0 OUTLIER -171.91 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.385 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.477 ' N ' ' HB3' ' A' ' 397' ' ' PRO . . . 93.11 15.42 51.79 Favored Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.923 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -75.08 172.7 11.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.26 150.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.459 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 7.7 t80 -148.97 161.33 42.12 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.01 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 28.4 tttt -131.78 151.6 51.55 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.865 -1.134 . . . . 0.0 113.701 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.779 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.365 179.645 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.395 0.617 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 41.8 t -39.4 139.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.09 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.478 HG13 ' N ' ' A' ' 393' ' ' GLY . 17.7 pt -99.81 -43.22 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.076 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.478 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -151.08 -162.9 10.99 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.706 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.8 t -179.21 127.42 0.09 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -117.61 -125.54 0.28 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.461 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 32.5 mt -100.49 139.01 20.3 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.277 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -67.56 93.42 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.274 1.316 . . . . 0.0 110.581 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.02 -66.71 0.5 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.107 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 24.2 t -136.97 131.07 17.8 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.848 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.85 92.56 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 121.059 1.173 . . . . 0.0 111.303 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.17 160.18 28.97 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 118.995 -1.574 . . . . 0.0 112.008 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.775 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -126.26 135.89 52.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . 0.428 ' CB ' ' OE2' ' A' ' 443' ' ' GLU . . . -150.42 160.32 43.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . 0.402 ' CB ' ' OH ' ' A' ' 495' ' ' TYR . . . -148.16 109.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.601 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.7 30.83 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.495 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.27 133.0 34.58 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.739 -0.785 . . . . 0.0 109.588 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 492' ' ' GLU . 79.9 t -60.67 154.43 4.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.325 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.468 ' CE1' ' HG2' ' A' ' 413' ' ' GLU . 0.5 OUTLIER -162.47 135.75 6.03 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.557 ' CE2' ' NZ ' ' A' ' 481' ' ' LYS . 4.7 m-85 -100.9 28.6 5.12 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.926 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 7.2 p -149.38 143.96 26.09 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.731 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.69 59.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.966 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.8 -43.16 31.47 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . 0.468 ' HG2' ' CE1' ' A' ' 408' ' ' TYR . 0.3 OUTLIER -62.08 -39.31 92.02 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.388 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.69 83.9 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.482 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -65.7 -34.64 78.66 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.77 21.99 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.464 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -82.62 -49.02 10.28 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.982 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -49.28 -27.13 3.53 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -91.57 -28.87 17.26 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -117.48 -35.05 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.111 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -93.19 -45.59 3.51 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.069 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . 0.43 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 1.1 mt-10 66.32 158.13 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.672 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 47.35 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.161 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.91 161.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.382 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.429 HG21 ' H ' ' A' ' 426' ' ' LEU . 47.0 mm -123.31 157.52 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.383 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.429 ' H ' HG21 ' A' ' 425' ' ' ILE . 3.1 tp -128.82 134.52 48.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.255 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 409' ' ' PHE . 48.1 t -119.94 123.5 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.689 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ARG . . . . . 0.496 ' H ' HG23 ' A' ' 447' ' ' THR . 0.6 OUTLIER -151.53 158.31 43.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.957 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.14 -49.73 73.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.311 -1.355 . . . . 0.0 109.799 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -132.27 177.64 7.43 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' THR . . . . . 0.468 HG21 ' H ' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -81.41 171.76 14.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.064 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 1.3 m -153.33 142.32 14.54 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.604 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 435' ' ' ASP . 1.3 Cg_endo -61.5 -72.92 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.481 1.454 . . . . 0.0 111.919 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.08 -10.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.288 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 433' ' ' PRO . 7.1 t70 -85.94 -8.68 57.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.658 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -43.34 -58.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.735 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.658 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 46.8 mt-10 -55.92 -31.5 62.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.522 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.04 -23.55 77.58 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 436' ' ' ILE . 2.4 ttm -74.57 -53.99 8.34 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.778 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.489 ' C ' ' N ' ' A' ' 442' ' ' ALA . 85.8 m-70 -58.77 -50.4 74.08 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.755 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 440' ' ' HIS . . . -45.88 -24.88 0.45 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.149 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . 0.703 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -107.15 86.27 2.28 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.488 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.491 ' C ' ' OE1' ' A' ' 443' ' ' GLU . 0.0 OUTLIER -58.26 14.01 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.955 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.703 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.24 133.95 3.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 445' ' ' ILE . 4.5 mp -139.48 150.45 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.135 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 tp -144.38 128.34 17.47 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.146 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 428' ' ' ARG . 5.7 p -140.61 159.31 42.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.242 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 27.4 t -68.86 -20.85 25.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.452 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -117.0 -151.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.963 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.487 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 84.98 26.17 38.33 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -44.44 161.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.659 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 25.0 mtt 45.4 -101.52 0.05 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 40.3 p -153.91 81.36 1.15 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.831 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.8 m -90.67 -163.02 0.96 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.704 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' HIS . . . . . 0.434 ' CD2' HG22 ' A' ' 459' ' ' VAL . 2.9 t60 -47.87 -39.78 19.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.43 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . 0.468 ' H ' HG21 ' A' ' 431' ' ' THR . . . -59.04 -61.88 2.3 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.032 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.78 -55.59 16.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.871 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 459' ' ' VAL . 0.3 OUTLIER -45.65 -49.8 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.694 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.645 ' N ' ' CG1' ' A' ' 458' ' ' VAL . 71.3 t -62.46 -37.15 78.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.34 -46.95 78.2 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -31.14 71.67 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.69 -18.81 69.61 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' MET . . . . . 0.482 ' C ' ' SD ' ' A' ' 463' ' ' MET . 0.0 OUTLIER -94.96 -59.86 1.81 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.955 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . 0.472 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 123.93 20.83 2.47 Favored Glycine 0 N--CA 1.503 3.149 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' THR . . . . . 0.453 HG23 ' N ' ' A' ' 466' ' ' CYS . 30.9 m -97.47 166.9 11.31 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.8 m -90.12 128.08 36.24 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.799 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 13.1 t -151.71 159.07 44.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.801 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 469' ' ' SER . 0.8 OUTLIER -137.08 162.44 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.886 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' SER . . . . . 0.487 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 11.7 t -144.27 160.42 41.01 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.894 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 44.17 79.87 0.05 OUTLIER Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.623 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . 0.43 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.0 OUTLIER -78.33 -175.18 4.08 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.107 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.82 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.006 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.9 57.99 1.61 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.611 0.72 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.43 HD12 ' SG ' ' A' ' 471' ' ' CYS . 4.5 mt -55.46 114.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.272 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 484' ' ' GLU . 4.4 ttpm? -99.63 122.74 43.1 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.406 HG22 ' HZ3' ' A' ' 481' ' ' LYS . 1.7 mt -86.89 127.74 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 117.771 -1.572 . . . . 0.0 112.097 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . 0.489 ' OD1' ' CG2' ' A' ' 489' ' ' THR . 7.8 m120 -96.91 113.38 24.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.123 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.625 ' C ' ' N ' ' A' ' 480' ' ' ALA . 10.5 mt-10 -64.0 -11.88 32.95 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.984 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -46.3 -17.82 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.811 1.291 . . . . 0.0 107.928 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.625 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.32 -97.8 0.01 OUTLIER 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 112.15 -2.296 . . . . 0.0 105.537 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . 0.557 ' NZ ' ' CE2' ' A' ' 409' ' ' PHE . 3.0 mmmt -168.97 70.72 0.08 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.578 HG21 ' H ' ' A' ' 491' ' ' ALA . 2.6 p -125.75 147.24 49.45 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.057 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' PHE . . . . . 0.632 ' H ' ' HB1' ' A' ' 491' ' ' ALA . 8.0 p90 -97.68 149.98 21.68 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.572 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 475' ' ' LYS . 7.5 tt0 -110.92 107.14 16.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.129 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.584 ' CD2' ' H ' ' A' ' 486' ' ' GLY . 0.4 OUTLIER -144.7 156.33 44.03 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.04 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' GLY . . . . . 0.584 ' H ' ' CD2' ' A' ' 485' ' ' LEU . . . 64.6 -111.4 4.15 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -134.75 26.7 3.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.729 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' HIS . . . . . 0.451 ' CD2' ' H ' ' A' ' 489' ' ' THR . 13.4 t-160 -150.75 152.14 33.41 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 477' ' ' ASN . 77.3 m -115.94 99.38 7.24 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.039 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.547 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 19.6 p90 -153.78 157.55 39.58 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.075 -1.45 . . . . 0.0 114.184 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.632 ' HB1' ' H ' ' A' ' 483' ' ' PHE . . . 179.85 -137.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.295 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.534 ' N ' ' CG1' ' A' ' 407' ' ' VAL . 8.2 tm-20 -34.93 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.654 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 139.68 3.66 1.52 Allowed Glycine 0 C--N 1.29 -2.009 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' ASP . . . . . 0.638 ' CG ' ' H ' ' A' ' 495' ' ' TYR . 36.2 t70 -144.26 -174.16 4.22 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.235 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . 0.638 ' H ' ' CG ' ' A' ' 494' ' ' ASP . 87.2 t80 -123.91 120.54 32.83 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.029 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.657 ' HA ' ' H ' ' A' ' 508' ' ' GLY . 0.0 OUTLIER -127.92 161.39 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.577 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 2.4 m -123.34 110.08 14.72 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -95.84 141.18 29.6 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.487 ' N ' HD13 ' A' ' 498' ' ' LEU . 10.3 t70 -99.99 161.41 13.63 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.064 0.935 . . . . 0.0 112.381 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -156.49 95.61 0.15 Allowed Glycine 0 C--N 1.281 -2.508 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 1.4 t 164.66 2.4 0.0 OUTLIER 'General case' 1 C--N 1.238 -4.265 0 CA-C-N 112.749 -1.726 . . . . 0.0 107.47 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 6.8 m -161.72 -17.74 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.073 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 73.52 75.8 0.72 Allowed Glycine 0 N--CA 1.485 1.959 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.736 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -165.24 118.95 1.23 Allowed 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.014 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' ILE . . . . . 0.516 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 2.0 tt -99.22 157.84 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.085 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' TYR . . . . . 0.516 ' N ' ' CG1' ' A' ' 505' ' ' ILE . 0.1 OUTLIER -151.04 170.49 19.25 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.456 ' HD2' ' CE2' ' A' ' 490' ' ' PHE . 27.2 mtpt -81.41 158.33 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 117.058 -1.857 . . . . 0.0 110.146 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . 0.657 ' H ' ' HA ' ' A' ' 496' ' ' ILE . . . . . . . . 0 N--CA 1.487 2.068 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.582 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 390' ' ' GLU . 1.5 pm0 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.983 0.421 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.712 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 74.8 t -64.39 137.05 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.018 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.634 ' CG1' ' H ' ' A' ' 393' ' ' GLY . 2.5 pt -103.26 -57.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.757 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . 0.634 ' H ' ' CG1' ' A' ' 392' ' ' ILE . . . -142.18 178.78 20.57 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 12.6 m -156.05 141.31 17.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.814 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -124.06 -158.81 0.83 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.835 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.19 126.66 78.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.772 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 101.93 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.033 1.155 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.32 -57.75 6.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.589 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 79.3 p -137.19 139.87 29.39 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.713 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.7 95.77 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 121.31 1.34 . . . . 0.0 110.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.82 162.2 30.3 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 118.186 -1.959 . . . . 0.0 112.906 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.56 21.15 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.41 160.87 43.44 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 117.946 -1.502 . . . . 0.0 112.884 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -131.78 102.6 5.94 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.67 166.55 30.81 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.94 156.26 22.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.65 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 492' ' ' GLU . 3.5 m -85.4 138.77 18.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.546 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.61 ' CZ ' ' OE1' ' A' ' 413' ' ' GLU . 0.4 OUTLIER -138.94 159.28 42.53 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.322 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.497 ' CE1' ' HB3' ' A' ' 481' ' ' LYS . 9.8 m-85 -122.88 32.81 5.59 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.813 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 1.6 p -158.82 143.74 16.02 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.438 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.57 -13.83 61.49 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.591 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -75.17 -43.19 53.65 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.49 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . 0.61 ' OE1' ' CZ ' ' A' ' 408' ' ' TYR . 68.9 mm-40 -62.28 -37.84 87.06 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.411 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.32 72.48 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.403 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -68.67 -36.81 79.01 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.518 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.81 23.41 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.837 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -68.12 -54.93 14.54 Favored 'General case' 0 C--N 1.276 -2.621 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 417' ' ' ALA . 25.6 t-80 -44.22 -26.55 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.6 OUTLIER -91.48 -22.87 20.18 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.884 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 417' ' ' ALA . 36.2 mmtt -80.64 -59.59 2.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.981 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -155.0 3.87 0.23 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.711 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 54.68 -146.95 0.53 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.094 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . 0.543 ' H ' ' HE ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER 52.37 64.68 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.838 -1.145 . . . . 0.0 107.965 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.842 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 6.9 mm -125.33 160.3 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.904 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 5.3 tp -125.57 134.06 52.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.017 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.485 HG12 ' CE2' ' A' ' 409' ' ' PHE . 15.5 t -120.38 121.57 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.036 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ARG . . . . . 0.508 ' H ' HG22 ' A' ' 447' ' ' THR . 7.3 ttt180 -152.2 148.76 27.97 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.247 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.501 ' H ' HD13 ' A' ' 429' ' ' LEU . 4.3 mp -48.41 -58.01 5.25 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.568 -1.253 . . . . 0.0 109.252 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 431' ' ' THR . 2.2 tm-20 -122.89 175.84 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.436 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' THR . . . . . 0.635 ' OG1' ' CD2' ' A' ' 455' ' ' HIS . 1.2 p -112.14 173.37 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.685 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.9 m -154.84 155.14 30.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.998 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 435' ' ' ASP . 3.6 Cg_endo -64.27 -66.58 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 121.758 1.638 . . . . 0.0 112.147 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -38.83 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.269 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 438' ' ' GLY . 1.1 m-20 -74.42 -8.7 57.16 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.829 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.614 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 9.8 tp -40.4 -50.56 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.827 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.614 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 69.6 mt-10 -53.85 -38.28 64.52 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.615 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.16 -26.65 70.13 Favored Glycine 0 C--N 1.303 -1.272 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 40.3 mtt -69.21 -39.11 78.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.988 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.456 ' CE1' HG13 ' A' ' 436' ' ' ILE . 6.8 m-70 -66.68 -57.94 6.14 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.171 -1.411 . . . . 0.0 109.174 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -46.13 -39.64 9.82 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.073 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . 0.647 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -97.55 85.28 3.57 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.087 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -62.91 35.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.848 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . 0.647 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -168.87 143.71 8.25 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . 0.449 HG21 ' SG ' ' A' ' 467' ' ' CYS . 1.3 mt -144.63 132.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.17 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.421 HD12 ' CG1' ' A' ' 468' ' ' VAL . 7.0 tp -135.79 98.36 3.89 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 428' ' ' ARG . 1.7 p -113.62 161.22 17.7 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.73 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.451 HG11 ' SG ' ' A' ' 471' ' ' CYS . 16.2 t -76.84 -26.34 16.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.796 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' GLY . 6.8 mtt-85 -108.46 -134.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.723 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 70.72 -166.85 51.32 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.948 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . 0.721 ' N ' ' HG ' ' A' ' 469' ' ' SER . . . 72.0 -31.85 0.64 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.937 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.536 ' H ' ' C ' ' A' ' 450' ' ' GLY . 15.6 ptm -68.38 42.31 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.946 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 47.22 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.13 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.8 t -171.32 -166.08 0.44 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.294 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' HIS . . . . . 0.642 ' H ' ' HD1' ' A' ' 455' ' ' HIS . 7.2 p-80 -49.66 -48.13 49.58 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.981 -1.087 . . . . 0.0 110.337 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 455' ' ' HIS . . . -38.21 -56.15 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.467 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -81.08 -52.53 7.29 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.487 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 43.5 t -47.42 -47.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.916 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 93.3 t -64.31 -43.78 97.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.782 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.99 -43.75 91.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -69.81 -19.38 63.49 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.57 -36.79 15.56 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 49.8 mmm -93.15 -26.1 17.57 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.24 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.25 42.1 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.63 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 16.7 m -46.83 163.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 401' ' ' GLY . 48.6 t -85.22 128.59 34.73 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.053 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . 0.449 ' SG ' HG21 ' A' ' 445' ' ' ILE . 13.1 t -151.42 140.49 21.14 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.382 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . 0.512 HG11 ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -110.65 161.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.137 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' SER . . . . . 0.721 ' HG ' ' N ' ' A' ' 451' ' ' GLY . 9.2 t -150.37 148.57 28.96 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.567 -1.253 . . . . 0.0 112.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 61.1 91.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.46 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . 0.451 ' SG ' HG11 ' A' ' 448' ' ' VAL . 7.7 p -100.22 176.06 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -59.52 -91.93 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -144.82 59.55 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.444 HG13 ' SG ' ' A' ' 471' ' ' CYS . 10.7 mt -51.6 107.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.839 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -89.16 110.31 21.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 482' ' ' THR . 4.9 mt -87.96 135.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.013 -1.475 . . . . 0.0 113.884 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -113.18 122.04 46.32 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.678 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.635 ' C ' ' H ' ' A' ' 480' ' ' ALA . 7.8 mt-10 -56.4 -5.53 0.21 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.438 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -48.03 -14.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 118.093 -1.443 . . . . 0.0 108.186 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.635 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 177.98 -90.88 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . 0.497 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.3 OUTLIER -167.46 54.56 0.07 Allowed 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 123.965 1.841 . . . . 0.0 108.949 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 491' ' ' ALA . 70.0 p -75.57 167.11 22.52 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 111.251 -2.704 . . . . 0.0 112.267 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' PHE . . . . . 0.634 ' CE2' ' CG ' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -153.46 112.83 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.693 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -89.64 120.07 30.61 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.047 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 486' ' ' GLY . 59.3 tp -149.82 157.21 42.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.141 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' GLY . . . . . 0.485 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.39 -117.82 12.54 Favored Glycine 0 N--CA 1.48 1.568 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -127.04 29.1 4.44 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.673 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -151.68 144.3 24.27 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.122 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 45.5 m -95.36 115.19 27.1 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.529 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.634 ' CG ' ' CE2' ' A' ' 483' ' ' PHE . 0.8 OUTLIER -88.49 160.73 17.37 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -141.0 113.95 8.42 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.856 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . 0.433 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.7 tm-20 -48.06 99.68 0.02 OUTLIER 'General case' 0 CA--C 1.481 -1.704 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.887 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 160.24 22.88 0.03 OUTLIER Glycine 0 C--N 1.274 -2.909 0 C-N-CA 118.623 -1.751 . . . . 0.0 109.865 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' ASP . . . . . 0.661 ' CG ' ' H ' ' A' ' 495' ' ' TYR . 16.2 t70 -143.72 -179.91 6.75 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.071 -1.051 . . . . 0.0 112.2 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . 0.661 ' H ' ' CG ' ' A' ' 494' ' ' ASP . 25.1 t80 -101.59 137.91 39.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.667 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . 0.454 HG13 ' N ' ' A' ' 497' ' ' SER . 0.1 OUTLIER -137.15 160.98 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.445 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' SER . . . . . 0.454 ' N ' HG13 ' A' ' 496' ' ' ILE . 29.7 t -123.6 104.57 9.11 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.658 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' LEU . . . . . 0.467 HD11 ' N ' ' A' ' 499' ' ' ASP . 0.2 OUTLIER -109.62 134.27 52.14 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.764 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.467 ' N ' HD11 ' A' ' 498' ' ' LEU . 9.1 m-20 -115.36 148.67 39.01 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.821 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -148.45 89.55 0.14 Allowed Glycine 0 C--O 1.188 -2.777 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 22.5 m -162.77 -3.88 0.04 OUTLIER 'General case' 0 C--N 1.255 -3.537 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' THR . . . . . 0.407 ' H ' ' H ' ' A' ' 503' ' ' GLY . 75.8 p -152.77 -14.65 0.16 Allowed 'General case' 0 C--N 1.275 -2.667 0 CA-C-N 111.417 -2.629 . . . . 0.0 105.969 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 79.04 77.25 0.91 Allowed Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.29 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -156.69 136.13 12.23 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.729 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' ILE . . . . . 0.625 ' C ' ' CD1' ' A' ' 506' ' ' TYR . 10.7 mt -110.54 161.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.807 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' TYR . . . . . 0.712 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 24.6 m-85 -150.33 161.72 41.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 508' ' ' GLY . 13.0 ttmt -134.97 157.47 46.84 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 507' ' ' LYS . . . . . . . . 0 N--CA 1.497 2.72 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.648 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.012 0.434 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . 0.753 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 67.7 t -93.91 158.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.333 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.461 ' N ' HG11 ' A' ' 391' ' ' VAL . 10.3 pt -102.36 -33.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -178.3 -163.97 30.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 118.899 -1.619 . . . . 0.0 111.279 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 p -165.31 130.44 2.53 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.264 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.65 -147.92 0.42 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.943 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 63.2 mt -81.93 132.31 54.45 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.08 93.61 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.143 1.229 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -58.31 -62.12 2.07 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.47 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -148.61 146.88 23.34 Favored Pre-proline 0 C--N 1.305 -1.333 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.353 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.76 103.05 0.1 Allowed 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.258 1.305 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.06 162.61 29.85 Favored Glycine 0 N--CA 1.509 3.508 0 C-N-CA 118.723 -1.704 . . . . 0.0 112.379 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . 0.49 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -145.65 118.72 8.83 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.01 43.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.776 -1.57 . . . . 0.0 113.765 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -137.84 110.02 7.32 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.437 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.53 169.81 31.68 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.007 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' LYS . . . . . 0.653 ' CD ' ' N ' ' A' ' 406' ' ' LYS . 8.4 mptt -80.2 171.48 15.03 Favored 'General case' 0 C--O 1.201 -1.499 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -120.23 158.98 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.548 -1.261 . . . . 0.0 114.15 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' TYR . . . . . 0.622 ' CE2' ' CD1' ' A' ' 426' ' ' LEU . 20.0 p90 -156.24 -151.09 0.31 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.716 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 427' ' ' VAL . 28.4 m-85 -148.22 -42.28 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.406 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 36.8 p -94.71 138.55 32.39 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.548 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -56.12 -19.38 13.04 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.262 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -64.5 -49.07 72.78 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 417' ' ' ALA . 40.8 mm-40 -53.22 -50.9 63.77 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.286 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ALA . . . . . 0.409 ' HB2' ' CE2' ' A' ' 408' ' ' TYR . . . -48.58 -38.46 20.71 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -63.57 -41.19 98.4 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.505 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.3 -9.62 49.88 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.657 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.08 -60.7 1.86 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.401 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -56.23 -21.37 23.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.045 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -27.61 68.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.003 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -73.13 -6.99 49.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.94 71.47 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.16 152.03 3.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.163 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -72.17 153.11 41.83 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.643 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 425' ' ' ILE . 4.4 t -145.97 160.15 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.446 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ILE . . . . . 0.514 ' O ' ' CE1' ' A' ' 408' ' ' TYR . 5.2 mm -121.85 159.28 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' LEU . . . . . 0.622 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 13.5 tp -115.79 139.16 50.44 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.796 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.545 ' O ' ' CD2' ' A' ' 409' ' ' PHE . 51.9 t -130.57 119.71 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ARG . . . . . 0.435 ' H ' HG23 ' A' ' 447' ' ' THR . 1.0 OUTLIER -151.4 152.75 33.51 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.902 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.417 ' CB ' ' OE2' ' A' ' 430' ' ' GLU . 0.7 OUTLIER -80.31 20.56 0.67 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.393 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 428' ' ' ARG . 1.4 pm0 -179.69 153.08 0.53 Allowed 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 432' ' ' SER . 0.5 OUTLIER -83.14 -175.24 5.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.555 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 431' ' ' THR . 4.2 t -177.07 139.28 0.44 Allowed Pre-proline 0 C--N 1.305 -1.357 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.858 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.5 -69.18 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.367 1.378 . . . . 0.0 111.897 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -46.48 -27.32 1.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.879 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.16 -9.23 45.13 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.477 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' ILE . . . . . 0.605 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 8.3 tp -60.29 -49.99 82.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.031 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' GLU . . . . . 0.605 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 52.3 mm-40 -54.89 -29.96 57.03 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.924 -1.51 . . . . 0.0 108.459 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.66 63.41 Favored Glycine 0 N--CA 1.473 1.143 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 43.8 mtt -69.48 -44.83 70.35 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.893 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.568 ' C ' ' N ' ' A' ' 442' ' ' ALA . 7.0 m170 -61.26 -39.28 89.79 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.408 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -51.63 -18.16 1.08 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' ALA . . . . . 0.568 ' N ' ' C ' ' A' ' 440' ' ' HIS . . . -122.52 -155.48 0.65 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.283 -1.78 . . . . 0.0 108.077 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -168.62 37.75 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -169.52 143.41 7.93 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.3 mp -142.36 118.45 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.453 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' LEU . . . . . 0.433 HD13 ' CG1' ' A' ' 468' ' ' VAL . 2.5 tp -121.78 98.37 5.92 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.695 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 428' ' ' ARG . 5.5 p -115.16 160.32 19.84 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.24 -20.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.87 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' ARG . . . . . 0.609 ' CG ' ' H ' ' A' ' 450' ' ' GLY . 2.1 ttt85 -129.26 179.24 5.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' GLY . . . . . 0.609 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 92.59 60.19 1.23 Allowed Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.163 -1.494 . . . . 0.0 109.725 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 453' ' ' THR . . . -141.78 -145.25 4.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 453' ' ' THR . 5.4 ttt 46.52 16.54 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.838 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.53 89.53 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.675 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 455' ' ' HIS . 93.9 p -149.3 -174.58 4.7 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.714 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' HIS . . . . . 0.488 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 4.6 m170 -40.62 -45.1 2.27 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -47.49 -61.9 1.7 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.81 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.64 12.66 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.597 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 11.9 t -45.33 -40.18 2.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.393 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 72.3 t -71.58 -45.39 67.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.318 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.35 80.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -68.72 -37.27 79.35 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.705 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -74.95 -24.12 72.79 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.528 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' MET . . . . . 0.469 ' HG3' ' N ' ' A' ' 464' ' ' GLY . 8.9 tpt -90.17 -81.92 0.28 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.449 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . 0.469 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 136.12 37.59 0.18 Allowed Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.968 -1.11 . . . . 0.0 110.428 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 10.2 t -108.37 171.43 7.42 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -86.42 126.34 34.32 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.98 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -152.19 155.19 37.3 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.284 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.4 t -135.52 162.66 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.577 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' SER . . . . . 0.568 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 33.5 t -149.98 151.74 33.8 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.028 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.37 83.99 0.01 OUTLIER Glycine 0 N--CA 1.496 2.67 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.087 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' CYS . . . . . 0.46 ' SG ' HD12 ' A' ' 485' ' ' LEU . 7.9 t -85.57 -145.99 0.11 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.023 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -67.94 -101.16 0.03 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -130.18 54.86 1.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 0.5 OUTLIER -45.63 111.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -105.03 113.91 27.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.22 134.95 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.444 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -105.99 115.32 30.03 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' GLU . . . . . 0.774 ' C ' ' H ' ' A' ' 480' ' ' ALA . 8.3 mp0 -67.76 -8.27 34.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.291 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -59.08 6.77 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.152 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' ALA . . . . . 0.774 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 170.75 -77.72 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' LYS . . . . . 0.507 ' HD2' ' CD1' ' A' ' 409' ' ' PHE . 4.0 mmtp 158.93 84.07 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.79 1.306 . . . . 0.0 109.482 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' THR . . . . . 0.601 ' HA ' ' CB ' ' A' ' 491' ' ' ALA . 1.9 p -137.02 142.06 42.49 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' PHE . . . . . 0.604 ' H ' ' HB1' ' A' ' 491' ' ' ALA . 3.8 p90 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.441 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' A' ' 485' ' ' LEU . 5.5 tp10 -109.8 117.45 33.9 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' LEU . . . . . 0.464 ' N ' ' OE2' ' A' ' 484' ' ' GLU . 4.8 mt -150.21 159.85 44.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.789 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 53.98 -104.41 0.23 Allowed Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.575 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -139.96 28.72 2.49 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 119.079 -1.534 . . . . 0.0 111.897 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 23.8 m170 -150.68 142.29 23.58 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.639 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.9 m -106.81 99.04 8.63 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.988 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.559 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 23.3 p90 -154.32 155.13 34.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.302 -1.359 . . . . 0.0 113.948 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' ALA . . . . . 0.645 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -171.97 -129.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.669 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -47.12 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.187 -1.405 . . . . 0.0 108.94 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 157.69 0.48 0.1 OUTLIER Glycine 0 C--N 1.279 -2.584 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -159.81 -163.84 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.948 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' TYR . . . . . 0.473 ' CZ ' ' HA2' ' A' ' 508' ' ' GLY . 4.5 p90 -142.07 144.76 33.73 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.678 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.75 160.6 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.877 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 506' ' ' TYR . 6.7 t -115.31 99.91 7.74 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -98.2 144.44 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.377 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' ASP . . . . . 0.476 ' N ' HD12 ' A' ' 498' ' ' LEU . 6.7 t0 -103.55 157.43 17.05 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.697 0.761 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -145.25 95.47 0.18 Allowed Glycine 0 C--N 1.275 -2.816 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 0.3 OUTLIER 163.21 6.33 0.0 OUTLIER 'General case' 1 C--N 1.24 -4.156 0 CA-C-N 112.014 -2.093 . . . . 0.0 106.617 -179.97 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' THR . . . . . 0.456 HG21 ' H ' ' A' ' 504' ' ' LYS . 0.1 OUTLIER -163.56 -21.72 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.203 -2.271 . . . . 0.0 107.592 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.51 -10.35 62.01 Favored Glycine 0 N--CA 1.492 2.42 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.948 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' LYS . . . . . 0.456 ' H ' HG21 ' A' ' 502' ' ' THR . 7.9 mtmt -71.98 120.18 17.21 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.986 -1.086 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' ILE . . . . . 0.543 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.2 tt -96.97 160.65 2.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.867 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' TYR . . . . . 0.753 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 33.0 m-85 -138.18 162.58 33.89 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.128 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' LYS . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 3.1 tmtt? -123.53 151.02 43.28 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.999 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.201 0 C-N-CA 118.773 -1.679 . . . . 0.0 109.998 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.579 ' C ' ' H ' ' A' ' 387' ' ' LYS . . . 52.15 -159.5 0.11 Allowed 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 71.4 mt 50.37 12.09 0.09 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.977 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.579 ' H ' ' C ' ' A' ' 385' ' ' ALA . 0.0 OUTLIER -129.91 -5.27 4.53 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.024 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -171.97 23.94 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.03 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.603 ' C ' ' H ' ' A' ' 391' ' ' VAL . . . -63.14 144.04 49.05 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.586 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 391' ' ' VAL . 0.7 OUTLIER -68.12 36.88 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.551 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.603 ' H ' ' C ' ' A' ' 389' ' ' GLY . 25.4 t -41.01 143.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.326 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.619 ' CG1' ' N ' ' A' ' 393' ' ' GLY . 2.5 pt -87.72 -55.06 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.635 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.619 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -153.98 -157.13 7.97 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.4 p -164.51 108.47 0.93 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -84.84 -146.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 42.0 mt -96.79 139.99 21.89 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.92 93.07 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.61 0 C-N-CA 121.294 1.329 . . . . 0.0 111.303 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.02 -69.85 0.25 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.715 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 57.0 m -133.24 139.25 33.6 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.756 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.31 100.83 0.07 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.895 1.064 . . . . 0.0 110.406 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.616 ' C ' ' SG ' ' A' ' 466' ' ' CYS . . . -152.03 162.36 29.73 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.639 -1.743 . . . . 0.0 112.116 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -141.43 128.44 20.73 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.65 160.58 43.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.019 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -138.77 107.9 6.06 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.023 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.07 30.35 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.051 -1.547 . . . . 0.0 111.307 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . 0.467 ' HE3' ' CD2' ' A' ' 495' ' ' TYR . 3.7 mttp -85.98 137.93 32.36 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.936 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.54 ' O ' ' CG ' ' A' ' 408' ' ' TYR . 49.6 t -55.44 148.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.986 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 407' ' ' VAL . 17.8 m-85 -170.98 139.9 1.48 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.653 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.762 ' CB ' ' HZ2' ' A' ' 481' ' ' LYS . 4.1 m-85 -113.79 42.43 2.01 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.313 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.462 ' OG1' ' OE1' ' A' ' 413' ' ' GLU . 1.0 OUTLIER -159.36 145.0 16.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.886 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -76.83 -18.23 58.51 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.787 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -74.16 -39.93 62.91 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.69 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.462 ' OE1' ' OG1' ' A' ' 410' ' ' THR . 41.8 mt-10 -66.78 -26.76 67.12 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.6 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 418' ' ' HIS . . . -72.5 -38.27 68.17 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.54 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -43.1 86.42 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.876 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.57 -49.58 52.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.842 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -58.77 -62.11 2.11 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.083 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 414' ' ' ALA . 24.8 t-80 -41.53 -30.58 0.21 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.663 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -89.53 -22.02 22.62 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.575 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 417' ' ' ALA . 0.0 OUTLIER -94.91 -49.2 5.67 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.521 -0.871 . . . . 0.0 112.842 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 422' ' ' GLU . . . -153.74 -10.64 0.07 OUTLIER Glycine 0 N--CA 1.497 2.737 0 C-N-CA 118.763 -1.684 . . . . 0.0 112.03 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . 0.446 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 3.0 mt-10 64.24 -145.89 0.28 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 49.87 65.89 1.29 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.614 -1.234 . . . . 0.0 108.352 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 3.3 t -122.47 154.92 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.702 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.459 HG21 ' H ' ' A' ' 426' ' ' LEU . 18.9 mm -118.75 160.9 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.406 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.459 ' H ' HG21 ' A' ' 425' ' ' ILE . 1.4 tp -134.58 125.56 27.47 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.183 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.496 ' HB ' ' CZ ' ' A' ' 409' ' ' PHE . 38.2 t -114.14 127.16 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.75 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ARG . . . . . 0.477 ' H ' HG21 ' A' ' 447' ' ' THR . 0.0 OUTLIER -152.48 146.69 25.47 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.122 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 12.03 2.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.566 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 428' ' ' ARG . 67.2 tt0 -176.4 139.76 0.35 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 9.1 p -106.14 153.49 22.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.271 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.32 158.67 63.39 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.715 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.9 Cg_endo -65.79 -69.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.903 1.736 . . . . 0.0 112.394 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -35.23 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.568 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.624 ' OD1' ' SD ' ' A' ' 439' ' ' MET . 0.6 OUTLIER -62.83 -8.41 6.88 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.622 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 439' ' ' MET . 0.3 OUTLIER -32.68 -58.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.462 ' N ' HG21 ' A' ' 436' ' ' ILE . 53.2 mt-10 -47.93 -41.19 24.15 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 117.961 -1.496 . . . . 0.0 109.086 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -71.91 -25.85 73.92 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' MET . . . . . 0.624 ' SD ' ' OD1' ' A' ' 435' ' ' ASP . 40.5 mtp -70.65 -46.93 62.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.444 ' CE1' ' SD ' ' A' ' 463' ' ' MET . 85.9 m-70 -58.26 -61.66 2.41 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 118.267 -1.373 . . . . 0.0 109.546 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -49.25 -32.15 10.18 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.096 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.652 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -98.04 71.45 2.15 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.544 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.18 3.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.239 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.652 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -144.32 145.17 14.46 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 49.8 mt -148.01 118.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.091 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.444 HD11 ' CG1' ' A' ' 468' ' ' VAL . 4.6 tp -115.55 97.96 6.45 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.477 HG21 ' H ' ' A' ' 428' ' ' ARG . 4.4 p -106.16 160.94 14.95 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.901 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 56.6 t -86.47 -20.62 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.157 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 470' ' ' GLY . 2.0 tpt85 -99.54 -136.04 0.29 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.615 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.522 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 73.14 -170.47 52.05 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.62 -170.34 40.54 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.897 -1.62 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 13.9 ttt -46.95 -37.97 9.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.854 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -158.91 129.26 5.91 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.182 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.1 m -174.29 -178.29 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' HIS . . . . . 0.479 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 34.4 m80 -45.63 -38.3 6.52 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.952 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -59.51 -51.27 70.58 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.694 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -78.19 -52.09 9.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 3.4 t -47.85 -50.49 9.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.284 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 65.9 t -63.99 -39.27 84.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 464' ' ' GLY . . . -65.51 -50.59 64.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.381 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -53.96 -29.07 41.15 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.422 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.15 -35.33 27.4 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' MET . . . . . 0.444 ' SD ' ' CE1' ' A' ' 440' ' ' HIS . 16.2 mmt -97.49 6.43 48.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.727 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 460' ' ' ALA . . . 48.78 24.72 4.4 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.953 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 94.3 m -84.11 146.4 27.91 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.831 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' CYS . . . . . 0.616 ' SG ' ' C ' ' A' ' 401' ' ' GLY . 17.0 t -76.1 129.5 36.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 80.0 m -151.54 146.98 26.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.822 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . 0.529 HG11 ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.69 160.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.393 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' SER . . . . . 0.529 ' N ' HG11 ' A' ' 468' ' ' VAL . 7.0 t -151.04 148.15 27.99 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.596 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 52.0 92.39 0.01 OUTLIER Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . 0.434 ' SG ' HD11 ' A' ' 474' ' ' ILE . 7.9 m -100.69 -159.39 0.73 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.643 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.72 -99.0 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.959 -1.591 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -133.92 43.87 2.8 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.416 0.627 . . . . 0.0 109.34 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.434 HD11 ' SG ' ' A' ' 471' ' ' CYS . 5.0 mt -39.09 110.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.846 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -94.3 121.96 36.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.36 131.13 35.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 117.829 -1.548 . . . . 0.0 112.795 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -104.39 119.45 38.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.552 ' C ' ' N ' ' A' ' 480' ' ' ALA . 1.5 mp0 -62.65 -10.69 13.26 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.598 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -45.51 -20.18 0.06 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 118.236 -1.386 . . . . 0.0 108.518 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.552 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.68 -103.67 0.01 OUTLIER 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . 0.762 ' HZ2' ' CB ' ' A' ' 409' ' ' PHE . 11.2 mmmm -155.96 65.87 0.59 Allowed 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.482 ' CB ' ' HA ' ' A' ' 491' ' ' ALA . 4.8 p -98.43 -179.5 4.36 Favored 'General case' 0 C--O 1.201 -1.475 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.783 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 483' ' ' PHE . 0.5 OUTLIER -150.78 117.23 5.72 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.043 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.17 118.48 28.9 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.839 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.479 HD13 ' H ' ' A' ' 486' ' ' GLY . 61.6 tp -143.53 154.79 43.98 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.775 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . 0.479 ' H ' HD13 ' A' ' 485' ' ' LEU . . . 56.89 -114.59 5.48 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.484 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.85 3.91 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.11 152.19 33.04 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 88.3 m -107.79 112.03 24.49 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.946 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 483' ' ' PHE . 5.6 m-30 -89.45 110.93 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.061 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -98.23 149.01 23.02 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.865 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.485 ' O ' ' CG ' ' A' ' 492' ' ' GLU . 1.9 tm-20 -67.29 69.49 0.09 Allowed 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -173.96 22.47 0.06 OUTLIER Glycine 0 C--N 1.269 -3.139 0 C-N-CA 119.206 -1.473 . . . . 0.0 109.765 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 495' ' ' TYR . 2.4 t0 -140.69 -173.94 3.83 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.655 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . 0.467 ' CD2' ' HE3' ' A' ' 406' ' ' LYS . 0.2 OUTLIER -116.41 129.64 56.34 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.587 ' C ' ' CD1' ' A' ' 496' ' ' ILE . 0.6 OUTLIER -138.37 160.5 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.554 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' SER . . . . . 0.464 ' N ' HD11 ' A' ' 496' ' ' ILE . 17.3 m -125.05 112.11 16.15 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.76 141.25 41.03 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.539 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.12 161.7 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.037 0.922 . . . . 0.0 112.531 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' GLY . . . . . 0.603 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -150.65 94.73 0.15 Allowed Glycine 0 C--N 1.287 -2.189 0 N-CA-C 106.737 -2.545 . . . . 0.0 106.737 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' SER . . . . . 0.469 ' C ' ' OG1' ' A' ' 502' ' ' THR . 0.3 OUTLIER 174.31 1.55 0.0 OUTLIER 'General case' 1 C--N 1.241 -4.122 0 CA-C-N 112.995 -1.602 . . . . 0.0 108.161 179.797 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' THR . . . . . 0.469 ' OG1' ' C ' ' A' ' 501' ' ' SER . 0.6 OUTLIER -168.66 -21.03 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.019 -1.9 . . . . 0.0 107.844 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.19 72.97 1.28 Allowed Glycine 0 N--CA 1.484 1.865 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.46 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -139.88 112.74 8.06 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.348 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 5.8 mt -89.46 149.05 4.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.286 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 507' ' ' LYS . 46.4 t80 -147.66 161.44 41.18 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.412 ' O ' ' CE2' ' A' ' 506' ' ' TYR . 15.7 tttt -116.89 160.61 20.61 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.965 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 76.66 128.42 0.31 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.605 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.26 115.31 4.05 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.828 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' ILE . . . . . 0.478 HG22 ' H ' ' A' ' 511' ' ' GLU . 1.5 mt -63.89 165.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.718 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.478 ' H ' HG22 ' A' ' 510' ' ' ILE . 21.0 tp10 . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.877 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.724 0.297 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -138.16 15.85 2.81 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.575 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 75.1 mt -95.94 9.81 39.41 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.611 -0.835 . . . . 0.0 109.198 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -120.62 1.55 10.6 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.271 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -164.26 22.53 0.07 Allowed 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.487 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -77.8 -126.9 0.37 Allowed Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.323 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -147.41 85.87 1.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.613 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.572 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 24.3 t -96.59 135.18 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.4 pt -90.75 -31.6 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 164.65 -176.34 40.5 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.075 -1.536 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.8 p -141.5 151.47 43.34 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.184 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -142.46 -152.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.344 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.718 ' N ' ' CD2' ' A' ' 396' ' ' LEU . 0.1 OUTLIER -63.45 115.51 18.77 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.323 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.79 100.52 0.83 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.023 1.149 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -59.89 -76.03 0.05 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.094 -1.043 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.3 t -137.85 151.38 70.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.732 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.08 104.04 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.447 1.431 . . . . 0.0 110.822 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.62 163.24 30.29 Favored Glycine 0 N--CA 1.503 3.152 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.87 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -137.81 123.41 19.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.48 161.16 43.06 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.703 -1.599 . . . . 0.0 114.12 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -148.5 107.11 3.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.001 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.47 31.81 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 118.905 -1.617 . . . . 0.0 112.151 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . 0.637 ' HZ3' ' CB ' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -84.5 132.51 34.53 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.522 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.419 HG11 ' N ' ' A' ' 408' ' ' TYR . 40.8 t -69.49 158.59 5.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.028 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.577 ' CD1' ' CD ' ' A' ' 413' ' ' GLU . 3.8 m-85 -151.8 -170.62 3.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.463 ' CZ ' HG13 ' A' ' 427' ' ' VAL . 2.3 m-85 -142.27 6.43 1.71 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.798 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.0 p -141.64 142.25 33.41 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -67.25 -12.17 59.41 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.661 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -73.12 -42.86 62.45 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.577 ' CD ' ' CD1' ' A' ' 408' ' ' TYR . 49.9 mt-10 -63.92 -37.9 89.12 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.873 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.42 68.37 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.773 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -69.93 -38.42 76.19 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.271 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.53 -13.29 34.91 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.206 -0.997 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -90.2 -52.43 4.94 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.83 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -47.79 -21.58 0.42 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.328 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.9 OUTLIER -83.75 -68.68 0.69 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.205 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -93.2 -24.35 18.24 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.761 -0.776 . . . . 0.0 112.342 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -89.27 -51.87 2.85 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.027 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 417' ' ' ALA . 3.6 mt-10 62.38 165.65 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.022 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 422' ' ' GLU . 12.6 mpt_? 45.0 80.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.535 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 425' ' ' ILE . 4.2 t -130.21 161.4 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.984 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.414 ' N ' HG11 ' A' ' 424' ' ' VAL . 7.2 mm -133.42 160.81 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.653 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.448 ' HG ' ' N ' ' A' ' 427' ' ' VAL . 9.8 tp -131.65 151.69 51.42 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.613 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.463 HG13 ' CZ ' ' A' ' 409' ' ' PHE . 6.2 t -131.45 126.28 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ARG . . . . . 0.502 ' O ' ' CG2' ' A' ' 447' ' ' THR . 90.4 mtt180 -151.89 150.77 30.44 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.354 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 429' ' ' LEU . 7.0 mt -59.55 -44.09 93.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.646 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.62 -178.16 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.81 -178.07 6.83 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.927 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.78 122.42 0.81 Allowed Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.6 -33.6 93.34 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.036 1.157 . . . . 0.0 111.779 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -73.81 -9.4 58.62 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.1 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -87.26 -8.33 56.91 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.565 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 7.9 tp -39.91 -50.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.5 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.643 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 27.3 mt-10 -61.19 -31.53 71.28 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 117.877 -1.529 . . . . 0.0 108.387 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.16 -28.09 60.88 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 75.0 mtp -66.91 -42.65 85.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.191 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -67.46 -58.88 3.94 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.198 -1.401 . . . . 0.0 108.924 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -49.36 -36.07 20.51 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.392 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.699 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -94.19 81.59 4.07 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.158 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.95 21.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.113 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.699 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -165.97 149.57 15.86 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.4 HG23 ' SG ' ' A' ' 467' ' ' CYS . 0.2 OUTLIER -149.39 131.56 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.97 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.72 108.66 12.77 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.06 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 428' ' ' ARG . 3.4 p -121.83 160.23 25.12 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.538 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 2.6 t -79.09 -25.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.406 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -121.13 -142.22 0.34 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.197 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 81.13 -143.9 24.36 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.137 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . 0.608 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 55.67 -140.87 40.05 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.204 -1.474 . . . . 0.0 110.122 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.48 ' C ' ' HG1' ' A' ' 453' ' ' THR . 24.9 mtm 43.82 38.95 2.3 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.487 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' THR . . . . . 0.48 ' HG1' ' C ' ' A' ' 452' ' ' MET . 56.2 p 42.43 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.575 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 45.5 p -160.06 -164.64 1.33 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.168 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' HIS . . . . . 0.49 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 69.0 m80 -43.9 -51.36 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.211 -0.995 . . . . 0.0 110.593 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -42.34 -55.33 3.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.764 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.48 6.31 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.667 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 50.3 t -47.02 -40.83 5.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.49 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 43.4 t -74.36 -42.13 50.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.26 -35.89 81.57 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -68.46 -40.34 81.07 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.456 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -61.12 -36.52 92.48 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.388 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.78 -15.65 29.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.989 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 61.91 57.88 15.4 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.644 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 161.24 17.4 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 401' ' ' GLY . 19.0 t -81.11 91.7 6.16 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.481 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.4 ' SG ' HG23 ' A' ' 445' ' ' ILE . 4.2 t -129.34 158.8 38.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.397 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -136.62 162.71 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.055 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' SER . . . . . 0.608 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 32.1 t -143.59 160.17 41.13 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.669 -1.213 . . . . 0.0 113.093 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 47.35 75.18 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.434 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . 0.481 ' SG ' ' CD1' ' A' ' 485' ' ' LEU . 1.8 t -84.75 -171.67 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.215 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -50.25 -90.83 0.01 OUTLIER Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.672 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -155.67 66.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 0.0 OUTLIER -62.79 107.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.41 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -89.91 123.28 33.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.58 126.58 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.565 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -97.39 113.63 25.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.731 ' C ' ' H ' ' A' ' 480' ' ' ALA . 0.8 OUTLIER -67.87 -6.12 20.1 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.416 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -52.92 -7.43 0.07 Allowed 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.551 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.731 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -179.72 -82.3 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 112.527 -2.124 . . . . 0.0 105.487 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . 0.483 ' HB3' ' CG ' ' A' ' 492' ' ' GLU . 4.5 mttt 169.17 89.18 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.099 0.952 . . . . 0.0 109.772 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.599 HG22 ' H ' ' A' ' 491' ' ' ALA . 1.4 p -151.29 138.78 19.53 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.301 -1.772 . . . . 0.0 111.885 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' PHE . . . . . 0.446 ' HB2' ' CG2' ' A' ' 474' ' ' ILE . 16.0 p90 -97.83 152.0 19.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -119.33 116.28 25.9 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.198 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.481 ' CD1' ' SG ' ' A' ' 471' ' ' CYS . 6.2 tt -150.5 152.87 34.86 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 69.04 -108.35 2.44 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 118.828 -1.653 . . . . 0.0 110.286 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.614 ' C ' ' CD2' ' A' ' 488' ' ' HIS . . . -137.34 27.21 2.89 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.194 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.614 ' CD2' ' C ' ' A' ' 487' ' ' GLY . 26.7 m-70 -150.68 152.51 34.06 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.829 -1.149 . . . . 0.0 111.286 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.9 m -119.83 97.12 5.47 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.12 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 490' ' ' PHE . 39.0 p90 -155.48 155.31 33.26 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.98 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.599 ' H ' HG22 ' A' ' 482' ' ' THR . . . -152.1 -124.31 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.483 ' CG ' ' HB3' ' A' ' 481' ' ' LYS . 1.1 pt-20 -67.9 49.03 0.05 Allowed 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -138.51 2.63 2.83 Favored Glycine 0 C--N 1.283 -2.37 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -167.56 -173.97 2.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.477 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -122.94 141.94 51.36 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.742 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.491 ' H ' HD13 ' A' ' 496' ' ' ILE . 0.6 OUTLIER -121.47 160.06 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.944 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 506' ' ' TYR . 6.3 m -115.37 99.46 7.4 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -100.48 140.83 34.18 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.219 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.486 ' N ' HD13 ' A' ' 498' ' ' LEU . 21.7 t70 -93.42 160.64 14.72 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-O 122.018 0.913 . . . . 0.0 111.896 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -148.27 95.14 0.16 Allowed Glycine 0 C--N 1.272 -3.026 0 N-CA-C 106.508 -2.637 . . . . 0.0 106.508 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 2.0 t 171.15 4.47 0.0 OUTLIER 'General case' 0 C--N 1.244 -3.981 0 CA-C-N 112.177 -2.012 . . . . 0.0 107.065 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.38 -22.79 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.516 -2.129 . . . . 0.0 107.496 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 96.93 -7.86 65.08 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.882 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 154.74 9.8 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.914 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 2.1 mp -135.04 146.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.295 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' TYR . . . . . 0.572 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 14.0 m-85 -133.79 161.96 33.3 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -127.74 153.86 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.209 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 72.78 124.31 0.08 OUTLIER Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.209 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.562 ' N ' ' OD1' ' A' ' 509' ' ' ASP . 13.1 p-10 -42.19 108.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.011 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' ILE . . . . . . . . . . . . . 14.5 pt -74.14 176.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.575 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--N 1.303 -1.437 0 CA-C-O 116.3 -1.809 . . . . 0.0 110.818 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.677 0.275 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 388' ' ' ALA . . . -99.31 119.18 37.51 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.482 ' O ' ' N ' ' A' ' 389' ' ' GLY . 4.7 mt 51.25 46.91 25.77 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 388' ' ' ALA . 5.0 tttt 52.62 35.34 17.87 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 385' ' ' ALA . . . 79.72 23.02 0.49 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.616 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 385' ' ' ALA . . . 51.38 55.2 20.64 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 118.882 -1.628 . . . . 0.0 110.411 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -92.37 59.04 3.34 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.709 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.657 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 65.1 t -46.3 156.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.289 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.422 ' N ' ' CG1' ' A' ' 391' ' ' VAL . 34.3 pt -128.29 -11.8 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.363 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -175.25 -167.41 34.37 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.896 -1.621 . . . . 0.0 111.481 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.2 p 177.12 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.327 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.36 -151.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 8.9 mt -80.74 127.16 76.12 Favored Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.601 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.08 97.32 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -60.39 -59.37 5.51 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.946 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.01 133.72 12.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.91 98.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 120.791 0.994 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -153.43 159.58 28.7 Favored Glycine 0 N--CA 1.504 3.169 0 C-N-CA 118.876 -1.63 . . . . 0.0 111.882 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.756 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -133.13 132.05 41.2 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.711 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.39 161.38 42.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.184 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.14 110.94 6.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.231 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -153.16 167.69 31.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.812 -1.661 . . . . 0.0 111.774 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -83.89 156.46 22.39 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.179 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.579 ' HB ' ' H ' ' A' ' 492' ' ' GLU . 0.0 OUTLIER -78.79 165.23 3.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.639 -0.825 . . . . 0.0 113.072 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.59 ' CE1' ' OE1' ' A' ' 413' ' ' GLU . 3.6 m-85 -170.37 170.0 7.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.993 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.48 ' CG ' ' HD2' ' A' ' 481' ' ' LYS . 14.2 m-85 -137.36 23.21 2.97 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.805 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 12.6 p -146.95 142.0 27.09 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.25 -12.28 61.37 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -78.22 -36.47 47.12 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.451 -0.899 . . . . 0.0 109.718 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.59 ' OE1' ' CE1' ' A' ' 408' ' ' TYR . 62.0 mm-40 -65.58 -40.38 92.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.63 85.19 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.345 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -56.48 -34.25 66.74 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.762 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.62 -50.82 5.71 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.717 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -55.17 -48.02 74.35 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.28 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' HIS . . . . . 0.594 ' ND1' ' OE1' ' A' ' 419' ' ' GLU . 17.9 t-80 -43.76 -41.01 4.66 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.045 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.594 ' OE1' ' ND1' ' A' ' 418' ' ' HIS . 0.6 OUTLIER -91.92 -25.6 18.83 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.457 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 420' ' ' LYS . 7.6 mtpm? -92.69 -52.8 4.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.63 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -101.3 -31.6 5.52 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.148 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . 0.461 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 0.9 OUTLIER 65.96 148.6 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.396 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 55.89 95.01 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.879 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.54 162.45 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.484 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.406 ' CD1' ' HA3' ' A' ' 444' ' ' GLY . 16.8 mm -121.69 159.93 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 6.6 tp -136.15 134.52 38.34 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.345 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' ' 483' ' ' PHE . 8.7 t -117.72 121.73 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.714 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ARG . . . . . 0.494 ' O ' ' CG2' ' A' ' 447' ' ' THR . 47.8 mtt180 -151.29 161.64 42.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -66.5 0.53 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.62 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -109.3 -165.53 1.02 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 432' ' ' SER . 0.1 OUTLIER -99.0 -163.97 1.09 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.32 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.517 ' N ' ' OG1' ' A' ' 431' ' ' THR . 1.4 t -175.61 137.16 0.51 Allowed Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.557 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.5 Cg_endo -62.27 -77.59 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.388 1.392 . . . . 0.0 112.126 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -44.01 -18.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 439' ' ' MET . 11.0 m-20 -82.53 -9.0 59.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.39 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.751 ' CG2' ' H ' ' A' ' 437' ' ' GLU . 6.1 tp -46.78 -63.54 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.579 -0.849 . . . . 0.0 111.145 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.751 ' H ' ' CG2' ' A' ' 436' ' ' ILE . 5.4 mt-10 -52.27 -26.98 13.34 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.414 -1.315 . . . . 0.0 108.59 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -81.17 -24.67 56.9 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 435' ' ' ASP . 53.3 mtt -77.64 -41.97 36.47 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.861 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.589 ' NE2' ' CD1' ' A' ' 436' ' ' ILE . 28.1 m170 -65.14 -49.04 71.41 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.813 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -48.38 -20.83 0.45 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.536 ' N ' ' C ' ' A' ' 440' ' ' HIS . . . -116.57 61.77 0.72 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.53 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.641 ' H ' ' CD ' ' A' ' 443' ' ' GLU . 1.4 pm0 -26.03 -58.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.875 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.406 ' HA3' ' CD1' ' A' ' 425' ' ' ILE . . . -81.48 145.2 25.01 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 118.494 -1.812 . . . . 0.0 109.009 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 41.0 mt -147.81 112.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 118.449 -1.301 . . . . 0.0 112.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.425 ' CD2' HD23 ' A' ' 498' ' ' LEU . 1.3 mm? -100.35 137.63 38.51 Favored 'General case' 0 C--O 1.187 -2.217 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 428' ' ' ARG . 0.3 OUTLIER -149.64 151.44 33.76 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.019 -1.473 . . . . 0.0 111.896 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.429 ' HA ' ' SG ' ' A' ' 471' ' ' CYS . 18.8 t -77.02 -24.29 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.805 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 10.7 ttt-85 -108.13 -143.66 0.38 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.225 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.508 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 73.93 -162.69 54.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . 0.702 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 77.21 -41.92 1.85 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.159 -1.496 . . . . 0.0 110.392 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.461 ' C ' ' CG2' ' A' ' 453' ' ' THR . 53.7 mtt -64.86 19.09 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' THR . . . . . 0.702 ' H ' ' C ' ' A' ' 451' ' ' GLY . 1.0 OUTLIER 62.84 114.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.874 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.7 t -173.28 -155.54 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' HIS . . . . . 0.473 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 45.8 t60 -57.67 -36.8 72.4 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . 0.418 ' HB3' ' CG2' ' A' ' 431' ' ' THR . . . -63.23 -44.67 94.59 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.0 -57.43 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.648 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.67 -41.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.7 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 51.5 t -65.95 -53.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.11 73.48 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -69.33 -24.0 63.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.606 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.05 -48.3 5.8 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.642 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 56.7 mmm -78.41 -40.81 34.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.982 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.35 22.0 30.68 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.574 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' THR . . . . . 0.481 ' CG2' ' H ' ' A' ' 466' ' ' CYS . 7.3 m -76.03 -170.51 1.41 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' CYS . . . . . 0.756 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -99.1 120.32 39.29 Favored 'General case' 0 C--O 1.202 -1.414 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.667 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 23.4 t -151.29 147.24 26.72 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.055 -1.458 . . . . 0.0 112.005 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.89 162.71 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.747 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' SER . . . . . 0.508 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 28.8 t -147.79 160.58 42.58 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.995 -1.082 . . . . 0.0 112.62 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 46.94 72.92 0.35 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.184 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . 0.445 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.5 OUTLIER -83.43 -158.82 0.32 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.878 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -67.69 -101.71 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.31 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -135.33 54.57 1.92 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.861 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.445 HD12 ' SG ' ' A' ' 471' ' ' CYS . 5.1 mt -45.67 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.921 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -89.37 121.39 31.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.01 122.44 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.929 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.431 ' C ' ' H ' ' A' ' 479' ' ' GLU . 5.0 m120 -99.46 111.97 24.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.904 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.784 ' C ' ' H ' ' A' ' 480' ' ' ALA . 35.9 mt-10 -60.54 0.29 0.21 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.286 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 480' ' ' ALA . 47.4 mt-10 -64.24 17.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.254 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.784 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 155.2 -71.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . 0.48 ' HD2' ' CG ' ' A' ' 409' ' ' PHE . 2.1 mmtt 158.51 79.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.492 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 491' ' ' ALA . 6.7 p -132.28 143.76 50.12 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.681 -0.807 . . . . 0.0 112.325 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' PHE . . . . . 0.627 ' H ' ' HB1' ' A' ' 491' ' ' ALA . 10.8 p90 -98.96 143.51 29.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.201 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 485' ' ' LEU . 5.1 tp10 -101.54 111.24 23.42 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.196 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 487' ' ' GLY . 0.8 OUTLIER -134.6 117.83 16.55 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.002 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 485' ' ' LEU . . . 21.3 -74.15 0.0 OUTLIER Glycine 0 N--CA 1.51 3.593 0 O-C-N 124.486 1.116 . . . . 0.0 114.439 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 485' ' ' LEU . . . -51.76 -67.92 1.78 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.543 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 26.6 m80 -154.44 163.53 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.156 -1.418 . . . . 0.0 112.869 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' THR . . . . . 0.474 ' OG1' ' CD ' ' A' ' 484' ' ' GLU . 9.2 m -93.6 99.29 11.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.554 ' CG ' ' NZ ' ' A' ' 507' ' ' LYS . 40.3 p90 -153.22 154.13 34.07 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 118.455 -1.298 . . . . 0.0 113.825 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.627 ' HB1' ' H ' ' A' ' 483' ' ' PHE . . . 170.94 172.52 0.07 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 113.767 -1.561 . . . . 0.0 108.678 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.579 ' H ' ' HB ' ' A' ' 407' ' ' VAL . 19.7 tt0 26.06 41.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 O-C-N 124.266 0.979 . . . . 0.0 109.978 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -167.61 1.43 0.04 OUTLIER Glycine 0 C--N 1.281 -2.505 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 495' ' ' TYR . 2.9 m-20 -156.96 -152.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . 0.424 ' H ' ' HB3' ' A' ' 494' ' ' ASP . 1.5 p90 -154.32 140.52 18.51 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.433 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.487 ' H ' ' CD1' ' A' ' 496' ' ' ILE . 0.2 OUTLIER -122.99 160.6 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.569 -0.852 . . . . 0.0 113.073 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 506' ' ' TYR . 1.8 p -115.29 98.37 6.72 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' LEU . . . . . 0.466 HD13 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -93.39 142.31 27.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.893 -1.123 . . . . 0.0 113.012 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.466 ' N ' HD13 ' A' ' 498' ' ' LEU . 0.9 OUTLIER -106.52 161.54 14.52 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.479 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -156.28 95.41 0.15 Allowed Glycine 0 C--N 1.277 -2.707 0 N-CA-C 106.836 -2.505 . . . . 0.0 106.836 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 77.7 p -178.03 6.68 0.01 OUTLIER 'General case' 1 C--N 1.241 -4.142 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.33 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -175.35 -19.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 112.822 -1.99 . . . . 0.0 107.72 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 86.77 74.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.558 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 499' ' ' ASP . 19.8 mttp -155.45 115.16 3.68 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.258 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' ILE . . . . . 0.548 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.1 tt -93.91 160.45 2.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.687 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' TYR . . . . . 0.657 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 18.8 m-85 -141.82 161.44 37.95 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.771 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.554 ' NZ ' ' CG ' ' A' ' 490' ' ' PHE . 47.6 tttt -107.67 154.36 21.57 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.695 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 77.27 144.7 1.98 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.567 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -61.41 157.31 17.09 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.701 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' ILE . . . . . 0.753 ' CD1' ' H ' ' A' ' 511' ' ' GLU . 0.2 OUTLIER -103.28 164.99 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.907 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.753 ' H ' ' CD1' ' A' ' 510' ' ' ILE . 6.4 tm-20 . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 116.381 -1.771 . . . . 0.0 110.82 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.866 0.365 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -99.39 33.75 2.37 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.733 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 386' ' ' LEU . 2.4 pp -103.3 13.67 33.27 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.23 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.0 -5.99 7.32 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.942 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -169.15 19.54 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -75.26 -109.71 0.1 OUTLIER Glycine 0 N--CA 1.489 2.192 0 C-N-CA 118.889 -1.624 . . . . 0.0 110.425 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -154.31 90.41 1.34 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.485 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.486 HG23 ' CE1' ' A' ' 506' ' ' TYR . 0.4 OUTLIER -83.79 137.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.707 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.503 HG13 ' N ' ' A' ' 393' ' ' GLY . 28.2 pt -77.48 -39.38 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.571 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.503 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -178.56 -162.33 27.97 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.499 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 121.11 0.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.615 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . 0.431 ' HB2' ' SG ' ' A' ' 471' ' ' CYS . . . -94.86 -142.69 0.25 Allowed 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.913 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.77 128.34 48.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.328 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.73 98.2 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 121.076 1.184 . . . . 0.0 111.756 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . 0.433 ' HB1' ' SG ' ' A' ' 467' ' ' CYS . . . -62.93 -74.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.26 146.24 60.07 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.946 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -52.27 100.4 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.762 1.642 . . . . 0.0 111.078 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.65 161.22 29.74 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 117.9 -2.095 . . . . 0.0 112.989 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -150.48 117.23 5.83 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.135 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.49 161.57 42.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.652 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.35 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.746 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.16 166.64 31.09 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.337 -1.887 . . . . 0.0 112.338 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -85.24 134.29 34.14 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.567 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 408' ' ' TYR . 2.2 p -66.21 138.24 23.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.998 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.658 ' CE1' ' OE2' ' A' ' 413' ' ' GLU . 1.5 m-85 -153.08 146.16 24.63 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.584 ' CD2' ' CD ' ' A' ' 481' ' ' LYS . 4.2 m-85 -110.94 41.53 1.8 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.531 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.95 143.65 12.72 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -78.11 -13.36 59.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.606 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.61 -41.04 24.61 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.06 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.658 ' OE2' ' CE1' ' A' ' 408' ' ' TYR . 6.0 mm-40 -64.38 -40.6 96.14 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.966 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.07 97.99 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.46 -38.28 90.54 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -82.01 -16.96 48.52 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.56 -52.4 4.91 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.183 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.51 -19.06 55.78 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.563 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 421' ' ' GLY . 0.7 OUTLIER -64.6 -48.24 75.67 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.877 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -1.07 0.08 Allowed 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 77.82 64.86 1.98 Allowed Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.08 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . 0.67 ' C ' ' HE ' ' A' ' 423' ' ' ARG . 7.2 mt-10 -146.43 -166.53 2.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.414 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . 0.725 ' N ' ' HE ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER -115.69 148.36 39.82 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.632 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.419 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 1.7 t -148.97 162.1 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.075 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 6.2 mm -123.81 160.74 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.24 121.14 30.39 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.432 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.49 HG11 ' CE2' ' A' ' 409' ' ' PHE . 24.8 t -111.31 117.27 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.246 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ARG . . . . . 0.523 ' H ' HG22 ' A' ' 447' ' ' THR . 17.0 mtp85 -152.43 155.52 37.7 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.76 ' H ' ' CD2' ' A' ' 429' ' ' LEU . 0.7 OUTLIER -106.32 28.71 7.48 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.571 1.177 . . . . 0.0 109.649 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.39 121.17 2.96 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 456' ' ' ALA . 0.8 OUTLIER -76.08 179.56 5.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.97 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 2.9 t -177.24 139.5 0.44 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.068 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.91 -72.9 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.617 1.545 . . . . 0.0 111.871 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 435' ' ' ASP . 7.4 pt-20 -39.48 -32.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.659 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 438' ' ' GLY . 4.0 m-20 -62.14 -8.6 5.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.727 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.505 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 6.7 tp -48.54 -43.4 13.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.878 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.505 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 23.2 mt-10 -62.66 -27.19 69.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 117.769 -1.572 . . . . 0.0 107.957 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -78.88 -26.93 57.58 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 27.8 mtt -66.49 -39.22 88.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.756 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -74.54 -39.72 62.16 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.336 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.756 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -55.76 -28.77 57.71 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.782 -1.167 . . . . 0.0 107.91 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.619 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -112.84 89.47 3.09 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.118 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -64.36 37.23 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.862 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -171.58 140.52 5.9 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.9 mm -139.24 132.17 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.913 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.418 HD11 ' CG1' ' A' ' 468' ' ' VAL . 1.4 tp -135.96 95.98 3.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.533 ' H ' ' HG1' ' A' ' 447' ' ' THR . 2.2 p -109.14 161.44 15.21 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.804 -0.758 . . . . 0.0 112.768 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 37.0 t -85.23 -21.0 8.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.971 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 470' ' ' GLY . 19.1 mmm-85 -105.97 -148.11 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.626 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 89.08 -136.58 13.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . 0.578 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 82.59 163.69 33.76 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 16.8 tpp 46.64 13.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.482 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 451' ' ' GLY . 0.3 OUTLIER 66.97 131.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.592 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 455' ' ' HIS . 9.0 t -163.58 -169.97 2.08 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.957 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' HIS . . . . . 0.492 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 4.6 m80 -43.41 -46.04 6.47 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . 0.424 ' HB3' ' CG2' ' A' ' 431' ' ' THR . . . -61.39 -48.12 82.68 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.663 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -74.66 -55.02 6.33 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.534 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 2.2 t -50.25 -53.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.548 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.492 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 88.6 t -54.08 -44.1 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.527 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.461 ' HB1' ' SG ' ' A' ' 467' ' ' CYS . . . -61.22 -55.17 35.15 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -55.38 -28.69 55.64 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.534 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.11 66.14 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.602 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 463' ' ' MET . 1.1 tpt -91.46 -41.66 10.72 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.03 83.94 1.64 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.523 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' THR . . . . . 0.598 ' CG2' ' N ' ' A' ' 466' ' ' CYS . 1.9 m -162.36 171.93 16.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.8 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' CYS . . . . . 0.598 ' N ' ' CG2' ' A' ' 465' ' ' THR . 12.8 t -78.1 126.47 30.87 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.958 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.461 ' SG ' ' HB1' ' A' ' 460' ' ' ALA . 0.5 OUTLIER -151.2 148.36 28.15 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.89 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . 0.508 HG12 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.01 160.78 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.67 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' SER . . . . . 0.578 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 6.9 t -150.85 152.6 33.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.443 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 44.16 87.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.431 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . 0.451 ' SG ' HD13 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -99.63 -174.78 2.8 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.45 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -47.22 -84.29 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -158.15 66.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.95 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.462 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.3 mt -61.96 102.71 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.604 -0.839 . . . . 0.0 112.45 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.69 120.29 29.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 477' ' ' ASN . 52.9 mt -88.76 137.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.327 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.529 ' CB ' ' OG1' ' A' ' 482' ' ' THR . 0.3 OUTLIER -107.42 123.15 47.96 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.682 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.604 ' C ' ' N ' ' A' ' 480' ' ' ALA . 20.3 mm-40 -54.58 -7.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 478' ' ' GLU . 0.1 OUTLIER -46.46 -18.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.239 -1.384 . . . . 0.0 108.311 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.604 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . 177.56 -97.37 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 112.283 -2.235 . . . . 0.0 105.43 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . 0.584 ' CD ' ' CD2' ' A' ' 409' ' ' PHE . 3.6 mmpp? -148.55 40.49 0.92 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.529 ' OG1' ' CB ' ' A' ' 477' ' ' ASN . 44.5 p -68.94 172.94 5.88 Favored 'General case' 0 C--O 1.197 -1.708 0 CA-C-N 113.975 -1.466 . . . . 0.0 114.384 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 483' ' ' PHE . 0.1 OUTLIER -151.5 147.94 27.45 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.812 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' GLU . . . . . 0.495 ' C ' ' CD ' ' A' ' 484' ' ' GLU . 3.1 tp10 -131.72 113.89 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.372 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.469 ' CD2' ' C ' ' A' ' 485' ' ' LEU . 0.3 OUTLIER -151.08 161.73 42.18 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.786 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.21 -115.41 7.97 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.036 -1.554 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.454 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -130.17 29.53 3.67 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.38 -1.391 . . . . 0.0 110.804 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 15.3 m170 -151.21 148.77 28.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.68 -1.208 . . . . 0.0 111.41 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' THR . . . . . 0.434 ' OG1' ' OE1' ' A' ' 484' ' ' GLU . 3.3 m -116.71 99.14 6.92 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.169 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.49 ' CZ ' ' HG3' ' A' ' 507' ' ' LYS . 38.3 m-85 -90.06 160.6 16.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.444 ' HA ' ' CB ' ' A' ' 482' ' ' THR . . . -126.5 126.27 43.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.116 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.477 ' H ' ' HA ' ' A' ' 482' ' ' THR . 2.6 tm-20 -45.05 103.12 0.03 OUTLIER 'General case' 0 CA--C 1.478 -1.794 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.402 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 159.01 14.26 0.04 OUTLIER Glycine 0 C--N 1.261 -3.613 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' ASP . . . . . 0.594 ' CG ' ' N ' ' A' ' 495' ' ' TYR . 0.4 OUTLIER -138.44 -153.31 0.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.139 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . 0.594 ' N ' ' CG ' ' A' ' 494' ' ' ASP . 2.5 p90 -152.55 139.79 19.39 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.597 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 496' ' ' ILE . 0.0 OUTLIER -127.38 161.34 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.528 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 506' ' ' TYR . 3.3 t -104.61 102.88 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' LEU . . . . . 0.482 HD11 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -102.28 134.29 45.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.642 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.482 ' N ' HD11 ' A' ' 498' ' ' LEU . 0.1 OUTLIER -121.03 142.38 49.86 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.481 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -147.8 90.4 0.15 Allowed Glycine 0 C--O 1.197 -2.188 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 7.4 p -160.74 8.34 0.08 Allowed 'General case' 0 C--N 1.252 -3.642 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.41 -16.48 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 111.67 -2.514 . . . . 0.0 106.863 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 86.3 85.45 1.06 Allowed Glycine 0 N--CA 1.484 1.835 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.194 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -158.04 102.82 1.82 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 3.5 mt -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.391 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' A' ' 497' ' ' SER . 75.5 m-85 -123.01 161.81 23.55 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.902 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.49 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 10.7 tmtt? -108.76 152.82 24.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . 0.438 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . 67.99 141.39 0.08 OUTLIER Glycine 0 N--CA 1.484 1.84 0 C-N-CA 119.057 -1.545 . . . . 0.0 110.243 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -57.93 146.02 33.7 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.6 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' ILE . . . . . 0.514 HG21 ' H ' ' A' ' 511' ' ' GLU . 1.7 mt -140.69 165.58 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.66 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.514 ' H ' HG21 ' A' ' 510' ' ' ILE . 2.2 tt0 . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.638 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.95 0.405 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.576 ' C ' ' H ' ' A' ' 387' ' ' LYS . . . 60.78 172.97 0.1 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.008 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 12.1 mt 46.79 15.05 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.791 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.576 ' H ' ' C ' ' A' ' 385' ' ' ALA . 47.9 mttm -136.98 -1.6 2.17 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.354 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -153.72 15.31 0.5 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.96 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -85.93 139.2 16.82 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.028 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -80.91 59.36 3.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.794 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 2.3 t -50.13 132.21 9.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.564 ' CG1' ' N ' ' A' ' 393' ' ' GLY . 3.4 pt -78.03 -52.49 15.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . 170.84 -170.92 43.54 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.7 p -143.2 142.11 31.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.769 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.09 -145.75 0.4 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 6.8 mt -77.17 125.28 86.8 Favored Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.768 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.82 102.36 0.63 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.982 1.122 . . . . 0.0 111.26 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -70.77 -62.15 1.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.356 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.8 t -146.73 140.88 15.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.975 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.29 103.36 0.15 Allowed 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.078 1.185 . . . . 0.0 111.072 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -151.25 161.68 29.22 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.772 -1.68 . . . . 0.0 112.28 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -134.93 124.6 25.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -149.76 160.89 43.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.143 -1.423 . . . . 0.0 112.595 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.16 110.11 5.87 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.017 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.12 165.92 30.89 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.957 -1.592 . . . . 0.0 111.292 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . 0.488 ' N ' ' HD2' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -85.18 147.14 26.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.486 ' CG2' ' HA ' ' A' ' 492' ' ' GLU . 2.0 m -78.72 142.7 13.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.473 -1.291 . . . . 0.0 113.228 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -146.87 146.47 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.892 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.502 ' CD2' ' HD2' ' A' ' 481' ' ' LYS . 4.9 m-85 -105.84 37.41 2.25 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.439 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 21.5 p -155.85 141.45 17.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 -12.8 59.89 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.278 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.47 -43.62 59.81 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.672 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.15 -42.62 86.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.674 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -61.29 -39.67 91.31 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.523 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -58.86 -30.15 67.51 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.985 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -88.6 -38.74 14.62 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.537 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -69.04 -61.01 1.97 Allowed 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.114 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 417' ' ' ALA . 19.5 t-80 -43.4 -26.52 0.2 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.811 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.435 ' N ' ' C ' ' A' ' 417' ' ' ALA . 30.1 tt0 -91.17 -33.92 15.22 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.375 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 417' ' ' ALA . 29.4 mtmt -131.74 49.9 2.28 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.813 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -178.38 -48.24 0.07 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . 0.469 ' O ' ' NE ' ' A' ' 423' ' ' ARG . 2.5 mt-10 48.96 71.23 0.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.167 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . 0.469 ' NE ' ' O ' ' A' ' 422' ' ' GLU . 6.3 mtm180 164.04 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 0.2 OUTLIER -147.51 160.34 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.698 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 43.2 mm -121.25 160.66 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.102 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 13.1 tp -127.31 118.55 24.4 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.83 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 409' ' ' PHE . 1.5 t -104.66 130.82 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.038 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ARG . . . . . 0.549 ' O ' ' CG2' ' A' ' 447' ' ' THR . 1.6 mtp85 -153.01 145.94 24.51 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.471 ' H ' HD13 ' A' ' 429' ' ' LEU . 5.8 mp -56.61 -60.72 3.13 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.816 -1.553 . . . . 0.0 109.698 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.9 -175.09 2.59 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.611 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.17 176.61 6.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.183 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.2 t -173.09 128.35 0.52 Allowed Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.357 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.0 Cg_endo -61.41 -56.37 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.107 1.205 . . . . 0.0 111.501 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -45.71 -13.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.968 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 433' ' ' PRO . 13.4 t70 -90.31 -8.3 51.2 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.557 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.717 ' CG2' ' H ' ' A' ' 437' ' ' GLU . 4.9 tp -41.85 -60.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.174 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.717 ' H ' ' CG2' ' A' ' 436' ' ' ILE . 19.3 mm-40 -49.11 -33.75 12.51 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.419 -1.312 . . . . 0.0 109.189 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.46 -24.18 68.66 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 436' ' ' ILE . 26.8 mtt -72.71 -34.37 67.08 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.71 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -75.74 -45.6 35.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 118.113 -1.435 . . . . 0.0 109.622 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.629 ' N ' ' CG ' ' A' ' 440' ' ' HIS . . . -47.41 -36.39 9.73 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.426 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.695 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -106.86 93.07 4.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.501 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.79 28.22 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.597 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.695 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -160.28 132.01 2.82 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.2 mm -127.97 142.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.001 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.428 HD13 ' CG1' ' A' ' 468' ' ' VAL . 4.7 tp -150.1 97.32 2.55 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.261 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.549 ' CG2' ' O ' ' A' ' 428' ' ' ARG . 0.9 OUTLIER -108.72 160.33 16.04 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.874 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 34.0 t -75.76 -45.05 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.829 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 470' ' ' GLY . 8.1 mtt180 -94.08 -150.15 0.29 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.458 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 77.46 128.29 0.39 Allowed Glycine 0 N--CA 1.482 1.759 0 C-N-CA 119.145 -1.502 . . . . 0.0 109.4 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 453' ' ' THR . . . 175.62 -163.43 33.19 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 53.9 mtp 44.04 19.58 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.084 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 67.16 122.87 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.66 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' SER . . . . . 0.492 ' H ' ' HB1' ' A' ' 457' ' ' ALA . 69.9 p -166.64 -156.2 0.23 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.318 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' HIS . . . . . 0.485 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 26.3 m80 -51.88 -51.1 59.16 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.971 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -52.55 -42.4 64.4 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.533 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 454' ' ' SER . . . -84.55 -51.02 7.2 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.519 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 454' ' ' SER . 79.0 t -55.28 -44.82 76.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.748 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 47.2 t -67.16 -55.2 18.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.066 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.27 -28.96 65.43 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.289 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -65.35 -45.62 83.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -67.15 -24.29 73.28 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.147 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -21.31 31.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.815 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 63.02 21.12 63.32 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.675 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' THR . . . . . 0.553 ' CG2' ' H ' ' A' ' 466' ' ' CYS . 14.4 m -93.08 -168.89 2.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' CYS . . . . . 0.553 ' H ' ' CG2' ' A' ' 465' ' ' THR . 8.9 t -97.44 122.6 40.68 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 1.7 t -151.18 149.2 29.18 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.351 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . 0.499 HG11 ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -127.37 160.89 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.393 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' SER . . . . . 0.499 ' N ' HG11 ' A' ' 468' ' ' VAL . 6.2 t -150.43 155.68 40.01 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.34 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 450' ' ' GLY . . . 53.72 75.46 0.23 Allowed Glycine 0 N--CA 1.497 2.747 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . 0.495 ' SG ' ' CD2' ' A' ' 485' ' ' LEU . 0.6 OUTLIER -82.93 -179.58 7.48 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.919 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -57.82 -96.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -140.38 58.52 1.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.433 HD12 ' SG ' ' A' ' 471' ' ' CYS . 11.3 mt -53.36 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.637 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.26 115.3 26.65 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.443 HG23 ' N ' ' A' ' 477' ' ' ASN . 11.1 mt -88.18 136.6 22.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.129 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.451 ' H ' ' HG1' ' A' ' 482' ' ' THR . 4.9 m120 -114.63 127.2 55.64 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.18 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' A' ' 480' ' ' ALA . 10.3 pt-20 -62.85 -5.44 2.83 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.048 -0.978 . . . . 0.0 113.227 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 478' ' ' GLU . 5.2 mm-40 -46.13 -19.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.437 -1.305 . . . . 0.0 108.45 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -175.14 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . 0.502 ' HD2' ' CD2' ' A' ' 409' ' ' PHE . 0.8 OUTLIER -153.5 56.78 0.75 Allowed 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.481 ' CB ' ' HA ' ' A' ' 491' ' ' ALA . 1.6 p -86.6 175.37 8.34 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 483' ' ' PHE . 0.3 OUTLIER -151.93 120.86 6.61 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.762 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -91.95 114.42 26.95 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.533 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.495 ' CD2' ' SG ' ' A' ' 471' ' ' CYS . 63.6 tp -138.3 155.69 48.35 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.843 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . 0.461 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.66 -107.92 1.86 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -139.11 28.87 2.58 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.065 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.24 160.56 43.6 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.781 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.4 m -113.82 107.96 16.42 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.19 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.494 ' HB2' ' CE2' ' A' ' 483' ' ' PHE . 10.0 m-30 -89.55 119.44 29.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.505 -0.878 . . . . 0.0 108.859 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -100.24 136.78 39.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.155 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.486 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.9 tm-20 -50.05 95.12 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.949 0 C-N-CA 118.438 -1.305 . . . . 0.0 108.742 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 161.44 17.87 0.03 OUTLIER Glycine 0 C--N 1.267 -3.3 0 C-N-CA 118.313 -1.899 . . . . 0.0 109.624 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -128.69 -161.33 1.1 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.08 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 496' ' ' ILE . 1.8 t80 -137.64 132.7 33.37 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.484 ' N ' ' CD1' ' A' ' 495' ' ' TYR . 0.6 OUTLIER -136.81 162.35 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.818 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 28.9 p -130.17 113.21 14.18 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.684 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.13 152.61 24.87 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.716 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -99.42 160.39 14.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.027 0.918 . . . . 0.0 112.847 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -155.64 96.46 0.16 Allowed Glycine 0 C--N 1.289 -2.032 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 502' ' ' THR . 3.6 t 175.06 5.38 0.0 OUTLIER 'General case' 1 C--N 1.242 -4.071 0 CA-C-N 112.911 -1.644 . . . . 0.0 107.779 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' THR . . . . . 0.453 ' CG2' ' O ' ' A' ' 501' ' ' SER . 0.4 OUTLIER -175.0 -23.26 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.542 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 96.26 85.52 1.74 Allowed Glycine 0 N--CA 1.479 1.506 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -151.38 101.78 2.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.465 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 4.7 mt -89.05 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.286 -0.965 . . . . 0.0 110.749 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 12.2 t80 -148.96 161.7 41.38 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.59 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 1.8 ttpt -125.74 156.36 39.53 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.598 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 84.72 142.51 5.73 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.249 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.93 154.65 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.296 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' ILE . . . . . 0.423 ' CG2' ' H ' ' A' ' 511' ' ' GLU . 12.4 mm -88.68 175.61 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.589 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.423 ' H ' ' CG2' ' A' ' 510' ' ' ILE . 35.6 mt-10 . . . . . 0 C--N 1.304 -1.372 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 386' ' ' LEU . . . . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.799 0.333 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.508 ' HA ' ' CA ' ' A' ' 389' ' ' GLY . . . -84.3 33.46 0.5 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.118 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.708 ' H ' ' CD1' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -94.0 17.84 11.64 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.874 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.518 ' HB3' ' CD2' ' A' ' 506' ' ' TYR . 3.4 tptp -152.8 22.9 0.59 Allowed 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 387' ' ' LYS . . . 85.31 19.87 0.11 Allowed 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.022 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 385' ' ' ALA . . . 37.82 -161.26 0.01 OUTLIER Glycine 0 N--CA 1.512 3.733 0 CA-C-N 114.176 -1.375 . . . . 0.0 112.218 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 46.62 93.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.277 -0.462 . . . . 0.0 112.243 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.686 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 19.9 t -112.66 140.41 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.388 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -92.06 -25.32 5.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.215 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 162.78 -172.65 38.87 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.04 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.95 129.76 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.764 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.48 -146.22 0.24 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.274 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.7 140.79 33.51 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.94 96.94 0.46 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.227 1.285 . . . . 0.0 111.65 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -75.14 -73.14 0.26 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.351 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.9 p -136.88 144.16 45.46 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.347 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.89 101.66 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.983 1.122 . . . . 0.0 110.344 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.54 162.45 29.93 Favored Glycine 0 N--CA 1.51 3.624 0 C-N-CA 117.685 -2.198 . . . . 0.0 113.658 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.752 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -136.53 119.76 16.71 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.71 161.77 41.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.936 -1.506 . . . . 0.0 113.802 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -144.92 112.59 6.25 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 113.904 -1.498 . . . . 0.0 107.708 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.85 168.03 31.7 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.848 -1.644 . . . . 0.0 112.124 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 142.67 29.96 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.149 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.444 HG21 ' N ' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -78.46 148.15 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.7 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.546 ' C ' ' H ' ' A' ' 410' ' ' THR . 0.4 OUTLIER -159.97 99.61 1.38 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.769 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 481' ' ' LYS . 7.8 m-85 -57.12 -0.32 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.846 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 408' ' ' TYR . 3.2 p -106.39 140.91 38.57 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.99 26.12 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.515 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -70.7 -38.09 73.63 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.167 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 417' ' ' ALA . 68.9 mm-40 -62.81 -51.42 67.14 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -54.67 -31.71 58.13 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.982 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -71.27 -47.36 57.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.59 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -86.19 -9.35 56.75 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.03 -55.11 3.75 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -56.8 -28.03 60.77 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.863 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 421' ' ' GLY . 1.6 tt0 -55.58 -45.48 77.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.189 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 420' ' ' LYS . 0.8 OUTLIER -59.33 -6.12 0.92 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.493 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 82.92 49.02 5.23 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.467 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -133.33 154.21 50.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.679 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . 0.464 ' H ' ' HD2' ' A' ' 423' ' ' ARG . 0.4 OUTLIER -79.12 146.46 33.19 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.775 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.21 160.84 15.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.637 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.462 HG23 ' H ' ' A' ' 426' ' ' LEU . 41.5 mm -125.83 160.55 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.731 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.462 ' H ' HG23 ' A' ' 425' ' ' ILE . 3.4 tp -132.17 121.19 23.32 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.042 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.484 ' CG1' ' CZ ' ' A' ' 409' ' ' PHE . 7.2 t -110.57 121.03 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.36 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ARG . . . . . 0.493 ' O ' ' CG2' ' A' ' 447' ' ' THR . 0.1 OUTLIER -150.9 148.67 28.72 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.02 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' A' ' 449' ' ' ARG . 5.7 mt -53.43 -49.64 66.91 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.199 -1.401 . . . . 0.0 109.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -135.82 167.82 20.46 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.65 161.66 14.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.317 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.94 160.92 32.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.64 -31.51 94.45 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.99 1.793 . . . . 0.0 112.329 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.46 -12.91 61.64 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 439' ' ' MET . 15.0 m-20 -90.85 -9.05 47.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.919 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.644 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -35.78 -56.12 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.644 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 32.9 mt-10 -61.07 -38.69 87.12 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.341 -1.344 . . . . 0.0 109.052 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -72.83 -21.77 79.52 Favored Glycine 0 C--N 1.3 -1.45 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 435' ' ' ASP . 70.9 mtp -79.22 -46.41 17.92 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.336 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.773 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.1 OUTLIER -71.84 -34.79 69.58 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.398 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.773 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -56.45 -23.74 40.88 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.647 -1.221 . . . . 0.0 107.979 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.655 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -117.11 85.4 2.32 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.969 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.428 ' HA ' ' CG2' ' A' ' 465' ' ' THR . 11.8 pt-20 -52.41 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.591 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -136.24 139.66 10.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.406 ' HB ' ' SG ' ' A' ' 467' ' ' CYS . 67.8 mt -141.36 142.8 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.689 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.427 HD11 ' CG1' ' A' ' 468' ' ' VAL . 4.6 tp -140.24 98.95 3.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.493 ' CG2' ' O ' ' A' ' 428' ' ' ARG . 2.6 p -111.53 161.27 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.42 -24.45 12.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 470' ' ' GLY . 14.0 mmt180 -100.87 -121.88 0.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.324 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.497 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 68.43 144.6 0.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -131.16 179.87 16.68 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.22 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 86.9 mtp -43.72 -28.83 0.45 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.091 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 453' ' ' THR . 6.7 t -160.59 132.28 5.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.325 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.3 p 179.05 -176.85 0.26 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.53 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' HIS . . . . . 0.487 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 68.0 m80 -42.98 -49.52 5.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.336 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -48.44 -48.64 37.28 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.819 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.567 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 2.6 t -45.13 -45.58 3.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 24.2 t -70.42 -40.27 77.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.575 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -68.66 -32.77 72.85 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.595 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -67.7 -36.95 81.59 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -75.28 -33.67 53.09 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.534 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 6.7 mmt -94.27 0.32 55.56 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.96 60.53 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' THR . . . . . 0.428 ' CG2' ' HA ' ' A' ' 443' ' ' GLU . 0.2 OUTLIER -95.31 156.1 16.46 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.0 OUTLIER -89.43 129.88 35.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.692 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.406 ' SG ' ' HB ' ' A' ' 445' ' ' ILE . 99.5 m -152.86 157.42 40.68 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.062 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -126.15 162.28 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.263 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' SER . . . . . 0.525 ' N ' HG12 ' A' ' 468' ' ' VAL . 7.9 t -150.3 147.71 27.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.278 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 57.23 90.45 0.01 OUTLIER Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.349 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.85 170.18 8.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.569 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -44.77 -82.02 0.03 OUTLIER Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.614 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -156.06 68.06 0.62 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.037 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 17.4 mt -66.47 102.64 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.081 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -88.72 120.03 29.74 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 3.8 mt -87.68 132.32 33.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.77 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.416 ' CB ' ' HG1' ' A' ' 482' ' ' THR . 0.5 OUTLIER -107.22 122.13 45.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.898 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.609 ' C ' ' N ' ' A' ' 480' ' ' ALA . 0.4 OUTLIER -53.06 -9.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.338 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -44.92 -18.45 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.401 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.609 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -177.88 -102.29 0.0 OUTLIER 'General case' 0 C--N 1.263 -3.176 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 409' ' ' PHE . 10.9 mmmt -150.61 43.39 0.83 Allowed 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.479 ' HA ' ' H ' ' A' ' 492' ' ' GLU . 52.1 p -69.06 174.35 4.64 Favored 'General case' 0 C--O 1.194 -1.857 0 CA-C-N 113.23 -1.805 . . . . 0.0 114.41 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 483' ' ' PHE . 0.7 OUTLIER -152.04 132.18 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.809 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' GLU . . . . . 0.407 ' HG2' ' HG1' ' A' ' 489' ' ' THR . 6.4 tm-20 -112.59 116.53 30.34 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.031 -0.667 . . . . 0.0 111.146 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.459 ' CD2' ' C ' ' A' ' 485' ' ' LEU . 0.3 OUTLIER -150.63 161.89 41.72 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.903 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.55 -113.01 5.47 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -132.21 26.15 3.77 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 2.7 m-70 -150.16 153.23 35.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' THR . . . . . 0.407 ' HG1' ' HG2' ' A' ' 484' ' ' GLU . 58.4 m -115.06 100.23 8.02 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.481 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.54 ' CZ ' ' NZ ' ' A' ' 507' ' ' LYS . 7.6 m-85 -89.78 158.37 17.53 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -126.43 128.21 46.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.323 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.479 ' H ' ' HA ' ' A' ' 482' ' ' THR . 0.0 OUTLIER -47.4 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.472 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 168.53 14.32 0.02 OUTLIER Glycine 0 C--N 1.266 -3.311 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' ASP . . . . . 0.426 ' HB3' ' H ' ' A' ' 495' ' ' TYR . 57.2 m-20 -142.64 -153.57 0.47 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.887 -0.657 . . . . 0.0 109.76 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -147.99 155.39 41.47 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.849 -1.141 . . . . 0.0 111.841 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 39.9 pt -136.99 162.31 34.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.833 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 30.7 t -127.76 108.84 11.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' LEU . . . . . 0.608 ' CD2' ' H ' ' A' ' 498' ' ' LEU . 1.7 pt? -117.03 159.35 22.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.723 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 500' ' ' GLY . 50.5 t0 -94.95 161.44 14.14 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.272 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -144.73 93.69 0.17 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 53.6 p 175.22 -7.32 0.0 OUTLIER 'General case' 0 C--N 1.25 -3.754 0 CA-C-N 111.66 -2.27 . . . . 0.0 106.08 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.8 -28.02 0.13 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.045 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 100.52 -11.44 59.67 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.638 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -50.38 125.81 13.56 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 6.9 mt -113.88 135.04 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.397 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' TYR . . . . . 0.686 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 0.5 OUTLIER -128.21 159.89 33.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.566 ' HE3' ' H ' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -119.29 161.01 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.186 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 73.19 133.44 0.2 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.376 -1.392 . . . . 0.0 110.991 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 509' ' ' ASP . 6.6 p30 -48.31 153.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.047 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' ILE . . . . . 0.503 ' HB ' ' N ' ' A' ' 388' ' ' ALA . 0.1 OUTLIER -96.89 161.42 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.421 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.497 ' N ' ' CG1' ' A' ' 510' ' ' ILE . 46.6 tt0 . . . . . 0 C--N 1.305 -1.34 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.623 ' O ' ' N ' ' A' ' 387' ' ' LYS . . . -90.21 -163.73 1.06 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.889 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.455 ' CD1' ' O ' ' A' ' 385' ' ' ALA . 0.6 OUTLIER 33.47 26.4 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 124.109 0.881 . . . . 0.0 110.915 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.623 ' N ' ' O ' ' A' ' 385' ' ' ALA . 17.0 ttpp -140.94 -10.35 1.0 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.519 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . 0.407 ' H ' ' H ' ' A' ' 387' ' ' LYS . . . -139.29 14.07 2.59 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.152 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -74.87 -142.06 0.81 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.407 -1.377 . . . . 0.0 110.285 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -119.91 73.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.709 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.716 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 45.5 t -66.57 150.18 11.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.645 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.504 ' CG1' ' N ' ' A' ' 393' ' ' GLY . 5.2 pt -117.22 -48.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.694 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -159.14 -157.54 8.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.554 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.5 p -171.41 116.1 0.41 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.78 -145.87 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 96.4 mt -87.44 134.3 36.46 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.674 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.51 86.44 0.44 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.016 1.144 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -60.89 -60.83 3.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.084 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.3 p -143.77 145.87 32.58 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.217 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.35 119.36 6.24 Favored 'Trans proline' 0 C--N 1.326 -0.642 0 C-N-CA 121.085 1.19 . . . . 0.0 109.916 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.48 162.88 30.11 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.524 -2.274 . . . . 0.0 114.556 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -151.85 107.17 3.3 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.4 161.39 42.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 117.968 -1.493 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.23 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.013 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.97 167.58 31.15 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.649 -1.262 . . . . 0.0 111.134 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -82.72 161.76 21.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.305 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 492' ' ' GLU . 1.5 m -97.79 149.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.639 ' CE2' ' CD1' ' A' ' 426' ' ' LEU . 33.1 p90 -153.44 174.75 13.98 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.035 -1.438 . . . . 0.0 107.536 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 481' ' ' LYS . 2.7 m-85 -129.76 -19.32 3.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.203 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 38.8 p -100.51 135.6 41.7 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.47 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.82 -23.1 67.11 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.837 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -68.68 -41.36 79.34 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.098 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.92 -40.91 90.51 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.076 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -57.69 -37.55 73.67 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.394 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.19 -35.45 80.83 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.433 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.53 -13.52 37.17 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.59 -55.51 3.55 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.74 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 418' ' ' HIS . 0.3 OUTLIER -61.21 -21.1 63.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.846 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.486 ' CA ' ' OE1' ' A' ' 419' ' ' GLU . 0.6 OUTLIER -69.65 -38.08 76.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.588 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -64.53 -1.87 2.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 73.12 44.14 36.89 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.665 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -137.12 136.37 38.24 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . 0.41 ' C ' ' CG2' ' A' ' 424' ' ' VAL . 11.4 mmt180 -56.23 155.62 6.55 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.311 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 408' ' ' TYR . 2.0 t -147.64 158.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.988 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.434 ' O ' ' CD1' ' A' ' 408' ' ' TYR . 6.3 mm -126.24 158.58 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.618 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 5.3 tp -127.61 142.97 51.21 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.511 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.438 ' N ' ' HG ' ' A' ' 426' ' ' LEU . 25.1 t -128.04 120.13 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.268 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ARG . . . . . 0.496 ' O ' ' CG2' ' A' ' 447' ' ' THR . 0.1 OUTLIER -151.37 149.42 29.3 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.093 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 449' ' ' ARG . 3.5 mp -48.04 -57.04 6.32 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.366 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 431' ' ' THR . 1.0 OUTLIER -130.4 165.18 23.11 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.467 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' THR . . . . . 0.459 ' H ' ' HG3' ' A' ' 430' ' ' GLU . 0.4 OUTLIER -101.17 -179.63 4.1 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.383 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 27.2 p -163.98 151.73 10.81 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.564 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.8 Cg_endo -61.59 -53.07 2.51 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.467 1.445 . . . . 0.0 112.036 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -45.08 -18.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.8 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.8 m-20 -87.2 -6.35 58.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.656 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.616 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 10.4 tp -33.63 -51.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.667 ' CD ' ' H ' ' A' ' 438' ' ' GLY . 3.0 pm0 -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.074 -1.45 . . . . 0.0 108.448 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.667 ' H ' ' CD ' ' A' ' 437' ' ' GLU . . . -66.49 -30.82 77.15 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -62.4 -44.01 97.45 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.959 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -62.29 -56.88 14.16 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -46.73 -33.2 4.14 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.56 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.715 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -96.2 81.01 3.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.069 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.76 17.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.715 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.72 143.93 9.15 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.447 HG22 ' SG ' ' A' ' 467' ' ' CYS . 0.6 OUTLIER -135.3 133.95 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.316 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.43 HD13 ' CG1' ' A' ' 468' ' ' VAL . 3.5 tp -135.8 98.12 3.82 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.105 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 428' ' ' ARG . 2.1 p -116.24 161.84 18.37 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.67 -23.18 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.72 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' ARG . . . . . 0.435 HH22 ' CE ' ' A' ' 452' ' ' MET . 1.3 mmp_? -112.44 -128.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.861 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.69 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 62.52 -170.97 11.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . 0.6 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 61.51 -20.97 0.05 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.69 ' H ' ' C ' ' A' ' 450' ' ' GLY . 7.5 mmt -68.92 42.72 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' THR . . . . . 0.6 ' H ' ' C ' ' A' ' 451' ' ' GLY . 39.1 p 45.66 90.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.1 t -173.32 -155.66 0.08 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.122 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' HIS . . . . . 0.682 ' H ' ' HD1' ' A' ' 455' ' ' HIS . 8.5 p-80 -55.24 -41.69 72.46 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.44 50.98 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.366 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.46 -28.41 52.34 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.903 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.51 -54.31 12.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.573 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 455' ' ' HIS . 92.1 t -56.49 -40.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.115 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.64 55.15 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.78 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -65.96 -14.78 62.2 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.814 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.46 -35.61 19.54 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.489 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 7.3 mmt -91.75 -9.72 42.61 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 62.06 24.42 65.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 466' ' ' CYS . 14.3 t -87.7 -166.86 1.7 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' CYS . . . . . 0.44 ' SG ' ' HA3' ' A' ' 401' ' ' GLY . 8.9 t -98.98 123.26 43.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.424 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.447 ' SG ' HG22 ' A' ' 445' ' ' ILE . 1.4 t -152.06 139.91 19.97 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 118.018 -1.473 . . . . 0.0 112.708 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.99 161.27 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' SER . . . . . 0.64 ' HG ' ' N ' ' A' ' 470' ' ' GLY . 9.0 t -151.46 151.8 32.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.971 -1.491 . . . . 0.0 113.86 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.64 ' N ' ' HG ' ' A' ' 469' ' ' SER . . . 48.2 90.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.146 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . . . . . . . . . 96.7 m -98.42 -160.53 0.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.834 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.75 -95.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.63 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . 0.555 ' N ' ' CD ' ' A' ' 473' ' ' GLU . 1.6 pm0 -142.07 58.94 1.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.1 mt -43.17 102.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.775 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -88.86 113.76 24.75 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.409 HG23 ' HZ3' ' A' ' 481' ' ' LYS . 9.5 mt -88.69 134.37 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 118.602 -1.239 . . . . 0.0 112.38 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.5 123.47 50.29 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.385 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' A' ' 480' ' ' ALA . 1.2 tt0 -63.6 -3.43 2.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.442 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -47.71 -16.56 0.07 Allowed 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 118.194 -1.402 . . . . 0.0 108.296 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.627 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -174.8 -100.38 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.0 OUTLIER -158.05 65.91 0.46 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.488 ' CB ' ' HA ' ' A' ' 491' ' ' ALA . 1.4 p -97.51 178.34 5.22 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 483' ' ' PHE . 0.2 OUTLIER -151.56 129.69 11.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.471 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -99.61 116.46 31.78 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.665 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 486' ' ' GLY . 3.2 tt -136.51 156.25 48.85 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.012 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 485' ' ' LEU . . . 44.65 -117.43 2.11 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.283 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -124.42 37.15 2.71 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.532 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.506 ' CG ' ' CZ ' ' A' ' 490' ' ' PHE . 0.3 OUTLIER -150.68 129.65 12.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.404 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 83.5 m -102.98 115.07 29.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.59 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.506 ' CZ ' ' CG ' ' A' ' 488' ' ' HIS . 22.8 m-85 -112.43 130.94 55.81 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.751 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -99.18 156.84 16.75 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.469 ' O ' ' CG ' ' A' ' 492' ' ' GLU . 1.5 tm-20 -65.46 63.67 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.602 -1.239 . . . . 0.0 108.566 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -160.43 25.45 0.29 Allowed Glycine 0 C--N 1.263 -3.512 0 C-N-CA 119.263 -1.446 . . . . 0.0 109.838 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -146.26 -164.62 2.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.046 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -128.23 137.58 52.08 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.215 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 2.0 pt -131.93 160.14 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.089 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 506' ' ' TYR . 48.3 m -123.46 110.98 15.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.348 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' LEU . . . . . 0.606 ' C ' ' CD1' ' A' ' 498' ' ' LEU . 0.1 OUTLIER -105.57 136.92 44.27 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.418 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.633 ' N ' ' OD1' ' A' ' 499' ' ' ASP . 0.5 OUTLIER -108.6 160.58 15.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.027 0.917 . . . . 0.0 112.244 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -142.11 94.2 0.18 Allowed Glycine 0 C--N 1.285 -2.299 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 4.6 m -171.42 -3.01 0.01 OUTLIER 'General case' 0 C--N 1.244 -3.98 0 CA-C-N 112.577 -1.812 . . . . 0.0 107.398 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -167.09 -16.68 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.555 -2.111 . . . . 0.0 107.276 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.46 40.13 8.58 Favored Glycine 0 N--CA 1.482 1.725 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.371 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -115.37 119.97 38.03 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' ILE . . . . . 0.541 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.5 tt -97.57 160.23 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.425 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' TYR . . . . . 0.716 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 17.8 m-85 -135.15 162.09 33.5 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.178 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.504 ' HD2' ' CE1' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -136.71 142.93 43.12 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.779 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 510' ' ' ILE . . . 94.81 141.55 11.72 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.758 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -50.43 89.52 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.683 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' ILE . . . . . 0.781 ' CD1' ' H ' ' A' ' 511' ' ' GLU . 0.2 OUTLIER -51.93 165.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.713 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.781 ' H ' ' CD1' ' A' ' 510' ' ' ILE . 22.9 tt0 . . . . . 0 C--N 1.297 -1.703 0 CA-C-O 116.309 -1.805 . . . . 0.0 110.744 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 385' ' ' ALA . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.928 0.394 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 387' ' ' LYS . . . 71.7 165.95 0.3 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.82 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 49.41 11.04 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.717 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.611 ' H ' ' C ' ' A' ' 385' ' ' ALA . 10.8 tptm -134.63 0.09 2.95 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.299 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -153.35 12.24 0.47 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.115 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -81.98 -125.03 0.8 Allowed Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.247 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -168.2 83.28 0.18 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.115 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.57 142.76 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.539 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 1.9 pt -94.42 -33.53 5.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.757 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 179.67 -167.49 37.39 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.87 -1.633 . . . . 0.0 111.314 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 31.1 t -154.79 120.78 5.21 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.583 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . 0.436 ' HB3' ' SG ' ' A' ' 471' ' ' CYS . . . -93.09 -144.06 0.22 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.076 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 51.2 mt -93.42 128.69 41.48 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . 0.552 ' HG3' ' O ' ' A' ' 502' ' ' THR . 7.7 Cg_endo -68.37 89.35 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.142 1.228 . . . . 0.0 111.565 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -55.37 -54.73 40.06 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.506 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' SER . . . . . 0.403 ' HG ' ' N ' ' A' ' 400' ' ' PRO . 1.1 t -150.45 141.85 15.1 Favored Pre-proline 0 C--N 1.307 -1.281 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.177 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.403 ' N ' ' HG ' ' A' ' 399' ' ' SER . 5.8 Cg_exo -54.34 101.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.121 1.214 . . . . 0.0 110.569 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -151.46 161.81 29.33 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.544 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.564 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -139.21 114.87 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -138.39 160.73 38.77 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.862 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.454 ' HB2' ' HH ' ' A' ' 495' ' ' TYR . . . -142.17 110.62 6.07 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.709 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.07 167.92 31.24 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.923 -1.608 . . . . 0.0 111.268 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -82.82 137.11 34.43 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.571 ' CG1' ' C ' ' A' ' 491' ' ' ALA . 1.0 OUTLIER -83.37 151.68 3.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 C-N-CA 118.925 -1.11 . . . . 0.0 113.374 -179.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -149.86 -152.79 0.45 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.924 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.466 ' CD2' ' HE2' ' A' ' 481' ' ' LYS . 10.5 m-85 -146.31 -47.71 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.058 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' THR . . . . . 0.426 ' OG1' ' OE1' ' A' ' 413' ' ' GLU . 37.4 p -86.03 143.36 28.15 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.235 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -69.47 -10.91 60.07 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.503 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 412' ' ' ASP . 10.2 m-20 -74.26 -42.55 59.46 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.775 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 413' ' ' GLU . 2.1 mp0 -66.88 -42.47 85.52 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.568 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.7 66.28 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.88 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -73.68 -38.63 64.85 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.396 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.58 -12.2 37.74 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.84 -43.58 9.95 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.837 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' HIS . . . . . 0.463 ' O ' ' CD2' ' A' ' 418' ' ' HIS . 8.8 t60 -69.88 -29.42 66.63 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.219 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.68 -21.89 61.0 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 -5.93 42.86 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.797 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 89.99 45.44 4.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -147.44 131.87 17.63 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.812 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -58.58 157.09 9.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.432 ' N ' ' OE2' ' A' ' 443' ' ' GLU . 2.4 t -148.27 160.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.931 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 7.5 mm -130.63 160.97 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.911 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 4.3 tp -139.42 144.6 38.16 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.594 -1.242 . . . . 0.0 112.851 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 81.6 t -118.46 130.21 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.557 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ARG . . . . . 0.552 ' C ' ' H ' ' A' ' 430' ' ' GLU . 0.0 OUTLIER -151.79 135.26 16.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.59 -1.244 . . . . 0.0 112.06 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.11 17.87 0.12 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.552 ' H ' ' C ' ' A' ' 428' ' ' ARG . 5.9 pt-20 175.86 147.46 0.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' THR . . . . . 0.425 ' HG1' ' HB2' ' A' ' 455' ' ' HIS . 0.1 OUTLIER -87.77 177.39 7.02 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.89 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.2 m -161.6 131.08 3.23 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.712 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.03 -31.61 91.32 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 121.183 1.255 . . . . 0.0 111.807 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -75.46 -16.41 60.32 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.191 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.1 t70 -90.41 -9.24 48.27 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.723 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.679 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -39.3 -52.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.861 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.679 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 26.9 mt-10 -58.23 -35.77 72.18 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.925 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.22 -22.44 73.55 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 2.1 mmt -74.75 -42.02 58.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.433 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.794 ' HD1' ' N ' ' A' ' 441' ' ' ALA . 0.2 OUTLIER -70.7 -32.98 70.38 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.332 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.794 ' N ' ' HD1' ' A' ' 440' ' ' HIS . . . -50.09 -29.04 8.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.642 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -109.38 92.02 3.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.679 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.572 ' H ' ' CD ' ' A' ' 443' ' ' GLU . 1.4 pm0 -53.0 0.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.949 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.642 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -142.01 144.47 14.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.446 ' HB ' ' SG ' ' A' ' 467' ' ' CYS . 38.8 mt -145.73 135.45 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.459 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.445 HD11 ' CG1' ' A' ' 468' ' ' VAL . 5.8 tp -131.05 98.23 4.52 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.004 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.458 HG21 ' N ' ' A' ' 428' ' ' ARG . 1.5 p -107.9 161.49 14.87 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.7 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 4.9 t -85.28 -20.11 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.969 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -106.6 -152.05 0.47 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.755 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.445 ' HA3' ' HG ' ' A' ' 469' ' ' SER . . . 81.28 -151.39 31.31 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . 0.653 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 76.78 -50.99 3.03 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.548 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.485 ' O ' ' CB ' ' A' ' 453' ' ' THR . 70.7 mmm -64.45 11.97 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.413 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' THR . . . . . 0.653 ' H ' ' C ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.31 108.27 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.019 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 455' ' ' HIS . 30.2 t -158.41 -173.16 4.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.841 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' HIS . . . . . 0.552 ' N ' ' OG ' ' A' ' 454' ' ' SER . 60.4 m80 -50.34 -35.3 27.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -53.7 -58.71 6.23 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.322 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.63 -52.21 9.37 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.347 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 13.3 t -44.76 -43.42 2.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.675 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 97.5 t -69.38 -43.55 80.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.201 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.94 -41.08 87.59 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.84 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -66.35 -27.71 68.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -90.0 -26.7 23.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.671 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 11.2 mmt -94.07 -23.11 18.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.302 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.69 -21.25 30.66 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.966 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 60.2 m -44.22 160.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -87.25 129.1 35.11 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.937 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.446 ' SG ' ' HB ' ' A' ' 445' ' ' ILE . 1.8 m -153.3 153.1 31.96 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.434 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . 0.542 HG11 ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -124.38 161.16 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 108.995 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 28.1 t -150.27 155.31 39.46 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.7 -1.2 . . . . 0.0 112.213 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 42.63 82.98 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . 0.462 ' HG ' HD13 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -90.07 -160.4 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.272 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -61.13 -99.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.542 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 474' ' ' ILE . 1.4 mm-40 -145.07 41.25 1.27 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.417 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 0.0 OUTLIER -38.81 107.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.901 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -89.71 123.99 34.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.205 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 3.0 mt -86.41 119.59 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.191 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.408 HD22 ' HG3' ' A' ' 479' ' ' GLU . 53.1 t-20 -89.24 110.83 21.55 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.163 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.636 ' H ' ' CD ' ' A' ' 478' ' ' GLU . 1.4 pm0 -67.67 -9.33 42.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.525 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 478' ' ' GLU . 11.4 mm-40 -46.3 -19.87 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.342 -1.343 . . . . 0.0 107.661 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.607 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -163.64 -107.21 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.412 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . 0.466 ' HE2' ' CD2' ' A' ' 409' ' ' PHE . 20.2 mmmt -159.47 70.94 0.48 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.606 ' HA ' ' CB ' ' A' ' 491' ' ' ALA . 1.2 p -138.63 148.46 44.11 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.867 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' PHE . . . . . 0.539 ' H ' ' HB3' ' A' ' 491' ' ' ALA . 6.2 p90 -104.74 156.53 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.895 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.44 103.57 12.22 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.287 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.478 ' CD2' ' N ' ' A' ' 486' ' ' GLY . 1.4 tt -126.61 139.72 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . 0.478 ' N ' ' CD2' ' A' ' 485' ' ' LEU . . . 57.06 -110.59 2.28 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.128 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -128.82 36.76 2.36 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.372 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 24.4 m170 -150.35 126.15 10.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.482 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.2 m -99.38 97.36 8.41 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.971 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.621 ' CB ' ' HZ2' ' A' ' 507' ' ' LYS . 35.6 p90 -155.3 158.18 38.37 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.036 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.606 ' CB ' ' HA ' ' A' ' 482' ' ' THR . . . -170.09 -136.08 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.177 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.464 ' N ' HG11 ' A' ' 407' ' ' VAL . 57.6 tt0 -49.63 94.18 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 117.964 -1.494 . . . . 0.0 109.39 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 152.02 17.7 0.06 OUTLIER Glycine 0 C--N 1.297 -1.611 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -156.25 -152.62 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.435 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . 0.454 ' HH ' ' HB2' ' A' ' 404' ' ' ALA . 6.8 t80 -149.71 126.77 11.25 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.284 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.96 161.59 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.49 106.16 11.54 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.3 OUTLIER -92.48 134.77 34.64 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.169 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.506 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.4 OUTLIER -89.48 159.25 17.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.424 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -155.65 95.17 0.15 Allowed Glycine 0 C--N 1.282 -2.453 0 N-CA-C 106.923 -2.471 . . . . 0.0 106.923 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 3.3 t 172.86 7.28 0.0 OUTLIER 'General case' 0 C--N 1.245 -3.956 0 CA-C-N 112.507 -1.846 . . . . 0.0 106.943 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' THR . . . . . 0.552 ' O ' ' HG3' ' A' ' 397' ' ' PRO . 0.0 OUTLIER -171.91 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.385 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.477 ' N ' ' HB3' ' A' ' 397' ' ' PRO . . . 93.11 15.42 51.79 Favored Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.923 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -75.08 172.7 11.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.26 150.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.459 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 7.7 t80 -148.97 161.33 42.12 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.01 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 28.4 tttt -131.78 151.6 51.55 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.865 -1.134 . . . . 0.0 113.701 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 85.35 133.43 2.97 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.365 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 31.6 -153.83 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' ILE . . . . . 0.736 ' CG2' ' N ' ' A' ' 511' ' ' GLU . 1.0 OUTLIER 55.28 -163.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.875 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.736 ' N ' ' CG2' ' A' ' 510' ' ' ILE . 4.9 tt0 . . . . . 0 C--N 1.295 -1.803 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.75 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.576 ' C ' ' N ' ' A' ' 387' ' ' LYS . . . 62.0 -157.34 0.33 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.051 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . 0.404 HD21 ' N ' ' A' ' 386' ' ' LEU . 5.6 mt 46.91 15.87 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.309 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.576 ' N ' ' C ' ' A' ' 385' ' ' ALA . 1.7 ttmp? -129.78 -5.31 4.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.608 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -140.78 15.05 2.31 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.564 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -93.13 120.59 6.26 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.088 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -84.93 63.3 8.0 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.797 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 41.8 t -39.4 139.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.09 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.478 HG13 ' N ' ' A' ' 393' ' ' GLY . 17.7 pt -99.81 -43.22 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.076 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.478 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -151.08 -162.9 10.99 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.706 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.8 t -179.21 127.42 0.09 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -117.61 -125.54 0.28 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.461 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 32.5 mt -100.49 139.01 20.3 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.277 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -67.56 93.42 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.274 1.316 . . . . 0.0 110.581 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -64.02 -66.71 0.5 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.107 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 24.2 t -136.97 131.07 17.8 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.848 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.85 92.56 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 121.059 1.173 . . . . 0.0 111.303 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.17 160.18 28.97 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 118.995 -1.574 . . . . 0.0 112.008 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.775 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -126.26 135.89 52.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . 0.428 ' CB ' ' OE2' ' A' ' 443' ' ' GLU . . . -150.42 160.32 43.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . 0.402 ' CB ' ' OH ' ' A' ' 495' ' ' TYR . . . -148.16 109.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.601 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.7 30.83 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.495 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.27 133.0 34.58 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.739 -0.785 . . . . 0.0 109.588 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 492' ' ' GLU . 79.9 t -60.67 154.43 4.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.325 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.468 ' CE1' ' HG2' ' A' ' 413' ' ' GLU . 0.5 OUTLIER -162.47 135.75 6.03 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.557 ' CE2' ' NZ ' ' A' ' 481' ' ' LYS . 4.7 m-85 -100.9 28.6 5.12 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.926 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 7.2 p -149.38 143.96 26.09 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.731 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.69 59.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.966 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.8 -43.16 31.47 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.468 ' HG2' ' CE1' ' A' ' 408' ' ' TYR . 0.3 OUTLIER -62.08 -39.31 92.02 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.388 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.69 83.9 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.482 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -65.7 -34.64 78.66 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.77 21.99 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.464 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -82.62 -49.02 10.28 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.982 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -49.28 -27.13 3.53 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -91.57 -28.87 17.26 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -117.48 -35.05 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.111 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -93.19 -45.59 3.51 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.069 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . 0.43 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 1.1 mt-10 66.32 158.13 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.672 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 47.35 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.161 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.91 161.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.382 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.429 HG21 ' H ' ' A' ' 426' ' ' LEU . 47.0 mm -123.31 157.52 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.383 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.429 ' H ' HG21 ' A' ' 425' ' ' ILE . 3.1 tp -128.82 134.52 48.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.255 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 409' ' ' PHE . 48.1 t -119.94 123.5 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.689 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ARG . . . . . 0.496 ' H ' HG23 ' A' ' 447' ' ' THR . 0.6 OUTLIER -151.53 158.31 43.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.957 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.14 -49.73 73.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.311 -1.355 . . . . 0.0 109.799 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -132.27 177.64 7.43 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' THR . . . . . 0.468 HG21 ' H ' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -81.41 171.76 14.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.064 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 1.3 m -153.33 142.32 14.54 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.604 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 435' ' ' ASP . 1.3 Cg_endo -61.5 -72.92 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.481 1.454 . . . . 0.0 111.919 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.08 -10.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.288 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 433' ' ' PRO . 7.1 t70 -85.94 -8.68 57.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.658 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -43.34 -58.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.735 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.658 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 46.8 mt-10 -55.92 -31.5 62.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.522 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.04 -23.55 77.58 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 436' ' ' ILE . 2.4 ttm -74.57 -53.99 8.34 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.778 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.489 ' C ' ' N ' ' A' ' 442' ' ' ALA . 85.8 m-70 -58.77 -50.4 74.08 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.755 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 440' ' ' HIS . . . -45.88 -24.88 0.45 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.149 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.703 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -107.15 86.27 2.28 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.488 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.491 ' C ' ' OE1' ' A' ' 443' ' ' GLU . 0.0 OUTLIER -58.26 14.01 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.955 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.703 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.24 133.95 3.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 445' ' ' ILE . 4.5 mp -139.48 150.45 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.135 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . . . . . . . . . 1.2 tp -144.38 128.34 17.47 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.146 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 428' ' ' ARG . 5.7 p -140.61 159.31 42.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.242 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 27.4 t -68.86 -20.85 25.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.452 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -117.0 -151.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.963 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.487 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 84.98 26.17 38.33 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -44.44 161.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.659 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 25.0 mtt 45.4 -101.52 0.05 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.837 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 40.3 p -153.91 81.36 1.15 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.831 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.8 m -90.67 -163.02 0.96 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.704 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' HIS . . . . . 0.434 ' CD2' HG22 ' A' ' 459' ' ' VAL . 2.9 t60 -47.87 -39.78 19.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.43 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . 0.468 ' H ' HG21 ' A' ' 431' ' ' THR . . . -59.04 -61.88 2.3 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.032 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.78 -55.59 16.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.871 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 459' ' ' VAL . 0.3 OUTLIER -45.65 -49.8 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.694 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.645 ' N ' ' CG1' ' A' ' 458' ' ' VAL . 71.3 t -62.46 -37.15 78.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.34 -46.95 78.2 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -31.14 71.67 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.69 -18.81 69.61 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' MET . . . . . 0.482 ' C ' ' SD ' ' A' ' 463' ' ' MET . 0.0 OUTLIER -94.96 -59.86 1.81 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.955 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . 0.472 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 123.93 20.83 2.47 Favored Glycine 0 N--CA 1.503 3.149 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' THR . . . . . 0.453 HG23 ' N ' ' A' ' 466' ' ' CYS . 30.9 m -97.47 166.9 11.31 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.8 m -90.12 128.08 36.24 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.799 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 13.1 t -151.71 159.07 44.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.801 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 469' ' ' SER . 0.8 OUTLIER -137.08 162.44 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.886 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' SER . . . . . 0.487 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 11.7 t -144.27 160.42 41.01 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.894 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 44.17 79.87 0.05 OUTLIER Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.623 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . 0.43 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.0 OUTLIER -78.33 -175.18 4.08 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.107 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.82 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.006 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.9 57.99 1.61 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.611 0.72 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.43 HD12 ' SG ' ' A' ' 471' ' ' CYS . 4.5 mt -55.46 114.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.272 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 484' ' ' GLU . 4.4 ttpm? -99.63 122.74 43.1 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.406 HG22 ' HZ3' ' A' ' 481' ' ' LYS . 1.7 mt -86.89 127.74 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 117.771 -1.572 . . . . 0.0 112.097 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . 0.489 ' OD1' ' CG2' ' A' ' 489' ' ' THR . 7.8 m120 -96.91 113.38 24.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.123 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.625 ' C ' ' N ' ' A' ' 480' ' ' ALA . 10.5 mt-10 -64.0 -11.88 32.95 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.984 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -46.3 -17.82 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.811 1.291 . . . . 0.0 107.928 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.625 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.32 -97.8 0.01 OUTLIER 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 112.15 -2.296 . . . . 0.0 105.537 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . 0.557 ' NZ ' ' CE2' ' A' ' 409' ' ' PHE . 3.0 mmmt -168.97 70.72 0.08 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.578 HG21 ' H ' ' A' ' 491' ' ' ALA . 2.6 p -125.75 147.24 49.45 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.057 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' PHE . . . . . 0.632 ' H ' ' HB1' ' A' ' 491' ' ' ALA . 8.0 p90 -97.68 149.98 21.68 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.572 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 475' ' ' LYS . 7.5 tt0 -110.92 107.14 16.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.129 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.584 ' CD2' ' H ' ' A' ' 486' ' ' GLY . 0.4 OUTLIER -144.7 156.33 44.03 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.04 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . 0.584 ' H ' ' CD2' ' A' ' 485' ' ' LEU . . . 64.6 -111.4 4.15 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -134.75 26.7 3.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.729 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.451 ' CD2' ' H ' ' A' ' 489' ' ' THR . 13.4 t-160 -150.75 152.14 33.41 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 477' ' ' ASN . 77.3 m -115.94 99.38 7.24 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.039 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.547 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 19.6 p90 -153.78 157.55 39.58 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.075 -1.45 . . . . 0.0 114.184 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.632 ' HB1' ' H ' ' A' ' 483' ' ' PHE . . . 179.85 -137.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.295 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.534 ' N ' ' CG1' ' A' ' 407' ' ' VAL . 8.2 tm-20 -34.93 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.654 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 139.68 3.66 1.52 Allowed Glycine 0 C--N 1.29 -2.009 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' ASP . . . . . 0.638 ' CG ' ' H ' ' A' ' 495' ' ' TYR . 36.2 t70 -144.26 -174.16 4.22 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.235 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . 0.638 ' H ' ' CG ' ' A' ' 494' ' ' ASP . 87.2 t80 -123.91 120.54 32.83 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.029 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.657 ' HA ' ' H ' ' A' ' 508' ' ' GLY . 0.0 OUTLIER -127.92 161.39 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.577 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 2.4 m -123.34 110.08 14.72 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' LEU . . . . . 0.487 HD13 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -95.84 141.18 29.6 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.487 ' N ' HD13 ' A' ' 498' ' ' LEU . 10.3 t70 -99.99 161.41 13.63 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.064 0.935 . . . . 0.0 112.381 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -156.49 95.61 0.15 Allowed Glycine 0 C--N 1.281 -2.508 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 1.4 t 164.66 2.4 0.0 OUTLIER 'General case' 1 C--N 1.238 -4.265 0 CA-C-N 112.749 -1.726 . . . . 0.0 107.47 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 6.8 m -161.72 -17.74 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.073 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 73.52 75.8 0.72 Allowed Glycine 0 N--CA 1.485 1.959 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.736 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -165.24 118.95 1.23 Allowed 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.014 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' ILE . . . . . 0.516 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 2.0 tt -99.22 157.84 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.085 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' TYR . . . . . 0.516 ' N ' ' CG1' ' A' ' 505' ' ' ILE . 0.1 OUTLIER -151.04 170.49 19.25 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.456 ' HD2' ' CE2' ' A' ' 490' ' ' PHE . 27.2 mtpt -81.41 158.33 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 117.058 -1.857 . . . . 0.0 110.146 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . 0.657 ' H ' ' HA ' ' A' ' 496' ' ' ILE . . . -69.08 -169.38 6.1 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.582 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 508' ' ' GLY . 0.9 OUTLIER 75.14 33.78 0.69 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.456 -0.872 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' ILE . . . . . 0.412 ' HB ' ' H ' ' A' ' 511' ' ' GLU . 1.3 pt -102.21 -162.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.811 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.412 ' H ' ' HB ' ' A' ' 510' ' ' ILE . 12.6 mp0 . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 116.366 -1.778 . . . . 0.0 110.617 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 120.792 0.329 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -142.11 18.96 2.1 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.736 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 76.1 mt -96.91 10.03 40.23 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.645 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -120.44 -0.46 10.34 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.323 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -149.83 16.88 0.88 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.434 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -73.18 -145.35 0.71 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.239 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 390' ' ' GLU . 1.5 pm0 -147.64 65.28 1.12 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.649 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.712 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 74.8 t -64.39 137.05 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.018 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.634 ' CG1' ' H ' ' A' ' 393' ' ' GLY . 2.5 pt -103.26 -57.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.757 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . 0.634 ' H ' ' CG1' ' A' ' 392' ' ' ILE . . . -142.18 178.78 20.57 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 12.6 m -156.05 141.31 17.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.814 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -124.06 -158.81 0.83 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.835 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.19 126.66 78.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.772 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 101.93 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.033 1.155 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -67.32 -57.75 6.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.589 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 79.3 p -137.19 139.87 29.39 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.713 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.7 95.77 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 121.31 1.34 . . . . 0.0 110.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.82 162.2 30.3 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 118.186 -1.959 . . . . 0.0 112.906 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.56 21.15 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.41 160.87 43.44 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 117.946 -1.502 . . . . 0.0 112.884 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -131.78 102.6 5.94 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.67 166.55 30.81 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.94 156.26 22.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.65 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 492' ' ' GLU . 3.5 m -85.4 138.77 18.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.546 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.61 ' CZ ' ' OE1' ' A' ' 413' ' ' GLU . 0.4 OUTLIER -138.94 159.28 42.53 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.322 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.497 ' CE1' ' HB3' ' A' ' 481' ' ' LYS . 9.8 m-85 -122.88 32.81 5.59 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.813 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 1.6 p -158.82 143.74 16.02 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.438 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.57 -13.83 61.49 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.591 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -75.17 -43.19 53.65 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.49 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.61 ' OE1' ' CZ ' ' A' ' 408' ' ' TYR . 68.9 mm-40 -62.28 -37.84 87.06 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.411 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -68.18 -32.32 72.48 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.403 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -68.67 -36.81 79.01 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.518 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.81 23.41 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.837 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -68.12 -54.93 14.54 Favored 'General case' 0 C--N 1.276 -2.621 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 417' ' ' ALA . 25.6 t-80 -44.22 -26.55 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.6 OUTLIER -91.48 -22.87 20.18 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.884 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 417' ' ' ALA . 36.2 mmtt -80.64 -59.59 2.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.981 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -155.0 3.87 0.23 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.711 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 54.68 -146.95 0.53 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.094 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . 0.543 ' H ' ' HE ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER 52.37 64.68 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.838 -1.145 . . . . 0.0 107.965 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.842 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 6.9 mm -125.33 160.3 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.904 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 5.3 tp -125.57 134.06 52.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.017 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.485 HG12 ' CE2' ' A' ' 409' ' ' PHE . 15.5 t -120.38 121.57 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.036 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ARG . . . . . 0.508 ' H ' HG22 ' A' ' 447' ' ' THR . 7.3 ttt180 -152.2 148.76 27.97 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.247 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.501 ' H ' HD13 ' A' ' 429' ' ' LEU . 4.3 mp -48.41 -58.01 5.25 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.568 -1.253 . . . . 0.0 109.252 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 431' ' ' THR . 2.2 tm-20 -122.89 175.84 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.436 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' THR . . . . . 0.635 ' OG1' ' CD2' ' A' ' 455' ' ' HIS . 1.2 p -112.14 173.37 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.685 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.9 m -154.84 155.14 30.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.998 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 435' ' ' ASP . 3.6 Cg_endo -64.27 -66.58 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 121.758 1.638 . . . . 0.0 112.147 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -38.83 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.269 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 438' ' ' GLY . 1.1 m-20 -74.42 -8.7 57.16 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.829 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.614 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 9.8 tp -40.4 -50.56 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.827 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.614 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 69.6 mt-10 -53.85 -38.28 64.52 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.615 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.16 -26.65 70.13 Favored Glycine 0 C--N 1.303 -1.272 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 40.3 mtt -69.21 -39.11 78.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.988 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.456 ' CE1' HG13 ' A' ' 436' ' ' ILE . 6.8 m-70 -66.68 -57.94 6.14 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.171 -1.411 . . . . 0.0 109.174 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -46.13 -39.64 9.82 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.073 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.647 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -97.55 85.28 3.57 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.087 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -62.91 35.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.848 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . 0.647 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -168.87 143.71 8.25 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . 0.449 HG21 ' SG ' ' A' ' 467' ' ' CYS . 1.3 mt -144.63 132.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.17 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.421 HD12 ' CG1' ' A' ' 468' ' ' VAL . 7.0 tp -135.79 98.36 3.89 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 428' ' ' ARG . 1.7 p -113.62 161.22 17.7 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.73 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.451 HG11 ' SG ' ' A' ' 471' ' ' CYS . 16.2 t -76.84 -26.34 16.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.796 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' GLY . 6.8 mtt-85 -108.46 -134.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.723 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 70.72 -166.85 51.32 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.948 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . 0.721 ' N ' ' HG ' ' A' ' 469' ' ' SER . . . 72.0 -31.85 0.64 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.937 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.536 ' H ' ' C ' ' A' ' 450' ' ' GLY . 15.6 ptm -68.38 42.31 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.946 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 47.22 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.13 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.8 t -171.32 -166.08 0.44 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.294 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' HIS . . . . . 0.642 ' H ' ' HD1' ' A' ' 455' ' ' HIS . 7.2 p-80 -49.66 -48.13 49.58 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.981 -1.087 . . . . 0.0 110.337 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 455' ' ' HIS . . . -38.21 -56.15 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.467 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -81.08 -52.53 7.29 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.487 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 43.5 t -47.42 -47.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.916 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . . . . . . . . . 93.3 t -64.31 -43.78 97.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.782 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.99 -43.75 91.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -69.81 -19.38 63.49 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.57 -36.79 15.56 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 49.8 mmm -93.15 -26.1 17.57 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.24 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.25 42.1 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.63 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 16.7 m -46.83 163.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 401' ' ' GLY . 48.6 t -85.22 128.59 34.73 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.053 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . 0.449 ' SG ' HG21 ' A' ' 445' ' ' ILE . 13.1 t -151.42 140.49 21.14 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.382 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . 0.512 HG11 ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -110.65 161.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.137 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' SER . . . . . 0.721 ' HG ' ' N ' ' A' ' 451' ' ' GLY . 9.2 t -150.37 148.57 28.96 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.567 -1.253 . . . . 0.0 112.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 61.1 91.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.46 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . 0.451 ' SG ' HG11 ' A' ' 448' ' ' VAL . 7.7 p -100.22 176.06 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -59.52 -91.93 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -144.82 59.55 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.444 HG13 ' SG ' ' A' ' 471' ' ' CYS . 10.7 mt -51.6 107.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.839 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -89.16 110.31 21.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 482' ' ' THR . 4.9 mt -87.96 135.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.013 -1.475 . . . . 0.0 113.884 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -113.18 122.04 46.32 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.678 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.635 ' C ' ' H ' ' A' ' 480' ' ' ALA . 7.8 mt-10 -56.4 -5.53 0.21 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.438 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -48.03 -14.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 118.093 -1.443 . . . . 0.0 108.186 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.635 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 177.98 -90.88 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . 0.497 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.3 OUTLIER -167.46 54.56 0.07 Allowed 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 123.965 1.841 . . . . 0.0 108.949 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.421 ' CG2' ' HA ' ' A' ' 491' ' ' ALA . 70.0 p -75.57 167.11 22.52 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 111.251 -2.704 . . . . 0.0 112.267 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' PHE . . . . . 0.634 ' CE2' ' CG ' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -153.46 112.83 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.693 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -89.64 120.07 30.61 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.047 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 486' ' ' GLY . 59.3 tp -149.82 157.21 42.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.141 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . 0.485 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.39 -117.82 12.54 Favored Glycine 0 N--CA 1.48 1.568 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -127.04 29.1 4.44 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.673 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -151.68 144.3 24.27 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.122 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 45.5 m -95.36 115.19 27.1 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.529 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.634 ' CG ' ' CE2' ' A' ' 483' ' ' PHE . 0.8 OUTLIER -88.49 160.73 17.37 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -141.0 113.95 8.42 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.856 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . 0.433 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.7 tm-20 -48.06 99.68 0.02 OUTLIER 'General case' 0 CA--C 1.481 -1.704 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.887 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 160.24 22.88 0.03 OUTLIER Glycine 0 C--N 1.274 -2.909 0 C-N-CA 118.623 -1.751 . . . . 0.0 109.865 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' ASP . . . . . 0.661 ' CG ' ' H ' ' A' ' 495' ' ' TYR . 16.2 t70 -143.72 -179.91 6.75 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.071 -1.051 . . . . 0.0 112.2 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . 0.661 ' H ' ' CG ' ' A' ' 494' ' ' ASP . 25.1 t80 -101.59 137.91 39.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.667 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . 0.454 HG13 ' N ' ' A' ' 497' ' ' SER . 0.1 OUTLIER -137.15 160.98 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.445 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' SER . . . . . 0.454 ' N ' HG13 ' A' ' 496' ' ' ILE . 29.7 t -123.6 104.57 9.11 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.658 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' LEU . . . . . 0.467 HD11 ' N ' ' A' ' 499' ' ' ASP . 0.2 OUTLIER -109.62 134.27 52.14 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.764 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.467 ' N ' HD11 ' A' ' 498' ' ' LEU . 9.1 m-20 -115.36 148.67 39.01 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.821 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -148.45 89.55 0.14 Allowed Glycine 0 C--O 1.188 -2.777 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 22.5 m -162.77 -3.88 0.04 OUTLIER 'General case' 0 C--N 1.255 -3.537 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' THR . . . . . 0.407 ' H ' ' H ' ' A' ' 503' ' ' GLY . 75.8 p -152.77 -14.65 0.16 Allowed 'General case' 0 C--N 1.275 -2.667 0 CA-C-N 111.417 -2.629 . . . . 0.0 105.969 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 79.04 77.25 0.91 Allowed Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.29 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -156.69 136.13 12.23 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.729 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' ILE . . . . . 0.625 ' C ' ' CD1' ' A' ' 506' ' ' TYR . 10.7 mt -110.54 161.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.807 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' TYR . . . . . 0.712 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 24.6 m-85 -150.33 161.72 41.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.434 ' HG2' ' N ' ' A' ' 508' ' ' GLY . 13.0 ttmt -134.97 157.47 46.84 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 507' ' ' LYS . . . 101.6 -179.32 27.88 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.648 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 510' ' ' ILE . 11.4 t0 -90.52 142.54 27.64 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' ILE . . . . . 0.464 HG21 ' H ' ' A' ' 511' ' ' GLU . 7.7 mt -148.45 171.73 2.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.464 ' H ' HG21 ' A' ' 510' ' ' ILE . 2.9 mp0 . . . . . 0 C--N 1.303 -1.423 0 CA-C-O 116.305 -1.807 . . . . 0.0 110.846 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.916 0.389 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . 0.611 ' C ' ' H ' ' A' ' 387' ' ' LYS . . . -162.94 -152.44 0.22 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.575 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 57.6 mt 49.45 10.94 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.969 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.611 ' H ' ' C ' ' A' ' 385' ' ' ALA . 26.6 ttpp -122.43 -11.29 8.34 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.653 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -147.29 21.34 1.21 Allowed 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.35 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -79.93 -130.24 0.82 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.279 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -158.03 92.83 1.2 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.622 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.753 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 67.7 t -93.91 158.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.333 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.461 ' N ' HG11 ' A' ' 391' ' ' VAL . 10.3 pt -102.36 -33.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -178.3 -163.97 30.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 118.899 -1.619 . . . . 0.0 111.279 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 p -165.31 130.44 2.53 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.264 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.65 -147.92 0.42 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.943 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 63.2 mt -81.93 132.31 54.45 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.08 93.61 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.143 1.229 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ALA . . . . . . . . . . . . . . . -58.31 -62.12 2.07 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.47 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -148.61 146.88 23.34 Favored Pre-proline 0 C--N 1.305 -1.333 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.353 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.76 103.05 0.1 Allowed 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.258 1.305 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.06 162.61 29.85 Favored Glycine 0 N--CA 1.509 3.508 0 C-N-CA 118.723 -1.704 . . . . 0.0 112.379 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . 0.49 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -145.65 118.72 8.83 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.01 43.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.776 -1.57 . . . . 0.0 113.765 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -137.84 110.02 7.32 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.437 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.53 169.81 31.68 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.007 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' LYS . . . . . 0.653 ' CD ' ' N ' ' A' ' 406' ' ' LYS . 8.4 mptt -80.2 171.48 15.03 Favored 'General case' 0 C--O 1.201 -1.499 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -120.23 158.98 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.548 -1.261 . . . . 0.0 114.15 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' TYR . . . . . 0.622 ' CE2' ' CD1' ' A' ' 426' ' ' LEU . 20.0 p90 -156.24 -151.09 0.31 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.716 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 427' ' ' VAL . 28.4 m-85 -148.22 -42.28 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.406 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 36.8 p -94.71 138.55 32.39 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.548 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -56.12 -19.38 13.04 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.262 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -64.5 -49.07 72.78 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 417' ' ' ALA . 40.8 mm-40 -53.22 -50.9 63.77 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.286 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ALA . . . . . 0.409 ' HB2' ' CE2' ' A' ' 408' ' ' TYR . . . -48.58 -38.46 20.71 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -63.57 -41.19 98.4 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.505 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.3 -9.62 49.88 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.657 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.08 -60.7 1.86 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.401 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -56.23 -21.37 23.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.045 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -27.61 68.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.003 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -73.13 -6.99 49.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.94 71.47 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.16 152.03 3.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.163 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -72.17 153.11 41.83 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.643 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' VAL . . . . . 0.471 HG13 ' N ' ' A' ' 425' ' ' ILE . 4.4 t -145.97 160.15 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.446 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ILE . . . . . 0.514 ' O ' ' CE1' ' A' ' 408' ' ' TYR . 5.2 mm -121.85 159.28 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' LEU . . . . . 0.622 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 13.5 tp -115.79 139.16 50.44 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.796 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.545 ' O ' ' CD2' ' A' ' 409' ' ' PHE . 51.9 t -130.57 119.71 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ARG . . . . . 0.435 ' H ' HG23 ' A' ' 447' ' ' THR . 1.0 OUTLIER -151.4 152.75 33.51 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.902 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.417 ' CB ' ' OE2' ' A' ' 430' ' ' GLU . 0.7 OUTLIER -80.31 20.56 0.67 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.393 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 428' ' ' ARG . 1.4 pm0 -179.69 153.08 0.53 Allowed 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 432' ' ' SER . 0.5 OUTLIER -83.14 -175.24 5.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.555 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 431' ' ' THR . 4.2 t -177.07 139.28 0.44 Allowed Pre-proline 0 C--N 1.305 -1.357 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.858 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.5 -69.18 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.367 1.378 . . . . 0.0 111.897 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -46.48 -27.32 1.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.879 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.16 -9.23 45.13 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.477 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' ILE . . . . . 0.605 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 8.3 tp -60.29 -49.99 82.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.031 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . 0.605 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 52.3 mm-40 -54.89 -29.96 57.03 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.924 -1.51 . . . . 0.0 108.459 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.66 63.41 Favored Glycine 0 N--CA 1.473 1.143 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 43.8 mtt -69.48 -44.83 70.35 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.893 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.568 ' C ' ' N ' ' A' ' 442' ' ' ALA . 7.0 m170 -61.26 -39.28 89.79 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.408 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -51.63 -18.16 1.08 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' ALA . . . . . 0.568 ' N ' ' C ' ' A' ' 440' ' ' HIS . . . -122.52 -155.48 0.65 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.283 -1.78 . . . . 0.0 108.077 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -168.62 37.75 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -169.52 143.41 7.93 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.3 mp -142.36 118.45 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.453 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' LEU . . . . . 0.433 HD13 ' CG1' ' A' ' 468' ' ' VAL . 2.5 tp -121.78 98.37 5.92 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.695 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 428' ' ' ARG . 5.5 p -115.16 160.32 19.84 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.24 -20.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.87 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' ARG . . . . . 0.609 ' CG ' ' H ' ' A' ' 450' ' ' GLY . 2.1 ttt85 -129.26 179.24 5.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' GLY . . . . . 0.609 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 92.59 60.19 1.23 Allowed Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.163 -1.494 . . . . 0.0 109.725 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 453' ' ' THR . . . -141.78 -145.25 4.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 453' ' ' THR . 5.4 ttt 46.52 16.54 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.838 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.53 89.53 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.675 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 455' ' ' HIS . 93.9 p -149.3 -174.58 4.7 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.714 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' HIS . . . . . 0.488 ' O ' ' CG2' ' A' ' 459' ' ' VAL . 4.6 m170 -40.62 -45.1 2.27 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -47.49 -61.9 1.7 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.81 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.64 12.66 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.597 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 11.9 t -45.33 -40.18 2.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.393 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 455' ' ' HIS . 72.3 t -71.58 -45.39 67.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.318 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.35 80.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -68.72 -37.27 79.35 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.705 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -74.95 -24.12 72.79 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.528 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' MET . . . . . 0.469 ' HG3' ' N ' ' A' ' 464' ' ' GLY . 8.9 tpt -90.17 -81.92 0.28 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.449 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . 0.469 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 136.12 37.59 0.18 Allowed Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.968 -1.11 . . . . 0.0 110.428 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 10.2 t -108.37 171.43 7.42 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -86.42 126.34 34.32 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.98 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -152.19 155.19 37.3 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.284 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.4 t -135.52 162.66 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.577 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' SER . . . . . 0.568 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 33.5 t -149.98 151.74 33.8 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.028 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.37 83.99 0.01 OUTLIER Glycine 0 N--CA 1.496 2.67 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.087 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' CYS . . . . . 0.46 ' SG ' HD12 ' A' ' 485' ' ' LEU . 7.9 t -85.57 -145.99 0.11 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.023 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -67.94 -101.16 0.03 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -130.18 54.86 1.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 0.5 OUTLIER -45.63 111.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -105.03 113.91 27.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.22 134.95 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.444 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -105.99 115.32 30.03 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' GLU . . . . . 0.774 ' C ' ' H ' ' A' ' 480' ' ' ALA . 8.3 mp0 -67.76 -8.27 34.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.291 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -59.08 6.77 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.152 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ALA . . . . . 0.774 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 170.75 -77.72 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' LYS . . . . . 0.507 ' HD2' ' CD1' ' A' ' 409' ' ' PHE . 4.0 mmtp 158.93 84.07 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.79 1.306 . . . . 0.0 109.482 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' THR . . . . . 0.601 ' HA ' ' CB ' ' A' ' 491' ' ' ALA . 1.9 p -137.02 142.06 42.49 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' PHE . . . . . 0.604 ' H ' ' HB1' ' A' ' 491' ' ' ALA . 3.8 p90 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.441 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' A' ' 485' ' ' LEU . 5.5 tp10 -109.8 117.45 33.9 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' LEU . . . . . 0.464 ' N ' ' OE2' ' A' ' 484' ' ' GLU . 4.8 mt -150.21 159.85 44.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.789 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 53.98 -104.41 0.23 Allowed Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.575 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -139.96 28.72 2.49 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 119.079 -1.534 . . . . 0.0 111.897 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 23.8 m170 -150.68 142.29 23.58 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.639 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.9 m -106.81 99.04 8.63 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.988 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.559 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 23.3 p90 -154.32 155.13 34.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.302 -1.359 . . . . 0.0 113.948 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' ALA . . . . . 0.645 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -171.97 -129.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.669 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -47.12 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.187 -1.405 . . . . 0.0 108.94 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 157.69 0.48 0.1 OUTLIER Glycine 0 C--N 1.279 -2.584 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -159.81 -163.84 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.948 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' TYR . . . . . 0.473 ' CZ ' ' HA2' ' A' ' 508' ' ' GLY . 4.5 p90 -142.07 144.76 33.73 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.678 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.75 160.6 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.877 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 506' ' ' TYR . 6.7 t -115.31 99.91 7.74 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -98.2 144.44 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.377 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' ASP . . . . . 0.476 ' N ' HD12 ' A' ' 498' ' ' LEU . 6.7 t0 -103.55 157.43 17.05 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.697 0.761 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -145.25 95.47 0.18 Allowed Glycine 0 C--N 1.275 -2.816 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 0.3 OUTLIER 163.21 6.33 0.0 OUTLIER 'General case' 1 C--N 1.24 -4.156 0 CA-C-N 112.014 -2.093 . . . . 0.0 106.617 -179.97 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' THR . . . . . 0.456 HG21 ' H ' ' A' ' 504' ' ' LYS . 0.1 OUTLIER -163.56 -21.72 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.203 -2.271 . . . . 0.0 107.592 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.51 -10.35 62.01 Favored Glycine 0 N--CA 1.492 2.42 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.948 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' LYS . . . . . 0.456 ' H ' HG21 ' A' ' 502' ' ' THR . 7.9 mtmt -71.98 120.18 17.21 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.986 -1.086 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' ILE . . . . . 0.543 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.2 tt -96.97 160.65 2.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.867 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' TYR . . . . . 0.753 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 33.0 m-85 -138.18 162.58 33.89 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.128 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' LYS . . . . . 0.48 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 3.1 tmtt? -123.53 151.02 43.28 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.999 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . 60.89 99.2 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 C-N-CA 118.773 -1.679 . . . . 0.0 109.998 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 508' ' ' GLY . 36.2 m-20 -35.9 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.795 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 511' ' ' GLU . 0.9 OUTLIER -68.49 -26.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.224 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' GLU . . . . . 0.401 ' N ' HG21 ' A' ' 510' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.271 -2.822 0 CA-C-O 116.378 -1.772 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 391' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 121.468 0.652 . . . . 0.0 110.551 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 505' ' ' ILE . 25.4 t -41.01 143.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.326 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.667 HD13 ' CZ ' ' A' ' 490' ' ' PHE . 2.5 pt -87.72 -55.06 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.635 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.619 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -153.98 -157.13 7.97 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.4 p -164.51 108.47 0.93 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -84.84 -146.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 42.0 mt -96.79 139.99 21.89 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.92 93.07 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.61 0 C-N-CA 121.294 1.329 . . . . 0.0 111.303 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -64.02 -69.85 0.25 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.715 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 57.0 m -133.24 139.25 33.6 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.756 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.31 100.83 0.07 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.895 1.064 . . . . 0.0 110.406 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.616 ' C ' ' SG ' ' A' ' 466' ' ' CYS . . . -152.03 162.36 29.73 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.639 -1.743 . . . . 0.0 112.116 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -141.43 128.44 20.73 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.65 160.58 43.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.019 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -138.77 107.9 6.06 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.023 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.07 30.35 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.051 -1.547 . . . . 0.0 111.307 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.485 ' HE3' ' CD2' ' A' ' 495' ' ' TYR . 3.7 mttp -85.98 137.93 32.36 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.936 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.54 ' O ' ' CG ' ' A' ' 408' ' ' TYR . 49.6 t -55.44 148.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.986 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 407' ' ' VAL . 17.8 m-85 -170.98 139.9 1.48 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.653 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.731 ' CD2' ' NZ ' ' A' ' 481' ' ' LYS . 4.1 m-85 -113.79 42.43 2.01 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.313 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 409' ' ' PHE . 1.0 OUTLIER -159.36 145.0 16.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.886 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -76.83 -18.23 58.51 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.787 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -74.16 -39.93 62.91 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.69 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' GLU . . . . . 0.462 ' OE1' ' OG1' ' A' ' 410' ' ' THR . 41.8 mt-10 -66.78 -26.76 67.12 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.6 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.27 68.17 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.54 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -43.1 86.42 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.876 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.57 -49.58 52.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.842 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -58.77 -62.11 2.11 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.083 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -41.53 -30.58 0.21 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.663 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -89.53 -22.02 22.62 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.575 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 417' ' ' ALA . 0.0 OUTLIER -94.91 -49.2 5.67 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.521 -0.871 . . . . 0.0 112.842 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 422' ' ' GLU . . . -153.74 -10.64 0.07 OUTLIER Glycine 0 N--CA 1.497 2.737 0 C-N-CA 118.763 -1.684 . . . . 0.0 112.03 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' GLU . . . . . 0.446 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 3.0 mt-10 64.24 -145.89 0.28 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 49.87 65.89 1.29 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.614 -1.234 . . . . 0.0 108.352 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 408' ' ' TYR . 3.3 t -122.47 154.92 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.702 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 426' ' ' LEU . 18.9 mm -118.75 160.9 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.406 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.521 ' N ' HG22 ' A' ' 425' ' ' ILE . 1.4 tp -134.58 125.56 27.47 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.183 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 446' ' ' LEU . 38.2 t -114.14 127.16 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.75 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ARG . . . . . 0.613 ' H ' HG22 ' A' ' 447' ' ' THR . 0.0 OUTLIER -152.48 146.69 25.47 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.122 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 12.03 2.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.566 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 428' ' ' ARG . 67.2 tt0 -176.4 139.76 0.35 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.699 HG21 ' HB2' ' A' ' 456' ' ' ALA . 9.1 p -106.14 153.49 22.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.271 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.32 158.67 63.39 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.715 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.9 Cg_endo -65.79 -69.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.903 1.736 . . . . 0.0 112.394 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -35.23 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.568 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.624 ' OD1' ' SD ' ' A' ' 439' ' ' MET . 0.6 OUTLIER -62.83 -8.41 6.88 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.622 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.649 HG22 ' N ' ' A' ' 437' ' ' GLU . 0.3 OUTLIER -32.68 -58.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.649 ' N ' HG22 ' A' ' 436' ' ' ILE . 53.2 mt-10 -47.93 -41.19 24.15 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 117.961 -1.496 . . . . 0.0 109.086 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -71.91 -25.85 73.92 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' MET . . . . . 0.632 ' SD ' HG11 ' A' ' 459' ' ' VAL . 40.5 mtp -70.65 -46.93 62.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -58.26 -61.66 2.41 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 118.267 -1.373 . . . . 0.0 109.546 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -49.25 -32.15 10.18 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.096 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -98.04 71.45 2.15 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.544 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.18 3.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.239 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.627 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -144.32 145.17 14.46 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 49.8 mt -148.01 118.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.091 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 427' ' ' VAL . 4.6 tp -115.55 97.96 6.45 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 428' ' ' ARG . 4.4 p -106.16 160.94 14.95 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.901 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 56.6 t -86.47 -20.62 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.157 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 470' ' ' GLY . 2.0 tpt85 -99.54 -136.04 0.29 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.615 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.509 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 73.14 -170.47 52.05 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.62 -170.34 40.54 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.897 -1.62 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.571 ' O ' HG23 ' A' ' 453' ' ' THR . 13.9 ttt -46.95 -37.97 9.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 452' ' ' MET . 0.7 OUTLIER -158.91 129.26 5.91 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.182 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.1 m -174.29 -178.29 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 459' ' ' VAL . 34.4 m80 -45.63 -38.3 6.52 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.952 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.699 ' HB2' HG21 ' A' ' 431' ' ' THR . . . -59.51 -51.27 70.58 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.694 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -78.19 -52.09 9.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 3.4 t -47.85 -50.49 9.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.284 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 455' ' ' HIS . 65.9 t -63.99 -39.27 84.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 464' ' ' GLY . . . -65.51 -50.59 64.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.381 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -53.96 -29.07 41.15 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.422 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.15 -35.33 27.4 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 16.2 mmt -97.49 6.43 48.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.727 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 460' ' ' ALA . . . 48.78 24.72 4.4 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.953 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 94.3 m -84.11 146.4 27.91 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.831 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' CYS . . . . . 0.616 ' SG ' ' C ' ' A' ' 401' ' ' GLY . 17.0 t -76.1 129.5 36.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 80.0 m -151.54 146.98 26.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.822 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.69 160.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.393 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 469' ' ' SER . . . . . 0.507 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 7.0 t -151.04 148.15 27.99 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.596 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 52.0 92.39 0.01 OUTLIER Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 471' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 446' ' ' LEU . 7.9 m -100.69 -159.39 0.73 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.643 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.72 -99.0 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.959 -1.591 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -133.92 43.87 2.8 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.416 0.627 . . . . 0.0 109.34 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.607 HG23 ' CB ' ' A' ' 483' ' ' PHE . 5.0 mt -39.09 110.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.846 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -94.3 121.96 36.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 482' ' ' THR . 3.8 mt -87.36 131.13 35.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 117.829 -1.548 . . . . 0.0 112.795 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -104.39 119.45 38.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.552 ' C ' ' N ' ' A' ' 480' ' ' ALA . 1.5 mp0 -62.65 -10.69 13.26 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.598 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -45.51 -20.18 0.06 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 118.236 -1.386 . . . . 0.0 108.518 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.552 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.68 -103.67 0.01 OUTLIER 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 481' ' ' LYS . . . . . 0.731 ' NZ ' ' CD2' ' A' ' 409' ' ' PHE . 11.2 mmmm -155.96 65.87 0.59 Allowed 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.642 ' O ' HG23 ' A' ' 476' ' ' ILE . 4.8 p -98.43 -179.5 4.36 Favored 'General case' 0 C--O 1.201 -1.475 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.783 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 483' ' ' PHE . . . . . 0.607 ' CB ' HG23 ' A' ' 474' ' ' ILE . 0.5 OUTLIER -150.78 117.23 5.72 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.043 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 484' ' ' GLU . . . . . 0.427 ' CG ' HG23 ' A' ' 489' ' ' THR . 33.8 mt-10 -89.17 118.48 28.9 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.839 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 486' ' ' GLY . 61.6 tp -143.53 154.79 43.98 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.775 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 486' ' ' GLY . . . . . 0.468 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 56.89 -114.59 5.48 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.484 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.85 3.91 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.11 152.19 33.04 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.427 HG23 ' CG ' ' A' ' 484' ' ' GLU . 88.3 m -107.79 112.03 24.49 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.946 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.667 ' CZ ' HD13 ' A' ' 392' ' ' ILE . 5.6 m-30 -89.45 110.93 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.061 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -98.23 149.01 23.02 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.865 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.485 ' CG ' ' O ' ' A' ' 492' ' ' GLU . 1.9 tm-20 -67.29 69.49 0.09 Allowed 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 493' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -173.96 22.47 0.06 OUTLIER Glycine 0 C--N 1.269 -3.139 0 C-N-CA 119.206 -1.473 . . . . 0.0 109.765 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 494' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 495' ' ' TYR . 2.4 t0 -140.69 -173.94 3.83 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.655 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 495' ' ' TYR . . . . . 0.485 ' CD2' ' HE3' ' A' ' 406' ' ' LYS . 0.2 OUTLIER -116.41 129.64 56.34 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.892 HD12 ' N ' ' A' ' 497' ' ' SER . 0.6 OUTLIER -138.37 160.5 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.554 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 497' ' ' SER . . . . . 0.892 ' N ' HD12 ' A' ' 496' ' ' ILE . 17.3 m -125.05 112.11 16.15 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 498' ' ' LEU . . . . . 0.418 HD13 ' CG1' ' A' ' 505' ' ' ILE . 0.0 OUTLIER -108.76 141.25 41.03 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.539 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 498' ' ' LEU . 3.6 m-20 -93.12 161.7 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.037 0.922 . . . . 0.0 112.531 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 500' ' ' GLY . . . . . 0.608 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -150.65 94.73 0.15 Allowed Glycine 0 C--N 1.287 -2.189 0 N-CA-C 106.737 -2.545 . . . . 0.0 106.737 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 501' ' ' SER . . . . . 0.469 ' C ' ' OG1' ' A' ' 502' ' ' THR . 0.3 OUTLIER 174.31 1.55 0.0 OUTLIER 'General case' 1 C--N 1.241 -4.122 0 CA-C-N 112.995 -1.602 . . . . 0.0 108.161 179.797 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 502' ' ' THR . . . . . 0.469 ' OG1' ' C ' ' A' ' 501' ' ' SER . 0.6 OUTLIER -168.66 -21.03 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.019 -1.9 . . . . 0.0 107.844 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.19 72.97 1.28 Allowed Glycine 0 N--CA 1.484 1.865 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.46 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -139.88 112.74 8.06 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.348 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' ILE . . . . . 0.65 ' O ' HG13 ' A' ' 391' ' ' VAL . 5.8 mt -89.46 149.05 4.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.286 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 506' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 507' ' ' LYS . 46.4 t80 -147.66 161.44 41.18 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.412 ' O ' ' CE2' ' A' ' 506' ' ' TYR . 15.7 tttt -116.89 160.61 20.61 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.965 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.605 179.952 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.401 ' OE2' ' HE1' ' A' ' 488' ' ' HIS . 12.3 tp10 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.832 0.349 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.572 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 24.3 t -96.59 135.18 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.4 pt -90.75 -31.6 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 164.65 -176.34 40.5 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.075 -1.536 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.8 p -141.5 151.47 43.34 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.184 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -142.46 -152.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.344 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.718 ' CD2' ' N ' ' A' ' 396' ' ' LEU . 0.1 OUTLIER -63.45 115.51 18.77 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.323 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.79 100.52 0.83 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.023 1.149 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -59.89 -76.03 0.05 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.094 -1.043 . . . . 0.0 110.859 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.3 t -137.85 151.38 70.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.732 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.08 104.04 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.447 1.431 . . . . 0.0 110.822 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.605 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -152.62 163.24 30.29 Favored Glycine 0 N--CA 1.503 3.152 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.87 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -137.81 123.41 19.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.48 161.16 43.06 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.703 -1.599 . . . . 0.0 114.12 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -148.5 107.11 3.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.001 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.47 31.81 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 118.905 -1.617 . . . . 0.0 112.151 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.464 ' NZ ' ' HB2' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -84.5 132.51 34.53 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.522 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.49 158.59 5.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.028 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.577 ' CD1' ' CD ' ' A' ' 413' ' ' GLU . 3.8 m-85 -151.8 -170.62 3.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -142.27 6.43 1.71 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.798 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.0 p -141.64 142.25 33.41 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -67.25 -12.17 59.41 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.661 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -73.12 -42.86 62.45 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' GLU . . . . . 0.577 ' CD ' ' CD1' ' A' ' 408' ' ' TYR . 49.9 mt-10 -63.92 -37.9 89.12 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.873 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.42 68.37 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.773 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -69.93 -38.42 76.19 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.271 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.53 -13.29 34.91 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.206 -0.997 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -90.2 -52.43 4.94 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.83 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' HIS . . . . . 0.583 ' HB2' ' HB1' ' A' ' 441' ' ' ALA . 16.3 t-80 -47.79 -21.58 0.42 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.328 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.9 OUTLIER -83.75 -68.68 0.69 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.205 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -93.2 -24.35 18.24 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.761 -0.776 . . . . 0.0 112.342 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -89.27 -51.87 2.85 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.027 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 417' ' ' ALA . 3.6 mt-10 62.38 165.65 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.022 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 422' ' ' GLU . 12.6 mpt_? 45.0 80.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.535 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 4.2 t -130.21 161.4 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.984 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 426' ' ' LEU . 7.2 mm -133.42 160.81 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.653 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.478 ' N ' HG22 ' A' ' 425' ' ' ILE . 9.8 tp -131.65 151.69 51.42 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.613 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 426' ' ' LEU . 6.2 t -131.45 126.28 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ARG . . . . . 0.67 ' O ' HG22 ' A' ' 447' ' ' THR . 90.4 mtt180 -151.89 150.77 30.44 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.354 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.524 ' N ' HD23 ' A' ' 429' ' ' LEU . 7.0 mt -59.55 -44.09 93.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.646 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.62 -178.16 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -81.81 -178.07 6.83 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.927 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.78 122.42 0.81 Allowed Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.6 -33.6 93.34 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.036 1.157 . . . . 0.0 111.779 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -73.81 -9.4 58.62 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.1 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -87.26 -8.33 56.91 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.565 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 7.9 tp -39.91 -50.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.5 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.643 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 27.3 mt-10 -61.19 -31.53 71.28 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 117.877 -1.529 . . . . 0.0 108.387 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.16 -28.09 60.88 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' MET . . . . . 0.552 ' SD ' HG11 ' A' ' 459' ' ' VAL . 75.0 mtp -66.91 -42.65 85.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.191 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -67.46 -58.88 3.94 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.198 -1.401 . . . . 0.0 108.924 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 418' ' ' HIS . . . -49.36 -36.07 20.51 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.392 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -94.19 81.59 4.07 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.158 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.95 21.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.113 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.664 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -165.97 149.57 15.86 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.39 131.56 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.97 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.611 ' CD2' HD22 ' A' ' 498' ' ' LEU . 0.6 OUTLIER -123.72 108.66 12.77 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.06 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 447' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 428' ' ' ARG . 3.4 p -121.83 160.23 25.12 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.538 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.578 HG13 HG13 ' A' ' 474' ' ' ILE . 2.6 t -79.09 -25.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.406 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -121.13 -142.22 0.34 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.197 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 81.13 -143.9 24.36 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.137 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' GLY . . . . . 0.608 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 55.67 -140.87 40.05 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.204 -1.474 . . . . 0.0 110.122 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 24.9 mtm 43.82 38.95 2.3 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.487 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 56.2 p 42.43 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.575 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 458' ' ' VAL . 45.5 p -160.06 -164.64 1.33 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.168 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' HIS . . . . . 0.696 ' O ' HG23 ' A' ' 459' ' ' VAL . 69.0 m80 -43.9 -51.36 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.211 -0.995 . . . . 0.0 110.593 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.405 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -42.34 -55.33 3.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.764 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.48 6.31 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.667 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 454' ' ' SER . 50.3 t -47.02 -40.83 5.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.49 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 455' ' ' HIS . 43.4 t -74.36 -42.13 50.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.26 -35.89 81.57 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -68.46 -40.34 81.07 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.456 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -61.12 -36.52 92.48 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.388 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.78 -15.65 29.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.989 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 61.91 57.88 15.4 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.644 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 161.24 17.4 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 401' ' ' GLY . 19.0 t -81.11 91.7 6.16 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.481 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.6 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 4.2 t -129.34 158.8 38.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.397 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 468' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -136.62 162.71 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.055 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 469' ' ' SER . . . . . 0.608 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 32.1 t -143.59 160.17 41.13 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.669 -1.213 . . . . 0.0 113.093 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 47.35 75.18 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.434 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' CYS . . . . . 0.654 ' SG ' HD13 ' A' ' 485' ' ' LEU . 1.8 t -84.75 -171.67 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.215 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.461 ' H ' HD11 ' A' ' 485' ' ' LEU . . . -50.25 -90.83 0.01 OUTLIER Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.672 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -155.67 66.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.578 HG13 HG13 ' A' ' 448' ' ' VAL . 0.0 OUTLIER -62.79 107.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.41 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -89.91 123.28 33.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.58 126.58 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.565 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -97.39 113.63 25.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.702 ' C ' ' H ' ' A' ' 480' ' ' ALA . 0.8 OUTLIER -67.87 -6.12 20.1 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.416 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.428 ' H ' ' HG2' ' A' ' 479' ' ' GLU . 34.8 mm-40 -52.92 -7.43 0.07 Allowed 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.551 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -179.72 -82.3 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 112.527 -2.124 . . . . 0.0 105.487 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 481' ' ' LYS . . . . . 0.528 ' HB3' ' CG ' ' A' ' 492' ' ' GLU . 4.5 mttt 169.17 89.18 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.099 0.952 . . . . 0.0 109.772 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 491' ' ' ALA . 1.4 p -151.29 138.78 19.53 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.301 -1.772 . . . . 0.0 111.885 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 483' ' ' PHE . . . . . 0.53 ' HB2' HG22 ' A' ' 474' ' ' ILE . 16.0 p90 -97.83 152.0 19.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -119.33 116.28 25.9 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.198 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.654 HD13 ' SG ' ' A' ' 471' ' ' CYS . 6.2 tt -150.5 152.87 34.86 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 69.04 -108.35 2.44 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 118.828 -1.653 . . . . 0.0 110.286 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 487' ' ' GLY . . . . . 0.414 ' C ' ' ND1' ' A' ' 488' ' ' HIS . . . -137.34 27.21 2.89 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.194 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 488' ' ' HIS . . . . . 0.414 ' ND1' ' C ' ' A' ' 487' ' ' GLY . 42.5 m80 -150.68 152.51 34.06 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.829 -1.149 . . . . 0.0 111.286 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.9 m -119.83 97.12 5.47 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.12 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 490' ' ' PHE . 39.0 p90 -155.48 155.31 33.26 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.98 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.716 ' H ' HG22 ' A' ' 482' ' ' THR . . . -152.1 -124.31 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.528 ' CG ' ' HB3' ' A' ' 481' ' ' LYS . 1.1 pt-20 -67.9 49.03 0.05 Allowed 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 493' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -138.51 2.63 2.83 Favored Glycine 0 C--N 1.283 -2.37 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -167.56 -173.97 2.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.477 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 495' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -122.94 141.94 51.36 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.742 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.598 ' H ' HD12 ' A' ' 496' ' ' ILE . 0.6 OUTLIER -121.47 160.06 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.944 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 497' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 506' ' ' TYR . 6.3 m -115.37 99.46 7.4 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 498' ' ' LEU . . . . . 0.611 HD22 ' CD2' ' A' ' 446' ' ' LEU . 0.1 OUTLIER -100.48 140.83 34.18 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.219 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.524 ' N ' HD12 ' A' ' 498' ' ' LEU . 21.7 t70 -93.42 160.64 14.72 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-O 122.018 0.913 . . . . 0.0 111.896 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 500' ' ' GLY . . . . . 0.605 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -148.27 95.14 0.16 Allowed Glycine 0 C--N 1.272 -3.026 0 N-CA-C 106.508 -2.637 . . . . 0.0 106.508 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 2.0 t 171.15 4.47 0.0 OUTLIER 'General case' 0 C--N 1.244 -3.981 0 CA-C-N 112.177 -2.012 . . . . 0.0 107.065 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 502' ' ' THR . . . . . 0.413 ' H ' ' H ' ' A' ' 503' ' ' GLY . 0.0 OUTLIER -168.38 -22.79 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.516 -2.129 . . . . 0.0 107.496 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 96.93 -7.86 65.08 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.882 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 154.74 9.8 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.914 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 2.1 mp -135.04 146.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.295 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' TYR . . . . . 0.572 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 14.0 m-85 -133.79 161.96 33.3 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -127.74 153.86 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.209 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.209 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.773 0.32 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.657 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 65.1 t -46.3 156.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.289 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.47 ' N ' HG12 ' A' ' 391' ' ' VAL . 34.3 pt -128.29 -11.8 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.363 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -175.25 -167.41 34.37 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.896 -1.621 . . . . 0.0 111.481 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.2 p 177.12 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.327 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.36 -151.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 396' ' ' LEU . 8.9 mt -80.74 127.16 76.12 Favored Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.601 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.08 97.32 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -60.39 -59.37 5.51 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.946 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.01 133.72 12.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.91 98.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 120.791 0.994 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.592 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -153.43 159.58 28.7 Favored Glycine 0 N--CA 1.504 3.169 0 C-N-CA 118.876 -1.63 . . . . 0.0 111.882 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.756 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -133.13 132.05 41.2 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.711 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.421 ' HB2' ' SG ' ' A' ' 466' ' ' CYS . . . -150.39 161.38 42.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.184 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.14 110.94 6.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.231 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -153.16 167.69 31.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.812 -1.661 . . . . 0.0 111.774 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -83.89 156.46 22.39 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.179 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.71 ' HB ' ' H ' ' A' ' 492' ' ' GLU . 0.0 OUTLIER -78.79 165.23 3.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.639 -0.825 . . . . 0.0 113.072 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.59 ' CE1' ' OE1' ' A' ' 413' ' ' GLU . 3.6 m-85 -170.37 170.0 7.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.993 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.505 ' CG ' ' HD2' ' A' ' 481' ' ' LYS . 14.2 m-85 -137.36 23.21 2.97 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.805 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 12.6 p -146.95 142.0 27.09 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.25 -12.28 61.37 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -78.22 -36.47 47.12 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.451 -0.899 . . . . 0.0 109.718 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' GLU . . . . . 0.59 ' OE1' ' CE1' ' A' ' 408' ' ' TYR . 62.0 mm-40 -65.58 -40.38 92.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ALA . . . . . 0.589 ' HB1' ' CB ' ' A' ' 441' ' ' ALA . . . -67.5 -39.63 85.19 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.345 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -56.48 -34.25 66.74 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.762 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.62 -50.82 5.71 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.717 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -55.17 -48.02 74.35 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.28 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 418' ' ' HIS . . . . . 0.594 ' ND1' ' OE1' ' A' ' 419' ' ' GLU . 17.9 t-80 -43.76 -41.01 4.66 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.045 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.594 ' OE1' ' ND1' ' A' ' 418' ' ' HIS . 0.6 OUTLIER -91.92 -25.6 18.83 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.457 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 420' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 420' ' ' LYS . 7.6 mtpm? -92.69 -52.8 4.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.63 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -101.3 -31.6 5.52 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.148 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' GLU . . . . . 0.461 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 0.9 OUTLIER 65.96 148.6 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.396 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 55.89 95.01 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.879 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.54 162.45 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.484 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 426' ' ' LEU . 16.8 mm -121.69 159.93 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 425' ' ' ILE . 6.6 tp -136.15 134.52 38.34 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.345 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.556 HG21 ' CE2' ' A' ' 483' ' ' PHE . 8.7 t -117.72 121.73 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.714 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ARG . . . . . 0.911 ' O ' HG22 ' A' ' 447' ' ' THR . 47.8 mtt180 -151.29 161.64 42.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -66.5 0.53 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.62 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -109.3 -165.53 1.02 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.678 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -99.0 -163.97 1.09 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.32 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.517 ' N ' ' OG1' ' A' ' 431' ' ' THR . 1.4 t -175.61 137.16 0.51 Allowed Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.557 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.5 Cg_endo -62.27 -77.59 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.388 1.392 . . . . 0.0 112.126 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -44.01 -18.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 439' ' ' MET . 11.0 m-20 -82.53 -9.0 59.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.39 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.967 HG23 ' H ' ' A' ' 437' ' ' GLU . 6.1 tp -46.78 -63.54 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.579 -0.849 . . . . 0.0 111.145 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.967 ' H ' HG23 ' A' ' 436' ' ' ILE . 5.4 mt-10 -52.27 -26.98 13.34 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.414 -1.315 . . . . 0.0 108.59 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -81.17 -24.67 56.9 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 435' ' ' ASP . 53.3 mtt -77.64 -41.97 36.47 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.861 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.852 ' NE2' HD11 ' A' ' 436' ' ' ILE . 28.1 m170 -65.14 -49.04 71.41 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.813 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.589 ' CB ' ' HB1' ' A' ' 414' ' ' ALA . . . -48.38 -20.83 0.45 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.536 ' N ' ' C ' ' A' ' 440' ' ' HIS . . . -116.57 61.77 0.72 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.53 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.718 ' CD ' ' H ' ' A' ' 443' ' ' GLU . 1.4 pm0 -26.03 -58.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.875 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' A' ' 425' ' ' ILE . . . -81.48 145.2 25.01 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 118.494 -1.812 . . . . 0.0 109.009 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 41.0 mt -147.81 112.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 118.449 -1.301 . . . . 0.0 112.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 446' ' ' LEU . 1.3 mm? -100.35 137.63 38.51 Favored 'General case' 0 C--O 1.187 -2.217 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 447' ' ' THR . . . . . 0.911 HG22 ' O ' ' A' ' 428' ' ' ARG . 0.3 OUTLIER -149.64 151.44 33.76 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.019 -1.473 . . . . 0.0 111.896 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.703 HG22 ' HB ' ' A' ' 474' ' ' ILE . 18.8 t -77.02 -24.29 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.805 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 10.7 ttt-85 -108.13 -143.66 0.38 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.225 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.508 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 73.93 -162.69 54.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 77.21 -41.92 1.85 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.159 -1.496 . . . . 0.0 110.392 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.683 ' C ' HG23 ' A' ' 453' ' ' THR . 53.7 mtt -64.86 19.09 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' THR . . . . . 0.683 HG23 ' C ' ' A' ' 452' ' ' MET . 1.0 OUTLIER 62.84 114.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.874 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.7 t -173.28 -155.54 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 459' ' ' VAL . 45.8 t60 -57.67 -36.8 72.4 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.678 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -63.23 -44.67 94.59 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.0 -57.43 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.648 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.67 -41.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.7 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 455' ' ' HIS . 51.5 t -65.95 -53.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.11 73.48 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -69.33 -24.0 63.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.606 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.05 -48.3 5.8 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.642 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 56.7 mmm -78.41 -40.81 34.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.982 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.35 22.0 30.68 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.574 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' THR . . . . . 0.831 HG22 ' H ' ' A' ' 466' ' ' CYS . 7.3 m -76.03 -170.51 1.41 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 466' ' ' CYS . . . . . 0.831 ' H ' HG22 ' A' ' 465' ' ' THR . 0.0 OUTLIER -99.1 120.32 39.29 Favored 'General case' 0 C--O 1.202 -1.414 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.667 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 23.4 t -151.29 147.24 26.72 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.055 -1.458 . . . . 0.0 112.005 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.89 162.71 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.747 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' SER . . . . . 0.508 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 28.8 t -147.79 160.58 42.58 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.995 -1.082 . . . . 0.0 112.62 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 46.94 72.92 0.35 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.184 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' CYS . . . . . 0.618 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.5 OUTLIER -83.43 -158.82 0.32 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.878 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 471' ' ' CYS . . . -67.69 -101.71 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.31 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -135.33 54.57 1.92 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.861 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.812 HG23 ' CB ' ' A' ' 483' ' ' PHE . 5.1 mt -45.67 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.921 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -89.37 121.39 31.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.01 122.44 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.929 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -99.46 111.97 24.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.788 ' C ' ' H ' ' A' ' 480' ' ' ALA . 35.9 mt-10 -60.54 0.29 0.21 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.286 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.647 ' O ' ' HB2' ' A' ' 480' ' ' ALA . 47.4 mt-10 -64.24 17.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.254 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.788 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 155.2 -71.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 481' ' ' LYS . . . . . 0.505 ' HD2' ' CG ' ' A' ' 409' ' ' PHE . 2.1 mmtt 158.51 79.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.492 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 482' ' ' THR . . . . . 1.005 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 6.7 p -132.28 143.76 50.12 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.681 -0.807 . . . . 0.0 112.325 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 483' ' ' PHE . . . . . 1.015 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 10.8 p90 -98.96 143.51 29.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.201 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 485' ' ' LEU . 5.1 tp10 -101.54 111.24 23.42 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.196 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 487' ' ' GLY . 0.8 OUTLIER -134.6 117.83 16.55 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.002 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 486' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 485' ' ' LEU . . . 21.3 -74.15 0.0 OUTLIER Glycine 0 N--CA 1.51 3.593 0 O-C-N 124.486 1.116 . . . . 0.0 114.439 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 487' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 485' ' ' LEU . . . -51.76 -67.92 1.78 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.543 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 488' ' ' HIS . . . . . 0.421 ' CG ' ' O ' ' A' ' 487' ' ' GLY . 64.7 m-70 -154.44 163.53 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.156 -1.418 . . . . 0.0 112.869 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 484' ' ' GLU . 9.2 m -93.6 99.29 11.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.438 ' CE1' ' HE3' ' A' ' 507' ' ' LYS . 40.3 p90 -153.22 154.13 34.07 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 118.455 -1.298 . . . . 0.0 113.825 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 1.015 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . 170.94 172.52 0.07 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 113.767 -1.561 . . . . 0.0 108.678 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.71 ' H ' ' HB ' ' A' ' 407' ' ' VAL . 19.7 tt0 26.06 41.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 O-C-N 124.266 0.979 . . . . 0.0 109.978 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 493' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -167.61 1.43 0.04 OUTLIER Glycine 0 C--N 1.281 -2.505 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 494' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 407' ' ' VAL . 2.9 m-20 -156.96 -152.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 495' ' ' TYR . . . . . 0.408 ' N ' ' CD1' ' A' ' 495' ' ' TYR . 1.5 p90 -154.32 140.52 18.51 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.433 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.842 ' H ' HD12 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -122.99 160.6 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.569 -0.852 . . . . 0.0 113.073 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 497' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 506' ' ' TYR . 1.8 p -115.29 98.37 6.72 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 498' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -93.39 142.31 27.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.893 -1.123 . . . . 0.0 113.012 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.733 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.9 OUTLIER -106.52 161.54 14.52 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.479 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 500' ' ' GLY . . . . . 0.592 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -156.28 95.41 0.15 Allowed Glycine 0 C--N 1.277 -2.707 0 N-CA-C 106.836 -2.505 . . . . 0.0 106.836 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 501' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 502' ' ' THR . 77.7 p -178.03 6.68 0.01 OUTLIER 'General case' 1 C--N 1.241 -4.142 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.33 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 502' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 501' ' ' SER . 0.0 OUTLIER -175.35 -19.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 112.822 -1.99 . . . . 0.0 107.72 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 86.77 74.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.558 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 499' ' ' ASP . 19.8 mttp -155.45 115.16 3.68 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.258 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' ILE . . . . . 0.548 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.1 tt -93.91 160.45 2.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.687 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' TYR . . . . . 0.657 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 18.8 m-85 -141.82 161.44 37.95 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.771 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.438 ' HE3' ' CE1' ' A' ' 490' ' ' PHE . 47.6 tttt -107.67 154.36 21.57 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.695 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.567 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--O 1.215 -0.731 0 CA-C-O 120.822 0.344 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.72 HG23 ' CE1' ' A' ' 506' ' ' TYR . 0.4 OUTLIER -83.79 137.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.707 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.771 HD12 HD21 ' A' ' 485' ' ' LEU . 28.2 pt -77.48 -39.38 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.571 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.52 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -178.56 -162.33 27.97 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.499 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 121.11 0.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.615 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.434 ' HB2' ' SG ' ' A' ' 471' ' ' CYS . . . -94.86 -142.69 0.25 Allowed 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.913 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.77 128.34 48.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.328 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.73 98.2 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 121.076 1.184 . . . . 0.0 111.756 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -62.93 -74.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.26 146.24 60.07 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.946 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -52.27 100.4 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.762 1.642 . . . . 0.0 111.078 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.65 161.22 29.74 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 117.9 -2.095 . . . . 0.0 112.989 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -150.48 117.23 5.83 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.135 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.49 161.57 42.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.652 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.35 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.746 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.16 166.64 31.09 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.337 -1.887 . . . . 0.0 112.338 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -85.24 134.29 34.14 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.567 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 483' ' ' PHE . 2.2 p -66.21 138.24 23.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.998 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.658 ' CE1' ' OE2' ' A' ' 413' ' ' GLU . 1.5 m-85 -153.08 146.16 24.63 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.623 ' O ' HG23 ' A' ' 410' ' ' THR . 4.2 m-85 -110.94 41.53 1.8 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.531 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 409' ' ' PHE . 0.8 OUTLIER -160.95 143.65 12.72 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.189 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -78.11 -13.36 59.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.606 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.61 -41.04 24.61 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.06 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' GLU . . . . . 0.658 ' OE2' ' CE1' ' A' ' 408' ' ' TYR . 6.0 mm-40 -64.38 -40.6 96.14 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.966 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.07 97.99 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.46 -38.28 90.54 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -82.01 -16.96 48.52 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.56 -52.4 4.91 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.183 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.51 -19.06 55.78 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.563 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.579 ' C ' ' H ' ' A' ' 421' ' ' GLY . 0.7 OUTLIER -64.6 -48.24 75.67 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.877 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -1.07 0.08 Allowed 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 77.82 64.86 1.98 Allowed Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.08 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' GLU . . . . . 0.701 ' C ' ' HE ' ' A' ' 423' ' ' ARG . 7.2 mt-10 -146.43 -166.53 2.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.414 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' ARG . . . . . 0.753 ' HE ' ' N ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER -115.69 148.36 39.82 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.632 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.419 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 1.7 t -148.97 162.1 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.075 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 6.2 mm -123.81 160.74 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.24 121.14 30.39 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.432 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 409' ' ' PHE . 24.8 t -111.31 117.27 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.246 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 447' ' ' THR . 17.0 mtp85 -152.43 155.52 37.7 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.941 ' H ' HD23 ' A' ' 429' ' ' LEU . 0.7 OUTLIER -106.32 28.71 7.48 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.571 1.177 . . . . 0.0 109.649 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.39 121.17 2.96 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.721 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.8 OUTLIER -76.08 179.56 5.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.97 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 2.9 t -177.24 139.5 0.44 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.068 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.91 -72.9 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.617 1.545 . . . . 0.0 111.871 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 435' ' ' ASP . 7.4 pt-20 -39.48 -32.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.659 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 438' ' ' GLY . 4.0 m-20 -62.14 -8.6 5.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.727 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.624 HG23 ' N ' ' A' ' 437' ' ' GLU . 6.7 tp -48.54 -43.4 13.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.878 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.624 ' N ' HG23 ' A' ' 436' ' ' ILE . 23.2 mt-10 -62.66 -27.19 69.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 117.769 -1.572 . . . . 0.0 107.957 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -78.88 -26.93 57.58 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 27.8 mtt -66.49 -39.22 88.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.756 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -74.54 -39.72 62.16 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.336 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.756 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -55.76 -28.77 57.71 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.782 -1.167 . . . . 0.0 107.91 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -112.84 89.47 3.09 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.118 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 443' ' ' GLU . 7.0 pt-20 -64.36 37.23 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.862 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -171.58 140.52 5.9 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.9 mm -139.24 132.17 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.913 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 427' ' ' VAL . 1.4 tp -135.96 95.98 3.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.2 p -109.14 161.44 15.21 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.804 -0.758 . . . . 0.0 112.768 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 474' ' ' ILE . 37.0 t -85.23 -21.0 8.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.971 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 470' ' ' GLY . 19.1 mmm-85 -105.97 -148.11 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.626 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 89.08 -136.58 13.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' GLY . . . . . 0.578 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 82.59 163.69 33.76 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 16.8 tpp 46.64 13.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.482 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.3 OUTLIER 66.97 131.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.592 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.654 ' H ' ' HB3' ' A' ' 457' ' ' ALA . 9.0 t -163.58 -169.97 2.08 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.957 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' HIS . . . . . 0.603 ' O ' HG23 ' A' ' 459' ' ' VAL . 4.6 m80 -43.41 -46.04 6.47 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.721 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -61.39 -48.12 82.68 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.663 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.654 ' HB3' ' H ' ' A' ' 454' ' ' SER . . . -74.66 -55.02 6.33 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.534 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 459' ' ' VAL . 2.2 t -50.25 -53.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.548 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 455' ' ' HIS . 88.6 t -54.08 -44.1 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.527 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.696 ' HB1' ' SG ' ' A' ' 467' ' ' CYS . . . -61.22 -55.17 35.15 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -55.38 -28.69 55.64 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.534 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.11 66.14 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.602 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 463' ' ' MET . 1.1 tpt -91.46 -41.66 10.72 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.03 83.94 1.64 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.523 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' THR . . . . . 0.643 HG22 ' N ' ' A' ' 466' ' ' CYS . 1.9 m -162.36 171.93 16.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.8 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 466' ' ' CYS . . . . . 0.643 ' N ' HG22 ' A' ' 465' ' ' THR . 12.8 t -78.1 126.47 30.87 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.958 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.696 ' SG ' ' HB1' ' A' ' 460' ' ' ALA . 0.5 OUTLIER -151.2 148.36 28.15 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.89 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 468' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.01 160.78 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.67 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 469' ' ' SER . . . . . 0.578 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 6.9 t -150.85 152.6 33.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.443 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 44.16 87.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.431 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 471' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -99.63 -174.78 2.8 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.45 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -47.22 -84.29 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -158.15 66.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.95 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.3 mt -61.96 102.71 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.604 -0.839 . . . . 0.0 112.45 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.69 120.29 29.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.851 HG23 ' O ' ' A' ' 482' ' ' THR . 52.9 mt -88.76 137.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.327 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 477' ' ' ASN . . . . . 0.529 ' CB ' ' OG1' ' A' ' 482' ' ' THR . 0.3 OUTLIER -107.42 123.15 47.96 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.682 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.604 ' C ' ' N ' ' A' ' 480' ' ' ALA . 20.3 mm-40 -54.58 -7.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 478' ' ' GLU . 0.1 OUTLIER -46.46 -18.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.239 -1.384 . . . . 0.0 108.311 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.604 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . 177.56 -97.37 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 112.283 -2.235 . . . . 0.0 105.43 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 481' ' ' LYS . . . . . 0.584 ' CD ' ' CD2' ' A' ' 409' ' ' PHE . 3.6 mmpp? -148.55 40.49 0.92 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.851 ' O ' HG23 ' A' ' 476' ' ' ILE . 44.5 p -68.94 172.94 5.88 Favored 'General case' 0 C--O 1.197 -1.708 0 CA-C-N 113.975 -1.466 . . . . 0.0 114.384 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 483' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -151.5 147.94 27.45 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.812 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 484' ' ' GLU . . . . . 0.495 ' C ' ' CD ' ' A' ' 484' ' ' GLU . 3.1 tp10 -131.72 113.89 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.372 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.889 ' O ' HD23 ' A' ' 485' ' ' LEU . 0.3 OUTLIER -151.08 161.73 42.18 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.786 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.21 -115.41 7.97 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.036 -1.554 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 487' ' ' GLY . . . . . 0.454 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -130.17 29.53 3.67 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.38 -1.391 . . . . 0.0 110.804 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 488' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 15.3 m170 -151.21 148.77 28.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.68 -1.208 . . . . 0.0 111.41 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.427 ' OG1' ' OE1' ' A' ' 484' ' ' GLU . 3.3 m -116.71 99.14 6.92 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.169 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.568 ' HE2' HG21 ' A' ' 392' ' ' ILE . 38.3 m-85 -90.06 160.6 16.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.562 ' CA ' HG22 ' A' ' 482' ' ' THR . . . -126.5 126.27 43.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.116 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.478 ' CB ' ' HB2' ' A' ' 481' ' ' LYS . 2.6 tm-20 -45.05 103.12 0.03 OUTLIER 'General case' 0 CA--C 1.478 -1.794 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.402 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 493' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 159.01 14.26 0.04 OUTLIER Glycine 0 C--N 1.261 -3.613 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 494' ' ' ASP . . . . . 0.594 ' CG ' ' N ' ' A' ' 495' ' ' TYR . 0.4 OUTLIER -138.44 -153.31 0.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.139 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 495' ' ' TYR . . . . . 0.594 ' N ' ' CG ' ' A' ' 494' ' ' ASP . 2.5 p90 -152.55 139.79 19.39 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.597 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 496' ' ' ILE . 0.0 OUTLIER -127.38 161.34 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.528 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 497' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 506' ' ' TYR . 3.3 t -104.61 102.88 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 498' ' ' LEU . . . . . 0.824 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -102.28 134.29 45.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.642 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.824 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.1 OUTLIER -121.03 142.38 49.86 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.481 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 500' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -147.8 90.4 0.15 Allowed Glycine 0 C--O 1.197 -2.188 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 501' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 502' ' ' THR . 7.4 p -160.74 8.34 0.08 Allowed 'General case' 0 C--N 1.252 -3.642 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 502' ' ' THR . . . . . 0.462 ' H ' ' H ' ' A' ' 503' ' ' GLY . 0.0 OUTLIER -172.41 -16.48 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 111.67 -2.514 . . . . 0.0 106.863 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.462 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 86.3 85.45 1.06 Allowed Glycine 0 N--CA 1.484 1.835 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.194 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -158.04 102.82 1.82 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' ILE . . . . . 0.611 HG12 HD13 ' A' ' 498' ' ' LEU . 3.5 mt -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.391 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 506' ' ' TYR . . . . . 0.72 ' CE1' HG23 ' A' ' 391' ' ' VAL . 75.5 m-85 -123.01 161.81 23.55 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.902 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 10.7 tmtt? -108.76 152.82 24.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 508' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . . . . . . 0 N--CA 1.484 1.84 0 C-N-CA 119.057 -1.545 . . . . 0.0 110.243 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 2.3 t -50.13 132.21 9.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 505' ' ' ILE . 3.4 pt -78.03 -52.49 15.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . 170.84 -170.92 43.54 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.7 p -143.2 142.11 31.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.769 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.09 -145.75 0.4 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 396' ' ' LEU . 6.8 mt -77.17 125.28 86.8 Favored Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.768 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.82 102.36 0.63 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.982 1.122 . . . . 0.0 111.26 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -70.77 -62.15 1.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.356 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.8 t -146.73 140.88 15.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.975 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.29 103.36 0.15 Allowed 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.078 1.185 . . . . 0.0 111.072 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -151.25 161.68 29.22 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.772 -1.68 . . . . 0.0 112.28 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -134.93 124.6 25.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -149.76 160.89 43.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.143 -1.423 . . . . 0.0 112.595 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.698 ' HB1' ' OH ' ' A' ' 495' ' ' TYR . . . -142.16 110.11 5.87 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.017 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.12 165.92 30.89 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.957 -1.592 . . . . 0.0 111.292 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -85.18 147.14 26.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.688 HG11 ' HZ ' ' A' ' 483' ' ' PHE . 2.0 m -78.72 142.7 13.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.473 -1.291 . . . . 0.0 113.228 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -146.87 146.47 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.892 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 427' ' ' VAL . 4.9 m-85 -105.84 37.41 2.25 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.439 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 409' ' ' PHE . 21.5 p -155.85 141.45 17.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.028 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 -12.8 59.89 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.278 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.47 -43.62 59.81 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.672 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.15 -42.62 86.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.674 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ALA . . . . . 0.786 ' HB1' ' HB1' ' A' ' 441' ' ' ALA . . . -61.29 -39.67 91.31 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.523 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -58.86 -30.15 67.51 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.985 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -88.6 -38.74 14.62 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.537 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -69.04 -61.01 1.97 Allowed 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.114 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 417' ' ' ALA . 19.5 t-80 -43.4 -26.52 0.2 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.811 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.435 ' N ' ' C ' ' A' ' 417' ' ' ALA . 30.1 tt0 -91.17 -33.92 15.22 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.375 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 417' ' ' ALA . 29.4 mtmt -131.74 49.9 2.28 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.813 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -178.38 -48.24 0.07 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' GLU . . . . . 0.523 ' O ' ' NE ' ' A' ' 423' ' ' ARG . 2.5 mt-10 48.96 71.23 0.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.167 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 422' ' ' GLU . 6.3 mtm180 164.04 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 0.2 OUTLIER -147.51 160.34 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.698 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 426' ' ' LEU . 43.2 mm -121.25 160.66 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.102 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.48 ' N ' HG22 ' A' ' 425' ' ' ILE . 13.1 tp -127.31 118.55 24.4 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.83 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 409' ' ' PHE . 1.5 t -104.66 130.82 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.038 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ARG . . . . . 0.726 ' O ' HG22 ' A' ' 447' ' ' THR . 1.6 mtp85 -153.01 145.94 24.51 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 429' ' ' LEU . 5.8 mp -56.61 -60.72 3.13 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.816 -1.553 . . . . 0.0 109.698 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.9 -175.09 2.59 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.611 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.662 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -94.17 176.61 6.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.183 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.2 t -173.09 128.35 0.52 Allowed Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.357 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.0 Cg_endo -61.41 -56.37 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.107 1.205 . . . . 0.0 111.501 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 434' ' ' GLU . 8.1 mt-10 -45.71 -13.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 433' ' ' PRO . 13.4 t70 -90.31 -8.3 51.2 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.557 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.944 HG23 ' H ' ' A' ' 437' ' ' GLU . 4.9 tp -41.85 -60.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.174 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.944 ' H ' HG23 ' A' ' 436' ' ' ILE . 19.3 mm-40 -49.11 -33.75 12.51 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.419 -1.312 . . . . 0.0 109.189 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.46 -24.18 68.66 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 436' ' ' ILE . 26.8 mtt -72.71 -34.37 67.08 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.71 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -75.74 -45.6 35.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 118.113 -1.435 . . . . 0.0 109.622 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.786 ' HB1' ' HB1' ' A' ' 414' ' ' ALA . . . -47.41 -36.39 9.73 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.426 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.666 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -106.86 93.07 4.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.501 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.79 28.22 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.597 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.666 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -160.28 132.01 2.82 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.2 mm -127.97 142.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.001 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 427' ' ' VAL . 4.7 tp -150.1 97.32 2.55 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.261 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 428' ' ' ARG . 0.9 OUTLIER -108.72 160.33 16.04 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.874 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.557 HG22 ' HB ' ' A' ' 474' ' ' ILE . 34.0 t -75.76 -45.05 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.829 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -94.08 -150.15 0.29 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.458 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 77.46 128.29 0.39 Allowed Glycine 0 N--CA 1.482 1.759 0 C-N-CA 119.145 -1.502 . . . . 0.0 109.4 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 453' ' ' THR . . . 175.62 -163.43 33.19 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 53.9 mtp 44.04 19.58 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.084 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 67.16 122.87 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.66 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 458' ' ' VAL . 69.9 p -166.64 -156.2 0.23 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.318 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' HIS . . . . . 0.684 ' O ' HG23 ' A' ' 459' ' ' VAL . 26.3 m80 -51.88 -51.1 59.16 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.971 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.662 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -52.55 -42.4 64.4 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.533 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -84.55 -51.02 7.2 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.519 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 454' ' ' SER . 79.0 t -55.28 -44.82 76.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.748 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 455' ' ' HIS . 47.2 t -67.16 -55.2 18.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.066 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.27 -28.96 65.43 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.289 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -65.35 -45.62 83.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -67.15 -24.29 73.28 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.147 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -21.31 31.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.815 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 63.02 21.12 63.32 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.675 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' THR . . . . . 0.889 HG22 ' H ' ' A' ' 466' ' ' CYS . 14.4 m -93.08 -168.89 2.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 466' ' ' CYS . . . . . 0.889 ' H ' HG22 ' A' ' 465' ' ' THR . 8.9 t -97.44 122.6 40.68 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.7 t -151.18 149.2 29.18 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.351 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 468' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -127.37 160.89 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.393 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 469' ' ' SER . . . . . 0.482 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 6.2 t -150.43 155.68 40.01 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.34 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 450' ' ' GLY . . . 53.72 75.46 0.23 Allowed Glycine 0 N--CA 1.497 2.747 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' CYS . . . . . 0.734 ' SG ' HD22 ' A' ' 485' ' ' LEU . 0.6 OUTLIER -82.93 -179.58 7.48 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.919 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -57.82 -96.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -140.38 58.52 1.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.65 HG23 ' CB ' ' A' ' 483' ' ' PHE . 11.3 mt -53.36 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.637 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.26 115.3 26.65 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 482' ' ' THR . 11.1 mt -88.18 136.6 22.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.129 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -114.63 127.2 55.64 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' A' ' 480' ' ' ALA . 10.3 pt-20 -62.85 -5.44 2.83 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.048 -0.978 . . . . 0.0 113.227 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 478' ' ' GLU . 5.2 mm-40 -46.13 -19.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.437 -1.305 . . . . 0.0 108.45 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -175.14 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 481' ' ' LYS . . . . . 0.536 ' HD2' ' CD2' ' A' ' 409' ' ' PHE . 0.8 OUTLIER -153.5 56.78 0.75 Allowed 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.874 ' O ' HG23 ' A' ' 476' ' ' ILE . 1.6 p -86.6 175.37 8.34 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 483' ' ' PHE . . . . . 0.688 ' HZ ' HG11 ' A' ' 407' ' ' VAL . 0.3 OUTLIER -151.93 120.86 6.61 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.762 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -91.95 114.42 26.95 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.533 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.734 HD22 ' SG ' ' A' ' 471' ' ' CYS . 63.6 tp -138.3 155.69 48.35 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.843 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 486' ' ' GLY . . . . . 0.473 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.66 -107.92 1.86 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -139.11 28.87 2.58 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.065 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.24 160.56 43.6 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.781 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.4 m -113.82 107.96 16.42 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.19 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.52 ' HB2' ' CE2' ' A' ' 483' ' ' PHE . 10.0 m-30 -89.55 119.44 29.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.505 -0.878 . . . . 0.0 108.859 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -100.24 136.78 39.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.155 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.508 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.9 tm-20 -50.05 95.12 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.949 0 C-N-CA 118.438 -1.305 . . . . 0.0 108.742 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 493' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 161.44 17.87 0.03 OUTLIER Glycine 0 C--N 1.267 -3.3 0 C-N-CA 118.313 -1.899 . . . . 0.0 109.624 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -128.69 -161.33 1.1 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.08 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' TYR . . . . . 0.698 ' OH ' ' HB1' ' A' ' 404' ' ' ALA . 1.8 t80 -137.64 132.7 33.37 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.491 HG22 ' CG ' ' A' ' 507' ' ' LYS . 0.6 OUTLIER -136.81 162.35 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.818 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 28.9 p -130.17 113.21 14.18 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.684 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -109.13 152.61 24.87 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.716 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.491 ' O ' HD12 ' A' ' 498' ' ' LEU . 4.4 t70 -99.42 160.39 14.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.027 0.918 . . . . 0.0 112.847 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 500' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -155.64 96.46 0.16 Allowed Glycine 0 C--N 1.289 -2.032 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 501' ' ' SER . . . . . 0.814 ' O ' HG23 ' A' ' 502' ' ' THR . 3.6 t 175.06 5.38 0.0 OUTLIER 'General case' 1 C--N 1.242 -4.071 0 CA-C-N 112.911 -1.644 . . . . 0.0 107.779 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 502' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 501' ' ' SER . 0.4 OUTLIER -175.0 -23.26 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.542 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 96.26 85.52 1.74 Allowed Glycine 0 N--CA 1.479 1.506 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -151.38 101.78 2.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.465 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' ILE . . . . . 0.642 HG21 HD11 ' A' ' 392' ' ' ILE . 4.7 mt -89.05 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.286 -0.965 . . . . 0.0 110.749 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 506' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 12.2 t80 -148.96 161.7 41.38 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.59 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 1.8 ttpt -125.74 156.36 39.53 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.598 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.249 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.686 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 19.9 t -112.66 140.41 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.388 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.863 HD12 HD21 ' A' ' 485' ' ' LEU . 0.7 OUTLIER -92.06 -25.32 5.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.215 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 162.78 -172.65 38.87 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.04 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.95 129.76 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.764 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.48 -146.22 0.24 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.274 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.7 140.79 33.51 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.94 96.94 0.46 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.227 1.285 . . . . 0.0 111.65 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -75.14 -73.14 0.26 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.351 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.9 p -136.88 144.16 45.46 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.347 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.89 101.66 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.983 1.122 . . . . 0.0 110.344 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.54 162.45 29.93 Favored Glycine 0 N--CA 1.51 3.624 0 C-N-CA 117.685 -2.198 . . . . 0.0 113.658 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.752 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -136.53 119.76 16.71 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.71 161.77 41.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.936 -1.506 . . . . 0.0 113.802 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -144.92 112.59 6.25 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 113.904 -1.498 . . . . 0.0 107.708 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.85 168.03 31.7 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.848 -1.644 . . . . 0.0 112.124 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 142.67 29.96 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.149 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 407' ' ' VAL . 0.2 OUTLIER -78.46 148.15 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.7 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.506 ' C ' ' H ' ' A' ' 410' ' ' THR . 0.4 OUTLIER -159.97 99.61 1.38 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.769 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 481' ' ' LYS . 7.8 m-85 -57.12 -0.32 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.846 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' THR . . . . . 0.506 ' H ' ' C ' ' A' ' 408' ' ' TYR . 3.2 p -106.39 140.91 38.57 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.99 26.12 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.515 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -70.7 -38.09 73.63 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.167 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 417' ' ' ALA . 68.9 mm-40 -62.81 -51.42 67.14 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' A' ' 441' ' ' ALA . . . -54.67 -31.71 58.13 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.982 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -71.27 -47.36 57.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.59 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -86.19 -9.35 56.75 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.03 -55.11 3.75 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -56.8 -28.03 60.77 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.863 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 421' ' ' GLY . 1.6 tt0 -55.58 -45.48 77.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.189 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 420' ' ' LYS . 0.8 OUTLIER -59.33 -6.12 0.92 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.493 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 82.92 49.02 5.23 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.467 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -133.33 154.21 50.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.679 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' ARG . . . . . 0.519 ' HD2' ' H ' ' A' ' 423' ' ' ARG . 0.4 OUTLIER -79.12 146.46 33.19 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.775 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.21 160.84 15.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.637 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 426' ' ' LEU . 41.5 mm -125.83 160.55 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.731 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.546 ' N ' HG22 ' A' ' 425' ' ' ILE . 3.4 tp -132.17 121.19 23.32 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.042 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.484 ' CG1' ' CZ ' ' A' ' 409' ' ' PHE . 7.2 t -110.57 121.03 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.36 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ARG . . . . . 0.664 ' O ' HG22 ' A' ' 447' ' ' THR . 0.1 OUTLIER -150.9 148.67 28.72 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.02 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.509 ' N ' HD23 ' A' ' 429' ' ' LEU . 5.7 mt -53.43 -49.64 66.91 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.199 -1.401 . . . . 0.0 109.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -135.82 167.82 20.46 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.863 HG21 ' HB2' ' A' ' 456' ' ' ALA . 0.5 OUTLIER -107.65 161.66 14.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.317 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.94 160.92 32.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.64 -31.51 94.45 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.99 1.793 . . . . 0.0 112.329 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.46 -12.91 61.64 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 439' ' ' MET . 15.0 m-20 -90.85 -9.05 47.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.919 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.644 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -35.78 -56.12 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.644 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 32.9 mt-10 -61.07 -38.69 87.12 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.341 -1.344 . . . . 0.0 109.052 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -72.83 -21.77 79.52 Favored Glycine 0 C--N 1.3 -1.45 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 435' ' ' ASP . 70.9 mtp -79.22 -46.41 17.92 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.336 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.773 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.1 OUTLIER -71.84 -34.79 69.58 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.398 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.773 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -56.45 -23.74 40.88 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.647 -1.221 . . . . 0.0 107.979 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -117.11 85.4 2.32 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.969 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.437 ' HA ' ' CG2' ' A' ' 465' ' ' THR . 11.8 pt-20 -52.41 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.591 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -136.24 139.66 10.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.538 HD12 ' SG ' ' A' ' 467' ' ' CYS . 67.8 mt -141.36 142.8 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.689 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.406 HD11 ' SG ' ' A' ' 471' ' ' CYS . 4.6 tp -140.24 98.95 3.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.6 p -111.53 161.27 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.42 -24.45 12.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 470' ' ' GLY . 14.0 mmt180 -100.87 -121.88 0.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.324 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.497 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 68.43 144.6 0.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -131.16 179.87 16.68 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.22 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.437 ' H ' ' HG3' ' A' ' 452' ' ' MET . 86.9 mtp -43.72 -28.83 0.45 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.091 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 453' ' ' THR . 6.7 t -160.59 132.28 5.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.325 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.3 p 179.05 -176.85 0.26 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.53 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' HIS . . . . . 0.704 ' O ' HG23 ' A' ' 459' ' ' VAL . 68.0 m80 -42.98 -49.52 5.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.336 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 431' ' ' THR . . . -48.44 -48.64 37.28 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.819 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.567 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 2.6 t -45.13 -45.58 3.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 455' ' ' HIS . 24.2 t -70.42 -40.27 77.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.575 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -68.66 -32.77 72.85 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.595 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -67.7 -36.95 81.59 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -75.28 -33.67 53.09 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.534 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 6.7 mmt -94.27 0.32 55.56 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.96 60.53 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 443' ' ' GLU . 0.2 OUTLIER -95.31 156.1 16.46 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 466' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.0 OUTLIER -89.43 129.88 35.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.692 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.753 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 99.5 m -152.86 157.42 40.68 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.062 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 468' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -126.15 162.28 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.263 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 469' ' ' SER . . . . . 0.517 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 7.9 t -150.3 147.71 27.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.278 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 57.23 90.45 0.01 OUTLIER Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.349 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 471' ' ' CYS . . . . . 0.406 ' SG ' HD11 ' A' ' 446' ' ' LEU . 0.1 OUTLIER -99.85 170.18 8.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.569 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -44.77 -82.02 0.03 OUTLIER Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.614 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -156.06 68.06 0.62 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.037 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.644 HG23 ' CB ' ' A' ' 483' ' ' PHE . 17.4 mt -66.47 102.64 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.081 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -88.72 120.03 29.74 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.841 HG23 ' O ' ' A' ' 482' ' ' THR . 3.8 mt -87.68 132.32 33.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.77 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.22 122.13 45.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.609 ' C ' ' N ' ' A' ' 480' ' ' ALA . 0.4 OUTLIER -53.06 -9.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.338 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -44.92 -18.45 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.401 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.609 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -177.88 -102.29 0.0 OUTLIER 'General case' 0 C--N 1.263 -3.176 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 481' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 409' ' ' PHE . 10.9 mmmt -150.61 43.39 0.83 Allowed 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.841 ' O ' HG23 ' A' ' 476' ' ' ILE . 52.1 p -69.06 174.35 4.64 Favored 'General case' 0 C--O 1.194 -1.857 0 CA-C-N 113.23 -1.805 . . . . 0.0 114.41 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 483' ' ' PHE . . . . . 0.644 ' CB ' HG23 ' A' ' 474' ' ' ILE . 0.7 OUTLIER -152.04 132.18 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.809 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -112.59 116.53 30.34 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.031 -0.667 . . . . 0.0 111.146 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.866 ' O ' HD23 ' A' ' 485' ' ' LEU . 0.3 OUTLIER -150.63 161.89 41.72 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.903 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.55 -113.01 5.47 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -132.21 26.15 3.77 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -150.16 153.23 35.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 58.4 m -115.06 100.23 8.02 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.481 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 507' ' ' LYS . 7.6 m-85 -89.78 158.37 17.53 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.582 ' CB ' HG22 ' A' ' 482' ' ' THR . . . -126.43 128.21 46.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.323 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.47 ' CB ' ' HB2' ' A' ' 481' ' ' LYS . 0.0 OUTLIER -47.4 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.472 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 493' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 168.53 14.32 0.02 OUTLIER Glycine 0 C--N 1.266 -3.311 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -142.64 -153.57 0.47 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.887 -0.657 . . . . 0.0 109.76 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -147.99 155.39 41.47 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.849 -1.141 . . . . 0.0 111.841 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.4 ' CG2' ' HG3' ' A' ' 507' ' ' LYS . 39.9 pt -136.99 162.31 34.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.833 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 30.7 t -127.76 108.84 11.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' LEU . . . . . 1.087 ' H ' HD23 ' A' ' 498' ' ' LEU . 1.7 pt? -117.03 159.35 22.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.723 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 500' ' ' GLY . 50.5 t0 -94.95 161.44 14.14 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.272 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 500' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -144.73 93.69 0.17 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 53.6 p 175.22 -7.32 0.0 OUTLIER 'General case' 0 C--N 1.25 -3.754 0 CA-C-N 111.66 -2.27 . . . . 0.0 106.08 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.8 -28.02 0.13 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.045 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 100.52 -11.44 59.67 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.638 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -50.38 125.81 13.56 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' ILE . . . . . 0.626 HG23 ' HB3' ' A' ' 498' ' ' LEU . 6.9 mt -113.88 135.04 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.397 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 506' ' ' TYR . . . . . 0.686 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 0.5 OUTLIER -128.21 159.89 33.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.631 ' H ' ' HE3' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -119.29 161.01 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.186 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 C-N-CA 119.376 -1.392 . . . . 0.0 110.991 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.067 0.46 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.716 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 45.5 t -66.57 150.18 11.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.645 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.504 ' CG1' ' N ' ' A' ' 393' ' ' GLY . 5.2 pt -117.22 -48.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.694 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -159.14 -157.54 8.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.554 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.5 p -171.41 116.1 0.41 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.78 -145.87 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 396' ' ' LEU . 96.4 mt -87.44 134.3 36.46 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.674 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.51 86.44 0.44 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.016 1.144 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -60.89 -60.83 3.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.084 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.3 p -143.77 145.87 32.58 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.217 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.35 119.36 6.24 Favored 'Trans proline' 0 C--N 1.326 -0.642 0 C-N-CA 121.085 1.19 . . . . 0.0 109.916 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.612 ' H ' ' CA ' ' A' ' 500' ' ' GLY . . . -152.48 162.88 30.11 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.524 -2.274 . . . . 0.0 114.556 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -151.85 107.17 3.3 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.4 161.39 42.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 117.968 -1.493 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.23 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.013 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.97 167.58 31.15 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.649 -1.262 . . . . 0.0 111.134 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.443 ' HG3' HG13 ' A' ' 424' ' ' VAL . 9.5 ptpt -82.72 161.76 21.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.305 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.542 HG11 ' HZ ' ' A' ' 483' ' ' PHE . 1.5 m -97.79 149.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.757 ' CZ ' ' HB2' ' A' ' 414' ' ' ALA . 33.1 p90 -153.44 174.75 13.98 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.035 -1.438 . . . . 0.0 107.536 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.57 ' CE1' ' HB3' ' A' ' 481' ' ' LYS . 2.7 m-85 -129.76 -19.32 3.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.203 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 38.8 p -100.51 135.6 41.7 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.47 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.82 -23.1 67.11 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.837 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -68.68 -41.36 79.34 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.098 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.92 -40.91 90.51 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.076 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ALA . . . . . 0.757 ' HB2' ' CZ ' ' A' ' 408' ' ' TYR . . . -57.69 -37.55 73.67 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.394 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.19 -35.45 80.83 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.433 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.53 -13.52 37.17 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.59 -55.51 3.55 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.74 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' HIS . . . . . 0.516 ' O ' ' ND1' ' A' ' 418' ' ' HIS . 0.3 OUTLIER -61.21 -21.1 63.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.846 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.486 ' CA ' ' OE1' ' A' ' 419' ' ' GLU . 0.6 OUTLIER -69.65 -38.08 76.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.588 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -64.53 -1.87 2.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 73.12 44.14 36.89 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.665 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -137.12 136.37 38.24 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' ARG . . . . . 0.41 ' C ' ' CG2' ' A' ' 424' ' ' VAL . 11.4 mmt180 -56.23 155.62 6.55 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.311 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.443 HG13 ' HG3' ' A' ' 406' ' ' LYS . 2.0 t -147.64 158.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.988 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.434 ' O ' ' CD1' ' A' ' 408' ' ' TYR . 6.3 mm -126.24 158.58 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.618 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 5.3 tp -127.61 142.97 51.21 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.511 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.445 ' N ' ' HG ' ' A' ' 426' ' ' LEU . 25.1 t -128.04 120.13 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.268 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ARG . . . . . 0.667 ' O ' HG22 ' A' ' 447' ' ' THR . 0.1 OUTLIER -151.37 149.42 29.3 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.093 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 429' ' ' LEU . 3.5 mp -48.04 -57.04 6.32 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.366 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 431' ' ' THR . 1.0 OUTLIER -130.4 165.18 23.11 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.467 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.442 ' H ' ' HG3' ' A' ' 430' ' ' GLU . 0.4 OUTLIER -101.17 -179.63 4.1 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.383 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 27.2 p -163.98 151.73 10.81 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.564 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.8 Cg_endo -61.59 -53.07 2.51 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.467 1.445 . . . . 0.0 112.036 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 434' ' ' GLU . 8.4 mm-40 -45.08 -18.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.8 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.8 m-20 -87.2 -6.35 58.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.656 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.736 HG23 ' N ' ' A' ' 437' ' ' GLU . 10.4 tp -33.63 -51.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.736 ' N ' HG23 ' A' ' 436' ' ' ILE . 3.0 pm0 -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.074 -1.45 . . . . 0.0 108.448 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.656 ' H ' ' CD ' ' A' ' 437' ' ' GLU . . . -66.49 -30.82 77.15 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -62.4 -44.01 97.45 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.959 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -62.29 -56.88 14.16 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -46.73 -33.2 4.14 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.56 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -96.2 81.01 3.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.069 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.76 17.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.72 143.93 9.15 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.418 HG22 ' SG ' ' A' ' 467' ' ' CYS . 0.6 OUTLIER -135.3 133.95 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.316 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.462 HD11 ' SG ' ' A' ' 471' ' ' CYS . 3.5 tp -135.8 98.12 3.82 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.105 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.1 p -116.24 161.84 18.37 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.67 -23.18 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.72 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' ARG . . . . . 0.452 HH22 ' HE3' ' A' ' 452' ' ' MET . 1.3 mmp_? -112.44 -128.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.861 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 62.52 -170.97 11.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 61.51 -20.97 0.05 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.668 ' H ' ' C ' ' A' ' 450' ' ' GLY . 7.5 mmt -68.92 42.72 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' THR . . . . . 0.563 ' H ' ' C ' ' A' ' 451' ' ' GLY . 39.1 p 45.66 90.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.1 t -173.32 -155.66 0.08 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.122 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' HIS . . . . . 0.493 ' O ' HG23 ' A' ' 459' ' ' VAL . 8.5 p-80 -55.24 -41.69 72.46 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.44 50.98 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.366 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.46 -28.41 52.34 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.903 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.51 -54.31 12.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.573 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 455' ' ' HIS . 92.1 t -56.49 -40.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.115 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.64 55.15 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.78 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -65.96 -14.78 62.2 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.814 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.46 -35.61 19.54 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.489 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 7.3 mmt -91.75 -9.72 42.61 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 62.06 24.42 65.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 466' ' ' CYS . 14.3 t -87.7 -166.86 1.7 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 466' ' ' CYS . . . . . 0.46 ' CB ' ' HA3' ' A' ' 401' ' ' GLY . 8.9 t -98.98 123.26 43.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.424 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.759 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.4 t -152.06 139.91 19.97 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 118.018 -1.473 . . . . 0.0 112.708 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 468' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.99 161.27 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 469' ' ' SER . . . . . 0.55 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 9.0 t -151.46 151.8 32.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.971 -1.491 . . . . 0.0 113.86 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 48.2 90.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.146 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' CYS . . . . . 0.462 ' SG ' HD11 ' A' ' 446' ' ' LEU . 96.7 m -98.42 -160.53 0.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.834 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.75 -95.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.63 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' GLU . . . . . 0.555 ' CD ' ' N ' ' A' ' 473' ' ' GLU . 1.6 pm0 -142.07 58.94 1.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.1 mt -43.17 102.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.775 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -88.86 113.76 24.75 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 482' ' ' THR . 9.5 mt -88.69 134.37 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 118.602 -1.239 . . . . 0.0 112.38 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -111.5 123.47 50.29 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.385 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.622 ' C ' ' N ' ' A' ' 480' ' ' ALA . 1.2 tt0 -63.6 -3.43 2.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.442 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -47.71 -16.56 0.07 Allowed 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 118.194 -1.402 . . . . 0.0 108.296 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.622 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -174.8 -100.38 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 481' ' ' LYS . . . . . 0.57 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.0 OUTLIER -158.05 65.91 0.46 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.848 ' O ' HG23 ' A' ' 476' ' ' ILE . 1.4 p -97.51 178.34 5.22 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 483' ' ' PHE . . . . . 0.542 ' HZ ' HG11 ' A' ' 407' ' ' VAL . 0.2 OUTLIER -151.56 129.69 11.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.471 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -99.61 116.46 31.78 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.665 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 1.016 HD23 ' N ' ' A' ' 486' ' ' GLY . 3.2 tt -136.51 156.25 48.85 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.012 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 486' ' ' GLY . . . . . 1.016 ' N ' HD23 ' A' ' 485' ' ' LEU . . . 44.65 -117.43 2.11 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.283 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -124.42 37.15 2.71 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.532 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' HIS . . . . . 0.506 ' CG ' ' CZ ' ' A' ' 490' ' ' PHE . 0.3 OUTLIER -150.68 129.65 12.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.404 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 83.5 m -102.98 115.07 29.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.59 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.506 ' CZ ' ' CG ' ' A' ' 488' ' ' HIS . 22.8 m-85 -112.43 130.94 55.81 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.751 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -99.18 156.84 16.75 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.484 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.5 tm-20 -65.46 63.67 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.602 -1.239 . . . . 0.0 108.566 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 493' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -160.43 25.45 0.29 Allowed Glycine 0 C--N 1.263 -3.512 0 C-N-CA 119.263 -1.446 . . . . 0.0 109.838 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -146.26 -164.62 2.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.046 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -128.23 137.58 52.08 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.215 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 496' ' ' ILE . 2.0 pt -131.93 160.14 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.089 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 497' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 506' ' ' TYR . 48.3 m -123.46 110.98 15.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.348 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 498' ' ' LEU . . . . . 0.963 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -105.57 136.92 44.27 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.418 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.963 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.5 OUTLIER -108.6 160.58 15.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.027 0.917 . . . . 0.0 112.244 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 500' ' ' GLY . . . . . 0.612 ' CA ' ' H ' ' A' ' 401' ' ' GLY . . . -142.11 94.2 0.18 Allowed Glycine 0 C--N 1.285 -2.299 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 501' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 502' ' ' THR . 4.6 m -171.42 -3.01 0.01 OUTLIER 'General case' 0 C--N 1.244 -3.98 0 CA-C-N 112.577 -1.812 . . . . 0.0 107.398 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 502' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 501' ' ' SER . 0.8 OUTLIER -167.09 -16.68 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.555 -2.111 . . . . 0.0 107.276 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.46 40.13 8.58 Favored Glycine 0 N--CA 1.482 1.725 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.371 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -115.37 119.97 38.03 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' ILE . . . . . 0.541 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.5 tt -97.57 160.23 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.425 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' TYR . . . . . 0.716 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 17.8 m-85 -135.15 162.09 33.5 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.178 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.496 ' HD2' ' CE1' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -136.71 142.93 43.12 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.779 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 508' ' ' GLY . . . . . 0.474 ' N ' ' HD3' ' A' ' 507' ' ' LYS . . . . . . . . 0 N--CA 1.493 2.461 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.758 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.57 142.76 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.539 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 1.9 pt -94.42 -33.53 5.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.757 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 179.67 -167.49 37.39 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.87 -1.633 . . . . 0.0 111.314 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 31.1 t -154.79 120.78 5.21 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.583 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.463 ' HB2' ' SG ' ' A' ' 471' ' ' CYS . . . -93.09 -144.06 0.22 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.076 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 51.2 mt -93.42 128.69 41.48 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' PRO . . . . . 0.545 ' HG3' ' O ' ' A' ' 502' ' ' THR . 7.7 Cg_endo -68.37 89.35 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.142 1.228 . . . . 0.0 111.565 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -55.37 -54.73 40.06 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.506 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.1 t -150.45 141.85 15.1 Favored Pre-proline 0 C--N 1.307 -1.281 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.177 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -54.34 101.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.121 1.214 . . . . 0.0 110.569 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.584 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -151.46 161.81 29.33 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.544 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.564 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -139.21 114.87 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -138.39 160.73 38.77 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.862 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.17 110.62 6.07 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.709 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.07 167.92 31.24 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.923 -1.608 . . . . 0.0 111.268 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -82.82 137.11 34.43 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.571 ' CG1' ' C ' ' A' ' 491' ' ' ALA . 1.0 OUTLIER -83.37 151.68 3.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 C-N-CA 118.925 -1.11 . . . . 0.0 113.374 -179.478 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -149.86 -152.79 0.45 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.924 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.481 ' CD2' ' HE2' ' A' ' 481' ' ' LYS . 10.5 m-85 -146.31 -47.71 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.058 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 37.4 p -86.03 143.36 28.15 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.235 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -69.47 -10.91 60.07 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.503 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 412' ' ' ASP . 10.2 m-20 -74.26 -42.55 59.46 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.775 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' A' ' 413' ' ' GLU . 2.1 mp0 -66.88 -42.47 85.52 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.568 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.7 66.28 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.88 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -73.68 -38.63 64.85 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.396 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.58 -12.2 37.74 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.84 -43.58 9.95 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.837 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' HIS . . . . . 0.463 ' O ' ' CD2' ' A' ' 418' ' ' HIS . 8.8 t60 -69.88 -29.42 66.63 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.219 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.68 -21.89 61.0 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 -5.93 42.86 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.797 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 89.99 45.44 4.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -147.44 131.87 17.63 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.812 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -58.58 157.09 9.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.432 ' N ' ' OE2' ' A' ' 443' ' ' GLU . 2.4 t -148.27 160.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.931 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 426' ' ' LEU . 7.5 mm -130.63 160.97 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.911 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.421 ' N ' HG22 ' A' ' 425' ' ' ILE . 4.3 tp -139.42 144.6 38.16 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.594 -1.242 . . . . 0.0 112.851 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.52 HG23 ' CG2' ' A' ' 407' ' ' VAL . 81.6 t -118.46 130.21 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.557 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ARG . . . . . 0.684 ' H ' HG22 ' A' ' 447' ' ' THR . 0.0 OUTLIER -151.79 135.26 16.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.59 -1.244 . . . . 0.0 112.06 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.11 17.87 0.12 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 428' ' ' ARG . 5.9 pt-20 175.86 147.46 0.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.566 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -87.77 177.39 7.02 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.89 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.2 m -161.6 131.08 3.23 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.712 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.03 -31.61 91.32 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 121.183 1.255 . . . . 0.0 111.807 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -75.46 -16.41 60.32 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.191 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.1 t70 -90.41 -9.24 48.27 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.723 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.679 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -39.3 -52.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.861 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.679 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 26.9 mt-10 -58.23 -35.77 72.18 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.925 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.22 -22.44 73.55 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 2.1 mmt -74.75 -42.02 58.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.433 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.776 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.2 OUTLIER -70.7 -32.98 70.38 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.332 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.776 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -50.09 -29.04 8.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -109.38 92.02 3.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.679 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 443' ' ' GLU . 1.4 pm0 -53.0 0.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.949 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -142.01 144.47 14.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.515 HD12 ' SG ' ' A' ' 467' ' ' CYS . 38.8 mt -145.73 135.45 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.459 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.435 ' C ' HD12 ' A' ' 446' ' ' LEU . 5.8 tp -131.05 98.23 4.52 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.004 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 428' ' ' ARG . 1.5 p -107.9 161.49 14.87 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.7 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 474' ' ' ILE . 4.9 t -85.28 -20.11 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.969 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -106.6 -152.05 0.47 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.755 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 81.28 -151.39 31.31 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' GLY . . . . . 0.629 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 76.78 -50.99 3.03 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.548 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.485 ' O ' ' CB ' ' A' ' 453' ' ' THR . 70.7 mmm -64.45 11.97 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.413 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' THR . . . . . 0.62 ' H ' ' C ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.31 108.27 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.019 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 455' ' ' HIS . 30.2 t -158.41 -173.16 4.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.841 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 455' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 459' ' ' VAL . 60.4 m80 -50.34 -35.3 27.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.566 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -53.7 -58.71 6.23 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.322 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.63 -52.21 9.37 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.347 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 13.3 t -44.76 -43.42 2.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.675 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 455' ' ' HIS . 97.5 t -69.38 -43.55 80.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.201 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.94 -41.08 87.59 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.84 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -66.35 -27.71 68.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -90.0 -26.7 23.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.671 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 11.2 mmt -94.07 -23.11 18.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.302 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.69 -21.25 30.66 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.966 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 60.2 m -44.22 160.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -87.25 129.1 35.11 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.937 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.8 m -153.3 153.1 31.96 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.434 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 468' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -124.38 161.16 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 108.995 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 469' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 28.1 t -150.27 155.31 39.46 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.7 -1.2 . . . . 0.0 112.213 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 42.63 82.98 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' CYS . . . . . 0.667 ' SG ' HD11 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -90.07 -160.4 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.272 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -61.13 -99.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.542 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 474' ' ' ILE . 1.4 mm-40 -145.07 41.25 1.27 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.714 HD12 HG22 ' A' ' 448' ' ' VAL . 0.0 OUTLIER -38.81 107.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.901 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -89.71 123.99 34.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.205 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 3.0 mt -86.41 119.59 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.191 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' ASN . . . . . 0.452 HD21 ' HG3' ' A' ' 479' ' ' GLU . 53.1 t-20 -89.24 110.83 21.55 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.163 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.725 ' H ' ' CD ' ' A' ' 478' ' ' GLU . 1.4 pm0 -67.67 -9.33 42.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.525 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.452 ' HG3' HD21 ' A' ' 477' ' ' ASN . 11.4 mm-40 -46.3 -19.87 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.342 -1.343 . . . . 0.0 107.661 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.607 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -163.64 -107.21 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.412 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 481' ' ' LYS . . . . . 0.481 ' HE2' ' CD2' ' A' ' 409' ' ' PHE . 20.2 mmmt -159.47 70.94 0.48 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.881 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 1.2 p -138.63 148.46 44.11 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.867 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 483' ' ' PHE . . . . . 0.814 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 6.2 p90 -104.74 156.53 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.895 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.44 103.57 12.22 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.287 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 486' ' ' GLY . 1.4 tt -126.61 139.72 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 486' ' ' GLY . . . . . 0.827 ' N ' HD23 ' A' ' 485' ' ' LEU . . . 57.06 -110.59 2.28 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.128 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -128.82 36.76 2.36 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.372 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -150.35 126.15 10.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.482 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.2 m -99.38 97.36 8.41 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.971 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.565 ' CB ' ' HZ1' ' A' ' 507' ' ' LYS . 35.6 p90 -155.3 158.18 38.37 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.036 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.881 ' HB3' ' HA ' ' A' ' 482' ' ' THR . . . -170.09 -136.08 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.177 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.507 ' HA ' HG13 ' A' ' 407' ' ' VAL . 57.6 tt0 -49.63 94.18 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 117.964 -1.494 . . . . 0.0 109.39 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 493' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 152.02 17.7 0.06 OUTLIER Glycine 0 C--N 1.297 -1.611 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -156.25 -152.62 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.435 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -149.71 126.77 11.25 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.284 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.96 161.59 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.49 106.16 11.54 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 498' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.3 OUTLIER -92.48 134.77 34.64 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.169 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.513 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.4 OUTLIER -89.48 159.25 17.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.424 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 500' ' ' GLY . . . . . 0.584 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -155.65 95.17 0.15 Allowed Glycine 0 C--N 1.282 -2.453 0 N-CA-C 106.923 -2.471 . . . . 0.0 106.923 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 3.3 t 172.86 7.28 0.0 OUTLIER 'General case' 0 C--N 1.245 -3.956 0 CA-C-N 112.507 -1.846 . . . . 0.0 106.943 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' THR . . . . . 0.545 ' O ' ' HG3' ' A' ' 397' ' ' PRO . 0.0 OUTLIER -171.91 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.385 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.475 ' N ' ' HB3' ' A' ' 397' ' ' PRO . . . 93.11 15.42 51.79 Favored Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.923 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -75.08 172.7 11.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.26 150.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.459 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 506' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 7.7 t80 -148.97 161.33 42.12 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.01 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 28.4 tttt -131.78 151.6 51.55 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.865 -1.134 . . . . 0.0 113.701 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.779 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.365 179.645 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.395 0.617 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.575 HG22 ' HD1' ' A' ' 506' ' ' TYR . 41.8 t -39.4 139.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.09 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.494 HG13 ' N ' ' A' ' 393' ' ' GLY . 17.7 pt -99.81 -43.22 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.076 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -151.08 -162.9 10.99 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.706 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.8 t -179.21 127.42 0.09 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -117.61 -125.54 0.28 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.461 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 32.5 mt -100.49 139.01 20.3 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.277 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -67.56 93.42 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.274 1.316 . . . . 0.0 110.581 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -64.02 -66.71 0.5 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.107 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 24.2 t -136.97 131.07 17.8 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.848 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.85 92.56 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 121.059 1.173 . . . . 0.0 111.303 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.17 160.18 28.97 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 118.995 -1.574 . . . . 0.0 112.008 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.775 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -126.26 135.89 52.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ALA . . . . . 0.697 ' HB1' ' OE2' ' A' ' 443' ' ' GLU . . . -150.42 160.32 43.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' ALA . . . . . 0.61 ' HB1' ' OH ' ' A' ' 495' ' ' TYR . . . -148.16 109.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.601 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.7 30.83 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.495 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -84.27 133.0 34.58 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.739 -0.785 . . . . 0.0 109.588 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.593 HG11 ' HB1' ' A' ' 491' ' ' ALA . 79.9 t -60.67 154.43 4.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.325 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' A' ' 413' ' ' GLU . 0.5 OUTLIER -162.47 135.75 6.03 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.557 ' CE2' ' NZ ' ' A' ' 481' ' ' LYS . 4.7 m-85 -100.9 28.6 5.12 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.926 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 7.2 p -149.38 143.96 26.09 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.731 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.69 59.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.966 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.8 -43.16 31.47 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' GLU . . . . . 0.491 ' HG2' ' CE1' ' A' ' 408' ' ' TYR . 0.3 OUTLIER -62.08 -39.31 92.02 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.388 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.69 83.9 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.482 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -65.7 -34.64 78.66 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.77 21.99 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.464 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -82.62 -49.02 10.28 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.982 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -49.28 -27.13 3.53 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -91.57 -28.87 17.26 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -117.48 -35.05 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.111 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -93.19 -45.59 3.51 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.069 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' GLU . . . . . 0.43 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 1.1 mt-10 66.32 158.13 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.672 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 47.35 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.161 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.91 161.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.382 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 426' ' ' LEU . 47.0 mm -123.31 157.52 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.383 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.481 ' N ' HG22 ' A' ' 425' ' ' ILE . 3.1 tp -128.82 134.52 48.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.255 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 409' ' ' PHE . 48.1 t -119.94 123.5 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.689 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ARG . . . . . 0.663 ' O ' HG22 ' A' ' 447' ' ' THR . 0.6 OUTLIER -151.53 158.31 43.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.957 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 429' ' ' LEU . 7.7 mt -63.14 -49.73 73.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.311 -1.355 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -132.27 177.64 7.43 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -81.41 171.76 14.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.064 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 1.3 m -153.33 142.32 14.54 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.604 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.3 Cg_endo -61.5 -72.92 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.481 1.454 . . . . 0.0 111.919 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.08 -10.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.288 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 433' ' ' PRO . 7.1 t70 -85.94 -8.68 57.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.679 HD12 ' NE2' ' A' ' 440' ' ' HIS . 0.2 OUTLIER -43.34 -58.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.735 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.658 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 46.8 mt-10 -55.92 -31.5 62.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.522 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.04 -23.55 77.58 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 436' ' ' ILE . 2.4 ttm -74.57 -53.99 8.34 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.778 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.679 ' NE2' HD12 ' A' ' 436' ' ' ILE . 85.8 m-70 -58.77 -50.4 74.08 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.755 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 440' ' ' HIS . . . -45.88 -24.88 0.45 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.149 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.679 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -107.15 86.27 2.28 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.488 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.697 ' OE2' ' HB1' ' A' ' 403' ' ' ALA . 0.0 OUTLIER -58.26 14.01 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.955 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.24 133.95 3.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 445' ' ' ILE . 4.5 mp -139.48 150.45 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.135 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.456 HD11 ' CG1' ' A' ' 468' ' ' VAL . 1.2 tp -144.38 128.34 17.47 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.146 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 428' ' ' ARG . 5.7 p -140.61 159.31 42.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.242 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 27.4 t -68.86 -20.85 25.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.452 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -117.0 -151.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.963 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.487 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 84.98 26.17 38.33 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -44.44 161.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.659 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.404 ' C ' HG23 ' A' ' 453' ' ' THR . 25.0 mtt 45.4 -101.52 0.05 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.837 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 452' ' ' MET . 40.3 p -153.91 81.36 1.15 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.831 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.8 m -90.67 -163.02 0.96 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.704 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' HIS . . . . . 0.513 ' O ' HG23 ' A' ' 459' ' ' VAL . 2.5 t-80 -47.87 -39.78 19.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.43 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.527 ' H ' HG21 ' A' ' 431' ' ' THR . . . -59.04 -61.88 2.3 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.032 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.78 -55.59 16.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.871 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 459' ' ' VAL . 0.3 OUTLIER -45.65 -49.8 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.694 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.645 ' N ' ' CG1' ' A' ' 458' ' ' VAL . 71.3 t -62.46 -37.15 78.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.34 -46.95 78.2 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -31.14 71.67 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.69 -18.81 69.61 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' MET . . . . . 0.482 ' C ' ' SD ' ' A' ' 463' ' ' MET . 0.0 OUTLIER -94.96 -59.86 1.81 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.955 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 464' ' ' GLY . . . . . 0.474 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 123.93 20.83 2.47 Favored Glycine 0 N--CA 1.503 3.149 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 466' ' ' CYS . 30.9 m -97.47 166.9 11.31 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 466' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.8 m -90.12 128.08 36.24 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.799 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.72 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 13.1 t -151.71 159.07 44.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.801 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 468' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 469' ' ' SER . 0.8 OUTLIER -137.08 162.44 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.886 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 469' ' ' SER . . . . . 0.487 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 11.7 t -144.27 160.42 41.01 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.894 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 44.17 79.87 0.05 OUTLIER Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.623 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' CYS . . . . . 0.657 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.0 OUTLIER -78.33 -175.18 4.08 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.107 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.448 ' H ' HD11 ' A' ' 485' ' ' LEU . . . -53.82 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.006 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.9 57.99 1.61 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.611 0.72 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 483' ' ' PHE . 4.5 mt -55.46 114.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.272 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 475' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 484' ' ' GLU . 4.4 ttpm? -99.63 122.74 43.1 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 1.7 mt -86.89 127.74 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 117.771 -1.572 . . . . 0.0 112.097 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' ASN . . . . . 0.489 ' OD1' ' CG2' ' A' ' 489' ' ' THR . 7.8 m120 -96.91 113.38 24.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.123 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.625 ' C ' ' N ' ' A' ' 480' ' ' ALA . 10.5 mt-10 -64.0 -11.88 32.95 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.984 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -46.3 -17.82 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.811 1.291 . . . . 0.0 107.928 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.625 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.32 -97.8 0.01 OUTLIER 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 112.15 -2.296 . . . . 0.0 105.537 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 481' ' ' LYS . . . . . 0.557 ' NZ ' ' CE2' ' A' ' 409' ' ' PHE . 3.0 mmmt -168.97 70.72 0.08 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.921 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 2.6 p -125.75 147.24 49.45 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.057 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 483' ' ' PHE . . . . . 0.976 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 8.0 p90 -97.68 149.98 21.68 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.572 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 475' ' ' LYS . 7.5 tt0 -110.92 107.14 16.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.129 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.835 HD23 ' H ' ' A' ' 486' ' ' GLY . 0.4 OUTLIER -144.7 156.33 44.03 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.04 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 486' ' ' GLY . . . . . 0.835 ' H ' HD23 ' A' ' 485' ' ' LEU . . . 64.6 -111.4 4.15 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -134.75 26.7 3.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.729 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' HIS . . . . . 0.477 ' CD2' ' HD2' ' A' ' 490' ' ' PHE . 1.2 t60 -150.75 152.14 33.41 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 489' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 477' ' ' ASN . 77.3 m -115.94 99.38 7.24 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.039 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.547 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 19.6 p90 -153.78 157.55 39.58 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.075 -1.45 . . . . 0.0 114.184 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.976 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . 179.85 -137.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.295 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.591 ' N ' HG11 ' A' ' 407' ' ' VAL . 8.2 tm-20 -34.93 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.654 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 493' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 139.68 3.66 1.52 Allowed Glycine 0 C--N 1.29 -2.009 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 494' ' ' ASP . . . . . 0.608 ' CG ' ' H ' ' A' ' 495' ' ' TYR . 36.2 t70 -144.26 -174.16 4.22 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.235 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' TYR . . . . . 0.61 ' OH ' ' HB1' ' A' ' 404' ' ' ALA . 87.2 t80 -123.91 120.54 32.83 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.029 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.915 HD13 ' O ' ' A' ' 496' ' ' ILE . 0.0 OUTLIER -127.92 161.39 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.577 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 2.4 m -123.34 110.08 14.72 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -95.84 141.18 29.6 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.612 ' N ' HD12 ' A' ' 498' ' ' LEU . 10.3 t70 -99.99 161.41 13.63 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.064 0.935 . . . . 0.0 112.381 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 500' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -156.49 95.61 0.15 Allowed Glycine 0 C--N 1.281 -2.508 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 501' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 1.4 t 164.66 2.4 0.0 OUTLIER 'General case' 1 C--N 1.238 -4.265 0 CA-C-N 112.749 -1.726 . . . . 0.0 107.47 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 502' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 503' ' ' GLY . 6.8 m -161.72 -17.74 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.073 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 73.52 75.8 0.72 Allowed Glycine 0 N--CA 1.485 1.959 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.736 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -165.24 118.95 1.23 Allowed 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.014 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' ILE . . . . . 0.516 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 2.0 tt -99.22 157.84 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.085 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' TYR . . . . . 0.575 ' HD1' HG22 ' A' ' 391' ' ' VAL . 0.1 OUTLIER -151.04 170.49 19.25 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 490' ' ' PHE . 27.2 mtpt -81.41 158.33 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 117.058 -1.857 . . . . 0.0 110.146 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 508' ' ' GLY . . . . . 0.706 ' H ' ' HA ' ' A' ' 496' ' ' ILE . . . . . . . . 0 N--CA 1.487 2.068 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.582 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 390' ' ' GLU . 1.5 pm0 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.983 0.421 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.712 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 74.8 t -64.39 137.05 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.018 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.608 ' CG1' ' H ' ' A' ' 393' ' ' GLY . 2.5 pt -103.26 -57.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.757 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' GLY . . . . . 0.608 ' H ' ' CG1' ' A' ' 392' ' ' ILE . . . -142.18 178.78 20.57 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 12.6 m -156.05 141.31 17.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.814 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.597 ' HB3' HG13 ' A' ' 468' ' ' VAL . . . -124.06 -158.81 0.83 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.835 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.19 126.66 78.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.772 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 101.93 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.033 1.155 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -67.32 -57.75 6.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.589 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 79.3 p -137.19 139.87 29.39 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.713 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.7 95.77 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 121.31 1.34 . . . . 0.0 110.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.82 162.2 30.3 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 118.186 -1.959 . . . . 0.0 112.906 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.56 21.15 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.41 160.87 43.44 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 117.946 -1.502 . . . . 0.0 112.884 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -131.78 102.6 5.94 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.67 166.55 30.81 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.94 156.26 22.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.65 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 492' ' ' GLU . 3.5 m -85.4 138.77 18.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.546 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.61 ' CZ ' ' OE1' ' A' ' 413' ' ' GLU . 0.4 OUTLIER -138.94 159.28 42.53 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.322 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 410' ' ' THR . 9.8 m-85 -122.88 32.81 5.59 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.813 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 409' ' ' PHE . 1.6 p -158.82 143.74 16.02 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.438 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.57 -13.83 61.49 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.591 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -75.17 -43.19 53.65 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.49 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' GLU . . . . . 0.61 ' OE1' ' CZ ' ' A' ' 408' ' ' TYR . 68.9 mm-40 -62.28 -37.84 87.06 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.411 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 441' ' ' ALA . . . -68.18 -32.32 72.48 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.403 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -68.67 -36.81 79.01 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.518 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.81 23.41 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.837 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -68.12 -54.93 14.54 Favored 'General case' 0 C--N 1.276 -2.621 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' HIS . . . . . 0.639 ' HB2' ' HB1' ' A' ' 441' ' ' ALA . 71.2 t60 -44.22 -26.55 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.6 OUTLIER -91.48 -22.87 20.18 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.884 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 420' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 417' ' ' ALA . 36.2 mmtt -80.64 -59.59 2.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.981 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -155.0 3.87 0.23 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.711 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 54.68 -146.95 0.53 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.094 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' ARG . . . . . 0.644 ' HE ' ' H ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER 52.37 64.68 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.838 -1.145 . . . . 0.0 107.965 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.842 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 425' ' ' ILE . 6.9 mm -125.33 160.3 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.904 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 5.3 tp -125.57 134.06 52.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.017 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.38 121.57 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.036 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ARG . . . . . 0.675 ' O ' HG22 ' A' ' 447' ' ' THR . 7.3 ttt180 -152.2 148.76 27.97 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.247 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.663 ' H ' HD12 ' A' ' 429' ' ' LEU . 4.3 mp -48.41 -58.01 5.25 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.568 -1.253 . . . . 0.0 109.252 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 431' ' ' THR . 2.2 tm-20 -122.89 175.84 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.436 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.635 ' OG1' ' CD2' ' A' ' 455' ' ' HIS . 1.2 p -112.14 173.37 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.685 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.9 m -154.84 155.14 30.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.998 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 435' ' ' ASP . 3.6 Cg_endo -64.27 -66.58 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 121.758 1.638 . . . . 0.0 112.147 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -38.83 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.269 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 435' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 438' ' ' GLY . 1.1 m-20 -74.42 -8.7 57.16 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.829 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.732 HG23 ' N ' ' A' ' 437' ' ' GLU . 9.8 tp -40.4 -50.56 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.827 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.732 ' N ' HG23 ' A' ' 436' ' ' ILE . 69.6 mt-10 -53.85 -38.28 64.52 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.615 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.16 -26.65 70.13 Favored Glycine 0 C--N 1.303 -1.272 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' MET . . . . . 0.514 ' HG2' HD11 ' A' ' 445' ' ' ILE . 40.3 mtt -69.21 -39.11 78.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.988 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.48 ' NE2' HG13 ' A' ' 436' ' ' ILE . 6.8 m-70 -66.68 -57.94 6.14 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.171 -1.411 . . . . 0.0 109.174 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 441' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 418' ' ' HIS . . . -46.13 -39.64 9.82 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.073 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.616 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -97.55 85.28 3.57 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.087 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -62.91 35.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.848 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -168.87 143.71 8.25 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' ILE . . . . . 0.514 HD11 ' HG2' ' A' ' 439' ' ' MET . 1.3 mt -144.63 132.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.17 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.42 ' CD1' ' CG1' ' A' ' 468' ' ' VAL . 7.0 tp -135.79 98.36 3.89 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 428' ' ' ARG . 1.7 p -113.62 161.22 17.7 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.73 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.45 HG13 ' SG ' ' A' ' 471' ' ' CYS . 16.2 t -76.84 -26.34 16.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.796 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' GLY . 6.8 mtt-85 -108.46 -134.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.723 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 70.72 -166.85 51.32 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.948 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 451' ' ' GLY . . . . . 0.568 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 72.0 -31.85 0.64 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.937 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.505 ' H ' ' C ' ' A' ' 450' ' ' GLY . 15.6 ptm -68.38 42.31 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.946 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 47.22 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.13 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 458' ' ' VAL . 6.8 t -171.32 -166.08 0.44 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 455' ' ' HIS . . . . . 0.635 ' CD2' ' OG1' ' A' ' 431' ' ' THR . 7.2 p-80 -49.66 -48.13 49.58 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.981 -1.087 . . . . 0.0 110.337 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.435 ' CB ' HG21 ' A' ' 431' ' ' THR . . . -38.21 -56.15 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.467 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -81.08 -52.53 7.29 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.487 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 454' ' ' SER . 43.5 t -47.42 -47.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.916 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 455' ' ' HIS . 93.3 t -64.31 -43.78 97.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.782 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.99 -43.75 91.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -69.81 -19.38 63.49 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.57 -36.79 15.56 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 49.8 mmm -93.15 -26.1 17.57 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.24 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.25 42.1 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.63 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 16.7 m -46.83 163.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' CYS . . . . . 0.547 ' HG ' ' C ' ' A' ' 401' ' ' GLY . 48.6 t -85.22 128.59 34.73 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.053 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 13.1 t -151.42 140.49 21.14 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.382 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 468' ' ' VAL . . . . . 0.597 HG13 ' HB3' ' A' ' 395' ' ' ALA . 0.9 OUTLIER -110.65 161.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.137 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 469' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 9.2 t -150.37 148.57 28.96 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.567 -1.253 . . . . 0.0 112.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 61.1 91.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.46 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 448' ' ' VAL . 7.7 p -100.22 176.06 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -59.52 -91.93 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -144.82 59.55 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.632 HG23 ' CB ' ' A' ' 483' ' ' PHE . 10.7 mt -51.6 107.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.839 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -89.16 110.31 21.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 482' ' ' THR . 4.9 mt -87.96 135.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.013 -1.475 . . . . 0.0 113.884 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' ASN . . . . . 0.511 ' CG ' ' HG1' ' A' ' 482' ' ' THR . 1.3 m120 -113.18 122.04 46.32 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.678 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.65 ' C ' ' H ' ' A' ' 480' ' ' ALA . 7.8 mt-10 -56.4 -5.53 0.21 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.438 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -48.03 -14.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 118.093 -1.443 . . . . 0.0 108.186 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 177.98 -90.88 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 481' ' ' LYS . . . . . 0.512 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.3 OUTLIER -167.46 54.56 0.07 Allowed 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 123.965 1.841 . . . . 0.0 108.949 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 476' ' ' ILE . 70.0 p -75.57 167.11 22.52 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 111.251 -2.704 . . . . 0.0 112.267 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 483' ' ' PHE . . . . . 0.634 ' CE2' ' CG ' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -153.46 112.83 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.693 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -89.64 120.07 30.61 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.047 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 486' ' ' GLY . 59.3 tp -149.82 157.21 42.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.141 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 486' ' ' GLY . . . . . 0.501 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.39 -117.82 12.54 Favored Glycine 0 N--CA 1.48 1.568 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -127.04 29.1 4.44 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.673 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -151.68 144.3 24.27 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.122 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 45.5 m -95.36 115.19 27.1 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.529 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.634 ' CG ' ' CE2' ' A' ' 483' ' ' PHE . 0.8 OUTLIER -88.49 160.73 17.37 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.747 ' HA ' HG22 ' A' ' 482' ' ' THR . . . -141.0 113.95 8.42 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.856 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 492' ' ' GLU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.7 tm-20 -48.06 99.68 0.02 OUTLIER 'General case' 0 CA--C 1.481 -1.704 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.887 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 493' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 160.24 22.88 0.03 OUTLIER Glycine 0 C--N 1.274 -2.909 0 C-N-CA 118.623 -1.751 . . . . 0.0 109.865 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 494' ' ' ASP . . . . . 0.647 ' CG ' ' N ' ' A' ' 495' ' ' TYR . 16.2 t70 -143.72 -179.91 6.75 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.071 -1.051 . . . . 0.0 112.2 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 495' ' ' TYR . . . . . 0.647 ' N ' ' CG ' ' A' ' 494' ' ' ASP . 25.1 t80 -101.59 137.91 39.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.667 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.464 HG13 ' N ' ' A' ' 497' ' ' SER . 0.1 OUTLIER -137.15 160.98 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.445 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 497' ' ' SER . . . . . 0.464 ' N ' HG13 ' A' ' 496' ' ' ILE . 29.7 t -123.6 104.57 9.11 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.658 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 498' ' ' LEU . . . . . 0.883 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.2 OUTLIER -109.62 134.27 52.14 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.764 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.883 ' N ' HD12 ' A' ' 498' ' ' LEU . 9.1 m-20 -115.36 148.67 39.01 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.821 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 500' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -148.45 89.55 0.14 Allowed Glycine 0 C--O 1.188 -2.777 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 22.5 m -162.77 -3.88 0.04 OUTLIER 'General case' 0 C--N 1.255 -3.537 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' THR . . . . . 0.458 ' H ' ' H ' ' A' ' 503' ' ' GLY . 75.8 p -152.77 -14.65 0.16 Allowed 'General case' 0 C--N 1.275 -2.667 0 CA-C-N 111.417 -2.629 . . . . 0.0 105.969 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.458 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 79.04 77.25 0.91 Allowed Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.29 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -156.69 136.13 12.23 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.729 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' ILE . . . . . 0.625 ' C ' ' CD1' ' A' ' 506' ' ' TYR . 10.7 mt -110.54 161.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.807 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' TYR . . . . . 0.712 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 24.6 m-85 -150.33 161.72 41.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 508' ' ' GLY . 13.0 ttmt -134.97 157.47 46.84 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 508' ' ' GLY . . . . . 0.435 ' N ' ' HG2' ' A' ' 507' ' ' LYS . . . . . . . . 0 N--CA 1.497 2.72 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.648 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.012 0.434 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.753 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 67.7 t -93.91 158.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.333 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.477 ' N ' HG12 ' A' ' 391' ' ' VAL . 10.3 pt -102.36 -33.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -178.3 -163.97 30.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 118.899 -1.619 . . . . 0.0 111.279 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 p -165.31 130.44 2.53 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.264 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 471' ' ' CYS . . . -114.65 -147.92 0.42 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.943 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 63.2 mt -81.93 132.31 54.45 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.08 93.61 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.143 1.229 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -58.31 -62.12 2.07 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.47 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -148.61 146.88 23.34 Favored Pre-proline 0 C--N 1.305 -1.333 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.353 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.76 103.05 0.1 Allowed 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.258 1.305 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.06 162.61 29.85 Favored Glycine 0 N--CA 1.509 3.508 0 C-N-CA 118.723 -1.704 . . . . 0.0 112.379 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' ALA . . . . . 0.49 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -145.65 118.72 8.83 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.01 43.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.776 -1.57 . . . . 0.0 113.765 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -137.84 110.02 7.32 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.437 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.53 169.81 31.68 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.007 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' LYS . . . . . 0.653 ' N ' ' CD ' ' A' ' 406' ' ' LYS . 8.4 mptt -80.2 171.48 15.03 Favored 'General case' 0 C--O 1.201 -1.499 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -120.23 158.98 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.548 -1.261 . . . . 0.0 114.15 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 408' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 414' ' ' ALA . 20.0 p90 -156.24 -151.09 0.31 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.716 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 427' ' ' VAL . 28.4 m-85 -148.22 -42.28 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.406 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 36.8 p -94.71 138.55 32.39 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.548 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -56.12 -19.38 13.04 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.262 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -64.5 -49.07 72.78 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 417' ' ' ALA . 40.8 mm-40 -53.22 -50.9 63.77 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.286 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ALA . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 408' ' ' TYR . . . -48.58 -38.46 20.71 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -63.57 -41.19 98.4 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.505 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.3 -9.62 49.88 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.657 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.08 -60.7 1.86 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.401 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -56.23 -21.37 23.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.045 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -27.61 68.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.003 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -73.13 -6.99 49.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.94 71.47 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.16 152.03 3.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.163 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -72.17 153.11 41.83 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.643 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' VAL . . . . . 0.842 ' O ' ' HB1' ' A' ' 442' ' ' ALA . 4.4 t -145.97 160.15 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.446 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ILE . . . . . 0.514 ' O ' ' CE1' ' A' ' 408' ' ' TYR . 5.2 mm -121.85 159.28 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 426' ' ' LEU . . . . . 0.622 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 13.5 tp -115.79 139.16 50.44 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.796 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.545 ' O ' ' CD2' ' A' ' 409' ' ' PHE . 51.9 t -130.57 119.71 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ARG . . . . . 0.762 ' H ' HG22 ' A' ' 447' ' ' THR . 1.0 OUTLIER -151.4 152.75 33.51 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.902 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.417 ' CB ' ' OE2' ' A' ' 430' ' ' GLU . 0.7 OUTLIER -80.31 20.56 0.67 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.393 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.417 ' OE2' ' CB ' ' A' ' 429' ' ' LEU . 1.4 pm0 -179.69 153.08 0.53 Allowed 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 432' ' ' SER . 0.5 OUTLIER -83.14 -175.24 5.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.555 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 432' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 431' ' ' THR . 4.2 t -177.07 139.28 0.44 Allowed Pre-proline 0 C--N 1.305 -1.357 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.858 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.5 -69.18 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.367 1.378 . . . . 0.0 111.897 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -46.48 -27.32 1.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.879 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.16 -9.23 45.13 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.477 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 436' ' ' ILE . . . . . 0.722 HG23 ' N ' ' A' ' 437' ' ' GLU . 8.3 tp -60.29 -49.99 82.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.031 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 436' ' ' ILE . 52.3 mm-40 -54.89 -29.96 57.03 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.924 -1.51 . . . . 0.0 108.459 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.66 63.41 Favored Glycine 0 N--CA 1.473 1.143 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 43.8 mtt -69.48 -44.83 70.35 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.893 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.568 ' C ' ' N ' ' A' ' 442' ' ' ALA . 7.0 m170 -61.26 -39.28 89.79 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.408 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -51.63 -18.16 1.08 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' ALA . . . . . 0.842 ' HB1' ' O ' ' A' ' 424' ' ' VAL . . . -122.52 -155.48 0.65 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.283 -1.78 . . . . 0.0 108.077 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -168.62 37.75 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -169.52 143.41 7.93 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.3 mp -142.36 118.45 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.453 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' LEU . . . . . 0.436 HD13 ' CG1' ' A' ' 468' ' ' VAL . 2.5 tp -121.78 98.37 5.92 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.695 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' THR . . . . . 0.762 HG22 ' H ' ' A' ' 428' ' ' ARG . 5.5 p -115.16 160.32 19.84 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.24 -20.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.87 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' ARG . . . . . 0.584 ' CG ' ' H ' ' A' ' 450' ' ' GLY . 2.1 ttt85 -129.26 179.24 5.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' GLY . . . . . 0.584 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 92.59 60.19 1.23 Allowed Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.163 -1.494 . . . . 0.0 109.725 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 453' ' ' THR . . . -141.78 -145.25 4.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 453' ' ' THR . 5.4 ttt 46.52 16.54 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.838 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.53 89.53 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.675 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 454' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 455' ' ' HIS . 93.9 p -149.3 -174.58 4.7 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.714 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 455' ' ' HIS . . . . . 0.682 ' O ' HG23 ' A' ' 459' ' ' VAL . 4.6 m170 -40.62 -45.1 2.27 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ALA . . . . . 0.41 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -47.49 -61.9 1.7 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.81 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.64 12.66 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.597 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 11.9 t -45.33 -40.18 2.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.393 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 455' ' ' HIS . 72.3 t -71.58 -45.39 67.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.318 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.35 80.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -68.72 -37.27 79.35 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.705 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -74.95 -24.12 72.79 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.528 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' MET . . . . . 0.479 ' HG3' ' N ' ' A' ' 464' ' ' GLY . 8.9 tpt -90.17 -81.92 0.28 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.449 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 464' ' ' GLY . . . . . 0.479 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 136.12 37.59 0.18 Allowed Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.968 -1.11 . . . . 0.0 110.428 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 10.2 t -108.37 171.43 7.42 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -86.42 126.34 34.32 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.98 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 467' ' ' CYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 0.7 OUTLIER -152.19 155.19 37.3 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.284 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 468' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.4 t -135.52 162.66 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.577 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 469' ' ' SER . . . . . 0.568 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 33.5 t -149.98 151.74 33.8 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.028 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.37 83.99 0.01 OUTLIER Glycine 0 N--CA 1.496 2.67 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.087 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 395' ' ' ALA . 7.9 t -85.57 -145.99 0.11 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.023 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -67.94 -101.16 0.03 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -130.18 54.86 1.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.497 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 0.5 OUTLIER -45.63 111.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -105.03 113.91 27.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.22 134.95 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.444 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -105.99 115.32 30.03 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' GLU . . . . . 0.755 ' C ' ' H ' ' A' ' 480' ' ' ALA . 8.3 mp0 -67.76 -8.27 34.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.291 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 479' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 480' ' ' ALA . 6.1 mt-10 -59.08 6.77 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.152 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 480' ' ' ALA . . . . . 0.755 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 170.75 -77.72 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 481' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 409' ' ' PHE . 4.0 mmtp 158.93 84.07 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.79 1.306 . . . . 0.0 109.482 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 482' ' ' THR . . . . . 0.879 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 1.9 p -137.02 142.06 42.49 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 483' ' ' PHE . . . . . 0.968 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 3.8 p90 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.441 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 484' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' A' ' 485' ' ' LEU . 5.5 tp10 -109.8 117.45 33.9 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 485' ' ' LEU . . . . . 0.464 ' N ' ' OE2' ' A' ' 484' ' ' GLU . 4.8 mt -150.21 159.85 44.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.789 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 53.98 -104.41 0.23 Allowed Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.575 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -139.96 28.72 2.49 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 119.079 -1.534 . . . . 0.0 111.897 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -150.68 142.29 23.58 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.639 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.9 m -106.81 99.04 8.63 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.988 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.559 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 23.3 p90 -154.32 155.13 34.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.302 -1.359 . . . . 0.0 113.948 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 491' ' ' ALA . . . . . 0.968 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . -171.97 -129.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.669 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -47.12 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.187 -1.405 . . . . 0.0 108.94 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 157.69 0.48 0.1 OUTLIER Glycine 0 C--N 1.279 -2.584 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 494' ' ' ASP . . . . . 0.432 ' H ' ' H ' ' A' ' 493' ' ' GLY . 7.9 m-20 -159.81 -163.84 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.948 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' TYR . . . . . 0.484 ' CZ ' ' HA2' ' A' ' 508' ' ' GLY . 4.5 p90 -142.07 144.76 33.73 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.678 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 496' ' ' ILE . . . . . 0.439 HG23 ' CE1' ' A' ' 490' ' ' PHE . 0.0 OUTLIER -123.75 160.6 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.877 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 497' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 506' ' ' TYR . 6.7 t -115.31 99.91 7.74 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 498' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -98.2 144.44 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.377 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 499' ' ' ASP . . . . . 0.66 ' N ' HD12 ' A' ' 498' ' ' LEU . 6.7 t0 -103.55 157.43 17.05 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.697 0.761 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 500' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -145.25 95.47 0.18 Allowed Glycine 0 C--N 1.275 -2.816 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 501' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 0.3 OUTLIER 163.21 6.33 0.0 OUTLIER 'General case' 1 C--N 1.24 -4.156 0 CA-C-N 112.014 -2.093 . . . . 0.0 106.617 -179.97 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 502' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 504' ' ' LYS . 0.1 OUTLIER -163.56 -21.72 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.203 -2.271 . . . . 0.0 107.592 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.51 -10.35 62.01 Favored Glycine 0 N--CA 1.492 2.42 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.948 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' LYS . . . . . 0.536 ' H ' HG23 ' A' ' 502' ' ' THR . 7.9 mtmt -71.98 120.18 17.21 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.986 -1.086 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 505' ' ' ILE . . . . . 0.667 ' O ' HG13 ' A' ' 391' ' ' VAL . 1.2 tt -96.97 160.65 2.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.867 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 506' ' ' TYR . . . . . 0.753 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 33.0 m-85 -138.18 162.58 33.89 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.128 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 507' ' ' LYS . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 3.1 tmtt? -123.53 151.02 43.28 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.999 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 508' ' ' GLY . . . . . 0.484 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.201 0 C-N-CA 118.773 -1.679 . . . . 0.0 109.998 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 387' ' ' LYS . . . 52.15 -159.5 0.11 Allowed 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 386' ' ' LEU . 71.4 mt 50.37 12.09 0.09 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.977 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 385' ' ' ALA . 0.0 OUTLIER -129.91 -5.27 4.53 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.024 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -171.97 23.94 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.03 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.566 ' C ' ' H ' ' A' ' 391' ' ' VAL . . . -63.14 144.04 49.05 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.586 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 391' ' ' VAL . 0.7 OUTLIER -68.12 36.88 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.551 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 505' ' ' ILE . 25.4 t -41.01 143.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.326 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.667 HD13 ' CZ ' ' A' ' 490' ' ' PHE . 2.5 pt -87.72 -55.06 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.635 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.619 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -153.98 -157.13 7.97 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.4 p -164.51 108.47 0.93 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -84.84 -146.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 42.0 mt -96.79 139.99 21.89 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.92 93.07 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.61 0 C-N-CA 121.294 1.329 . . . . 0.0 111.303 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -64.02 -69.85 0.25 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.715 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 57.0 m -133.24 139.25 33.6 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.756 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.31 100.83 0.07 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.895 1.064 . . . . 0.0 110.406 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.616 ' C ' ' SG ' ' A' ' 466' ' ' CYS . . . -152.03 162.36 29.73 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.639 -1.743 . . . . 0.0 112.116 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -141.43 128.44 20.73 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.65 160.58 43.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.019 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -138.77 107.9 6.06 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.023 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.07 30.35 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.051 -1.547 . . . . 0.0 111.307 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.485 ' HE3' ' CD2' ' A' ' 495' ' ' TYR . 3.7 mttp -85.98 137.93 32.36 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.936 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.54 ' O ' ' CG ' ' A' ' 408' ' ' TYR . 49.6 t -55.44 148.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.986 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 407' ' ' VAL . 17.8 m-85 -170.98 139.9 1.48 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.653 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.731 ' CD2' ' NZ ' ' A' ' 481' ' ' LYS . 4.1 m-85 -113.79 42.43 2.01 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.313 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 409' ' ' PHE . 1.0 OUTLIER -159.36 145.0 16.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.886 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -76.83 -18.23 58.51 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.787 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -74.16 -39.93 62.91 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.69 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.462 ' OE1' ' OG1' ' A' ' 410' ' ' THR . 41.8 mt-10 -66.78 -26.76 67.12 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.6 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.27 68.17 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.54 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -43.1 86.42 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.876 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.57 -49.58 52.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.842 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -58.77 -62.11 2.11 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.083 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -41.53 -30.58 0.21 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.663 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -89.53 -22.02 22.62 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.575 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 417' ' ' ALA . 0.0 OUTLIER -94.91 -49.2 5.67 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.521 -0.871 . . . . 0.0 112.842 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 422' ' ' GLU . . . -153.74 -10.64 0.07 OUTLIER Glycine 0 N--CA 1.497 2.737 0 C-N-CA 118.763 -1.684 . . . . 0.0 112.03 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' GLU . . . . . 0.446 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 3.0 mt-10 64.24 -145.89 0.28 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 49.87 65.89 1.29 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.614 -1.234 . . . . 0.0 108.352 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 408' ' ' TYR . 3.3 t -122.47 154.92 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.702 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 426' ' ' LEU . 18.9 mm -118.75 160.9 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.406 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.521 ' N ' HG22 ' A' ' 425' ' ' ILE . 1.4 tp -134.58 125.56 27.47 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.183 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 446' ' ' LEU . 38.2 t -114.14 127.16 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.75 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ARG . . . . . 0.613 ' H ' HG22 ' A' ' 447' ' ' THR . 0.0 OUTLIER -152.48 146.69 25.47 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.122 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 12.03 2.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.566 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 428' ' ' ARG . 67.2 tt0 -176.4 139.76 0.35 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.699 HG21 ' HB2' ' A' ' 456' ' ' ALA . 9.1 p -106.14 153.49 22.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.271 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.32 158.67 63.39 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.715 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.9 Cg_endo -65.79 -69.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.903 1.736 . . . . 0.0 112.394 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -35.23 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.568 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.624 ' OD1' ' SD ' ' A' ' 439' ' ' MET . 0.6 OUTLIER -62.83 -8.41 6.88 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.622 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.649 HG22 ' N ' ' A' ' 437' ' ' GLU . 0.3 OUTLIER -32.68 -58.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.649 ' N ' HG22 ' A' ' 436' ' ' ILE . 53.2 mt-10 -47.93 -41.19 24.15 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 117.961 -1.496 . . . . 0.0 109.086 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -71.91 -25.85 73.92 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' MET . . . . . 0.632 ' SD ' HG11 ' A' ' 459' ' ' VAL . 40.5 mtp -70.65 -46.93 62.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -58.26 -61.66 2.41 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 118.267 -1.373 . . . . 0.0 109.546 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -49.25 -32.15 10.18 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.096 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -98.04 71.45 2.15 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.544 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.18 3.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.239 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.627 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -144.32 145.17 14.46 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 49.8 mt -148.01 118.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.091 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 427' ' ' VAL . 4.6 tp -115.55 97.96 6.45 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 428' ' ' ARG . 4.4 p -106.16 160.94 14.95 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.901 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 56.6 t -86.47 -20.62 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.157 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 470' ' ' GLY . 2.0 tpt85 -99.54 -136.04 0.29 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.615 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.509 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 73.14 -170.47 52.05 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.62 -170.34 40.54 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.897 -1.62 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.571 ' O ' HG23 ' A' ' 453' ' ' THR . 13.9 ttt -46.95 -37.97 9.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 452' ' ' MET . 0.7 OUTLIER -158.91 129.26 5.91 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.182 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.1 m -174.29 -178.29 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 459' ' ' VAL . 34.4 m80 -45.63 -38.3 6.52 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.952 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.699 ' HB2' HG21 ' A' ' 431' ' ' THR . . . -59.51 -51.27 70.58 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.694 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -78.19 -52.09 9.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 3.4 t -47.85 -50.49 9.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.284 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 455' ' ' HIS . 65.9 t -63.99 -39.27 84.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 464' ' ' GLY . . . -65.51 -50.59 64.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.381 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -53.96 -29.07 41.15 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.422 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.15 -35.33 27.4 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 16.2 mmt -97.49 6.43 48.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.727 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 460' ' ' ALA . . . 48.78 24.72 4.4 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.953 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 94.3 m -84.11 146.4 27.91 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.831 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' CYS . . . . . 0.616 ' SG ' ' C ' ' A' ' 401' ' ' GLY . 17.0 t -76.1 129.5 36.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 80.0 m -151.54 146.98 26.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.822 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.69 160.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.393 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 469' ' ' SER . . . . . 0.507 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 7.0 t -151.04 148.15 27.99 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.596 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 52.0 92.39 0.01 OUTLIER Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 471' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 446' ' ' LEU . 7.9 m -100.69 -159.39 0.73 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.643 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.72 -99.0 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.959 -1.591 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -133.92 43.87 2.8 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.416 0.627 . . . . 0.0 109.34 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.607 HG23 ' CB ' ' A' ' 483' ' ' PHE . 5.0 mt -39.09 110.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.846 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -94.3 121.96 36.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 482' ' ' THR . 3.8 mt -87.36 131.13 35.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 117.829 -1.548 . . . . 0.0 112.795 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -104.39 119.45 38.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.552 ' C ' ' N ' ' A' ' 480' ' ' ALA . 1.5 mp0 -62.65 -10.69 13.26 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.598 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -45.51 -20.18 0.06 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 118.236 -1.386 . . . . 0.0 108.518 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.552 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.68 -103.67 0.01 OUTLIER 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' LYS . . . . . 0.731 ' NZ ' ' CD2' ' A' ' 409' ' ' PHE . 11.2 mmmm -155.96 65.87 0.59 Allowed 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.642 ' O ' HG23 ' A' ' 476' ' ' ILE . 4.8 p -98.43 -179.5 4.36 Favored 'General case' 0 C--O 1.201 -1.475 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.783 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 483' ' ' PHE . . . . . 0.607 ' CB ' HG23 ' A' ' 474' ' ' ILE . 0.5 OUTLIER -150.78 117.23 5.72 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.043 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 484' ' ' GLU . . . . . 0.427 ' CG ' HG23 ' A' ' 489' ' ' THR . 33.8 mt-10 -89.17 118.48 28.9 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.839 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 486' ' ' GLY . 61.6 tp -143.53 154.79 43.98 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.775 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 486' ' ' GLY . . . . . 0.468 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 56.89 -114.59 5.48 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.484 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.85 3.91 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.11 152.19 33.04 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.427 HG23 ' CG ' ' A' ' 484' ' ' GLU . 88.3 m -107.79 112.03 24.49 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.946 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.667 ' CZ ' HD13 ' A' ' 392' ' ' ILE . 5.6 m-30 -89.45 110.93 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.061 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -98.23 149.01 23.02 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.865 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.485 ' CG ' ' O ' ' A' ' 492' ' ' GLU . 1.9 tm-20 -67.29 69.49 0.09 Allowed 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 493' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -173.96 22.47 0.06 OUTLIER Glycine 0 C--N 1.269 -3.139 0 C-N-CA 119.206 -1.473 . . . . 0.0 109.765 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 494' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 495' ' ' TYR . 2.4 t0 -140.69 -173.94 3.83 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.655 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 495' ' ' TYR . . . . . 0.485 ' CD2' ' HE3' ' A' ' 406' ' ' LYS . 0.2 OUTLIER -116.41 129.64 56.34 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.892 HD12 ' N ' ' A' ' 497' ' ' SER . 0.6 OUTLIER -138.37 160.5 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.554 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 497' ' ' SER . . . . . 0.892 ' N ' HD12 ' A' ' 496' ' ' ILE . 17.3 m -125.05 112.11 16.15 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 498' ' ' LEU . . . . . 0.418 HD13 ' CG1' ' A' ' 505' ' ' ILE . 0.0 OUTLIER -108.76 141.25 41.03 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.539 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 498' ' ' LEU . 3.6 m-20 -93.12 161.7 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.037 0.922 . . . . 0.0 112.531 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 500' ' ' GLY . . . . . 0.608 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -150.65 94.73 0.15 Allowed Glycine 0 C--N 1.287 -2.189 0 N-CA-C 106.737 -2.545 . . . . 0.0 106.737 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 501' ' ' SER . . . . . 0.469 ' C ' ' OG1' ' A' ' 502' ' ' THR . 0.3 OUTLIER 174.31 1.55 0.0 OUTLIER 'General case' 1 C--N 1.241 -4.122 0 CA-C-N 112.995 -1.602 . . . . 0.0 108.161 179.797 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 502' ' ' THR . . . . . 0.469 ' OG1' ' C ' ' A' ' 501' ' ' SER . 0.6 OUTLIER -168.66 -21.03 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.019 -1.9 . . . . 0.0 107.844 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.19 72.97 1.28 Allowed Glycine 0 N--CA 1.484 1.865 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.46 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -139.88 112.74 8.06 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.348 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' ILE . . . . . 0.65 ' O ' HG13 ' A' ' 391' ' ' VAL . 5.8 mt -89.46 149.05 4.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.286 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 506' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 507' ' ' LYS . 46.4 t80 -147.66 161.44 41.18 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.412 ' O ' ' CE2' ' A' ' 506' ' ' TYR . 15.7 tttt -116.89 160.61 20.61 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.965 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 76.66 128.42 0.31 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.605 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.26 115.31 4.05 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.828 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 510' ' ' ILE . 1.5 mt -63.89 165.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.718 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.877 179.981 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.724 0.297 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -138.16 15.85 2.81 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.575 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 75.1 mt -95.94 9.81 39.41 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.611 -0.835 . . . . 0.0 109.198 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -120.62 1.55 10.6 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.271 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -164.26 22.53 0.07 Allowed 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.487 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -77.8 -126.9 0.37 Allowed Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.323 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.401 ' OE2' ' HE1' ' A' ' 488' ' ' HIS . 12.3 tp10 -147.41 85.87 1.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.613 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.572 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 24.3 t -96.59 135.18 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.4 pt -90.75 -31.6 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 164.65 -176.34 40.5 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.075 -1.536 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.8 p -141.5 151.47 43.34 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.184 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -142.46 -152.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.344 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.718 ' CD2' ' N ' ' A' ' 396' ' ' LEU . 0.1 OUTLIER -63.45 115.51 18.77 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.323 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.79 100.52 0.83 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.023 1.149 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -59.89 -76.03 0.05 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.094 -1.043 . . . . 0.0 110.859 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.3 t -137.85 151.38 70.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.732 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.08 104.04 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.447 1.431 . . . . 0.0 110.822 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.605 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -152.62 163.24 30.29 Favored Glycine 0 N--CA 1.503 3.152 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.87 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -137.81 123.41 19.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.48 161.16 43.06 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.703 -1.599 . . . . 0.0 114.12 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -148.5 107.11 3.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.001 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.47 31.81 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 118.905 -1.617 . . . . 0.0 112.151 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.464 ' NZ ' ' HB2' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -84.5 132.51 34.53 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.522 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.49 158.59 5.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.028 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.577 ' CD1' ' CD ' ' A' ' 413' ' ' GLU . 3.8 m-85 -151.8 -170.62 3.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -142.27 6.43 1.71 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.798 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.0 p -141.64 142.25 33.41 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -67.25 -12.17 59.41 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.661 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -73.12 -42.86 62.45 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.577 ' CD ' ' CD1' ' A' ' 408' ' ' TYR . 49.9 mt-10 -63.92 -37.9 89.12 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.873 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.42 68.37 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.773 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -69.93 -38.42 76.19 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.271 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.53 -13.29 34.91 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.206 -0.997 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -90.2 -52.43 4.94 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.83 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' HIS . . . . . 0.583 ' HB2' ' HB1' ' A' ' 441' ' ' ALA . 16.3 t-80 -47.79 -21.58 0.42 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.328 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.9 OUTLIER -83.75 -68.68 0.69 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.205 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -93.2 -24.35 18.24 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.761 -0.776 . . . . 0.0 112.342 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -89.27 -51.87 2.85 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.027 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 417' ' ' ALA . 3.6 mt-10 62.38 165.65 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.022 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 422' ' ' GLU . 12.6 mpt_? 45.0 80.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.535 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 4.2 t -130.21 161.4 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.984 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 426' ' ' LEU . 7.2 mm -133.42 160.81 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.653 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.478 ' N ' HG22 ' A' ' 425' ' ' ILE . 9.8 tp -131.65 151.69 51.42 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.613 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 426' ' ' LEU . 6.2 t -131.45 126.28 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ARG . . . . . 0.67 ' O ' HG22 ' A' ' 447' ' ' THR . 90.4 mtt180 -151.89 150.77 30.44 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.354 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.524 ' N ' HD23 ' A' ' 429' ' ' LEU . 7.0 mt -59.55 -44.09 93.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.646 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.62 -178.16 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -81.81 -178.07 6.83 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.927 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.78 122.42 0.81 Allowed Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.6 -33.6 93.34 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.036 1.157 . . . . 0.0 111.779 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -73.81 -9.4 58.62 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.1 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -87.26 -8.33 56.91 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.565 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 7.9 tp -39.91 -50.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.5 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.643 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 27.3 mt-10 -61.19 -31.53 71.28 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 117.877 -1.529 . . . . 0.0 108.387 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.16 -28.09 60.88 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' MET . . . . . 0.552 ' SD ' HG11 ' A' ' 459' ' ' VAL . 75.0 mtp -66.91 -42.65 85.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.191 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -67.46 -58.88 3.94 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.198 -1.401 . . . . 0.0 108.924 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 418' ' ' HIS . . . -49.36 -36.07 20.51 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.392 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -94.19 81.59 4.07 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.158 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.95 21.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.113 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.664 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -165.97 149.57 15.86 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.39 131.56 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.97 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.611 ' CD2' HD22 ' A' ' 498' ' ' LEU . 0.6 OUTLIER -123.72 108.66 12.77 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.06 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 428' ' ' ARG . 3.4 p -121.83 160.23 25.12 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.538 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.578 HG13 HG13 ' A' ' 474' ' ' ILE . 2.6 t -79.09 -25.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.406 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -121.13 -142.22 0.34 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.197 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 81.13 -143.9 24.36 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.137 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' GLY . . . . . 0.608 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 55.67 -140.87 40.05 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.204 -1.474 . . . . 0.0 110.122 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 24.9 mtm 43.82 38.95 2.3 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.487 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 56.2 p 42.43 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.575 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 458' ' ' VAL . 45.5 p -160.06 -164.64 1.33 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.168 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' HIS . . . . . 0.696 ' O ' HG23 ' A' ' 459' ' ' VAL . 69.0 m80 -43.9 -51.36 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.211 -0.995 . . . . 0.0 110.593 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.405 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -42.34 -55.33 3.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.764 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.48 6.31 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.667 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 454' ' ' SER . 50.3 t -47.02 -40.83 5.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.49 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 455' ' ' HIS . 43.4 t -74.36 -42.13 50.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.26 -35.89 81.57 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -68.46 -40.34 81.07 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.456 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -61.12 -36.52 92.48 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.388 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.78 -15.65 29.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.989 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 61.91 57.88 15.4 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.644 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 161.24 17.4 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 401' ' ' GLY . 19.0 t -81.11 91.7 6.16 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.481 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.6 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 4.2 t -129.34 158.8 38.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.397 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -136.62 162.71 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.055 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 469' ' ' SER . . . . . 0.608 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 32.1 t -143.59 160.17 41.13 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.669 -1.213 . . . . 0.0 113.093 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 47.35 75.18 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.434 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' CYS . . . . . 0.654 ' SG ' HD13 ' A' ' 485' ' ' LEU . 1.8 t -84.75 -171.67 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.215 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.461 ' H ' HD11 ' A' ' 485' ' ' LEU . . . -50.25 -90.83 0.01 OUTLIER Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.672 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -155.67 66.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.578 HG13 HG13 ' A' ' 448' ' ' VAL . 0.0 OUTLIER -62.79 107.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.41 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -89.91 123.28 33.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.58 126.58 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.565 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -97.39 113.63 25.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.702 ' C ' ' H ' ' A' ' 480' ' ' ALA . 0.8 OUTLIER -67.87 -6.12 20.1 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.416 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.428 ' H ' ' HG2' ' A' ' 479' ' ' GLU . 34.8 mm-40 -52.92 -7.43 0.07 Allowed 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.551 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -179.72 -82.3 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 112.527 -2.124 . . . . 0.0 105.487 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' LYS . . . . . 0.528 ' HB3' ' CG ' ' A' ' 492' ' ' GLU . 4.5 mttt 169.17 89.18 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.099 0.952 . . . . 0.0 109.772 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 491' ' ' ALA . 1.4 p -151.29 138.78 19.53 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.301 -1.772 . . . . 0.0 111.885 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 483' ' ' PHE . . . . . 0.53 ' HB2' HG22 ' A' ' 474' ' ' ILE . 16.0 p90 -97.83 152.0 19.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -119.33 116.28 25.9 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.198 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.654 HD13 ' SG ' ' A' ' 471' ' ' CYS . 6.2 tt -150.5 152.87 34.86 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 69.04 -108.35 2.44 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 118.828 -1.653 . . . . 0.0 110.286 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.414 ' C ' ' ND1' ' A' ' 488' ' ' HIS . . . -137.34 27.21 2.89 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.194 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 488' ' ' HIS . . . . . 0.414 ' ND1' ' C ' ' A' ' 487' ' ' GLY . 42.5 m80 -150.68 152.51 34.06 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.829 -1.149 . . . . 0.0 111.286 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.9 m -119.83 97.12 5.47 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.12 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 490' ' ' PHE . 39.0 p90 -155.48 155.31 33.26 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.98 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.716 ' H ' HG22 ' A' ' 482' ' ' THR . . . -152.1 -124.31 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.528 ' CG ' ' HB3' ' A' ' 481' ' ' LYS . 1.1 pt-20 -67.9 49.03 0.05 Allowed 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 493' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -138.51 2.63 2.83 Favored Glycine 0 C--N 1.283 -2.37 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -167.56 -173.97 2.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.477 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -122.94 141.94 51.36 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.742 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.598 ' H ' HD12 ' A' ' 496' ' ' ILE . 0.6 OUTLIER -121.47 160.06 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.944 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 497' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 506' ' ' TYR . 6.3 m -115.37 99.46 7.4 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 498' ' ' LEU . . . . . 0.611 HD22 ' CD2' ' A' ' 446' ' ' LEU . 0.1 OUTLIER -100.48 140.83 34.18 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.219 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.524 ' N ' HD12 ' A' ' 498' ' ' LEU . 21.7 t70 -93.42 160.64 14.72 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-O 122.018 0.913 . . . . 0.0 111.896 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' GLY . . . . . 0.605 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -148.27 95.14 0.16 Allowed Glycine 0 C--N 1.272 -3.026 0 N-CA-C 106.508 -2.637 . . . . 0.0 106.508 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 2.0 t 171.15 4.47 0.0 OUTLIER 'General case' 0 C--N 1.244 -3.981 0 CA-C-N 112.177 -2.012 . . . . 0.0 107.065 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' THR . . . . . 0.413 ' H ' ' H ' ' A' ' 503' ' ' GLY . 0.0 OUTLIER -168.38 -22.79 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.516 -2.129 . . . . 0.0 107.496 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 96.93 -7.86 65.08 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.882 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 154.74 9.8 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.914 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 2.1 mp -135.04 146.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.295 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' TYR . . . . . 0.572 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 14.0 m-85 -133.79 161.96 33.3 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -127.74 153.86 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.209 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 72.78 124.31 0.08 OUTLIER Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.209 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.562 ' N ' ' OD1' ' A' ' 509' ' ' ASP . 13.1 p-10 -42.19 108.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.011 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 510' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 510' ' ' ILE . 14.5 pt -74.14 176.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.575 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--N 1.303 -1.437 0 CA-C-O 116.3 -1.809 . . . . 0.0 110.818 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.677 0.275 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 388' ' ' ALA . . . -99.31 119.18 37.51 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.491 ' HG ' HD13 ' A' ' 510' ' ' ILE . 4.7 mt 51.25 46.91 25.77 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 388' ' ' ALA . 5.0 tttt 52.62 35.34 17.87 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 387' ' ' LYS . . . 79.72 23.02 0.49 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.616 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 385' ' ' ALA . . . 51.38 55.2 20.64 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 118.882 -1.628 . . . . 0.0 110.411 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -92.37 59.04 3.34 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.709 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.657 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 65.1 t -46.3 156.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.289 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.47 ' N ' HG12 ' A' ' 391' ' ' VAL . 34.3 pt -128.29 -11.8 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.363 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -175.25 -167.41 34.37 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.896 -1.621 . . . . 0.0 111.481 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.2 p 177.12 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.327 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.36 -151.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 396' ' ' LEU . 8.9 mt -80.74 127.16 76.12 Favored Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.601 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.08 97.32 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -60.39 -59.37 5.51 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.946 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.01 133.72 12.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.91 98.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 120.791 0.994 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.592 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -153.43 159.58 28.7 Favored Glycine 0 N--CA 1.504 3.169 0 C-N-CA 118.876 -1.63 . . . . 0.0 111.882 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.756 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -133.13 132.05 41.2 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.711 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.421 ' HB2' ' SG ' ' A' ' 466' ' ' CYS . . . -150.39 161.38 42.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.184 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.14 110.94 6.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.231 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -153.16 167.69 31.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.812 -1.661 . . . . 0.0 111.774 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -83.89 156.46 22.39 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.179 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.71 ' HB ' ' H ' ' A' ' 492' ' ' GLU . 0.0 OUTLIER -78.79 165.23 3.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.639 -0.825 . . . . 0.0 113.072 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.59 ' CE1' ' OE1' ' A' ' 413' ' ' GLU . 3.6 m-85 -170.37 170.0 7.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.993 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.505 ' CG ' ' HD2' ' A' ' 481' ' ' LYS . 14.2 m-85 -137.36 23.21 2.97 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.805 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 12.6 p -146.95 142.0 27.09 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.25 -12.28 61.37 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -78.22 -36.47 47.12 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.451 -0.899 . . . . 0.0 109.718 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.59 ' OE1' ' CE1' ' A' ' 408' ' ' TYR . 62.0 mm-40 -65.58 -40.38 92.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ALA . . . . . 0.589 ' HB1' ' CB ' ' A' ' 441' ' ' ALA . . . -67.5 -39.63 85.19 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.345 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -56.48 -34.25 66.74 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.762 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.62 -50.82 5.71 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.717 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -55.17 -48.02 74.35 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.28 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' HIS . . . . . 0.594 ' ND1' ' OE1' ' A' ' 419' ' ' GLU . 17.9 t-80 -43.76 -41.01 4.66 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.045 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.594 ' OE1' ' ND1' ' A' ' 418' ' ' HIS . 0.6 OUTLIER -91.92 -25.6 18.83 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.457 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 420' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 420' ' ' LYS . 7.6 mtpm? -92.69 -52.8 4.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.63 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -101.3 -31.6 5.52 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.148 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' GLU . . . . . 0.461 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 0.9 OUTLIER 65.96 148.6 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.396 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 55.89 95.01 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.879 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.54 162.45 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.484 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 426' ' ' LEU . 16.8 mm -121.69 159.93 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 425' ' ' ILE . 6.6 tp -136.15 134.52 38.34 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.345 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.556 HG21 ' CE2' ' A' ' 483' ' ' PHE . 8.7 t -117.72 121.73 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.714 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ARG . . . . . 0.911 ' O ' HG22 ' A' ' 447' ' ' THR . 47.8 mtt180 -151.29 161.64 42.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -66.5 0.53 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.62 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -109.3 -165.53 1.02 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.678 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -99.0 -163.97 1.09 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.32 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.517 ' N ' ' OG1' ' A' ' 431' ' ' THR . 1.4 t -175.61 137.16 0.51 Allowed Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.557 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.5 Cg_endo -62.27 -77.59 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.388 1.392 . . . . 0.0 112.126 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -44.01 -18.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 439' ' ' MET . 11.0 m-20 -82.53 -9.0 59.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.39 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.967 HG23 ' H ' ' A' ' 437' ' ' GLU . 6.1 tp -46.78 -63.54 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.579 -0.849 . . . . 0.0 111.145 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.967 ' H ' HG23 ' A' ' 436' ' ' ILE . 5.4 mt-10 -52.27 -26.98 13.34 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.414 -1.315 . . . . 0.0 108.59 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -81.17 -24.67 56.9 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 435' ' ' ASP . 53.3 mtt -77.64 -41.97 36.47 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.861 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.852 ' NE2' HD11 ' A' ' 436' ' ' ILE . 28.1 m170 -65.14 -49.04 71.41 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.813 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.589 ' CB ' ' HB1' ' A' ' 414' ' ' ALA . . . -48.38 -20.83 0.45 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.536 ' N ' ' C ' ' A' ' 440' ' ' HIS . . . -116.57 61.77 0.72 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.53 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.718 ' CD ' ' H ' ' A' ' 443' ' ' GLU . 1.4 pm0 -26.03 -58.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.875 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' A' ' 425' ' ' ILE . . . -81.48 145.2 25.01 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 118.494 -1.812 . . . . 0.0 109.009 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 41.0 mt -147.81 112.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 118.449 -1.301 . . . . 0.0 112.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 446' ' ' LEU . 1.3 mm? -100.35 137.63 38.51 Favored 'General case' 0 C--O 1.187 -2.217 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.911 HG22 ' O ' ' A' ' 428' ' ' ARG . 0.3 OUTLIER -149.64 151.44 33.76 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.019 -1.473 . . . . 0.0 111.896 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.703 HG22 ' HB ' ' A' ' 474' ' ' ILE . 18.8 t -77.02 -24.29 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.805 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 10.7 ttt-85 -108.13 -143.66 0.38 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.225 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.508 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 73.93 -162.69 54.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 77.21 -41.92 1.85 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.159 -1.496 . . . . 0.0 110.392 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.683 ' C ' HG23 ' A' ' 453' ' ' THR . 53.7 mtt -64.86 19.09 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' THR . . . . . 0.683 HG23 ' C ' ' A' ' 452' ' ' MET . 1.0 OUTLIER 62.84 114.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.874 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.7 t -173.28 -155.54 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 459' ' ' VAL . 45.8 t60 -57.67 -36.8 72.4 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.678 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -63.23 -44.67 94.59 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.0 -57.43 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.648 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.67 -41.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.7 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 455' ' ' HIS . 51.5 t -65.95 -53.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.11 73.48 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -69.33 -24.0 63.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.606 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.05 -48.3 5.8 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.642 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 56.7 mmm -78.41 -40.81 34.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.982 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.35 22.0 30.68 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.574 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' THR . . . . . 0.831 HG22 ' H ' ' A' ' 466' ' ' CYS . 7.3 m -76.03 -170.51 1.41 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 466' ' ' CYS . . . . . 0.831 ' H ' HG22 ' A' ' 465' ' ' THR . 0.0 OUTLIER -99.1 120.32 39.29 Favored 'General case' 0 C--O 1.202 -1.414 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.667 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 23.4 t -151.29 147.24 26.72 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.055 -1.458 . . . . 0.0 112.005 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.89 162.71 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.747 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' SER . . . . . 0.508 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 28.8 t -147.79 160.58 42.58 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.995 -1.082 . . . . 0.0 112.62 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 46.94 72.92 0.35 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.184 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' CYS . . . . . 0.618 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.5 OUTLIER -83.43 -158.82 0.32 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.878 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 471' ' ' CYS . . . -67.69 -101.71 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.31 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -135.33 54.57 1.92 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.861 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.812 HG23 ' CB ' ' A' ' 483' ' ' PHE . 5.1 mt -45.67 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.921 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -89.37 121.39 31.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.01 122.44 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.929 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -99.46 111.97 24.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.788 ' C ' ' H ' ' A' ' 480' ' ' ALA . 35.9 mt-10 -60.54 0.29 0.21 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.286 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.647 ' O ' ' HB2' ' A' ' 480' ' ' ALA . 47.4 mt-10 -64.24 17.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.254 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.788 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 155.2 -71.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' LYS . . . . . 0.505 ' HD2' ' CG ' ' A' ' 409' ' ' PHE . 2.1 mmtt 158.51 79.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.492 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' THR . . . . . 1.005 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 6.7 p -132.28 143.76 50.12 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.681 -0.807 . . . . 0.0 112.325 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' PHE . . . . . 1.015 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 10.8 p90 -98.96 143.51 29.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.201 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 485' ' ' LEU . 5.1 tp10 -101.54 111.24 23.42 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.196 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 487' ' ' GLY . 0.8 OUTLIER -134.6 117.83 16.55 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.002 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 486' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 485' ' ' LEU . . . 21.3 -74.15 0.0 OUTLIER Glycine 0 N--CA 1.51 3.593 0 O-C-N 124.486 1.116 . . . . 0.0 114.439 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 485' ' ' LEU . . . -51.76 -67.92 1.78 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.543 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 488' ' ' HIS . . . . . 0.421 ' CG ' ' O ' ' A' ' 487' ' ' GLY . 64.7 m-70 -154.44 163.53 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.156 -1.418 . . . . 0.0 112.869 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 484' ' ' GLU . 9.2 m -93.6 99.29 11.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.438 ' CE1' ' HE3' ' A' ' 507' ' ' LYS . 40.3 p90 -153.22 154.13 34.07 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 118.455 -1.298 . . . . 0.0 113.825 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 1.015 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . 170.94 172.52 0.07 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 113.767 -1.561 . . . . 0.0 108.678 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.71 ' H ' ' HB ' ' A' ' 407' ' ' VAL . 19.7 tt0 26.06 41.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 O-C-N 124.266 0.979 . . . . 0.0 109.978 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 493' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -167.61 1.43 0.04 OUTLIER Glycine 0 C--N 1.281 -2.505 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 494' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 407' ' ' VAL . 2.9 m-20 -156.96 -152.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' TYR . . . . . 0.448 ' HE2' ' H ' ' A' ' 509' ' ' ASP . 1.5 p90 -154.32 140.52 18.51 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.433 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.842 ' H ' HD12 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -122.99 160.6 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.569 -0.852 . . . . 0.0 113.073 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 497' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 506' ' ' TYR . 1.8 p -115.29 98.37 6.72 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 498' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -93.39 142.31 27.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.893 -1.123 . . . . 0.0 113.012 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.733 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.9 OUTLIER -106.52 161.54 14.52 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.479 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 500' ' ' GLY . . . . . 0.592 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -156.28 95.41 0.15 Allowed Glycine 0 C--N 1.277 -2.707 0 N-CA-C 106.836 -2.505 . . . . 0.0 106.836 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 501' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 502' ' ' THR . 77.7 p -178.03 6.68 0.01 OUTLIER 'General case' 1 C--N 1.241 -4.142 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.33 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 502' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 501' ' ' SER . 0.0 OUTLIER -175.35 -19.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 112.822 -1.99 . . . . 0.0 107.72 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 86.77 74.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.558 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 499' ' ' ASP . 19.8 mttp -155.45 115.16 3.68 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.258 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' ILE . . . . . 0.548 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.1 tt -93.91 160.45 2.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.687 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' TYR . . . . . 0.657 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 18.8 m-85 -141.82 161.44 37.95 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.771 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.438 ' HE3' ' CE1' ' A' ' 490' ' ' PHE . 47.6 tttt -107.67 154.36 21.57 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.695 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 77.27 144.7 1.98 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.567 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.448 ' H ' ' HE2' ' A' ' 495' ' ' TYR . 2.9 p-10 -61.41 157.31 17.09 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.701 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 510' ' ' ILE . . . . . 1.11 HD12 ' H ' ' A' ' 511' ' ' GLU . 0.2 OUTLIER -103.28 164.99 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.907 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 1.11 ' H ' HD12 ' A' ' 510' ' ' ILE . 6.4 tm-20 . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 116.381 -1.771 . . . . 0.0 110.82 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.866 0.365 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -99.39 33.75 2.37 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.733 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 386' ' ' LEU . 2.4 pp -103.3 13.67 33.27 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.23 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.0 -5.99 7.32 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.942 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -169.15 19.54 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -75.26 -109.71 0.1 OUTLIER Glycine 0 N--CA 1.489 2.192 0 C-N-CA 118.889 -1.624 . . . . 0.0 110.425 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -154.31 90.41 1.34 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.485 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.72 HG23 ' CE1' ' A' ' 506' ' ' TYR . 0.4 OUTLIER -83.79 137.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.707 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.771 HD12 HD21 ' A' ' 485' ' ' LEU . 28.2 pt -77.48 -39.38 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.571 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.52 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -178.56 -162.33 27.97 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.499 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 121.11 0.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.615 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.434 ' HB2' ' SG ' ' A' ' 471' ' ' CYS . . . -94.86 -142.69 0.25 Allowed 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.913 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.77 128.34 48.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.328 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.73 98.2 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 121.076 1.184 . . . . 0.0 111.756 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -62.93 -74.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.26 146.24 60.07 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.946 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -52.27 100.4 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.762 1.642 . . . . 0.0 111.078 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.65 161.22 29.74 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 117.9 -2.095 . . . . 0.0 112.989 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -150.48 117.23 5.83 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.135 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.49 161.57 42.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.652 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.35 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.746 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.16 166.64 31.09 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.337 -1.887 . . . . 0.0 112.338 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -85.24 134.29 34.14 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.567 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 483' ' ' PHE . 2.2 p -66.21 138.24 23.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.998 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.658 ' CE1' ' OE2' ' A' ' 413' ' ' GLU . 1.5 m-85 -153.08 146.16 24.63 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.623 ' O ' HG23 ' A' ' 410' ' ' THR . 4.2 m-85 -110.94 41.53 1.8 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.531 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 409' ' ' PHE . 0.8 OUTLIER -160.95 143.65 12.72 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.189 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -78.11 -13.36 59.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.606 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.61 -41.04 24.61 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.06 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.658 ' OE2' ' CE1' ' A' ' 408' ' ' TYR . 6.0 mm-40 -64.38 -40.6 96.14 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.966 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.07 97.99 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.46 -38.28 90.54 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -82.01 -16.96 48.52 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.56 -52.4 4.91 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.183 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.51 -19.06 55.78 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.563 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.579 ' C ' ' H ' ' A' ' 421' ' ' GLY . 0.7 OUTLIER -64.6 -48.24 75.67 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.877 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -1.07 0.08 Allowed 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 77.82 64.86 1.98 Allowed Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.08 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' GLU . . . . . 0.701 ' C ' ' HE ' ' A' ' 423' ' ' ARG . 7.2 mt-10 -146.43 -166.53 2.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.414 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' ARG . . . . . 0.753 ' HE ' ' N ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER -115.69 148.36 39.82 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.632 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.419 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 1.7 t -148.97 162.1 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.075 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 6.2 mm -123.81 160.74 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.24 121.14 30.39 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.432 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 409' ' ' PHE . 24.8 t -111.31 117.27 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.246 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 447' ' ' THR . 17.0 mtp85 -152.43 155.52 37.7 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.941 ' H ' HD23 ' A' ' 429' ' ' LEU . 0.7 OUTLIER -106.32 28.71 7.48 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.571 1.177 . . . . 0.0 109.649 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.39 121.17 2.96 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.721 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.8 OUTLIER -76.08 179.56 5.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.97 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 2.9 t -177.24 139.5 0.44 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.068 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.91 -72.9 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.617 1.545 . . . . 0.0 111.871 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 435' ' ' ASP . 7.4 pt-20 -39.48 -32.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.659 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 438' ' ' GLY . 4.0 m-20 -62.14 -8.6 5.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.727 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.624 HG23 ' N ' ' A' ' 437' ' ' GLU . 6.7 tp -48.54 -43.4 13.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.878 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.624 ' N ' HG23 ' A' ' 436' ' ' ILE . 23.2 mt-10 -62.66 -27.19 69.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 117.769 -1.572 . . . . 0.0 107.957 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -78.88 -26.93 57.58 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 27.8 mtt -66.49 -39.22 88.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.756 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -74.54 -39.72 62.16 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.336 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.756 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -55.76 -28.77 57.71 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.782 -1.167 . . . . 0.0 107.91 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -112.84 89.47 3.09 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.118 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 443' ' ' GLU . 7.0 pt-20 -64.36 37.23 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.862 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -171.58 140.52 5.9 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.9 mm -139.24 132.17 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.913 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 427' ' ' VAL . 1.4 tp -135.96 95.98 3.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.2 p -109.14 161.44 15.21 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.804 -0.758 . . . . 0.0 112.768 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 474' ' ' ILE . 37.0 t -85.23 -21.0 8.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.971 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 470' ' ' GLY . 19.1 mmm-85 -105.97 -148.11 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.626 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 89.08 -136.58 13.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' GLY . . . . . 0.578 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 82.59 163.69 33.76 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 16.8 tpp 46.64 13.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.482 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.3 OUTLIER 66.97 131.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.592 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.654 ' H ' ' HB3' ' A' ' 457' ' ' ALA . 9.0 t -163.58 -169.97 2.08 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.957 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' HIS . . . . . 0.603 ' O ' HG23 ' A' ' 459' ' ' VAL . 4.6 m80 -43.41 -46.04 6.47 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.721 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -61.39 -48.12 82.68 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.663 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.654 ' HB3' ' H ' ' A' ' 454' ' ' SER . . . -74.66 -55.02 6.33 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.534 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 459' ' ' VAL . 2.2 t -50.25 -53.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.548 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 455' ' ' HIS . 88.6 t -54.08 -44.1 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.527 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.696 ' HB1' ' SG ' ' A' ' 467' ' ' CYS . . . -61.22 -55.17 35.15 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -55.38 -28.69 55.64 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.534 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.11 66.14 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.602 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' MET . . . . . 0.49 ' SD ' ' O ' ' A' ' 463' ' ' MET . 1.1 tpt -91.46 -41.66 10.72 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.03 83.94 1.64 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.523 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' THR . . . . . 0.643 HG22 ' N ' ' A' ' 466' ' ' CYS . 1.9 m -162.36 171.93 16.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.8 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 466' ' ' CYS . . . . . 0.643 ' N ' HG22 ' A' ' 465' ' ' THR . 12.8 t -78.1 126.47 30.87 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.958 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.696 ' SG ' ' HB1' ' A' ' 460' ' ' ALA . 0.5 OUTLIER -151.2 148.36 28.15 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.89 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 468' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.01 160.78 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.67 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' SER . . . . . 0.578 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 6.9 t -150.85 152.6 33.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.443 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 44.16 87.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.431 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -99.63 -174.78 2.8 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.45 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -47.22 -84.29 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -158.15 66.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.95 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.3 mt -61.96 102.71 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.604 -0.839 . . . . 0.0 112.45 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.69 120.29 29.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.851 HG23 ' O ' ' A' ' 482' ' ' THR . 52.9 mt -88.76 137.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.327 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.529 ' CB ' ' OG1' ' A' ' 482' ' ' THR . 0.3 OUTLIER -107.42 123.15 47.96 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.682 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.604 ' C ' ' N ' ' A' ' 480' ' ' ALA . 20.3 mm-40 -54.58 -7.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 478' ' ' GLU . 0.1 OUTLIER -46.46 -18.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.239 -1.384 . . . . 0.0 108.311 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.604 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . 177.56 -97.37 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 112.283 -2.235 . . . . 0.0 105.43 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 481' ' ' LYS . . . . . 0.584 ' CD ' ' CD2' ' A' ' 409' ' ' PHE . 3.6 mmpp? -148.55 40.49 0.92 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.851 ' O ' HG23 ' A' ' 476' ' ' ILE . 44.5 p -68.94 172.94 5.88 Favored 'General case' 0 C--O 1.197 -1.708 0 CA-C-N 113.975 -1.466 . . . . 0.0 114.384 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 483' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -151.5 147.94 27.45 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.812 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 484' ' ' GLU . . . . . 0.495 ' C ' ' CD ' ' A' ' 484' ' ' GLU . 3.1 tp10 -131.72 113.89 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.372 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.889 ' O ' HD23 ' A' ' 485' ' ' LEU . 0.3 OUTLIER -151.08 161.73 42.18 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.786 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.21 -115.41 7.97 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.036 -1.554 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' GLY . . . . . 0.454 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -130.17 29.53 3.67 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.38 -1.391 . . . . 0.0 110.804 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 488' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 15.3 m170 -151.21 148.77 28.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.68 -1.208 . . . . 0.0 111.41 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.427 ' OG1' ' OE1' ' A' ' 484' ' ' GLU . 3.3 m -116.71 99.14 6.92 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.169 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.568 ' HE2' HG21 ' A' ' 392' ' ' ILE . 38.3 m-85 -90.06 160.6 16.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.562 ' CA ' HG22 ' A' ' 482' ' ' THR . . . -126.5 126.27 43.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.116 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.478 ' CB ' ' HB2' ' A' ' 481' ' ' LYS . 2.6 tm-20 -45.05 103.12 0.03 OUTLIER 'General case' 0 CA--C 1.478 -1.794 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.402 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 493' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 159.01 14.26 0.04 OUTLIER Glycine 0 C--N 1.261 -3.613 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 494' ' ' ASP . . . . . 0.594 ' CG ' ' N ' ' A' ' 495' ' ' TYR . 0.4 OUTLIER -138.44 -153.31 0.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.139 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 495' ' ' TYR . . . . . 0.594 ' N ' ' CG ' ' A' ' 494' ' ' ASP . 2.5 p90 -152.55 139.79 19.39 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.597 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 496' ' ' ILE . 0.0 OUTLIER -127.38 161.34 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.528 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 497' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 506' ' ' TYR . 3.3 t -104.61 102.88 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 498' ' ' LEU . . . . . 0.824 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -102.28 134.29 45.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.642 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.824 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.1 OUTLIER -121.03 142.38 49.86 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.481 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 500' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -147.8 90.4 0.15 Allowed Glycine 0 C--O 1.197 -2.188 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 501' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 502' ' ' THR . 7.4 p -160.74 8.34 0.08 Allowed 'General case' 0 C--N 1.252 -3.642 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 502' ' ' THR . . . . . 0.462 ' H ' ' H ' ' A' ' 503' ' ' GLY . 0.0 OUTLIER -172.41 -16.48 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 111.67 -2.514 . . . . 0.0 106.863 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.462 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 86.3 85.45 1.06 Allowed Glycine 0 N--CA 1.484 1.835 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.194 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -158.04 102.82 1.82 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' ILE . . . . . 0.611 HG12 HD13 ' A' ' 498' ' ' LEU . 3.5 mt -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.391 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 506' ' ' TYR . . . . . 0.72 ' CE1' HG23 ' A' ' 391' ' ' VAL . 75.5 m-85 -123.01 161.81 23.55 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.902 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 10.7 tmtt? -108.76 152.82 24.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . 67.99 141.39 0.08 OUTLIER Glycine 0 N--CA 1.484 1.84 0 C-N-CA 119.057 -1.545 . . . . 0.0 110.243 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.424 ' H ' ' HE2' ' A' ' 495' ' ' TYR . 1.9 p30 -57.93 146.02 33.7 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.6 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 510' ' ' ILE . . . . . . . . . . . . . 1.7 mt -140.69 165.58 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.46 ' OXT' ' CG ' ' A' ' 511' ' ' GLU . 2.2 tt0 . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.638 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 385' ' ' ALA . . . . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.95 0.405 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.56 ' C ' ' N ' ' A' ' 387' ' ' LYS . . . 60.78 172.97 0.1 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.008 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 12.1 mt 46.79 15.05 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.791 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.56 ' N ' ' C ' ' A' ' 385' ' ' ALA . 47.9 mttm -136.98 -1.6 2.17 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.354 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -153.72 15.31 0.5 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.96 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -85.93 139.2 16.82 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.028 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -80.91 59.36 3.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.794 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 2.3 t -50.13 132.21 9.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 505' ' ' ILE . 3.4 pt -78.03 -52.49 15.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . 170.84 -170.92 43.54 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.7 p -143.2 142.11 31.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.769 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.09 -145.75 0.4 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 396' ' ' LEU . 6.8 mt -77.17 125.28 86.8 Favored Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.768 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.82 102.36 0.63 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.982 1.122 . . . . 0.0 111.26 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -70.77 -62.15 1.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.356 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.8 t -146.73 140.88 15.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.975 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.29 103.36 0.15 Allowed 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.078 1.185 . . . . 0.0 111.072 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -151.25 161.68 29.22 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.772 -1.68 . . . . 0.0 112.28 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -134.93 124.6 25.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -149.76 160.89 43.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.143 -1.423 . . . . 0.0 112.595 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.698 ' HB1' ' OH ' ' A' ' 495' ' ' TYR . . . -142.16 110.11 5.87 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.017 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.12 165.92 30.89 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.957 -1.592 . . . . 0.0 111.292 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.502 ' HD2' ' N ' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -85.18 147.14 26.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.688 HG11 ' HZ ' ' A' ' 483' ' ' PHE . 2.0 m -78.72 142.7 13.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.473 -1.291 . . . . 0.0 113.228 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -146.87 146.47 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.892 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 427' ' ' VAL . 4.9 m-85 -105.84 37.41 2.25 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.439 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 409' ' ' PHE . 21.5 p -155.85 141.45 17.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.028 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 -12.8 59.89 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.278 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.47 -43.62 59.81 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.672 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.15 -42.62 86.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.674 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ALA . . . . . 0.786 ' HB1' ' HB1' ' A' ' 441' ' ' ALA . . . -61.29 -39.67 91.31 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.523 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -58.86 -30.15 67.51 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.985 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -88.6 -38.74 14.62 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.537 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -69.04 -61.01 1.97 Allowed 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.114 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 417' ' ' ALA . 19.5 t-80 -43.4 -26.52 0.2 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.811 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.435 ' N ' ' C ' ' A' ' 417' ' ' ALA . 30.1 tt0 -91.17 -33.92 15.22 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.375 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 417' ' ' ALA . 29.4 mtmt -131.74 49.9 2.28 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.813 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -178.38 -48.24 0.07 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' GLU . . . . . 0.523 ' O ' ' NE ' ' A' ' 423' ' ' ARG . 2.5 mt-10 48.96 71.23 0.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.167 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 422' ' ' GLU . 6.3 mtm180 164.04 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 0.2 OUTLIER -147.51 160.34 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.698 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 426' ' ' LEU . 43.2 mm -121.25 160.66 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.102 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.48 ' N ' HG22 ' A' ' 425' ' ' ILE . 13.1 tp -127.31 118.55 24.4 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.83 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 409' ' ' PHE . 1.5 t -104.66 130.82 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.038 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ARG . . . . . 0.726 ' O ' HG22 ' A' ' 447' ' ' THR . 1.6 mtp85 -153.01 145.94 24.51 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 429' ' ' LEU . 5.8 mp -56.61 -60.72 3.13 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.816 -1.553 . . . . 0.0 109.698 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.9 -175.09 2.59 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.611 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.662 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -94.17 176.61 6.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.183 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.2 t -173.09 128.35 0.52 Allowed Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.357 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.0 Cg_endo -61.41 -56.37 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.107 1.205 . . . . 0.0 111.501 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 434' ' ' GLU . 8.1 mt-10 -45.71 -13.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 433' ' ' PRO . 13.4 t70 -90.31 -8.3 51.2 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.557 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.944 HG23 ' H ' ' A' ' 437' ' ' GLU . 4.9 tp -41.85 -60.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.174 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.944 ' H ' HG23 ' A' ' 436' ' ' ILE . 19.3 mm-40 -49.11 -33.75 12.51 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.419 -1.312 . . . . 0.0 109.189 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.46 -24.18 68.66 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 436' ' ' ILE . 26.8 mtt -72.71 -34.37 67.08 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.71 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -75.74 -45.6 35.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 118.113 -1.435 . . . . 0.0 109.622 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.786 ' HB1' ' HB1' ' A' ' 414' ' ' ALA . . . -47.41 -36.39 9.73 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.426 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.666 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -106.86 93.07 4.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.501 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.79 28.22 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.597 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.666 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -160.28 132.01 2.82 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.2 mm -127.97 142.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.001 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 427' ' ' VAL . 4.7 tp -150.1 97.32 2.55 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.261 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 428' ' ' ARG . 0.9 OUTLIER -108.72 160.33 16.04 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.874 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.557 HG22 ' HB ' ' A' ' 474' ' ' ILE . 34.0 t -75.76 -45.05 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.829 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -94.08 -150.15 0.29 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.458 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 77.46 128.29 0.39 Allowed Glycine 0 N--CA 1.482 1.759 0 C-N-CA 119.145 -1.502 . . . . 0.0 109.4 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 453' ' ' THR . . . 175.62 -163.43 33.19 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 53.9 mtp 44.04 19.58 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.084 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 67.16 122.87 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.66 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 458' ' ' VAL . 69.9 p -166.64 -156.2 0.23 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.318 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' HIS . . . . . 0.684 ' O ' HG23 ' A' ' 459' ' ' VAL . 26.3 m80 -51.88 -51.1 59.16 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.971 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.662 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -52.55 -42.4 64.4 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.533 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -84.55 -51.02 7.2 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.519 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 454' ' ' SER . 79.0 t -55.28 -44.82 76.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.748 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 455' ' ' HIS . 47.2 t -67.16 -55.2 18.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.066 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.27 -28.96 65.43 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.289 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -65.35 -45.62 83.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -67.15 -24.29 73.28 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.147 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -21.31 31.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.815 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 63.02 21.12 63.32 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.675 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' THR . . . . . 0.889 HG22 ' H ' ' A' ' 466' ' ' CYS . 14.4 m -93.08 -168.89 2.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 466' ' ' CYS . . . . . 0.889 ' H ' HG22 ' A' ' 465' ' ' THR . 8.9 t -97.44 122.6 40.68 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.7 t -151.18 149.2 29.18 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.351 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 468' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -127.37 160.89 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.393 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 469' ' ' SER . . . . . 0.482 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 6.2 t -150.43 155.68 40.01 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.34 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 450' ' ' GLY . . . 53.72 75.46 0.23 Allowed Glycine 0 N--CA 1.497 2.747 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' CYS . . . . . 0.734 ' SG ' HD22 ' A' ' 485' ' ' LEU . 0.6 OUTLIER -82.93 -179.58 7.48 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.919 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -57.82 -96.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -140.38 58.52 1.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.65 HG23 ' CB ' ' A' ' 483' ' ' PHE . 11.3 mt -53.36 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.637 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.26 115.3 26.65 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 482' ' ' THR . 11.1 mt -88.18 136.6 22.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.129 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -114.63 127.2 55.64 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.18 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' A' ' 480' ' ' ALA . 10.3 pt-20 -62.85 -5.44 2.83 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.048 -0.978 . . . . 0.0 113.227 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 478' ' ' GLU . 5.2 mm-40 -46.13 -19.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.437 -1.305 . . . . 0.0 108.45 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -175.14 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 481' ' ' LYS . . . . . 0.536 ' HD2' ' CD2' ' A' ' 409' ' ' PHE . 0.8 OUTLIER -153.5 56.78 0.75 Allowed 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.874 ' O ' HG23 ' A' ' 476' ' ' ILE . 1.6 p -86.6 175.37 8.34 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 483' ' ' PHE . . . . . 0.688 ' HZ ' HG11 ' A' ' 407' ' ' VAL . 0.3 OUTLIER -151.93 120.86 6.61 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.762 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -91.95 114.42 26.95 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.533 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.734 HD22 ' SG ' ' A' ' 471' ' ' CYS . 63.6 tp -138.3 155.69 48.35 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.843 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 486' ' ' GLY . . . . . 0.473 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.66 -107.92 1.86 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -139.11 28.87 2.58 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.065 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.24 160.56 43.6 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.781 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.4 m -113.82 107.96 16.42 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.19 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.52 ' HB2' ' CE2' ' A' ' 483' ' ' PHE . 10.0 m-30 -89.55 119.44 29.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.505 -0.878 . . . . 0.0 108.859 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -100.24 136.78 39.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.155 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.508 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.9 tm-20 -50.05 95.12 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.949 0 C-N-CA 118.438 -1.305 . . . . 0.0 108.742 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 493' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 161.44 17.87 0.03 OUTLIER Glycine 0 C--N 1.267 -3.3 0 C-N-CA 118.313 -1.899 . . . . 0.0 109.624 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -128.69 -161.33 1.1 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.08 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' TYR . . . . . 0.698 ' OH ' ' HB1' ' A' ' 404' ' ' ALA . 1.8 t80 -137.64 132.7 33.37 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.491 HG22 ' CG ' ' A' ' 507' ' ' LYS . 0.6 OUTLIER -136.81 162.35 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.818 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 28.9 p -130.17 113.21 14.18 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.684 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -109.13 152.61 24.87 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.716 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.491 ' O ' HD12 ' A' ' 498' ' ' LEU . 4.4 t70 -99.42 160.39 14.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.027 0.918 . . . . 0.0 112.847 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 500' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -155.64 96.46 0.16 Allowed Glycine 0 C--N 1.289 -2.032 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 501' ' ' SER . . . . . 0.814 ' O ' HG23 ' A' ' 502' ' ' THR . 3.6 t 175.06 5.38 0.0 OUTLIER 'General case' 1 C--N 1.242 -4.071 0 CA-C-N 112.911 -1.644 . . . . 0.0 107.779 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 502' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 501' ' ' SER . 0.4 OUTLIER -175.0 -23.26 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.542 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 96.26 85.52 1.74 Allowed Glycine 0 N--CA 1.479 1.506 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -151.38 101.78 2.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.465 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' ILE . . . . . 0.642 HG21 HD11 ' A' ' 392' ' ' ILE . 4.7 mt -89.05 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.286 -0.965 . . . . 0.0 110.749 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 506' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 12.2 t80 -148.96 161.7 41.38 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.59 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 1.8 ttpt -125.74 156.36 39.53 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.598 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 84.72 142.51 5.73 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.249 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.93 154.65 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.296 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' ILE . . . . . 0.705 HG22 ' H ' ' A' ' 511' ' ' GLU . 12.4 mm -88.68 175.61 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.589 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.705 ' H ' HG22 ' A' ' 510' ' ' ILE . 35.6 mt-10 . . . . . 0 C--N 1.304 -1.372 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.799 0.333 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.53 ' HA ' ' CA ' ' A' ' 389' ' ' GLY . . . -84.3 33.46 0.5 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.118 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.798 ' CD1' ' H ' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -94.0 17.84 11.64 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.874 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 388' ' ' ALA . 3.4 tptp -152.8 22.9 0.59 Allowed 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 387' ' ' LYS . . . 85.31 19.87 0.11 Allowed 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.022 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 385' ' ' ALA . . . 37.82 -161.26 0.01 OUTLIER Glycine 0 N--CA 1.512 3.733 0 CA-C-N 114.176 -1.375 . . . . 0.0 112.218 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 46.62 93.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.277 -0.462 . . . . 0.0 112.243 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.686 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 19.9 t -112.66 140.41 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.388 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.863 HD12 HD21 ' A' ' 485' ' ' LEU . 0.7 OUTLIER -92.06 -25.32 5.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.215 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 162.78 -172.65 38.87 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.04 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.95 129.76 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.764 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.48 -146.22 0.24 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.274 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.7 140.79 33.51 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.94 96.94 0.46 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.227 1.285 . . . . 0.0 111.65 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -75.14 -73.14 0.26 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.351 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.9 p -136.88 144.16 45.46 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.347 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.89 101.66 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.983 1.122 . . . . 0.0 110.344 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.54 162.45 29.93 Favored Glycine 0 N--CA 1.51 3.624 0 C-N-CA 117.685 -2.198 . . . . 0.0 113.658 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.752 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -136.53 119.76 16.71 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.71 161.77 41.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.936 -1.506 . . . . 0.0 113.802 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -144.92 112.59 6.25 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 113.904 -1.498 . . . . 0.0 107.708 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.85 168.03 31.7 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.848 -1.644 . . . . 0.0 112.124 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 142.67 29.96 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.149 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 407' ' ' VAL . 0.2 OUTLIER -78.46 148.15 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.7 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.506 ' C ' ' H ' ' A' ' 410' ' ' THR . 0.4 OUTLIER -159.97 99.61 1.38 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.769 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 481' ' ' LYS . 7.8 m-85 -57.12 -0.32 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.846 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' THR . . . . . 0.506 ' H ' ' C ' ' A' ' 408' ' ' TYR . 3.2 p -106.39 140.91 38.57 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.99 26.12 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.515 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -70.7 -38.09 73.63 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.167 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 417' ' ' ALA . 68.9 mm-40 -62.81 -51.42 67.14 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' A' ' 441' ' ' ALA . . . -54.67 -31.71 58.13 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.982 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -71.27 -47.36 57.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.59 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -86.19 -9.35 56.75 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.03 -55.11 3.75 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -56.8 -28.03 60.77 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.863 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 421' ' ' GLY . 1.6 tt0 -55.58 -45.48 77.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.189 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 420' ' ' LYS . 0.8 OUTLIER -59.33 -6.12 0.92 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.493 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 82.92 49.02 5.23 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.467 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -133.33 154.21 50.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.679 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' ARG . . . . . 0.519 ' HD2' ' H ' ' A' ' 423' ' ' ARG . 0.4 OUTLIER -79.12 146.46 33.19 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.775 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.21 160.84 15.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.637 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 426' ' ' LEU . 41.5 mm -125.83 160.55 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.731 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.546 ' N ' HG22 ' A' ' 425' ' ' ILE . 3.4 tp -132.17 121.19 23.32 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.042 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.484 ' CG1' ' CZ ' ' A' ' 409' ' ' PHE . 7.2 t -110.57 121.03 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.36 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ARG . . . . . 0.664 ' O ' HG22 ' A' ' 447' ' ' THR . 0.1 OUTLIER -150.9 148.67 28.72 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.02 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.509 ' N ' HD23 ' A' ' 429' ' ' LEU . 5.7 mt -53.43 -49.64 66.91 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.199 -1.401 . . . . 0.0 109.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -135.82 167.82 20.46 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.863 HG21 ' HB2' ' A' ' 456' ' ' ALA . 0.5 OUTLIER -107.65 161.66 14.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.317 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.94 160.92 32.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.64 -31.51 94.45 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.99 1.793 . . . . 0.0 112.329 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.46 -12.91 61.64 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 439' ' ' MET . 15.0 m-20 -90.85 -9.05 47.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.919 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.644 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -35.78 -56.12 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.644 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 32.9 mt-10 -61.07 -38.69 87.12 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.341 -1.344 . . . . 0.0 109.052 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -72.83 -21.77 79.52 Favored Glycine 0 C--N 1.3 -1.45 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 435' ' ' ASP . 70.9 mtp -79.22 -46.41 17.92 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.336 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.773 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.1 OUTLIER -71.84 -34.79 69.58 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.398 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.773 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -56.45 -23.74 40.88 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.647 -1.221 . . . . 0.0 107.979 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -117.11 85.4 2.32 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.969 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.437 ' HA ' ' CG2' ' A' ' 465' ' ' THR . 11.8 pt-20 -52.41 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.591 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -136.24 139.66 10.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.538 HD12 ' SG ' ' A' ' 467' ' ' CYS . 67.8 mt -141.36 142.8 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.689 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.406 HD11 ' SG ' ' A' ' 471' ' ' CYS . 4.6 tp -140.24 98.95 3.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.6 p -111.53 161.27 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.42 -24.45 12.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 470' ' ' GLY . 14.0 mmt180 -100.87 -121.88 0.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.324 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.497 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 68.43 144.6 0.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -131.16 179.87 16.68 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.22 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.437 ' H ' ' HG3' ' A' ' 452' ' ' MET . 86.9 mtp -43.72 -28.83 0.45 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.091 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 453' ' ' THR . 6.7 t -160.59 132.28 5.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.325 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.3 p 179.05 -176.85 0.26 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.53 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' HIS . . . . . 0.704 ' O ' HG23 ' A' ' 459' ' ' VAL . 68.0 m80 -42.98 -49.52 5.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.336 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 431' ' ' THR . . . -48.44 -48.64 37.28 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.819 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.567 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 2.6 t -45.13 -45.58 3.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 455' ' ' HIS . 24.2 t -70.42 -40.27 77.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.575 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -68.66 -32.77 72.85 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.595 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -67.7 -36.95 81.59 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -75.28 -33.67 53.09 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.534 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 6.7 mmt -94.27 0.32 55.56 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.96 60.53 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 443' ' ' GLU . 0.2 OUTLIER -95.31 156.1 16.46 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 466' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.0 OUTLIER -89.43 129.88 35.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.692 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.753 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 99.5 m -152.86 157.42 40.68 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.062 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 468' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -126.15 162.28 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.263 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 469' ' ' SER . . . . . 0.517 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 7.9 t -150.3 147.71 27.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.278 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 57.23 90.45 0.01 OUTLIER Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.349 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 471' ' ' CYS . . . . . 0.406 ' SG ' HD11 ' A' ' 446' ' ' LEU . 0.1 OUTLIER -99.85 170.18 8.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.569 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -44.77 -82.02 0.03 OUTLIER Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.614 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -156.06 68.06 0.62 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.037 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.644 HG23 ' CB ' ' A' ' 483' ' ' PHE . 17.4 mt -66.47 102.64 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.081 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -88.72 120.03 29.74 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.841 HG23 ' O ' ' A' ' 482' ' ' THR . 3.8 mt -87.68 132.32 33.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.77 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.22 122.13 45.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.609 ' C ' ' N ' ' A' ' 480' ' ' ALA . 0.4 OUTLIER -53.06 -9.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.338 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -44.92 -18.45 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.401 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.609 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -177.88 -102.29 0.0 OUTLIER 'General case' 0 C--N 1.263 -3.176 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 481' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 409' ' ' PHE . 10.9 mmmt -150.61 43.39 0.83 Allowed 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.841 ' O ' HG23 ' A' ' 476' ' ' ILE . 52.1 p -69.06 174.35 4.64 Favored 'General case' 0 C--O 1.194 -1.857 0 CA-C-N 113.23 -1.805 . . . . 0.0 114.41 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 483' ' ' PHE . . . . . 0.644 ' CB ' HG23 ' A' ' 474' ' ' ILE . 0.7 OUTLIER -152.04 132.18 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.809 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -112.59 116.53 30.34 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.031 -0.667 . . . . 0.0 111.146 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.866 ' O ' HD23 ' A' ' 485' ' ' LEU . 0.3 OUTLIER -150.63 161.89 41.72 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.903 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.55 -113.01 5.47 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -132.21 26.15 3.77 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -150.16 153.23 35.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 58.4 m -115.06 100.23 8.02 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.481 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 507' ' ' LYS . 7.6 m-85 -89.78 158.37 17.53 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.582 ' CB ' HG22 ' A' ' 482' ' ' THR . . . -126.43 128.21 46.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.323 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.47 ' CB ' ' HB2' ' A' ' 481' ' ' LYS . 0.0 OUTLIER -47.4 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.472 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 493' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 168.53 14.32 0.02 OUTLIER Glycine 0 C--N 1.266 -3.311 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -142.64 -153.57 0.47 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.887 -0.657 . . . . 0.0 109.76 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -147.99 155.39 41.47 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.849 -1.141 . . . . 0.0 111.841 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.4 ' CG2' ' HG3' ' A' ' 507' ' ' LYS . 39.9 pt -136.99 162.31 34.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.833 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 30.7 t -127.76 108.84 11.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' LEU . . . . . 1.087 ' H ' HD23 ' A' ' 498' ' ' LEU . 1.7 pt? -117.03 159.35 22.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.723 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 500' ' ' GLY . 50.5 t0 -94.95 161.44 14.14 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.272 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 500' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -144.73 93.69 0.17 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 53.6 p 175.22 -7.32 0.0 OUTLIER 'General case' 0 C--N 1.25 -3.754 0 CA-C-N 111.66 -2.27 . . . . 0.0 106.08 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.8 -28.02 0.13 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.045 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 100.52 -11.44 59.67 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.638 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -50.38 125.81 13.56 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' ILE . . . . . 0.626 HG23 ' HB3' ' A' ' 498' ' ' LEU . 6.9 mt -113.88 135.04 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.397 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' TYR . . . . . 0.686 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 0.5 OUTLIER -128.21 159.89 33.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.631 ' H ' ' HE3' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -119.29 161.01 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.186 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 73.19 133.44 0.2 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.376 -1.392 . . . . 0.0 110.991 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 509' ' ' ASP . 6.6 p30 -48.31 153.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.047 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 510' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 511' ' ' GLU . 0.1 OUTLIER -96.89 161.42 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.421 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.516 ' N ' HG13 ' A' ' 510' ' ' ILE . 46.6 tt0 . . . . . 0 C--N 1.305 -1.34 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.811 ' O ' HD12 ' A' ' 386' ' ' LEU . . . -90.21 -163.73 1.06 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.889 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.811 HD12 ' O ' ' A' ' 385' ' ' ALA . 0.6 OUTLIER 33.47 26.4 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 124.109 0.881 . . . . 0.0 110.915 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.623 ' N ' ' O ' ' A' ' 385' ' ' ALA . 17.0 ttpp -140.94 -10.35 1.0 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.519 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -139.29 14.07 2.59 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.152 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -74.87 -142.06 0.81 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.407 -1.377 . . . . 0.0 110.285 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -119.91 73.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.709 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.716 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 45.5 t -66.57 150.18 11.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.645 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.504 ' CG1' ' N ' ' A' ' 393' ' ' GLY . 5.2 pt -117.22 -48.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.694 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -159.14 -157.54 8.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.554 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.5 p -171.41 116.1 0.41 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.78 -145.87 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 396' ' ' LEU . 96.4 mt -87.44 134.3 36.46 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.674 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.51 86.44 0.44 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.016 1.144 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -60.89 -60.83 3.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.084 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.3 p -143.77 145.87 32.58 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.217 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.35 119.36 6.24 Favored 'Trans proline' 0 C--N 1.326 -0.642 0 C-N-CA 121.085 1.19 . . . . 0.0 109.916 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.612 ' H ' ' CA ' ' A' ' 500' ' ' GLY . . . -152.48 162.88 30.11 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.524 -2.274 . . . . 0.0 114.556 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -151.85 107.17 3.3 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.4 161.39 42.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 117.968 -1.493 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.23 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.013 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.97 167.58 31.15 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.649 -1.262 . . . . 0.0 111.134 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.443 ' HG3' HG13 ' A' ' 424' ' ' VAL . 9.5 ptpt -82.72 161.76 21.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.305 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.542 HG11 ' HZ ' ' A' ' 483' ' ' PHE . 1.5 m -97.79 149.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.757 ' CZ ' ' HB2' ' A' ' 414' ' ' ALA . 33.1 p90 -153.44 174.75 13.98 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.035 -1.438 . . . . 0.0 107.536 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.57 ' CE1' ' HB3' ' A' ' 481' ' ' LYS . 2.7 m-85 -129.76 -19.32 3.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.203 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 38.8 p -100.51 135.6 41.7 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.47 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.82 -23.1 67.11 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.837 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -68.68 -41.36 79.34 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.098 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.92 -40.91 90.51 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.076 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ALA . . . . . 0.757 ' HB2' ' CZ ' ' A' ' 408' ' ' TYR . . . -57.69 -37.55 73.67 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.394 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.19 -35.45 80.83 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.433 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.53 -13.52 37.17 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.59 -55.51 3.55 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.74 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' HIS . . . . . 0.516 ' O ' ' ND1' ' A' ' 418' ' ' HIS . 0.3 OUTLIER -61.21 -21.1 63.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.846 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.486 ' CA ' ' OE1' ' A' ' 419' ' ' GLU . 0.6 OUTLIER -69.65 -38.08 76.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.588 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -64.53 -1.87 2.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 73.12 44.14 36.89 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.665 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -137.12 136.37 38.24 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' ARG . . . . . 0.41 ' C ' ' CG2' ' A' ' 424' ' ' VAL . 11.4 mmt180 -56.23 155.62 6.55 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.311 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.443 HG13 ' HG3' ' A' ' 406' ' ' LYS . 2.0 t -147.64 158.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.988 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.434 ' O ' ' CD1' ' A' ' 408' ' ' TYR . 6.3 mm -126.24 158.58 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.618 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 5.3 tp -127.61 142.97 51.21 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.511 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.445 ' N ' ' HG ' ' A' ' 426' ' ' LEU . 25.1 t -128.04 120.13 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.268 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ARG . . . . . 0.667 ' O ' HG22 ' A' ' 447' ' ' THR . 0.1 OUTLIER -151.37 149.42 29.3 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.093 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 429' ' ' LEU . 3.5 mp -48.04 -57.04 6.32 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.366 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 431' ' ' THR . 1.0 OUTLIER -130.4 165.18 23.11 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.467 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.442 ' H ' ' HG3' ' A' ' 430' ' ' GLU . 0.4 OUTLIER -101.17 -179.63 4.1 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.383 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 27.2 p -163.98 151.73 10.81 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.564 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.8 Cg_endo -61.59 -53.07 2.51 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.467 1.445 . . . . 0.0 112.036 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 434' ' ' GLU . 8.4 mm-40 -45.08 -18.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.8 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.8 m-20 -87.2 -6.35 58.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.656 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.736 HG23 ' N ' ' A' ' 437' ' ' GLU . 10.4 tp -33.63 -51.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.736 ' N ' HG23 ' A' ' 436' ' ' ILE . 3.0 pm0 -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.074 -1.45 . . . . 0.0 108.448 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.656 ' H ' ' CD ' ' A' ' 437' ' ' GLU . . . -66.49 -30.82 77.15 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -62.4 -44.01 97.45 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.959 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -62.29 -56.88 14.16 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -46.73 -33.2 4.14 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.56 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -96.2 81.01 3.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.069 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.76 17.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.72 143.93 9.15 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.418 HG22 ' SG ' ' A' ' 467' ' ' CYS . 0.6 OUTLIER -135.3 133.95 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.316 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.462 HD11 ' SG ' ' A' ' 471' ' ' CYS . 3.5 tp -135.8 98.12 3.82 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.105 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.1 p -116.24 161.84 18.37 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.67 -23.18 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.72 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' ARG . . . . . 0.452 HH22 ' HE3' ' A' ' 452' ' ' MET . 1.3 mmp_? -112.44 -128.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.861 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 62.52 -170.97 11.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 61.51 -20.97 0.05 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.668 ' H ' ' C ' ' A' ' 450' ' ' GLY . 7.5 mmt -68.92 42.72 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' THR . . . . . 0.563 ' H ' ' C ' ' A' ' 451' ' ' GLY . 39.1 p 45.66 90.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.1 t -173.32 -155.66 0.08 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.122 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' HIS . . . . . 0.493 ' O ' HG23 ' A' ' 459' ' ' VAL . 8.5 p-80 -55.24 -41.69 72.46 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.44 50.98 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.366 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.46 -28.41 52.34 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.903 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.51 -54.31 12.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.573 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 455' ' ' HIS . 92.1 t -56.49 -40.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.115 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.64 55.15 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.78 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -65.96 -14.78 62.2 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.814 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.46 -35.61 19.54 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.489 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 7.3 mmt -91.75 -9.72 42.61 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 62.06 24.42 65.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 466' ' ' CYS . 14.3 t -87.7 -166.86 1.7 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' CYS . . . . . 0.46 ' CB ' ' HA3' ' A' ' 401' ' ' GLY . 8.9 t -98.98 123.26 43.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.424 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.759 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.4 t -152.06 139.91 19.97 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 118.018 -1.473 . . . . 0.0 112.708 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.99 161.27 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 469' ' ' SER . . . . . 0.55 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 9.0 t -151.46 151.8 32.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.971 -1.491 . . . . 0.0 113.86 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 48.2 90.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.146 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' CYS . . . . . 0.462 ' SG ' HD11 ' A' ' 446' ' ' LEU . 96.7 m -98.42 -160.53 0.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.834 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.75 -95.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.63 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' GLU . . . . . 0.555 ' CD ' ' N ' ' A' ' 473' ' ' GLU . 1.6 pm0 -142.07 58.94 1.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.1 mt -43.17 102.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.775 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -88.86 113.76 24.75 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 482' ' ' THR . 9.5 mt -88.69 134.37 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 118.602 -1.239 . . . . 0.0 112.38 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -111.5 123.47 50.29 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.385 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.622 ' C ' ' N ' ' A' ' 480' ' ' ALA . 1.2 tt0 -63.6 -3.43 2.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.442 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -47.71 -16.56 0.07 Allowed 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 118.194 -1.402 . . . . 0.0 108.296 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.622 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -174.8 -100.38 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 481' ' ' LYS . . . . . 0.57 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.0 OUTLIER -158.05 65.91 0.46 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.848 ' O ' HG23 ' A' ' 476' ' ' ILE . 1.4 p -97.51 178.34 5.22 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 483' ' ' PHE . . . . . 0.542 ' HZ ' HG11 ' A' ' 407' ' ' VAL . 0.2 OUTLIER -151.56 129.69 11.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.471 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -99.61 116.46 31.78 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.665 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 1.016 HD23 ' N ' ' A' ' 486' ' ' GLY . 3.2 tt -136.51 156.25 48.85 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.012 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 486' ' ' GLY . . . . . 1.016 ' N ' HD23 ' A' ' 485' ' ' LEU . . . 44.65 -117.43 2.11 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.283 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -124.42 37.15 2.71 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.532 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' HIS . . . . . 0.506 ' CG ' ' CZ ' ' A' ' 490' ' ' PHE . 0.3 OUTLIER -150.68 129.65 12.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.404 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 83.5 m -102.98 115.07 29.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.59 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.506 ' CZ ' ' CG ' ' A' ' 488' ' ' HIS . 22.8 m-85 -112.43 130.94 55.81 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.751 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -99.18 156.84 16.75 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.484 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.5 tm-20 -65.46 63.67 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.602 -1.239 . . . . 0.0 108.566 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 493' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -160.43 25.45 0.29 Allowed Glycine 0 C--N 1.263 -3.512 0 C-N-CA 119.263 -1.446 . . . . 0.0 109.838 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -146.26 -164.62 2.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.046 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -128.23 137.58 52.08 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.215 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 496' ' ' ILE . 2.0 pt -131.93 160.14 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.089 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 497' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 506' ' ' TYR . 48.3 m -123.46 110.98 15.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.348 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 498' ' ' LEU . . . . . 0.963 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -105.57 136.92 44.27 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.418 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.963 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.5 OUTLIER -108.6 160.58 15.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.027 0.917 . . . . 0.0 112.244 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 500' ' ' GLY . . . . . 0.612 ' CA ' ' H ' ' A' ' 401' ' ' GLY . . . -142.11 94.2 0.18 Allowed Glycine 0 C--N 1.285 -2.299 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 501' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 502' ' ' THR . 4.6 m -171.42 -3.01 0.01 OUTLIER 'General case' 0 C--N 1.244 -3.98 0 CA-C-N 112.577 -1.812 . . . . 0.0 107.398 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 502' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 501' ' ' SER . 0.8 OUTLIER -167.09 -16.68 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.555 -2.111 . . . . 0.0 107.276 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.46 40.13 8.58 Favored Glycine 0 N--CA 1.482 1.725 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.371 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -115.37 119.97 38.03 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' ILE . . . . . 0.541 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.5 tt -97.57 160.23 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.425 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' TYR . . . . . 0.716 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 17.8 m-85 -135.15 162.09 33.5 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.178 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.496 ' HD2' ' CE1' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -136.71 142.93 43.12 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.779 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 510' ' ' ILE . . . 94.81 141.55 11.72 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.758 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -50.43 89.52 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.683 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' ILE . . . . . 1.103 HD12 ' H ' ' A' ' 511' ' ' GLU . 0.2 OUTLIER -51.93 165.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.713 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 1.103 ' H ' HD12 ' A' ' 510' ' ' ILE . 22.9 tt0 . . . . . 0 C--N 1.297 -1.703 0 CA-C-O 116.309 -1.805 . . . . 0.0 110.744 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.649 ' O ' ' HB3' ' A' ' 385' ' ' ALA . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.928 0.394 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 384' ' ' ALA . . . 71.7 165.95 0.3 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.82 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 49.41 11.04 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.717 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.605 ' H ' ' C ' ' A' ' 385' ' ' ALA . 10.8 tptm -134.63 0.09 2.95 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.299 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -153.35 12.24 0.47 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.115 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -81.98 -125.03 0.8 Allowed Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.247 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -168.2 83.28 0.18 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.115 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.57 142.76 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.539 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 1.9 pt -94.42 -33.53 5.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.757 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 179.67 -167.49 37.39 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.87 -1.633 . . . . 0.0 111.314 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 31.1 t -154.79 120.78 5.21 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.583 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.463 ' HB2' ' SG ' ' A' ' 471' ' ' CYS . . . -93.09 -144.06 0.22 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.076 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 51.2 mt -93.42 128.69 41.48 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' PRO . . . . . 0.545 ' HG3' ' O ' ' A' ' 502' ' ' THR . 7.7 Cg_endo -68.37 89.35 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.142 1.228 . . . . 0.0 111.565 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -55.37 -54.73 40.06 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.506 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.1 t -150.45 141.85 15.1 Favored Pre-proline 0 C--N 1.307 -1.281 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.177 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -54.34 101.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.121 1.214 . . . . 0.0 110.569 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.584 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -151.46 161.81 29.33 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.544 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.564 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -139.21 114.87 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -138.39 160.73 38.77 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.862 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.17 110.62 6.07 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.709 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.07 167.92 31.24 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.923 -1.608 . . . . 0.0 111.268 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -82.82 137.11 34.43 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.571 ' CG1' ' C ' ' A' ' 491' ' ' ALA . 1.0 OUTLIER -83.37 151.68 3.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 C-N-CA 118.925 -1.11 . . . . 0.0 113.374 -179.478 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -149.86 -152.79 0.45 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.924 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.481 ' CD2' ' HE2' ' A' ' 481' ' ' LYS . 10.5 m-85 -146.31 -47.71 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.058 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 37.4 p -86.03 143.36 28.15 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.235 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -69.47 -10.91 60.07 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.503 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 412' ' ' ASP . 10.2 m-20 -74.26 -42.55 59.46 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.775 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.57 ' N ' ' OE1' ' A' ' 413' ' ' GLU . 2.1 mp0 -66.88 -42.47 85.52 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.568 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.7 66.28 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.88 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -73.68 -38.63 64.85 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.396 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.58 -12.2 37.74 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.84 -43.58 9.95 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.837 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' HIS . . . . . 0.463 ' O ' ' CD2' ' A' ' 418' ' ' HIS . 8.8 t60 -69.88 -29.42 66.63 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.219 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.68 -21.89 61.0 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 -5.93 42.86 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.797 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 89.99 45.44 4.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -147.44 131.87 17.63 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.812 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -58.58 157.09 9.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.432 ' N ' ' OE2' ' A' ' 443' ' ' GLU . 2.4 t -148.27 160.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.931 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 426' ' ' LEU . 7.5 mm -130.63 160.97 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.911 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.421 ' N ' HG22 ' A' ' 425' ' ' ILE . 4.3 tp -139.42 144.6 38.16 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.594 -1.242 . . . . 0.0 112.851 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.52 HG23 ' CG2' ' A' ' 407' ' ' VAL . 81.6 t -118.46 130.21 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.557 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ARG . . . . . 0.684 ' H ' HG22 ' A' ' 447' ' ' THR . 0.0 OUTLIER -151.79 135.26 16.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.59 -1.244 . . . . 0.0 112.06 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.11 17.87 0.12 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 428' ' ' ARG . 5.9 pt-20 175.86 147.46 0.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.566 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -87.77 177.39 7.02 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.89 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.2 m -161.6 131.08 3.23 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.712 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.03 -31.61 91.32 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 121.183 1.255 . . . . 0.0 111.807 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -75.46 -16.41 60.32 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.191 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.1 t70 -90.41 -9.24 48.27 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.723 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.679 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -39.3 -52.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.861 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.679 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 26.9 mt-10 -58.23 -35.77 72.18 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.925 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.22 -22.44 73.55 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 2.1 mmt -74.75 -42.02 58.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.433 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.776 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.2 OUTLIER -70.7 -32.98 70.38 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.332 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.776 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -50.09 -29.04 8.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -109.38 92.02 3.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.679 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 443' ' ' GLU . 1.4 pm0 -53.0 0.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.949 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -142.01 144.47 14.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.515 HD12 ' SG ' ' A' ' 467' ' ' CYS . 38.8 mt -145.73 135.45 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.459 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.435 ' C ' HD12 ' A' ' 446' ' ' LEU . 5.8 tp -131.05 98.23 4.52 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.004 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 428' ' ' ARG . 1.5 p -107.9 161.49 14.87 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.7 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 474' ' ' ILE . 4.9 t -85.28 -20.11 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.969 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -106.6 -152.05 0.47 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.755 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 81.28 -151.39 31.31 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' GLY . . . . . 0.629 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 76.78 -50.99 3.03 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.548 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.485 ' O ' ' CB ' ' A' ' 453' ' ' THR . 70.7 mmm -64.45 11.97 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.413 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' THR . . . . . 0.62 ' H ' ' C ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.31 108.27 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.019 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 455' ' ' HIS . 30.2 t -158.41 -173.16 4.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.841 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 459' ' ' VAL . 60.4 m80 -50.34 -35.3 27.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.566 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -53.7 -58.71 6.23 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.322 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.63 -52.21 9.37 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.347 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 13.3 t -44.76 -43.42 2.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.675 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 455' ' ' HIS . 97.5 t -69.38 -43.55 80.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.201 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.94 -41.08 87.59 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.84 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -66.35 -27.71 68.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -90.0 -26.7 23.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.671 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 11.2 mmt -94.07 -23.11 18.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.302 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.69 -21.25 30.66 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.966 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 60.2 m -44.22 160.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -87.25 129.1 35.11 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.937 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.8 m -153.3 153.1 31.96 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.434 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 468' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -124.38 161.16 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 108.995 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 469' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 28.1 t -150.27 155.31 39.46 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.7 -1.2 . . . . 0.0 112.213 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 42.63 82.98 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' CYS . . . . . 0.667 ' SG ' HD11 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -90.07 -160.4 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.272 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -61.13 -99.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.542 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 474' ' ' ILE . 1.4 mm-40 -145.07 41.25 1.27 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.714 HD12 HG22 ' A' ' 448' ' ' VAL . 0.0 OUTLIER -38.81 107.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.901 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -89.71 123.99 34.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.205 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 3.0 mt -86.41 119.59 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.191 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.452 HD21 ' HG3' ' A' ' 479' ' ' GLU . 53.1 t-20 -89.24 110.83 21.55 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.163 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.725 ' H ' ' CD ' ' A' ' 478' ' ' GLU . 1.4 pm0 -67.67 -9.33 42.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.525 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.452 ' HG3' HD21 ' A' ' 477' ' ' ASN . 11.4 mm-40 -46.3 -19.87 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.342 -1.343 . . . . 0.0 107.661 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.607 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -163.64 -107.21 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.412 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 481' ' ' LYS . . . . . 0.481 ' HE2' ' CD2' ' A' ' 409' ' ' PHE . 20.2 mmmt -159.47 70.94 0.48 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.881 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 1.2 p -138.63 148.46 44.11 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.867 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 483' ' ' PHE . . . . . 0.814 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 6.2 p90 -104.74 156.53 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.895 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.44 103.57 12.22 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.287 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 486' ' ' GLY . 1.4 tt -126.61 139.72 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 486' ' ' GLY . . . . . 0.827 ' N ' HD23 ' A' ' 485' ' ' LEU . . . 57.06 -110.59 2.28 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.128 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -128.82 36.76 2.36 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.372 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -150.35 126.15 10.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.482 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.2 m -99.38 97.36 8.41 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.971 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.565 ' CB ' ' HZ1' ' A' ' 507' ' ' LYS . 35.6 p90 -155.3 158.18 38.37 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.036 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.881 ' HB3' ' HA ' ' A' ' 482' ' ' THR . . . -170.09 -136.08 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.177 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.507 ' HA ' HG13 ' A' ' 407' ' ' VAL . 57.6 tt0 -49.63 94.18 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 117.964 -1.494 . . . . 0.0 109.39 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 493' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 152.02 17.7 0.06 OUTLIER Glycine 0 C--N 1.297 -1.611 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -156.25 -152.62 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.435 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -149.71 126.77 11.25 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.284 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.96 161.59 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.49 106.16 11.54 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 498' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.3 OUTLIER -92.48 134.77 34.64 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.169 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.513 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.4 OUTLIER -89.48 159.25 17.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.424 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 500' ' ' GLY . . . . . 0.584 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -155.65 95.17 0.15 Allowed Glycine 0 C--N 1.282 -2.453 0 N-CA-C 106.923 -2.471 . . . . 0.0 106.923 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 3.3 t 172.86 7.28 0.0 OUTLIER 'General case' 0 C--N 1.245 -3.956 0 CA-C-N 112.507 -1.846 . . . . 0.0 106.943 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' THR . . . . . 0.545 ' O ' ' HG3' ' A' ' 397' ' ' PRO . 0.0 OUTLIER -171.91 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.385 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.475 ' N ' ' HB3' ' A' ' 397' ' ' PRO . . . 93.11 15.42 51.79 Favored Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.923 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -75.08 172.7 11.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.26 150.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.459 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 506' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 7.7 t80 -148.97 161.33 42.12 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.01 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 28.4 tttt -131.78 151.6 51.55 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.865 -1.134 . . . . 0.0 113.701 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 85.35 133.43 2.97 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.365 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 31.6 -153.83 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 510' ' ' ILE . . . . . 0.905 HG23 ' N ' ' A' ' 511' ' ' GLU . 1.0 OUTLIER 55.28 -163.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.875 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.905 ' N ' HG23 ' A' ' 510' ' ' ILE . 4.9 tt0 . . . . . 0 C--N 1.295 -1.803 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.75 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 385' ' ' ALA . . . . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.576 ' C ' ' N ' ' A' ' 387' ' ' LYS . . . 62.0 -157.34 0.33 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.051 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 386' ' ' LEU . 5.6 mt 46.91 15.87 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.309 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.576 ' N ' ' C ' ' A' ' 385' ' ' ALA . 1.7 ttmp? -129.78 -5.31 4.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.608 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -140.78 15.05 2.31 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.564 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -93.13 120.59 6.26 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.088 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -84.93 63.3 8.0 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.797 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.575 HG22 ' HD1' ' A' ' 506' ' ' TYR . 41.8 t -39.4 139.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.09 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.494 HG13 ' N ' ' A' ' 393' ' ' GLY . 17.7 pt -99.81 -43.22 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.076 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -151.08 -162.9 10.99 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.706 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.8 t -179.21 127.42 0.09 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -117.61 -125.54 0.28 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.461 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 32.5 mt -100.49 139.01 20.3 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.277 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -67.56 93.42 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.274 1.316 . . . . 0.0 110.581 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -64.02 -66.71 0.5 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.107 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 24.2 t -136.97 131.07 17.8 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.848 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.85 92.56 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 121.059 1.173 . . . . 0.0 111.303 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.17 160.18 28.97 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 118.995 -1.574 . . . . 0.0 112.008 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.775 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -126.26 135.89 52.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ALA . . . . . 0.697 ' HB1' ' OE2' ' A' ' 443' ' ' GLU . . . -150.42 160.32 43.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' ALA . . . . . 0.61 ' HB1' ' OH ' ' A' ' 495' ' ' TYR . . . -148.16 109.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.601 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.7 30.83 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.495 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -84.27 133.0 34.58 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.739 -0.785 . . . . 0.0 109.588 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.593 HG11 ' HB1' ' A' ' 491' ' ' ALA . 79.9 t -60.67 154.43 4.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.325 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' A' ' 413' ' ' GLU . 0.5 OUTLIER -162.47 135.75 6.03 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.557 ' CE2' ' NZ ' ' A' ' 481' ' ' LYS . 4.7 m-85 -100.9 28.6 5.12 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.926 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 7.2 p -149.38 143.96 26.09 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.731 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.69 59.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.966 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.8 -43.16 31.47 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.491 ' HG2' ' CE1' ' A' ' 408' ' ' TYR . 0.3 OUTLIER -62.08 -39.31 92.02 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.388 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.69 83.9 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.482 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -65.7 -34.64 78.66 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.77 21.99 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.464 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -82.62 -49.02 10.28 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.982 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -49.28 -27.13 3.53 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -91.57 -28.87 17.26 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -117.48 -35.05 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.111 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -93.19 -45.59 3.51 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.069 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' GLU . . . . . 0.43 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 1.1 mt-10 66.32 158.13 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.672 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 47.35 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.161 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.91 161.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.382 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 426' ' ' LEU . 47.0 mm -123.31 157.52 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.383 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.481 ' N ' HG22 ' A' ' 425' ' ' ILE . 3.1 tp -128.82 134.52 48.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.255 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 409' ' ' PHE . 48.1 t -119.94 123.5 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.689 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ARG . . . . . 0.663 ' O ' HG22 ' A' ' 447' ' ' THR . 0.6 OUTLIER -151.53 158.31 43.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.957 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 429' ' ' LEU . 7.7 mt -63.14 -49.73 73.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.311 -1.355 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -132.27 177.64 7.43 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -81.41 171.76 14.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.064 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 1.3 m -153.33 142.32 14.54 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.604 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.3 Cg_endo -61.5 -72.92 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.481 1.454 . . . . 0.0 111.919 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.08 -10.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.288 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 433' ' ' PRO . 7.1 t70 -85.94 -8.68 57.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.679 HD12 ' NE2' ' A' ' 440' ' ' HIS . 0.2 OUTLIER -43.34 -58.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.735 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.658 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 46.8 mt-10 -55.92 -31.5 62.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.522 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.04 -23.55 77.58 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 436' ' ' ILE . 2.4 ttm -74.57 -53.99 8.34 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.778 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.679 ' NE2' HD12 ' A' ' 436' ' ' ILE . 85.8 m-70 -58.77 -50.4 74.08 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.755 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 440' ' ' HIS . . . -45.88 -24.88 0.45 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.149 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.679 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -107.15 86.27 2.28 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.488 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.697 ' OE2' ' HB1' ' A' ' 403' ' ' ALA . 0.0 OUTLIER -58.26 14.01 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.955 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.24 133.95 3.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 445' ' ' ILE . 4.5 mp -139.48 150.45 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.135 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.456 HD11 ' CG1' ' A' ' 468' ' ' VAL . 1.2 tp -144.38 128.34 17.47 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.146 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 428' ' ' ARG . 5.7 p -140.61 159.31 42.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.242 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 27.4 t -68.86 -20.85 25.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.452 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -117.0 -151.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.963 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.487 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 84.98 26.17 38.33 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -44.44 161.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.659 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.404 ' C ' HG23 ' A' ' 453' ' ' THR . 25.0 mtt 45.4 -101.52 0.05 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.837 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 452' ' ' MET . 40.3 p -153.91 81.36 1.15 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.831 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.8 m -90.67 -163.02 0.96 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.704 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' HIS . . . . . 0.513 ' O ' HG23 ' A' ' 459' ' ' VAL . 2.5 t-80 -47.87 -39.78 19.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.43 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.527 ' H ' HG21 ' A' ' 431' ' ' THR . . . -59.04 -61.88 2.3 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.032 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.78 -55.59 16.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.871 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 459' ' ' VAL . 0.3 OUTLIER -45.65 -49.8 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.694 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.645 ' N ' ' CG1' ' A' ' 458' ' ' VAL . 71.3 t -62.46 -37.15 78.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.34 -46.95 78.2 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -31.14 71.67 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.69 -18.81 69.61 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' MET . . . . . 0.482 ' C ' ' SD ' ' A' ' 463' ' ' MET . 0.0 OUTLIER -94.96 -59.86 1.81 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.955 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 464' ' ' GLY . . . . . 0.474 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 123.93 20.83 2.47 Favored Glycine 0 N--CA 1.503 3.149 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 466' ' ' CYS . 30.9 m -97.47 166.9 11.31 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.8 m -90.12 128.08 36.24 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.799 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.72 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 13.1 t -151.71 159.07 44.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.801 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 469' ' ' SER . 0.8 OUTLIER -137.08 162.44 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.886 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 469' ' ' SER . . . . . 0.487 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 11.7 t -144.27 160.42 41.01 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.894 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 44.17 79.87 0.05 OUTLIER Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.623 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' CYS . . . . . 0.657 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.0 OUTLIER -78.33 -175.18 4.08 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.107 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.448 ' H ' HD11 ' A' ' 485' ' ' LEU . . . -53.82 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.006 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.9 57.99 1.61 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.611 0.72 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 483' ' ' PHE . 4.5 mt -55.46 114.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.272 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 475' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 484' ' ' GLU . 4.4 ttpm? -99.63 122.74 43.1 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 1.7 mt -86.89 127.74 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 117.771 -1.572 . . . . 0.0 112.097 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.489 ' OD1' ' CG2' ' A' ' 489' ' ' THR . 7.8 m120 -96.91 113.38 24.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.123 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.625 ' C ' ' N ' ' A' ' 480' ' ' ALA . 10.5 mt-10 -64.0 -11.88 32.95 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.984 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -46.3 -17.82 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.811 1.291 . . . . 0.0 107.928 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.625 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.32 -97.8 0.01 OUTLIER 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 112.15 -2.296 . . . . 0.0 105.537 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 481' ' ' LYS . . . . . 0.557 ' NZ ' ' CE2' ' A' ' 409' ' ' PHE . 3.0 mmmt -168.97 70.72 0.08 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.921 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 2.6 p -125.75 147.24 49.45 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.057 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 483' ' ' PHE . . . . . 0.976 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 8.0 p90 -97.68 149.98 21.68 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.572 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 475' ' ' LYS . 7.5 tt0 -110.92 107.14 16.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.129 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.835 HD23 ' H ' ' A' ' 486' ' ' GLY . 0.4 OUTLIER -144.7 156.33 44.03 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.04 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 486' ' ' GLY . . . . . 0.835 ' H ' HD23 ' A' ' 485' ' ' LEU . . . 64.6 -111.4 4.15 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -134.75 26.7 3.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.729 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' HIS . . . . . 0.477 ' CD2' ' HD2' ' A' ' 490' ' ' PHE . 1.2 t60 -150.75 152.14 33.41 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 489' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 477' ' ' ASN . 77.3 m -115.94 99.38 7.24 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.039 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.547 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 19.6 p90 -153.78 157.55 39.58 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.075 -1.45 . . . . 0.0 114.184 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.976 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . 179.85 -137.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.295 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.591 ' N ' HG11 ' A' ' 407' ' ' VAL . 8.2 tm-20 -34.93 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.654 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 493' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 139.68 3.66 1.52 Allowed Glycine 0 C--N 1.29 -2.009 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 494' ' ' ASP . . . . . 0.608 ' CG ' ' H ' ' A' ' 495' ' ' TYR . 36.2 t70 -144.26 -174.16 4.22 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.235 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' TYR . . . . . 0.61 ' OH ' ' HB1' ' A' ' 404' ' ' ALA . 87.2 t80 -123.91 120.54 32.83 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.029 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.915 HD13 ' O ' ' A' ' 496' ' ' ILE . 0.0 OUTLIER -127.92 161.39 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.577 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 2.4 m -123.34 110.08 14.72 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -95.84 141.18 29.6 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.612 ' N ' HD12 ' A' ' 498' ' ' LEU . 10.3 t70 -99.99 161.41 13.63 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.064 0.935 . . . . 0.0 112.381 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 500' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -156.49 95.61 0.15 Allowed Glycine 0 C--N 1.281 -2.508 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 501' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 1.4 t 164.66 2.4 0.0 OUTLIER 'General case' 1 C--N 1.238 -4.265 0 CA-C-N 112.749 -1.726 . . . . 0.0 107.47 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 502' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 503' ' ' GLY . 6.8 m -161.72 -17.74 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.073 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 73.52 75.8 0.72 Allowed Glycine 0 N--CA 1.485 1.959 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.736 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -165.24 118.95 1.23 Allowed 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.014 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' ILE . . . . . 0.516 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 2.0 tt -99.22 157.84 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.085 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' TYR . . . . . 0.575 ' HD1' HG22 ' A' ' 391' ' ' VAL . 0.1 OUTLIER -151.04 170.49 19.25 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 490' ' ' PHE . 27.2 mtpt -81.41 158.33 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 117.058 -1.857 . . . . 0.0 110.146 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLY . . . . . 0.706 ' H ' ' HA ' ' A' ' 496' ' ' ILE . . . -69.08 -169.38 6.1 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.582 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 508' ' ' GLY . 0.9 OUTLIER 75.14 33.78 0.69 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.456 -0.872 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 510' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.21 -162.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.811 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 116.366 -1.778 . . . . 0.0 110.617 179.925 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 120.792 0.329 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -142.11 18.96 2.1 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.736 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 76.1 mt -96.91 10.03 40.23 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.645 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -120.44 -0.46 10.34 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.323 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -149.83 16.88 0.88 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.434 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -73.18 -145.35 0.71 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.239 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 390' ' ' GLU . 1.5 pm0 -147.64 65.28 1.12 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.649 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.712 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 74.8 t -64.39 137.05 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.018 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.608 ' CG1' ' H ' ' A' ' 393' ' ' GLY . 2.5 pt -103.26 -57.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.757 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' GLY . . . . . 0.608 ' H ' ' CG1' ' A' ' 392' ' ' ILE . . . -142.18 178.78 20.57 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 12.6 m -156.05 141.31 17.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.814 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.597 ' HB3' HG13 ' A' ' 468' ' ' VAL . . . -124.06 -158.81 0.83 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.835 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.19 126.66 78.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.772 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 101.93 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.033 1.155 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -67.32 -57.75 6.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.589 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 79.3 p -137.19 139.87 29.39 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.713 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.7 95.77 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 121.31 1.34 . . . . 0.0 110.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.82 162.2 30.3 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 118.186 -1.959 . . . . 0.0 112.906 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.56 21.15 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.41 160.87 43.44 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 117.946 -1.502 . . . . 0.0 112.884 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -131.78 102.6 5.94 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.67 166.55 30.81 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.94 156.26 22.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.65 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 492' ' ' GLU . 3.5 m -85.4 138.77 18.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.546 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.61 ' CZ ' ' OE1' ' A' ' 413' ' ' GLU . 0.4 OUTLIER -138.94 159.28 42.53 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.322 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 410' ' ' THR . 9.8 m-85 -122.88 32.81 5.59 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.813 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 409' ' ' PHE . 1.6 p -158.82 143.74 16.02 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.438 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.57 -13.83 61.49 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.591 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -75.17 -43.19 53.65 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.49 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.61 ' OE1' ' CZ ' ' A' ' 408' ' ' TYR . 68.9 mm-40 -62.28 -37.84 87.06 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.411 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 441' ' ' ALA . . . -68.18 -32.32 72.48 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.403 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -68.67 -36.81 79.01 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.518 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.81 23.41 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.837 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -68.12 -54.93 14.54 Favored 'General case' 0 C--N 1.276 -2.621 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' HIS . . . . . 0.639 ' HB2' ' HB1' ' A' ' 441' ' ' ALA . 71.2 t60 -44.22 -26.55 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.6 OUTLIER -91.48 -22.87 20.18 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.884 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 420' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 417' ' ' ALA . 36.2 mmtt -80.64 -59.59 2.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.981 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -155.0 3.87 0.23 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.711 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 54.68 -146.95 0.53 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.094 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' ARG . . . . . 0.644 ' HE ' ' H ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER 52.37 64.68 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.838 -1.145 . . . . 0.0 107.965 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.842 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 425' ' ' ILE . 6.9 mm -125.33 160.3 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.904 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 5.3 tp -125.57 134.06 52.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.017 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.38 121.57 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.036 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ARG . . . . . 0.675 ' O ' HG22 ' A' ' 447' ' ' THR . 7.3 ttt180 -152.2 148.76 27.97 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.247 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.663 ' H ' HD12 ' A' ' 429' ' ' LEU . 4.3 mp -48.41 -58.01 5.25 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.568 -1.253 . . . . 0.0 109.252 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 431' ' ' THR . 2.2 tm-20 -122.89 175.84 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.436 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.635 ' OG1' ' CD2' ' A' ' 455' ' ' HIS . 1.2 p -112.14 173.37 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.685 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.9 m -154.84 155.14 30.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.998 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 435' ' ' ASP . 3.6 Cg_endo -64.27 -66.58 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 121.758 1.638 . . . . 0.0 112.147 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -38.83 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.269 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 438' ' ' GLY . 1.1 m-20 -74.42 -8.7 57.16 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.829 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.732 HG23 ' N ' ' A' ' 437' ' ' GLU . 9.8 tp -40.4 -50.56 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.827 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.732 ' N ' HG23 ' A' ' 436' ' ' ILE . 69.6 mt-10 -53.85 -38.28 64.52 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.615 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.16 -26.65 70.13 Favored Glycine 0 C--N 1.303 -1.272 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' MET . . . . . 0.514 ' HG2' HD11 ' A' ' 445' ' ' ILE . 40.3 mtt -69.21 -39.11 78.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.988 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.48 ' NE2' HG13 ' A' ' 436' ' ' ILE . 6.8 m-70 -66.68 -57.94 6.14 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.171 -1.411 . . . . 0.0 109.174 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 418' ' ' HIS . . . -46.13 -39.64 9.82 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.073 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.616 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -97.55 85.28 3.57 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.087 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -62.91 35.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.848 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -168.87 143.71 8.25 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' ILE . . . . . 0.514 HD11 ' HG2' ' A' ' 439' ' ' MET . 1.3 mt -144.63 132.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.17 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.42 ' CD1' ' CG1' ' A' ' 468' ' ' VAL . 7.0 tp -135.79 98.36 3.89 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 428' ' ' ARG . 1.7 p -113.62 161.22 17.7 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.73 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.45 HG13 ' SG ' ' A' ' 471' ' ' CYS . 16.2 t -76.84 -26.34 16.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.796 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' GLY . 6.8 mtt-85 -108.46 -134.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.723 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 70.72 -166.85 51.32 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.948 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 451' ' ' GLY . . . . . 0.568 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 72.0 -31.85 0.64 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.937 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.505 ' H ' ' C ' ' A' ' 450' ' ' GLY . 15.6 ptm -68.38 42.31 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.946 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 47.22 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.13 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 458' ' ' VAL . 6.8 t -171.32 -166.08 0.44 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' HIS . . . . . 0.635 ' CD2' ' OG1' ' A' ' 431' ' ' THR . 7.2 p-80 -49.66 -48.13 49.58 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.981 -1.087 . . . . 0.0 110.337 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.435 ' CB ' HG21 ' A' ' 431' ' ' THR . . . -38.21 -56.15 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.467 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -81.08 -52.53 7.29 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.487 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 454' ' ' SER . 43.5 t -47.42 -47.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.916 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 455' ' ' HIS . 93.3 t -64.31 -43.78 97.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.782 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.99 -43.75 91.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -69.81 -19.38 63.49 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.57 -36.79 15.56 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 49.8 mmm -93.15 -26.1 17.57 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.24 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.25 42.1 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.63 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 16.7 m -46.83 163.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' CYS . . . . . 0.547 ' HG ' ' C ' ' A' ' 401' ' ' GLY . 48.6 t -85.22 128.59 34.73 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.053 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 13.1 t -151.42 140.49 21.14 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.382 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 468' ' ' VAL . . . . . 0.597 HG13 ' HB3' ' A' ' 395' ' ' ALA . 0.9 OUTLIER -110.65 161.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.137 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 469' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 9.2 t -150.37 148.57 28.96 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.567 -1.253 . . . . 0.0 112.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 61.1 91.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.46 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 448' ' ' VAL . 7.7 p -100.22 176.06 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -59.52 -91.93 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -144.82 59.55 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.632 HG23 ' CB ' ' A' ' 483' ' ' PHE . 10.7 mt -51.6 107.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.839 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -89.16 110.31 21.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 482' ' ' THR . 4.9 mt -87.96 135.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.013 -1.475 . . . . 0.0 113.884 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' ASN . . . . . 0.511 ' CG ' ' HG1' ' A' ' 482' ' ' THR . 1.3 m120 -113.18 122.04 46.32 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.678 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.65 ' C ' ' H ' ' A' ' 480' ' ' ALA . 7.8 mt-10 -56.4 -5.53 0.21 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.438 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -48.03 -14.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 118.093 -1.443 . . . . 0.0 108.186 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 177.98 -90.88 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 481' ' ' LYS . . . . . 0.512 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.3 OUTLIER -167.46 54.56 0.07 Allowed 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 123.965 1.841 . . . . 0.0 108.949 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 476' ' ' ILE . 70.0 p -75.57 167.11 22.52 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 111.251 -2.704 . . . . 0.0 112.267 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 483' ' ' PHE . . . . . 0.634 ' CE2' ' CG ' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -153.46 112.83 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.693 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -89.64 120.07 30.61 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.047 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 486' ' ' GLY . 59.3 tp -149.82 157.21 42.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.141 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 486' ' ' GLY . . . . . 0.501 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.39 -117.82 12.54 Favored Glycine 0 N--CA 1.48 1.568 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -127.04 29.1 4.44 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.673 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -151.68 144.3 24.27 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.122 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 45.5 m -95.36 115.19 27.1 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.529 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.634 ' CG ' ' CE2' ' A' ' 483' ' ' PHE . 0.8 OUTLIER -88.49 160.73 17.37 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.747 ' HA ' HG22 ' A' ' 482' ' ' THR . . . -141.0 113.95 8.42 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.856 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' GLU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.7 tm-20 -48.06 99.68 0.02 OUTLIER 'General case' 0 CA--C 1.481 -1.704 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.887 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 493' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 160.24 22.88 0.03 OUTLIER Glycine 0 C--N 1.274 -2.909 0 C-N-CA 118.623 -1.751 . . . . 0.0 109.865 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 494' ' ' ASP . . . . . 0.647 ' CG ' ' N ' ' A' ' 495' ' ' TYR . 16.2 t70 -143.72 -179.91 6.75 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.071 -1.051 . . . . 0.0 112.2 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 495' ' ' TYR . . . . . 0.647 ' N ' ' CG ' ' A' ' 494' ' ' ASP . 25.1 t80 -101.59 137.91 39.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.667 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.464 HG13 ' N ' ' A' ' 497' ' ' SER . 0.1 OUTLIER -137.15 160.98 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.445 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 497' ' ' SER . . . . . 0.464 ' N ' HG13 ' A' ' 496' ' ' ILE . 29.7 t -123.6 104.57 9.11 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.658 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 498' ' ' LEU . . . . . 0.883 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.2 OUTLIER -109.62 134.27 52.14 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.764 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.883 ' N ' HD12 ' A' ' 498' ' ' LEU . 9.1 m-20 -115.36 148.67 39.01 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.821 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 500' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -148.45 89.55 0.14 Allowed Glycine 0 C--O 1.188 -2.777 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 22.5 m -162.77 -3.88 0.04 OUTLIER 'General case' 0 C--N 1.255 -3.537 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' THR . . . . . 0.458 ' H ' ' H ' ' A' ' 503' ' ' GLY . 75.8 p -152.77 -14.65 0.16 Allowed 'General case' 0 C--N 1.275 -2.667 0 CA-C-N 111.417 -2.629 . . . . 0.0 105.969 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.458 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 79.04 77.25 0.91 Allowed Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.29 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -156.69 136.13 12.23 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.729 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' ILE . . . . . 0.625 ' C ' ' CD1' ' A' ' 506' ' ' TYR . 10.7 mt -110.54 161.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.807 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' TYR . . . . . 0.712 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 24.6 m-85 -150.33 161.72 41.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 508' ' ' GLY . 13.0 ttmt -134.97 157.47 46.84 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLY . . . . . 0.435 ' N ' ' HG2' ' A' ' 507' ' ' LYS . . . 101.6 -179.32 27.88 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.648 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 510' ' ' ILE . 11.4 t0 -90.52 142.54 27.64 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 510' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 511' ' ' GLU . 7.7 mt -148.45 171.73 2.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.591 ' H ' HG22 ' A' ' 510' ' ' ILE . 2.9 mp0 . . . . . 0 C--N 1.303 -1.423 0 CA-C-O 116.305 -1.807 . . . . 0.0 110.846 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.916 0.389 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 387' ' ' LYS . . . -162.94 -152.44 0.22 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.575 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 57.6 mt 49.45 10.94 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.969 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.589 ' H ' ' C ' ' A' ' 385' ' ' ALA . 26.6 ttpp -122.43 -11.29 8.34 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.653 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -147.29 21.34 1.21 Allowed 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.35 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -79.93 -130.24 0.82 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.279 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -158.03 92.83 1.2 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.622 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.753 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 67.7 t -93.91 158.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.333 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.477 ' N ' HG12 ' A' ' 391' ' ' VAL . 10.3 pt -102.36 -33.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -178.3 -163.97 30.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 118.899 -1.619 . . . . 0.0 111.279 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 p -165.31 130.44 2.53 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.264 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 471' ' ' CYS . . . -114.65 -147.92 0.42 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.943 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 63.2 mt -81.93 132.31 54.45 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.08 93.61 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.143 1.229 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -58.31 -62.12 2.07 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.47 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -148.61 146.88 23.34 Favored Pre-proline 0 C--N 1.305 -1.333 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.353 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.76 103.05 0.1 Allowed 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.258 1.305 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.06 162.61 29.85 Favored Glycine 0 N--CA 1.509 3.508 0 C-N-CA 118.723 -1.704 . . . . 0.0 112.379 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' ALA . . . . . 0.49 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -145.65 118.72 8.83 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.01 43.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.776 -1.57 . . . . 0.0 113.765 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -137.84 110.02 7.32 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.437 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.53 169.81 31.68 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.007 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' LYS . . . . . 0.653 ' N ' ' CD ' ' A' ' 406' ' ' LYS . 8.4 mptt -80.2 171.48 15.03 Favored 'General case' 0 C--O 1.201 -1.499 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -120.23 158.98 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.548 -1.261 . . . . 0.0 114.15 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 408' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 414' ' ' ALA . 20.0 p90 -156.24 -151.09 0.31 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.716 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 427' ' ' VAL . 28.4 m-85 -148.22 -42.28 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.406 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 36.8 p -94.71 138.55 32.39 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.548 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -56.12 -19.38 13.04 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.262 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -64.5 -49.07 72.78 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 417' ' ' ALA . 40.8 mm-40 -53.22 -50.9 63.77 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.286 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ALA . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 408' ' ' TYR . . . -48.58 -38.46 20.71 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -63.57 -41.19 98.4 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.505 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.3 -9.62 49.88 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.657 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.08 -60.7 1.86 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.401 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -56.23 -21.37 23.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.045 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -27.61 68.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.003 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -73.13 -6.99 49.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.94 71.47 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.16 152.03 3.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.163 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -72.17 153.11 41.83 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.643 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' VAL . . . . . 0.842 ' O ' ' HB1' ' A' ' 442' ' ' ALA . 4.4 t -145.97 160.15 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.446 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ILE . . . . . 0.514 ' O ' ' CE1' ' A' ' 408' ' ' TYR . 5.2 mm -121.85 159.28 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' LEU . . . . . 0.622 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 13.5 tp -115.79 139.16 50.44 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.796 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.545 ' O ' ' CD2' ' A' ' 409' ' ' PHE . 51.9 t -130.57 119.71 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ARG . . . . . 0.762 ' H ' HG22 ' A' ' 447' ' ' THR . 1.0 OUTLIER -151.4 152.75 33.51 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.902 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.417 ' CB ' ' OE2' ' A' ' 430' ' ' GLU . 0.7 OUTLIER -80.31 20.56 0.67 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.393 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.417 ' OE2' ' CB ' ' A' ' 429' ' ' LEU . 1.4 pm0 -179.69 153.08 0.53 Allowed 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 432' ' ' SER . 0.5 OUTLIER -83.14 -175.24 5.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.555 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 431' ' ' THR . 4.2 t -177.07 139.28 0.44 Allowed Pre-proline 0 C--N 1.305 -1.357 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.858 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.5 -69.18 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.367 1.378 . . . . 0.0 111.897 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -46.48 -27.32 1.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.879 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.16 -9.23 45.13 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.477 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' ILE . . . . . 0.722 HG23 ' N ' ' A' ' 437' ' ' GLU . 8.3 tp -60.29 -49.99 82.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.031 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 436' ' ' ILE . 52.3 mm-40 -54.89 -29.96 57.03 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.924 -1.51 . . . . 0.0 108.459 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.66 63.41 Favored Glycine 0 N--CA 1.473 1.143 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 43.8 mtt -69.48 -44.83 70.35 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.893 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.568 ' C ' ' N ' ' A' ' 442' ' ' ALA . 7.0 m170 -61.26 -39.28 89.79 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.408 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -51.63 -18.16 1.08 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' ALA . . . . . 0.842 ' HB1' ' O ' ' A' ' 424' ' ' VAL . . . -122.52 -155.48 0.65 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.283 -1.78 . . . . 0.0 108.077 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -168.62 37.75 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -169.52 143.41 7.93 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.3 mp -142.36 118.45 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.453 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' LEU . . . . . 0.436 HD13 ' CG1' ' A' ' 468' ' ' VAL . 2.5 tp -121.78 98.37 5.92 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.695 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' THR . . . . . 0.762 HG22 ' H ' ' A' ' 428' ' ' ARG . 5.5 p -115.16 160.32 19.84 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.24 -20.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.87 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' ARG . . . . . 0.584 ' CG ' ' H ' ' A' ' 450' ' ' GLY . 2.1 ttt85 -129.26 179.24 5.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' GLY . . . . . 0.584 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 92.59 60.19 1.23 Allowed Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.163 -1.494 . . . . 0.0 109.725 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 453' ' ' THR . . . -141.78 -145.25 4.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 453' ' ' THR . 5.4 ttt 46.52 16.54 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.838 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.53 89.53 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.675 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 454' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 455' ' ' HIS . 93.9 p -149.3 -174.58 4.7 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.714 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 455' ' ' HIS . . . . . 0.682 ' O ' HG23 ' A' ' 459' ' ' VAL . 4.6 m170 -40.62 -45.1 2.27 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ALA . . . . . 0.41 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -47.49 -61.9 1.7 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.81 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.64 12.66 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.597 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 11.9 t -45.33 -40.18 2.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.393 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 455' ' ' HIS . 72.3 t -71.58 -45.39 67.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.318 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.35 80.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -68.72 -37.27 79.35 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.705 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -74.95 -24.12 72.79 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.528 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' MET . . . . . 0.479 ' HG3' ' N ' ' A' ' 464' ' ' GLY . 8.9 tpt -90.17 -81.92 0.28 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.449 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' GLY . . . . . 0.479 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 136.12 37.59 0.18 Allowed Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.968 -1.11 . . . . 0.0 110.428 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 10.2 t -108.37 171.43 7.42 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -86.42 126.34 34.32 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.98 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 467' ' ' CYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 0.7 OUTLIER -152.19 155.19 37.3 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.284 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 468' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.4 t -135.52 162.66 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.577 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 469' ' ' SER . . . . . 0.568 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 33.5 t -149.98 151.74 33.8 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.028 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.37 83.99 0.01 OUTLIER Glycine 0 N--CA 1.496 2.67 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.087 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 395' ' ' ALA . 7.9 t -85.57 -145.99 0.11 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.023 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -67.94 -101.16 0.03 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -130.18 54.86 1.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.497 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 0.5 OUTLIER -45.63 111.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -105.03 113.91 27.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.22 134.95 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.444 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -105.99 115.32 30.03 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' GLU . . . . . 0.755 ' C ' ' H ' ' A' ' 480' ' ' ALA . 8.3 mp0 -67.76 -8.27 34.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.291 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 479' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 480' ' ' ALA . 6.1 mt-10 -59.08 6.77 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.152 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ALA . . . . . 0.755 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 170.75 -77.72 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 481' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 409' ' ' PHE . 4.0 mmtp 158.93 84.07 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.79 1.306 . . . . 0.0 109.482 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 482' ' ' THR . . . . . 0.879 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 1.9 p -137.02 142.06 42.49 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 483' ' ' PHE . . . . . 0.968 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 3.8 p90 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.441 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 484' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' A' ' 485' ' ' LEU . 5.5 tp10 -109.8 117.45 33.9 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' LEU . . . . . 0.464 ' N ' ' OE2' ' A' ' 484' ' ' GLU . 4.8 mt -150.21 159.85 44.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.789 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 53.98 -104.41 0.23 Allowed Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.575 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -139.96 28.72 2.49 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 119.079 -1.534 . . . . 0.0 111.897 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -150.68 142.29 23.58 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.639 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.9 m -106.81 99.04 8.63 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.988 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.559 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 23.3 p90 -154.32 155.13 34.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.302 -1.359 . . . . 0.0 113.948 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' ALA . . . . . 0.968 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . -171.97 -129.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.669 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -47.12 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.187 -1.405 . . . . 0.0 108.94 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 157.69 0.48 0.1 OUTLIER Glycine 0 C--N 1.279 -2.584 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 494' ' ' ASP . . . . . 0.432 ' H ' ' H ' ' A' ' 493' ' ' GLY . 7.9 m-20 -159.81 -163.84 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.948 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' TYR . . . . . 0.484 ' CZ ' ' HA2' ' A' ' 508' ' ' GLY . 4.5 p90 -142.07 144.76 33.73 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.678 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 496' ' ' ILE . . . . . 0.439 HG23 ' CE1' ' A' ' 490' ' ' PHE . 0.0 OUTLIER -123.75 160.6 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.877 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 497' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 506' ' ' TYR . 6.7 t -115.31 99.91 7.74 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 498' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -98.2 144.44 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.377 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 499' ' ' ASP . . . . . 0.66 ' N ' HD12 ' A' ' 498' ' ' LEU . 6.7 t0 -103.55 157.43 17.05 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.697 0.761 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 500' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -145.25 95.47 0.18 Allowed Glycine 0 C--N 1.275 -2.816 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 501' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 0.3 OUTLIER 163.21 6.33 0.0 OUTLIER 'General case' 1 C--N 1.24 -4.156 0 CA-C-N 112.014 -2.093 . . . . 0.0 106.617 -179.97 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 502' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 504' ' ' LYS . 0.1 OUTLIER -163.56 -21.72 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.203 -2.271 . . . . 0.0 107.592 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.51 -10.35 62.01 Favored Glycine 0 N--CA 1.492 2.42 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.948 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' LYS . . . . . 0.536 ' H ' HG23 ' A' ' 502' ' ' THR . 7.9 mtmt -71.98 120.18 17.21 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.986 -1.086 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 505' ' ' ILE . . . . . 0.667 ' O ' HG13 ' A' ' 391' ' ' VAL . 1.2 tt -96.97 160.65 2.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.867 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 506' ' ' TYR . . . . . 0.753 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 33.0 m-85 -138.18 162.58 33.89 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.128 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 507' ' ' LYS . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 3.1 tmtt? -123.53 151.02 43.28 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.999 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLY . . . . . 0.484 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . 60.89 99.2 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 C-N-CA 118.773 -1.679 . . . . 0.0 109.998 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 508' ' ' GLY . 36.2 m-20 -35.9 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.795 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 510' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.49 -26.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.224 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' GLU . . . . . 0.464 ' H ' ' HG3' ' A' ' 511' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.271 -2.822 0 CA-C-O 116.378 -1.772 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 391' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 121.468 0.652 . . . . 0.0 110.551 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 505' ' ' ILE . 25.4 t -41.01 143.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.326 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.667 HD13 ' CZ ' ' A' ' 490' ' ' PHE . 2.5 pt -87.72 -55.06 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.635 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.619 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -153.98 -157.13 7.97 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.4 p -164.51 108.47 0.93 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -84.84 -146.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 42.0 mt -96.79 139.99 21.89 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.92 93.07 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.61 0 C-N-CA 121.294 1.329 . . . . 0.0 111.303 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -64.02 -69.85 0.25 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.715 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 57.0 m -133.24 139.25 33.6 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.756 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.31 100.83 0.07 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.895 1.064 . . . . 0.0 110.406 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.616 ' C ' ' SG ' ' A' ' 466' ' ' CYS . . . -152.03 162.36 29.73 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.639 -1.743 . . . . 0.0 112.116 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -141.43 128.44 20.73 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.65 160.58 43.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.019 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -138.77 107.9 6.06 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.023 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.07 30.35 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.051 -1.547 . . . . 0.0 111.307 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.485 ' HE3' ' CD2' ' A' ' 495' ' ' TYR . 3.7 mttp -85.98 137.93 32.36 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.936 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.54 ' O ' ' CG ' ' A' ' 408' ' ' TYR . 49.6 t -55.44 148.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.986 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 407' ' ' VAL . 17.8 m-85 -170.98 139.9 1.48 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.653 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.731 ' CD2' ' NZ ' ' A' ' 481' ' ' LYS . 4.1 m-85 -113.79 42.43 2.01 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.313 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 409' ' ' PHE . 1.0 OUTLIER -159.36 145.0 16.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.886 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -76.83 -18.23 58.51 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.787 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -74.16 -39.93 62.91 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.69 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . 0.462 ' OE1' ' OG1' ' A' ' 410' ' ' THR . 41.8 mt-10 -66.78 -26.76 67.12 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.6 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.27 68.17 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.54 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -43.1 86.42 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.876 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.57 -49.58 52.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.842 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -58.77 -62.11 2.11 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.083 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -41.53 -30.58 0.21 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.663 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -89.53 -22.02 22.62 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.575 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 417' ' ' ALA . 0.0 OUTLIER -94.91 -49.2 5.67 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.521 -0.871 . . . . 0.0 112.842 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 422' ' ' GLU . . . -153.74 -10.64 0.07 OUTLIER Glycine 0 N--CA 1.497 2.737 0 C-N-CA 118.763 -1.684 . . . . 0.0 112.03 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . 0.446 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 3.0 mt-10 64.24 -145.89 0.28 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 49.87 65.89 1.29 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.614 -1.234 . . . . 0.0 108.352 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 408' ' ' TYR . 3.3 t -122.47 154.92 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.702 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 426' ' ' LEU . 18.9 mm -118.75 160.9 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.406 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.521 ' N ' HG22 ' A' ' 425' ' ' ILE . 1.4 tp -134.58 125.56 27.47 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.183 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 446' ' ' LEU . 38.2 t -114.14 127.16 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.75 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ARG . . . . . 0.613 ' H ' HG22 ' A' ' 447' ' ' THR . 0.0 OUTLIER -152.48 146.69 25.47 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.122 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 12.03 2.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.566 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 428' ' ' ARG . 67.2 tt0 -176.4 139.76 0.35 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.699 HG21 ' HB2' ' A' ' 456' ' ' ALA . 9.1 p -106.14 153.49 22.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.271 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.32 158.67 63.39 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.715 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.9 Cg_endo -65.79 -69.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.903 1.736 . . . . 0.0 112.394 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -35.23 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.568 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.624 ' OD1' ' SD ' ' A' ' 439' ' ' MET . 0.6 OUTLIER -62.83 -8.41 6.88 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.622 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.649 HG22 ' N ' ' A' ' 437' ' ' GLU . 0.3 OUTLIER -32.68 -58.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.649 ' N ' HG22 ' A' ' 436' ' ' ILE . 53.2 mt-10 -47.93 -41.19 24.15 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 117.961 -1.496 . . . . 0.0 109.086 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -71.91 -25.85 73.92 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' MET . . . . . 0.632 ' SD ' HG11 ' A' ' 459' ' ' VAL . 40.5 mtp -70.65 -46.93 62.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.444 ' CE1' ' SD ' ' A' ' 463' ' ' MET . 85.9 m-70 -58.26 -61.66 2.41 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 118.267 -1.373 . . . . 0.0 109.546 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -49.25 -32.15 10.18 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.096 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -98.04 71.45 2.15 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.544 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.18 3.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.239 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.627 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -144.32 145.17 14.46 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 49.8 mt -148.01 118.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.091 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 427' ' ' VAL . 4.6 tp -115.55 97.96 6.45 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 428' ' ' ARG . 4.4 p -106.16 160.94 14.95 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.901 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 56.6 t -86.47 -20.62 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.157 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 470' ' ' GLY . 2.0 tpt85 -99.54 -136.04 0.29 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.615 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.509 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 73.14 -170.47 52.05 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.62 -170.34 40.54 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.897 -1.62 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.571 ' O ' HG23 ' A' ' 453' ' ' THR . 13.9 ttt -46.95 -37.97 9.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 452' ' ' MET . 0.7 OUTLIER -158.91 129.26 5.91 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.182 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.1 m -174.29 -178.29 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 459' ' ' VAL . 34.4 m80 -45.63 -38.3 6.52 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.952 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.699 ' HB2' HG21 ' A' ' 431' ' ' THR . . . -59.51 -51.27 70.58 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.694 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -78.19 -52.09 9.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 3.4 t -47.85 -50.49 9.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.284 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 455' ' ' HIS . 65.9 t -63.99 -39.27 84.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 464' ' ' GLY . . . -65.51 -50.59 64.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.381 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -53.96 -29.07 41.15 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.422 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.15 -35.33 27.4 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' MET . . . . . 0.444 ' SD ' ' CE1' ' A' ' 440' ' ' HIS . 16.2 mmt -97.49 6.43 48.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.727 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 460' ' ' ALA . . . 48.78 24.72 4.4 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.953 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 94.3 m -84.11 146.4 27.91 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.831 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' CYS . . . . . 0.616 ' SG ' ' C ' ' A' ' 401' ' ' GLY . 17.0 t -76.1 129.5 36.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 80.0 m -151.54 146.98 26.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.822 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.69 160.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.393 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . 0.507 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 7.0 t -151.04 148.15 27.99 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.596 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 52.0 92.39 0.01 OUTLIER Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 446' ' ' LEU . 7.9 m -100.69 -159.39 0.73 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.643 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.72 -99.0 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.959 -1.591 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -133.92 43.87 2.8 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.416 0.627 . . . . 0.0 109.34 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.607 HG23 ' CB ' ' A' ' 483' ' ' PHE . 5.0 mt -39.09 110.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.846 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -94.3 121.96 36.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 482' ' ' THR . 3.8 mt -87.36 131.13 35.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 117.829 -1.548 . . . . 0.0 112.795 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -104.39 119.45 38.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.552 ' C ' ' N ' ' A' ' 480' ' ' ALA . 1.5 mp0 -62.65 -10.69 13.26 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.598 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -45.51 -20.18 0.06 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 118.236 -1.386 . . . . 0.0 108.518 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.552 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.68 -103.67 0.01 OUTLIER 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . 0.731 ' NZ ' ' CD2' ' A' ' 409' ' ' PHE . 11.2 mmmm -155.96 65.87 0.59 Allowed 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.642 ' O ' HG23 ' A' ' 476' ' ' ILE . 4.8 p -98.43 -179.5 4.36 Favored 'General case' 0 C--O 1.201 -1.475 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.783 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' PHE . . . . . 0.607 ' CB ' HG23 ' A' ' 474' ' ' ILE . 0.5 OUTLIER -150.78 117.23 5.72 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.043 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' GLU . . . . . 0.427 ' CG ' HG23 ' A' ' 489' ' ' THR . 33.8 mt-10 -89.17 118.48 28.9 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.839 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 486' ' ' GLY . 61.6 tp -143.53 154.79 43.98 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.775 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' GLY . . . . . 0.468 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 56.89 -114.59 5.48 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.484 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.85 3.91 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.11 152.19 33.04 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.427 HG23 ' CG ' ' A' ' 484' ' ' GLU . 88.3 m -107.79 112.03 24.49 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.946 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.667 ' CZ ' HD13 ' A' ' 392' ' ' ILE . 5.6 m-30 -89.45 110.93 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.061 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -98.23 149.01 23.02 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.865 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.485 ' O ' ' CG ' ' A' ' 492' ' ' GLU . 1.9 tm-20 -67.29 69.49 0.09 Allowed 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -173.96 22.47 0.06 OUTLIER Glycine 0 C--N 1.269 -3.139 0 C-N-CA 119.206 -1.473 . . . . 0.0 109.765 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 495' ' ' TYR . 2.4 t0 -140.69 -173.94 3.83 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.655 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . 0.485 ' CD2' ' HE3' ' A' ' 406' ' ' LYS . 0.2 OUTLIER -116.41 129.64 56.34 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.892 HD12 ' N ' ' A' ' 497' ' ' SER . 0.6 OUTLIER -138.37 160.5 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.554 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . 0.892 ' N ' HD12 ' A' ' 496' ' ' ILE . 17.3 m -125.05 112.11 16.15 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' LEU . . . . . 0.418 HD13 ' CG1' ' A' ' 505' ' ' ILE . 0.0 OUTLIER -108.76 141.25 41.03 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.539 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 498' ' ' LEU . 3.6 m-20 -93.12 161.7 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.037 0.922 . . . . 0.0 112.531 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' GLY . . . . . 0.608 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -150.65 94.73 0.15 Allowed Glycine 0 C--N 1.287 -2.189 0 N-CA-C 106.737 -2.545 . . . . 0.0 106.737 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' SER . . . . . 0.469 ' C ' ' OG1' ' A' ' 502' ' ' THR . 0.3 OUTLIER 174.31 1.55 0.0 OUTLIER 'General case' 1 C--N 1.241 -4.122 0 CA-C-N 112.995 -1.602 . . . . 0.0 108.161 179.797 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' THR . . . . . 0.469 ' OG1' ' C ' ' A' ' 501' ' ' SER . 0.6 OUTLIER -168.66 -21.03 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.019 -1.9 . . . . 0.0 107.844 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.19 72.97 1.28 Allowed Glycine 0 N--CA 1.484 1.865 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.46 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -139.88 112.74 8.06 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.348 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' ILE . . . . . 0.65 ' O ' HG13 ' A' ' 391' ' ' VAL . 5.8 mt -89.46 149.05 4.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.286 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 507' ' ' LYS . 46.4 t80 -147.66 161.44 41.18 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.412 ' O ' ' CE2' ' A' ' 506' ' ' TYR . 15.7 tttt -116.89 160.61 20.61 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.965 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.605 179.952 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.832 0.349 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.572 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 24.3 t -96.59 135.18 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.4 pt -90.75 -31.6 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 164.65 -176.34 40.5 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.075 -1.536 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.8 p -141.5 151.47 43.34 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.184 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -142.46 -152.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.344 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.718 ' N ' ' CD2' ' A' ' 396' ' ' LEU . 0.1 OUTLIER -63.45 115.51 18.77 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.323 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.79 100.52 0.83 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.023 1.149 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -59.89 -76.03 0.05 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.094 -1.043 . . . . 0.0 110.859 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.3 t -137.85 151.38 70.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.732 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.08 104.04 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.447 1.431 . . . . 0.0 110.822 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.605 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -152.62 163.24 30.29 Favored Glycine 0 N--CA 1.503 3.152 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.87 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -137.81 123.41 19.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.48 161.16 43.06 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.703 -1.599 . . . . 0.0 114.12 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -148.5 107.11 3.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.001 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.47 31.81 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 118.905 -1.617 . . . . 0.0 112.151 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.464 ' NZ ' ' HB2' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -84.5 132.51 34.53 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.522 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.49 158.59 5.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.028 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.577 ' CD1' ' CD ' ' A' ' 413' ' ' GLU . 3.8 m-85 -151.8 -170.62 3.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -142.27 6.43 1.71 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.798 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.0 p -141.64 142.25 33.41 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -67.25 -12.17 59.41 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.661 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -73.12 -42.86 62.45 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . 0.577 ' CD ' ' CD1' ' A' ' 408' ' ' TYR . 49.9 mt-10 -63.92 -37.9 89.12 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.873 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.42 68.37 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.773 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -69.93 -38.42 76.19 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.271 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.53 -13.29 34.91 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.206 -0.997 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -90.2 -52.43 4.94 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.83 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' HIS . . . . . 0.583 ' HB2' ' HB1' ' A' ' 441' ' ' ALA . 16.3 t-80 -47.79 -21.58 0.42 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.328 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.9 OUTLIER -83.75 -68.68 0.69 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.205 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -93.2 -24.35 18.24 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.761 -0.776 . . . . 0.0 112.342 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -89.27 -51.87 2.85 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.027 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 417' ' ' ALA . 3.6 mt-10 62.38 165.65 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.022 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 422' ' ' GLU . 12.6 mpt_? 45.0 80.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.535 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 4.2 t -130.21 161.4 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.984 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 426' ' ' LEU . 7.2 mm -133.42 160.81 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.653 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.478 ' N ' HG22 ' A' ' 425' ' ' ILE . 9.8 tp -131.65 151.69 51.42 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.613 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 426' ' ' LEU . 6.2 t -131.45 126.28 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ARG . . . . . 0.67 ' O ' HG22 ' A' ' 447' ' ' THR . 90.4 mtt180 -151.89 150.77 30.44 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.354 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 429' ' ' LEU . 7.0 mt -59.55 -44.09 93.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.646 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.62 -178.16 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -81.81 -178.07 6.83 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.927 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.78 122.42 0.81 Allowed Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.6 -33.6 93.34 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.036 1.157 . . . . 0.0 111.779 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -73.81 -9.4 58.62 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.1 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -87.26 -8.33 56.91 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.565 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 7.9 tp -39.91 -50.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.5 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.643 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 27.3 mt-10 -61.19 -31.53 71.28 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 117.877 -1.529 . . . . 0.0 108.387 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.16 -28.09 60.88 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' MET . . . . . 0.552 ' SD ' HG11 ' A' ' 459' ' ' VAL . 75.0 mtp -66.91 -42.65 85.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.191 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -67.46 -58.88 3.94 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.198 -1.401 . . . . 0.0 108.924 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 418' ' ' HIS . . . -49.36 -36.07 20.51 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.392 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -94.19 81.59 4.07 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.158 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.95 21.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.113 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.664 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -165.97 149.57 15.86 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.39 131.56 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.97 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.611 ' CD2' HD22 ' A' ' 498' ' ' LEU . 0.6 OUTLIER -123.72 108.66 12.77 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.06 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 428' ' ' ARG . 3.4 p -121.83 160.23 25.12 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.538 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.578 HG13 HG13 ' A' ' 474' ' ' ILE . 2.6 t -79.09 -25.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.406 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -121.13 -142.22 0.34 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.197 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 81.13 -143.9 24.36 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.137 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . 0.608 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 55.67 -140.87 40.05 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.204 -1.474 . . . . 0.0 110.122 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 24.9 mtm 43.82 38.95 2.3 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.487 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 56.2 p 42.43 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.575 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 458' ' ' VAL . 45.5 p -160.06 -164.64 1.33 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.168 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' HIS . . . . . 0.696 ' O ' HG23 ' A' ' 459' ' ' VAL . 69.0 m80 -43.9 -51.36 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.211 -0.995 . . . . 0.0 110.593 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.405 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -42.34 -55.33 3.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.764 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.48 6.31 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.667 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 454' ' ' SER . 50.3 t -47.02 -40.83 5.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.49 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 455' ' ' HIS . 43.4 t -74.36 -42.13 50.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.26 -35.89 81.57 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -68.46 -40.34 81.07 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.456 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -61.12 -36.52 92.48 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.388 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.78 -15.65 29.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.989 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 61.91 57.88 15.4 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.644 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 161.24 17.4 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 401' ' ' GLY . 19.0 t -81.11 91.7 6.16 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.481 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.6 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 4.2 t -129.34 158.8 38.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.397 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -136.62 162.71 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.055 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . 0.608 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 32.1 t -143.59 160.17 41.13 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.669 -1.213 . . . . 0.0 113.093 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 47.35 75.18 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.434 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . 0.654 ' SG ' HD13 ' A' ' 485' ' ' LEU . 1.8 t -84.75 -171.67 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.215 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.461 ' H ' HD11 ' A' ' 485' ' ' LEU . . . -50.25 -90.83 0.01 OUTLIER Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.672 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -155.67 66.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.578 HG13 HG13 ' A' ' 448' ' ' VAL . 0.0 OUTLIER -62.79 107.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.41 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -89.91 123.28 33.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.58 126.58 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.565 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -97.39 113.63 25.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.702 ' C ' ' H ' ' A' ' 480' ' ' ALA . 0.8 OUTLIER -67.87 -6.12 20.1 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.416 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.428 ' H ' ' HG2' ' A' ' 479' ' ' GLU . 34.8 mm-40 -52.92 -7.43 0.07 Allowed 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.551 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -179.72 -82.3 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 112.527 -2.124 . . . . 0.0 105.487 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . 0.528 ' HB3' ' CG ' ' A' ' 492' ' ' GLU . 4.5 mttt 169.17 89.18 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.099 0.952 . . . . 0.0 109.772 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 491' ' ' ALA . 1.4 p -151.29 138.78 19.53 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.301 -1.772 . . . . 0.0 111.885 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' PHE . . . . . 0.53 ' HB2' HG22 ' A' ' 474' ' ' ILE . 16.0 p90 -97.83 152.0 19.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -119.33 116.28 25.9 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.198 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.654 HD13 ' SG ' ' A' ' 471' ' ' CYS . 6.2 tt -150.5 152.87 34.86 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 69.04 -108.35 2.44 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 118.828 -1.653 . . . . 0.0 110.286 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . 0.614 ' C ' ' CD2' ' A' ' 488' ' ' HIS . . . -137.34 27.21 2.89 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.194 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' HIS . . . . . 0.614 ' CD2' ' C ' ' A' ' 487' ' ' GLY . 26.7 m-70 -150.68 152.51 34.06 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.829 -1.149 . . . . 0.0 111.286 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.9 m -119.83 97.12 5.47 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.12 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 490' ' ' PHE . 39.0 p90 -155.48 155.31 33.26 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.98 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.716 ' H ' HG22 ' A' ' 482' ' ' THR . . . -152.1 -124.31 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.528 ' CG ' ' HB3' ' A' ' 481' ' ' LYS . 1.1 pt-20 -67.9 49.03 0.05 Allowed 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -138.51 2.63 2.83 Favored Glycine 0 C--N 1.283 -2.37 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -167.56 -173.97 2.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.477 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -122.94 141.94 51.36 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.742 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.598 ' H ' HD12 ' A' ' 496' ' ' ILE . 0.6 OUTLIER -121.47 160.06 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.944 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 506' ' ' TYR . 6.3 m -115.37 99.46 7.4 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' LEU . . . . . 0.611 HD22 ' CD2' ' A' ' 446' ' ' LEU . 0.1 OUTLIER -100.48 140.83 34.18 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.219 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.524 ' N ' HD12 ' A' ' 498' ' ' LEU . 21.7 t70 -93.42 160.64 14.72 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-O 122.018 0.913 . . . . 0.0 111.896 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' GLY . . . . . 0.605 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -148.27 95.14 0.16 Allowed Glycine 0 C--N 1.272 -3.026 0 N-CA-C 106.508 -2.637 . . . . 0.0 106.508 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 2.0 t 171.15 4.47 0.0 OUTLIER 'General case' 0 C--N 1.244 -3.981 0 CA-C-N 112.177 -2.012 . . . . 0.0 107.065 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' THR . . . . . 0.413 ' H ' ' H ' ' A' ' 503' ' ' GLY . 0.0 OUTLIER -168.38 -22.79 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.516 -2.129 . . . . 0.0 107.496 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 96.93 -7.86 65.08 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.882 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 154.74 9.8 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.914 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 2.1 mp -135.04 146.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.295 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' TYR . . . . . 0.572 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 14.0 m-85 -133.79 161.96 33.3 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -127.74 153.86 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.209 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.209 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.773 0.32 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.657 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 65.1 t -46.3 156.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.289 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.47 ' N ' HG12 ' A' ' 391' ' ' VAL . 34.3 pt -128.29 -11.8 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.363 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -175.25 -167.41 34.37 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.896 -1.621 . . . . 0.0 111.481 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.2 p 177.12 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.327 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.36 -151.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 396' ' ' LEU . 8.9 mt -80.74 127.16 76.12 Favored Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.601 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.08 97.32 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -60.39 -59.37 5.51 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.946 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.01 133.72 12.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.91 98.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 120.791 0.994 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.592 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -153.43 159.58 28.7 Favored Glycine 0 N--CA 1.504 3.169 0 C-N-CA 118.876 -1.63 . . . . 0.0 111.882 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.756 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -133.13 132.05 41.2 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.711 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.421 ' HB2' ' SG ' ' A' ' 466' ' ' CYS . . . -150.39 161.38 42.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.184 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.14 110.94 6.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.231 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -153.16 167.69 31.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.812 -1.661 . . . . 0.0 111.774 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -83.89 156.46 22.39 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.179 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.71 ' HB ' ' H ' ' A' ' 492' ' ' GLU . 0.0 OUTLIER -78.79 165.23 3.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.639 -0.825 . . . . 0.0 113.072 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.59 ' CE1' ' OE1' ' A' ' 413' ' ' GLU . 3.6 m-85 -170.37 170.0 7.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.993 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.505 ' CG ' ' HD2' ' A' ' 481' ' ' LYS . 14.2 m-85 -137.36 23.21 2.97 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.805 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 12.6 p -146.95 142.0 27.09 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.25 -12.28 61.37 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -78.22 -36.47 47.12 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.451 -0.899 . . . . 0.0 109.718 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . 0.59 ' OE1' ' CE1' ' A' ' 408' ' ' TYR . 62.0 mm-40 -65.58 -40.38 92.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ALA . . . . . 0.589 ' HB1' ' CB ' ' A' ' 441' ' ' ALA . . . -67.5 -39.63 85.19 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.345 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -56.48 -34.25 66.74 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.762 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.62 -50.82 5.71 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.717 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -55.17 -48.02 74.35 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.28 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' HIS . . . . . 0.594 ' ND1' ' OE1' ' A' ' 419' ' ' GLU . 17.9 t-80 -43.76 -41.01 4.66 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.045 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.594 ' OE1' ' ND1' ' A' ' 418' ' ' HIS . 0.6 OUTLIER -91.92 -25.6 18.83 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.457 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 420' ' ' LYS . 7.6 mtpm? -92.69 -52.8 4.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.63 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -101.3 -31.6 5.52 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.148 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . 0.461 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 0.9 OUTLIER 65.96 148.6 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.396 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 55.89 95.01 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.879 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.54 162.45 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.484 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 426' ' ' LEU . 16.8 mm -121.69 159.93 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 425' ' ' ILE . 6.6 tp -136.15 134.52 38.34 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.345 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.556 HG21 ' CE2' ' A' ' 483' ' ' PHE . 8.7 t -117.72 121.73 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.714 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ARG . . . . . 0.911 ' O ' HG22 ' A' ' 447' ' ' THR . 47.8 mtt180 -151.29 161.64 42.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -66.5 0.53 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.62 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -109.3 -165.53 1.02 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.678 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -99.0 -163.97 1.09 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.32 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.517 ' N ' ' OG1' ' A' ' 431' ' ' THR . 1.4 t -175.61 137.16 0.51 Allowed Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.557 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.5 Cg_endo -62.27 -77.59 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.388 1.392 . . . . 0.0 112.126 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -44.01 -18.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 439' ' ' MET . 11.0 m-20 -82.53 -9.0 59.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.39 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.967 HG23 ' H ' ' A' ' 437' ' ' GLU . 6.1 tp -46.78 -63.54 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.579 -0.849 . . . . 0.0 111.145 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.967 ' H ' HG23 ' A' ' 436' ' ' ILE . 5.4 mt-10 -52.27 -26.98 13.34 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.414 -1.315 . . . . 0.0 108.59 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -81.17 -24.67 56.9 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 435' ' ' ASP . 53.3 mtt -77.64 -41.97 36.47 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.861 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.852 ' NE2' HD11 ' A' ' 436' ' ' ILE . 28.1 m170 -65.14 -49.04 71.41 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.813 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.589 ' CB ' ' HB1' ' A' ' 414' ' ' ALA . . . -48.38 -20.83 0.45 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.536 ' N ' ' C ' ' A' ' 440' ' ' HIS . . . -116.57 61.77 0.72 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.53 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.718 ' H ' ' CD ' ' A' ' 443' ' ' GLU . 1.4 pm0 -26.03 -58.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.875 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' A' ' 425' ' ' ILE . . . -81.48 145.2 25.01 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 118.494 -1.812 . . . . 0.0 109.009 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 41.0 mt -147.81 112.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 118.449 -1.301 . . . . 0.0 112.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.461 ' HA ' HD13 ' A' ' 446' ' ' LEU . 1.3 mm? -100.35 137.63 38.51 Favored 'General case' 0 C--O 1.187 -2.217 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' THR . . . . . 0.911 HG22 ' O ' ' A' ' 428' ' ' ARG . 0.3 OUTLIER -149.64 151.44 33.76 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.019 -1.473 . . . . 0.0 111.896 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.703 HG22 ' HB ' ' A' ' 474' ' ' ILE . 18.8 t -77.02 -24.29 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.805 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 10.7 ttt-85 -108.13 -143.66 0.38 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.225 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.508 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 73.93 -162.69 54.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 77.21 -41.92 1.85 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.159 -1.496 . . . . 0.0 110.392 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.683 ' C ' HG23 ' A' ' 453' ' ' THR . 53.7 mtt -64.86 19.09 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . 0.683 HG23 ' C ' ' A' ' 452' ' ' MET . 1.0 OUTLIER 62.84 114.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.874 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.7 t -173.28 -155.54 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 459' ' ' VAL . 45.8 t60 -57.67 -36.8 72.4 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.678 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -63.23 -44.67 94.59 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.0 -57.43 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.648 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.67 -41.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.7 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 455' ' ' HIS . 51.5 t -65.95 -53.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.11 73.48 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -69.33 -24.0 63.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.606 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.05 -48.3 5.8 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.642 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 56.7 mmm -78.41 -40.81 34.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.982 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.35 22.0 30.68 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.574 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' THR . . . . . 0.831 HG22 ' H ' ' A' ' 466' ' ' CYS . 7.3 m -76.03 -170.51 1.41 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' CYS . . . . . 0.831 ' H ' HG22 ' A' ' 465' ' ' THR . 0.0 OUTLIER -99.1 120.32 39.29 Favored 'General case' 0 C--O 1.202 -1.414 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.667 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 23.4 t -151.29 147.24 26.72 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.055 -1.458 . . . . 0.0 112.005 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.89 162.71 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.747 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . 0.508 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 28.8 t -147.79 160.58 42.58 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.995 -1.082 . . . . 0.0 112.62 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 46.94 72.92 0.35 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.184 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . 0.618 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.5 OUTLIER -83.43 -158.82 0.32 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.878 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 471' ' ' CYS . . . -67.69 -101.71 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.31 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -135.33 54.57 1.92 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.861 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.812 HG23 ' CB ' ' A' ' 483' ' ' PHE . 5.1 mt -45.67 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.921 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -89.37 121.39 31.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.01 122.44 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.929 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -99.46 111.97 24.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.788 ' C ' ' H ' ' A' ' 480' ' ' ALA . 35.9 mt-10 -60.54 0.29 0.21 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.286 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.647 ' O ' ' HB2' ' A' ' 480' ' ' ALA . 47.4 mt-10 -64.24 17.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.254 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.788 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 155.2 -71.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . 0.505 ' HD2' ' CG ' ' A' ' 409' ' ' PHE . 2.1 mmtt 158.51 79.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.492 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 1.005 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 6.7 p -132.28 143.76 50.12 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.681 -0.807 . . . . 0.0 112.325 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' PHE . . . . . 1.015 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 10.8 p90 -98.96 143.51 29.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.201 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 485' ' ' LEU . 5.1 tp10 -101.54 111.24 23.42 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.196 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 487' ' ' GLY . 0.8 OUTLIER -134.6 117.83 16.55 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.002 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 485' ' ' LEU . . . 21.3 -74.15 0.0 OUTLIER Glycine 0 N--CA 1.51 3.593 0 O-C-N 124.486 1.116 . . . . 0.0 114.439 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 485' ' ' LEU . . . -51.76 -67.92 1.78 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.543 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 26.6 m80 -154.44 163.53 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.156 -1.418 . . . . 0.0 112.869 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 484' ' ' GLU . 9.2 m -93.6 99.29 11.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.438 ' CE1' ' HE3' ' A' ' 507' ' ' LYS . 40.3 p90 -153.22 154.13 34.07 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 118.455 -1.298 . . . . 0.0 113.825 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 1.015 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . 170.94 172.52 0.07 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 113.767 -1.561 . . . . 0.0 108.678 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.71 ' H ' ' HB ' ' A' ' 407' ' ' VAL . 19.7 tt0 26.06 41.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 O-C-N 124.266 0.979 . . . . 0.0 109.978 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -167.61 1.43 0.04 OUTLIER Glycine 0 C--N 1.281 -2.505 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 407' ' ' VAL . 2.9 m-20 -156.96 -152.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . 0.408 ' N ' ' CD1' ' A' ' 495' ' ' TYR . 1.5 p90 -154.32 140.52 18.51 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.433 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.842 ' H ' HD12 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -122.99 160.6 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.569 -0.852 . . . . 0.0 113.073 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 506' ' ' TYR . 1.8 p -115.29 98.37 6.72 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -93.39 142.31 27.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.893 -1.123 . . . . 0.0 113.012 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.733 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.9 OUTLIER -106.52 161.54 14.52 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.479 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' GLY . . . . . 0.592 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -156.28 95.41 0.15 Allowed Glycine 0 C--N 1.277 -2.707 0 N-CA-C 106.836 -2.505 . . . . 0.0 106.836 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 502' ' ' THR . 77.7 p -178.03 6.68 0.01 OUTLIER 'General case' 1 C--N 1.241 -4.142 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.33 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 501' ' ' SER . 0.0 OUTLIER -175.35 -19.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 112.822 -1.99 . . . . 0.0 107.72 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 86.77 74.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.558 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 499' ' ' ASP . 19.8 mttp -155.45 115.16 3.68 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.258 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' ILE . . . . . 0.548 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.1 tt -93.91 160.45 2.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.687 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' TYR . . . . . 0.657 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 18.8 m-85 -141.82 161.44 37.95 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.771 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.438 ' HE3' ' CE1' ' A' ' 490' ' ' PHE . 47.6 tttt -107.67 154.36 21.57 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.695 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.567 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 . . . . . 0 C--O 1.215 -0.731 0 CA-C-O 120.822 0.344 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.72 HG23 ' CE1' ' A' ' 506' ' ' TYR . 0.4 OUTLIER -83.79 137.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.707 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.771 HD12 HD21 ' A' ' 485' ' ' LEU . 28.2 pt -77.48 -39.38 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.571 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.52 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -178.56 -162.33 27.97 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.499 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 121.11 0.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.615 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.434 ' HB2' ' SG ' ' A' ' 471' ' ' CYS . . . -94.86 -142.69 0.25 Allowed 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.913 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.77 128.34 48.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.328 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.73 98.2 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 121.076 1.184 . . . . 0.0 111.756 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -62.93 -74.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.26 146.24 60.07 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.946 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -52.27 100.4 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.762 1.642 . . . . 0.0 111.078 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.65 161.22 29.74 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 117.9 -2.095 . . . . 0.0 112.989 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -150.48 117.23 5.83 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.135 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.49 161.57 42.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.652 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.35 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.746 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.16 166.64 31.09 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.337 -1.887 . . . . 0.0 112.338 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -85.24 134.29 34.14 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.567 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 483' ' ' PHE . 2.2 p -66.21 138.24 23.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.998 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.658 ' CE1' ' OE2' ' A' ' 413' ' ' GLU . 1.5 m-85 -153.08 146.16 24.63 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.623 ' O ' HG23 ' A' ' 410' ' ' THR . 4.2 m-85 -110.94 41.53 1.8 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.531 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 409' ' ' PHE . 0.8 OUTLIER -160.95 143.65 12.72 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.189 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -78.11 -13.36 59.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.606 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.61 -41.04 24.61 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.06 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . 0.658 ' OE2' ' CE1' ' A' ' 408' ' ' TYR . 6.0 mm-40 -64.38 -40.6 96.14 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.966 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.07 97.99 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.46 -38.28 90.54 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -82.01 -16.96 48.52 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.56 -52.4 4.91 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.183 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.51 -19.06 55.78 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.563 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.579 ' C ' ' H ' ' A' ' 421' ' ' GLY . 0.7 OUTLIER -64.6 -48.24 75.67 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.877 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -1.07 0.08 Allowed 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 77.82 64.86 1.98 Allowed Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.08 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . 0.701 ' C ' ' HE ' ' A' ' 423' ' ' ARG . 7.2 mt-10 -146.43 -166.53 2.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.414 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . 0.753 ' N ' ' HE ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER -115.69 148.36 39.82 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.632 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.419 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 1.7 t -148.97 162.1 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.075 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 6.2 mm -123.81 160.74 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.24 121.14 30.39 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.432 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 409' ' ' PHE . 24.8 t -111.31 117.27 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.246 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 447' ' ' THR . 17.0 mtp85 -152.43 155.52 37.7 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.941 HD23 ' H ' ' A' ' 429' ' ' LEU . 0.7 OUTLIER -106.32 28.71 7.48 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.571 1.177 . . . . 0.0 109.649 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.39 121.17 2.96 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.721 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.8 OUTLIER -76.08 179.56 5.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.97 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 2.9 t -177.24 139.5 0.44 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.068 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.91 -72.9 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.617 1.545 . . . . 0.0 111.871 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 435' ' ' ASP . 7.4 pt-20 -39.48 -32.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.659 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 438' ' ' GLY . 4.0 m-20 -62.14 -8.6 5.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.727 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.624 HG23 ' N ' ' A' ' 437' ' ' GLU . 6.7 tp -48.54 -43.4 13.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.878 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.624 ' N ' HG23 ' A' ' 436' ' ' ILE . 23.2 mt-10 -62.66 -27.19 69.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 117.769 -1.572 . . . . 0.0 107.957 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -78.88 -26.93 57.58 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 27.8 mtt -66.49 -39.22 88.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.756 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -74.54 -39.72 62.16 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.336 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.756 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -55.76 -28.77 57.71 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.782 -1.167 . . . . 0.0 107.91 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -112.84 89.47 3.09 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.118 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 443' ' ' GLU . 7.0 pt-20 -64.36 37.23 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.862 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -171.58 140.52 5.9 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.9 mm -139.24 132.17 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.913 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 427' ' ' VAL . 1.4 tp -135.96 95.98 3.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.2 p -109.14 161.44 15.21 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.804 -0.758 . . . . 0.0 112.768 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 474' ' ' ILE . 37.0 t -85.23 -21.0 8.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.971 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 470' ' ' GLY . 19.1 mmm-85 -105.97 -148.11 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.626 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 89.08 -136.58 13.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . 0.578 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 82.59 163.69 33.76 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 16.8 tpp 46.64 13.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.482 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.3 OUTLIER 66.97 131.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.592 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.654 ' H ' ' HB3' ' A' ' 457' ' ' ALA . 9.0 t -163.58 -169.97 2.08 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.957 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' HIS . . . . . 0.603 ' O ' HG23 ' A' ' 459' ' ' VAL . 4.6 m80 -43.41 -46.04 6.47 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.721 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -61.39 -48.12 82.68 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.663 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.654 ' HB3' ' H ' ' A' ' 454' ' ' SER . . . -74.66 -55.02 6.33 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.534 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 459' ' ' VAL . 2.2 t -50.25 -53.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.548 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 455' ' ' HIS . 88.6 t -54.08 -44.1 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.527 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.696 ' HB1' ' SG ' ' A' ' 467' ' ' CYS . . . -61.22 -55.17 35.15 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -55.38 -28.69 55.64 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.534 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.11 66.14 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.602 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 463' ' ' MET . 1.1 tpt -91.46 -41.66 10.72 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.03 83.94 1.64 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.523 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' THR . . . . . 0.643 HG22 ' N ' ' A' ' 466' ' ' CYS . 1.9 m -162.36 171.93 16.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.8 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' CYS . . . . . 0.643 ' N ' HG22 ' A' ' 465' ' ' THR . 12.8 t -78.1 126.47 30.87 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.958 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.696 ' SG ' ' HB1' ' A' ' 460' ' ' ALA . 0.5 OUTLIER -151.2 148.36 28.15 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.89 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.01 160.78 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.67 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . 0.578 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 6.9 t -150.85 152.6 33.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.443 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 44.16 87.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.431 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -99.63 -174.78 2.8 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.45 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -47.22 -84.29 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -158.15 66.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.95 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.3 mt -61.96 102.71 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.604 -0.839 . . . . 0.0 112.45 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.69 120.29 29.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.851 HG23 ' O ' ' A' ' 482' ' ' THR . 52.9 mt -88.76 137.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.327 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . 0.529 ' CB ' ' OG1' ' A' ' 482' ' ' THR . 0.3 OUTLIER -107.42 123.15 47.96 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.682 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.604 ' C ' ' N ' ' A' ' 480' ' ' ALA . 20.3 mm-40 -54.58 -7.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 478' ' ' GLU . 0.1 OUTLIER -46.46 -18.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.239 -1.384 . . . . 0.0 108.311 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.604 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . 177.56 -97.37 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 112.283 -2.235 . . . . 0.0 105.43 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . 0.584 ' CD ' ' CD2' ' A' ' 409' ' ' PHE . 3.6 mmpp? -148.55 40.49 0.92 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.851 ' O ' HG23 ' A' ' 476' ' ' ILE . 44.5 p -68.94 172.94 5.88 Favored 'General case' 0 C--O 1.197 -1.708 0 CA-C-N 113.975 -1.466 . . . . 0.0 114.384 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -151.5 147.94 27.45 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.812 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' GLU . . . . . 0.495 ' C ' ' CD ' ' A' ' 484' ' ' GLU . 3.1 tp10 -131.72 113.89 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.372 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.889 HD23 ' O ' ' A' ' 485' ' ' LEU . 0.3 OUTLIER -151.08 161.73 42.18 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.786 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.21 -115.41 7.97 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.036 -1.554 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . 0.454 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -130.17 29.53 3.67 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.38 -1.391 . . . . 0.0 110.804 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 15.3 m170 -151.21 148.77 28.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.68 -1.208 . . . . 0.0 111.41 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.427 ' OG1' ' OE1' ' A' ' 484' ' ' GLU . 3.3 m -116.71 99.14 6.92 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.169 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.568 ' HE2' HG21 ' A' ' 392' ' ' ILE . 38.3 m-85 -90.06 160.6 16.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.562 ' CA ' HG22 ' A' ' 482' ' ' THR . . . -126.5 126.27 43.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.116 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.478 ' CB ' ' HB2' ' A' ' 481' ' ' LYS . 2.6 tm-20 -45.05 103.12 0.03 OUTLIER 'General case' 0 CA--C 1.478 -1.794 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.402 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 159.01 14.26 0.04 OUTLIER Glycine 0 C--N 1.261 -3.613 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' ASP . . . . . 0.594 ' CG ' ' N ' ' A' ' 495' ' ' TYR . 0.4 OUTLIER -138.44 -153.31 0.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.139 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . 0.594 ' N ' ' CG ' ' A' ' 494' ' ' ASP . 2.5 p90 -152.55 139.79 19.39 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.597 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 496' ' ' ILE . 0.0 OUTLIER -127.38 161.34 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.528 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 506' ' ' TYR . 3.3 t -104.61 102.88 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' LEU . . . . . 0.824 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -102.28 134.29 45.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.642 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.824 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.1 OUTLIER -121.03 142.38 49.86 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.481 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -147.8 90.4 0.15 Allowed Glycine 0 C--O 1.197 -2.188 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 502' ' ' THR . 7.4 p -160.74 8.34 0.08 Allowed 'General case' 0 C--N 1.252 -3.642 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' THR . . . . . 0.462 ' H ' ' H ' ' A' ' 503' ' ' GLY . 0.0 OUTLIER -172.41 -16.48 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 111.67 -2.514 . . . . 0.0 106.863 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.462 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 86.3 85.45 1.06 Allowed Glycine 0 N--CA 1.484 1.835 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.194 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -158.04 102.82 1.82 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' ILE . . . . . 0.611 HG12 HD13 ' A' ' 498' ' ' LEU . 3.5 mt -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.391 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' TYR . . . . . 0.72 ' CE1' HG23 ' A' ' 391' ' ' VAL . 75.5 m-85 -123.01 161.81 23.55 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.902 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 10.7 tmtt? -108.76 152.82 24.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . . . . . . 0 N--CA 1.484 1.84 0 C-N-CA 119.057 -1.545 . . . . 0.0 110.243 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 2.3 t -50.13 132.21 9.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 505' ' ' ILE . 3.4 pt -78.03 -52.49 15.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . 170.84 -170.92 43.54 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.7 p -143.2 142.11 31.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.769 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.09 -145.75 0.4 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 396' ' ' LEU . 6.8 mt -77.17 125.28 86.8 Favored Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.768 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.82 102.36 0.63 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.982 1.122 . . . . 0.0 111.26 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -70.77 -62.15 1.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.356 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.8 t -146.73 140.88 15.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.975 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.29 103.36 0.15 Allowed 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.078 1.185 . . . . 0.0 111.072 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -151.25 161.68 29.22 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.772 -1.68 . . . . 0.0 112.28 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -134.93 124.6 25.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -149.76 160.89 43.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.143 -1.423 . . . . 0.0 112.595 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.698 ' HB1' ' OH ' ' A' ' 495' ' ' TYR . . . -142.16 110.11 5.87 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.017 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.12 165.92 30.89 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.957 -1.592 . . . . 0.0 111.292 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.502 ' N ' ' HD2' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -85.18 147.14 26.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.688 HG11 ' HZ ' ' A' ' 483' ' ' PHE . 2.0 m -78.72 142.7 13.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.473 -1.291 . . . . 0.0 113.228 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -146.87 146.47 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.892 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 427' ' ' VAL . 4.9 m-85 -105.84 37.41 2.25 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.439 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 409' ' ' PHE . 21.5 p -155.85 141.45 17.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.028 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 -12.8 59.89 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.278 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.47 -43.62 59.81 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.672 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.15 -42.62 86.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.674 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ALA . . . . . 0.786 ' HB1' ' HB1' ' A' ' 441' ' ' ALA . . . -61.29 -39.67 91.31 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.523 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -58.86 -30.15 67.51 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.985 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -88.6 -38.74 14.62 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.537 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -69.04 -61.01 1.97 Allowed 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.114 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 417' ' ' ALA . 19.5 t-80 -43.4 -26.52 0.2 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.811 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.435 ' N ' ' C ' ' A' ' 417' ' ' ALA . 30.1 tt0 -91.17 -33.92 15.22 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.375 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 417' ' ' ALA . 29.4 mtmt -131.74 49.9 2.28 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.813 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -178.38 -48.24 0.07 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . 0.523 ' O ' ' NE ' ' A' ' 423' ' ' ARG . 2.5 mt-10 48.96 71.23 0.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.167 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 422' ' ' GLU . 6.3 mtm180 164.04 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 0.2 OUTLIER -147.51 160.34 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.698 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 426' ' ' LEU . 43.2 mm -121.25 160.66 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.102 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.48 ' N ' HG22 ' A' ' 425' ' ' ILE . 13.1 tp -127.31 118.55 24.4 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.83 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 409' ' ' PHE . 1.5 t -104.66 130.82 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.038 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ARG . . . . . 0.726 ' O ' HG22 ' A' ' 447' ' ' THR . 1.6 mtp85 -153.01 145.94 24.51 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 429' ' ' LEU . 5.8 mp -56.61 -60.72 3.13 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.816 -1.553 . . . . 0.0 109.698 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.9 -175.09 2.59 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.611 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.662 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -94.17 176.61 6.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.183 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.2 t -173.09 128.35 0.52 Allowed Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.357 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.0 Cg_endo -61.41 -56.37 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.107 1.205 . . . . 0.0 111.501 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 434' ' ' GLU . 8.1 mt-10 -45.71 -13.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 433' ' ' PRO . 13.4 t70 -90.31 -8.3 51.2 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.557 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.944 HG23 ' H ' ' A' ' 437' ' ' GLU . 4.9 tp -41.85 -60.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.174 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.944 ' H ' HG23 ' A' ' 436' ' ' ILE . 19.3 mm-40 -49.11 -33.75 12.51 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.419 -1.312 . . . . 0.0 109.189 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.46 -24.18 68.66 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 436' ' ' ILE . 26.8 mtt -72.71 -34.37 67.08 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.71 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -75.74 -45.6 35.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 118.113 -1.435 . . . . 0.0 109.622 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.786 ' HB1' ' HB1' ' A' ' 414' ' ' ALA . . . -47.41 -36.39 9.73 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.426 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.666 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -106.86 93.07 4.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.501 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.79 28.22 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.597 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.666 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -160.28 132.01 2.82 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.2 mm -127.97 142.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.001 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 427' ' ' VAL . 4.7 tp -150.1 97.32 2.55 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.261 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 428' ' ' ARG . 0.9 OUTLIER -108.72 160.33 16.04 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.874 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.557 HG22 ' HB ' ' A' ' 474' ' ' ILE . 34.0 t -75.76 -45.05 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.829 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -94.08 -150.15 0.29 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.458 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 77.46 128.29 0.39 Allowed Glycine 0 N--CA 1.482 1.759 0 C-N-CA 119.145 -1.502 . . . . 0.0 109.4 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 453' ' ' THR . . . 175.62 -163.43 33.19 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 53.9 mtp 44.04 19.58 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.084 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 67.16 122.87 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.66 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 458' ' ' VAL . 69.9 p -166.64 -156.2 0.23 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.318 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' HIS . . . . . 0.684 ' O ' HG23 ' A' ' 459' ' ' VAL . 26.3 m80 -51.88 -51.1 59.16 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.971 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.662 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -52.55 -42.4 64.4 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.533 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -84.55 -51.02 7.2 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.519 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 454' ' ' SER . 79.0 t -55.28 -44.82 76.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.748 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 455' ' ' HIS . 47.2 t -67.16 -55.2 18.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.066 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.27 -28.96 65.43 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.289 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -65.35 -45.62 83.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -67.15 -24.29 73.28 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.147 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -21.31 31.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.815 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 63.02 21.12 63.32 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.675 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' THR . . . . . 0.889 HG22 ' H ' ' A' ' 466' ' ' CYS . 14.4 m -93.08 -168.89 2.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' CYS . . . . . 0.889 ' H ' HG22 ' A' ' 465' ' ' THR . 8.9 t -97.44 122.6 40.68 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.7 t -151.18 149.2 29.18 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.351 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -127.37 160.89 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.393 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . 0.482 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 6.2 t -150.43 155.68 40.01 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.34 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 450' ' ' GLY . . . 53.72 75.46 0.23 Allowed Glycine 0 N--CA 1.497 2.747 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . 0.734 ' SG ' HD22 ' A' ' 485' ' ' LEU . 0.6 OUTLIER -82.93 -179.58 7.48 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.919 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -57.82 -96.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -140.38 58.52 1.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.65 HG23 ' CB ' ' A' ' 483' ' ' PHE . 11.3 mt -53.36 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.637 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.26 115.3 26.65 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 482' ' ' THR . 11.1 mt -88.18 136.6 22.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.129 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . 0.416 HD22 ' C ' ' A' ' 476' ' ' ILE . 4.9 m120 -114.63 127.2 55.64 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.18 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' A' ' 480' ' ' ALA . 10.3 pt-20 -62.85 -5.44 2.83 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.048 -0.978 . . . . 0.0 113.227 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 478' ' ' GLU . 5.2 mm-40 -46.13 -19.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.437 -1.305 . . . . 0.0 108.45 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -175.14 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . 0.536 ' HD2' ' CD2' ' A' ' 409' ' ' PHE . 0.8 OUTLIER -153.5 56.78 0.75 Allowed 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.874 ' O ' HG23 ' A' ' 476' ' ' ILE . 1.6 p -86.6 175.37 8.34 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' PHE . . . . . 0.688 ' HZ ' HG11 ' A' ' 407' ' ' VAL . 0.3 OUTLIER -151.93 120.86 6.61 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.762 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -91.95 114.42 26.95 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.533 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.734 HD22 ' SG ' ' A' ' 471' ' ' CYS . 63.6 tp -138.3 155.69 48.35 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.843 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' GLY . . . . . 0.473 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.66 -107.92 1.86 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -139.11 28.87 2.58 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.065 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.24 160.56 43.6 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.781 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.4 m -113.82 107.96 16.42 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.19 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.52 ' HB2' ' CE2' ' A' ' 483' ' ' PHE . 10.0 m-30 -89.55 119.44 29.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.505 -0.878 . . . . 0.0 108.859 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -100.24 136.78 39.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.155 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.508 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.9 tm-20 -50.05 95.12 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.949 0 C-N-CA 118.438 -1.305 . . . . 0.0 108.742 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 161.44 17.87 0.03 OUTLIER Glycine 0 C--N 1.267 -3.3 0 C-N-CA 118.313 -1.899 . . . . 0.0 109.624 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -128.69 -161.33 1.1 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.08 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . 0.698 ' OH ' ' HB1' ' A' ' 404' ' ' ALA . 1.8 t80 -137.64 132.7 33.37 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.491 HG22 ' CG ' ' A' ' 507' ' ' LYS . 0.6 OUTLIER -136.81 162.35 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.818 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 28.9 p -130.17 113.21 14.18 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.684 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -109.13 152.61 24.87 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.716 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.491 ' O ' HD12 ' A' ' 498' ' ' LEU . 4.4 t70 -99.42 160.39 14.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.027 0.918 . . . . 0.0 112.847 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -155.64 96.46 0.16 Allowed Glycine 0 C--N 1.289 -2.032 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' SER . . . . . 0.814 ' O ' HG23 ' A' ' 502' ' ' THR . 3.6 t 175.06 5.38 0.0 OUTLIER 'General case' 1 C--N 1.242 -4.071 0 CA-C-N 112.911 -1.644 . . . . 0.0 107.779 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 501' ' ' SER . 0.4 OUTLIER -175.0 -23.26 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.542 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 96.26 85.52 1.74 Allowed Glycine 0 N--CA 1.479 1.506 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -151.38 101.78 2.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.465 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' ILE . . . . . 0.642 HG21 HD11 ' A' ' 392' ' ' ILE . 4.7 mt -89.05 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.286 -0.965 . . . . 0.0 110.749 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 12.2 t80 -148.96 161.7 41.38 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.59 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 1.8 ttpt -125.74 156.36 39.53 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.598 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.249 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.686 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 19.9 t -112.66 140.41 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.388 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.863 HD12 HD21 ' A' ' 485' ' ' LEU . 0.7 OUTLIER -92.06 -25.32 5.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.215 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 162.78 -172.65 38.87 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.04 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.95 129.76 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.764 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.48 -146.22 0.24 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.274 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.7 140.79 33.51 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.94 96.94 0.46 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.227 1.285 . . . . 0.0 111.65 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -75.14 -73.14 0.26 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.351 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.9 p -136.88 144.16 45.46 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.347 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.89 101.66 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.983 1.122 . . . . 0.0 110.344 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.54 162.45 29.93 Favored Glycine 0 N--CA 1.51 3.624 0 C-N-CA 117.685 -2.198 . . . . 0.0 113.658 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.752 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -136.53 119.76 16.71 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.71 161.77 41.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.936 -1.506 . . . . 0.0 113.802 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -144.92 112.59 6.25 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 113.904 -1.498 . . . . 0.0 107.708 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.85 168.03 31.7 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.848 -1.644 . . . . 0.0 112.124 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 142.67 29.96 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.149 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 407' ' ' VAL . 0.2 OUTLIER -78.46 148.15 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.7 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.506 ' C ' ' H ' ' A' ' 410' ' ' THR . 0.4 OUTLIER -159.97 99.61 1.38 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.769 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 481' ' ' LYS . 7.8 m-85 -57.12 -0.32 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.846 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . 0.506 ' H ' ' C ' ' A' ' 408' ' ' TYR . 3.2 p -106.39 140.91 38.57 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.99 26.12 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.515 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -70.7 -38.09 73.63 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.167 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 417' ' ' ALA . 68.9 mm-40 -62.81 -51.42 67.14 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' A' ' 441' ' ' ALA . . . -54.67 -31.71 58.13 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.982 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -71.27 -47.36 57.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.59 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -86.19 -9.35 56.75 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.03 -55.11 3.75 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -56.8 -28.03 60.77 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.863 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 421' ' ' GLY . 1.6 tt0 -55.58 -45.48 77.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.189 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 420' ' ' LYS . 0.8 OUTLIER -59.33 -6.12 0.92 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.493 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 82.92 49.02 5.23 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.467 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -133.33 154.21 50.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.679 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . 0.519 ' H ' ' HD2' ' A' ' 423' ' ' ARG . 0.4 OUTLIER -79.12 146.46 33.19 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.775 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.21 160.84 15.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.637 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 426' ' ' LEU . 41.5 mm -125.83 160.55 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.731 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.546 ' N ' HG22 ' A' ' 425' ' ' ILE . 3.4 tp -132.17 121.19 23.32 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.042 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.484 ' CG1' ' CZ ' ' A' ' 409' ' ' PHE . 7.2 t -110.57 121.03 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.36 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ARG . . . . . 0.664 ' O ' HG22 ' A' ' 447' ' ' THR . 0.1 OUTLIER -150.9 148.67 28.72 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.02 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 429' ' ' LEU . 5.7 mt -53.43 -49.64 66.91 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.199 -1.401 . . . . 0.0 109.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -135.82 167.82 20.46 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.863 HG21 ' HB2' ' A' ' 456' ' ' ALA . 0.5 OUTLIER -107.65 161.66 14.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.317 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.94 160.92 32.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.64 -31.51 94.45 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.99 1.793 . . . . 0.0 112.329 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.46 -12.91 61.64 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 439' ' ' MET . 15.0 m-20 -90.85 -9.05 47.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.919 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.644 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -35.78 -56.12 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.644 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 32.9 mt-10 -61.07 -38.69 87.12 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.341 -1.344 . . . . 0.0 109.052 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -72.83 -21.77 79.52 Favored Glycine 0 C--N 1.3 -1.45 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 435' ' ' ASP . 70.9 mtp -79.22 -46.41 17.92 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.336 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.773 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.1 OUTLIER -71.84 -34.79 69.58 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.398 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.773 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -56.45 -23.74 40.88 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.647 -1.221 . . . . 0.0 107.979 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -117.11 85.4 2.32 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.969 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.437 ' HA ' ' CG2' ' A' ' 465' ' ' THR . 11.8 pt-20 -52.41 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.591 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -136.24 139.66 10.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.538 HD12 ' SG ' ' A' ' 467' ' ' CYS . 67.8 mt -141.36 142.8 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.689 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.406 HD11 ' SG ' ' A' ' 471' ' ' CYS . 4.6 tp -140.24 98.95 3.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.6 p -111.53 161.27 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.42 -24.45 12.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 470' ' ' GLY . 14.0 mmt180 -100.87 -121.88 0.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.324 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.497 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 68.43 144.6 0.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -131.16 179.87 16.68 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.22 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.437 ' H ' ' HG3' ' A' ' 452' ' ' MET . 86.9 mtp -43.72 -28.83 0.45 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.091 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 453' ' ' THR . 6.7 t -160.59 132.28 5.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.325 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.3 p 179.05 -176.85 0.26 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.53 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' HIS . . . . . 0.704 ' O ' HG23 ' A' ' 459' ' ' VAL . 68.0 m80 -42.98 -49.52 5.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.336 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 431' ' ' THR . . . -48.44 -48.64 37.28 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.819 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.567 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 2.6 t -45.13 -45.58 3.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 455' ' ' HIS . 24.2 t -70.42 -40.27 77.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.575 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -68.66 -32.77 72.85 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.595 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -67.7 -36.95 81.59 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -75.28 -33.67 53.09 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.534 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 6.7 mmt -94.27 0.32 55.56 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.96 60.53 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 443' ' ' GLU . 0.2 OUTLIER -95.31 156.1 16.46 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.0 OUTLIER -89.43 129.88 35.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.692 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.753 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 99.5 m -152.86 157.42 40.68 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.062 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -126.15 162.28 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.263 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . 0.517 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 7.9 t -150.3 147.71 27.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.278 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 57.23 90.45 0.01 OUTLIER Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.349 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . 0.406 ' SG ' HD11 ' A' ' 446' ' ' LEU . 0.1 OUTLIER -99.85 170.18 8.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.569 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -44.77 -82.02 0.03 OUTLIER Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.614 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -156.06 68.06 0.62 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.037 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.644 HG23 ' CB ' ' A' ' 483' ' ' PHE . 17.4 mt -66.47 102.64 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.081 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -88.72 120.03 29.74 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.841 HG23 ' O ' ' A' ' 482' ' ' THR . 3.8 mt -87.68 132.32 33.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.77 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.22 122.13 45.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.609 ' C ' ' N ' ' A' ' 480' ' ' ALA . 0.4 OUTLIER -53.06 -9.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.338 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -44.92 -18.45 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.401 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.609 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -177.88 -102.29 0.0 OUTLIER 'General case' 0 C--N 1.263 -3.176 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 409' ' ' PHE . 10.9 mmmt -150.61 43.39 0.83 Allowed 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.841 ' O ' HG23 ' A' ' 476' ' ' ILE . 52.1 p -69.06 174.35 4.64 Favored 'General case' 0 C--O 1.194 -1.857 0 CA-C-N 113.23 -1.805 . . . . 0.0 114.41 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' PHE . . . . . 0.644 ' CB ' HG23 ' A' ' 474' ' ' ILE . 0.7 OUTLIER -152.04 132.18 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.809 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -112.59 116.53 30.34 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.031 -0.667 . . . . 0.0 111.146 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.866 HD23 ' O ' ' A' ' 485' ' ' LEU . 0.3 OUTLIER -150.63 161.89 41.72 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.903 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.55 -113.01 5.47 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -132.21 26.15 3.77 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 2.7 m-70 -150.16 153.23 35.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 58.4 m -115.06 100.23 8.02 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.481 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 507' ' ' LYS . 7.6 m-85 -89.78 158.37 17.53 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.582 ' CB ' HG22 ' A' ' 482' ' ' THR . . . -126.43 128.21 46.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.323 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.47 ' CB ' ' HB2' ' A' ' 481' ' ' LYS . 0.0 OUTLIER -47.4 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.472 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 168.53 14.32 0.02 OUTLIER Glycine 0 C--N 1.266 -3.311 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -142.64 -153.57 0.47 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.887 -0.657 . . . . 0.0 109.76 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -147.99 155.39 41.47 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.849 -1.141 . . . . 0.0 111.841 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.4 ' CG2' ' HG3' ' A' ' 507' ' ' LYS . 39.9 pt -136.99 162.31 34.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.833 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 30.7 t -127.76 108.84 11.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' LEU . . . . . 1.087 HD23 ' H ' ' A' ' 498' ' ' LEU . 1.7 pt? -117.03 159.35 22.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.723 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 500' ' ' GLY . 50.5 t0 -94.95 161.44 14.14 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.272 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -144.73 93.69 0.17 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 53.6 p 175.22 -7.32 0.0 OUTLIER 'General case' 0 C--N 1.25 -3.754 0 CA-C-N 111.66 -2.27 . . . . 0.0 106.08 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.8 -28.02 0.13 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.045 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 100.52 -11.44 59.67 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.638 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -50.38 125.81 13.56 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' ILE . . . . . 0.626 HG23 ' HB3' ' A' ' 498' ' ' LEU . 6.9 mt -113.88 135.04 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.397 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' TYR . . . . . 0.686 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 0.5 OUTLIER -128.21 159.89 33.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.631 ' HE3' ' H ' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -119.29 161.01 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.186 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 C-N-CA 119.376 -1.392 . . . . 0.0 110.991 179.883 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.067 0.46 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.716 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 45.5 t -66.57 150.18 11.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.645 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.504 ' CG1' ' N ' ' A' ' 393' ' ' GLY . 5.2 pt -117.22 -48.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.694 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -159.14 -157.54 8.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.554 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.5 p -171.41 116.1 0.41 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.78 -145.87 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 396' ' ' LEU . 96.4 mt -87.44 134.3 36.46 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.674 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.51 86.44 0.44 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.016 1.144 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -60.89 -60.83 3.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.084 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.3 p -143.77 145.87 32.58 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.217 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.35 119.36 6.24 Favored 'Trans proline' 0 C--N 1.326 -0.642 0 C-N-CA 121.085 1.19 . . . . 0.0 109.916 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.612 ' H ' ' CA ' ' A' ' 500' ' ' GLY . . . -152.48 162.88 30.11 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.524 -2.274 . . . . 0.0 114.556 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -151.85 107.17 3.3 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.4 161.39 42.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 117.968 -1.493 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.23 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.013 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.97 167.58 31.15 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.649 -1.262 . . . . 0.0 111.134 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.443 ' HG3' HG13 ' A' ' 424' ' ' VAL . 9.5 ptpt -82.72 161.76 21.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.305 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.542 HG11 ' HZ ' ' A' ' 483' ' ' PHE . 1.5 m -97.79 149.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.757 ' CZ ' ' HB2' ' A' ' 414' ' ' ALA . 33.1 p90 -153.44 174.75 13.98 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.035 -1.438 . . . . 0.0 107.536 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.57 ' CE1' ' HB3' ' A' ' 481' ' ' LYS . 2.7 m-85 -129.76 -19.32 3.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.203 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 38.8 p -100.51 135.6 41.7 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.47 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.82 -23.1 67.11 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.837 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -68.68 -41.36 79.34 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.098 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.92 -40.91 90.51 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.076 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ALA . . . . . 0.757 ' HB2' ' CZ ' ' A' ' 408' ' ' TYR . . . -57.69 -37.55 73.67 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.394 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.19 -35.45 80.83 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.433 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.53 -13.52 37.17 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.59 -55.51 3.55 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.74 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 418' ' ' HIS . 0.3 OUTLIER -61.21 -21.1 63.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.846 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.486 ' CA ' ' OE1' ' A' ' 419' ' ' GLU . 0.6 OUTLIER -69.65 -38.08 76.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.588 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -64.53 -1.87 2.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 73.12 44.14 36.89 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.665 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -137.12 136.37 38.24 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . 0.41 ' C ' ' CG2' ' A' ' 424' ' ' VAL . 11.4 mmt180 -56.23 155.62 6.55 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.311 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.443 HG13 ' HG3' ' A' ' 406' ' ' LYS . 2.0 t -147.64 158.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.988 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.434 ' O ' ' CD1' ' A' ' 408' ' ' TYR . 6.3 mm -126.24 158.58 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.618 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 5.3 tp -127.61 142.97 51.21 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.511 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.445 ' N ' ' HG ' ' A' ' 426' ' ' LEU . 25.1 t -128.04 120.13 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.268 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ARG . . . . . 0.667 ' O ' HG22 ' A' ' 447' ' ' THR . 0.1 OUTLIER -151.37 149.42 29.3 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.093 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 429' ' ' LEU . 3.5 mp -48.04 -57.04 6.32 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.366 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 431' ' ' THR . 1.0 OUTLIER -130.4 165.18 23.11 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.467 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.442 ' H ' ' HG3' ' A' ' 430' ' ' GLU . 0.4 OUTLIER -101.17 -179.63 4.1 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.383 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 27.2 p -163.98 151.73 10.81 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.564 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.8 Cg_endo -61.59 -53.07 2.51 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.467 1.445 . . . . 0.0 112.036 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 434' ' ' GLU . 8.4 mm-40 -45.08 -18.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.8 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.8 m-20 -87.2 -6.35 58.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.656 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.736 HG23 ' N ' ' A' ' 437' ' ' GLU . 10.4 tp -33.63 -51.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.736 ' N ' HG23 ' A' ' 436' ' ' ILE . 3.0 pm0 -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.074 -1.45 . . . . 0.0 108.448 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.656 ' H ' ' CD ' ' A' ' 437' ' ' GLU . . . -66.49 -30.82 77.15 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -62.4 -44.01 97.45 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.959 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -62.29 -56.88 14.16 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -46.73 -33.2 4.14 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.56 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -96.2 81.01 3.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.069 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.76 17.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.72 143.93 9.15 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.418 HG22 ' SG ' ' A' ' 467' ' ' CYS . 0.6 OUTLIER -135.3 133.95 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.316 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.462 HD11 ' SG ' ' A' ' 471' ' ' CYS . 3.5 tp -135.8 98.12 3.82 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.105 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.1 p -116.24 161.84 18.37 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.67 -23.18 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.72 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' ARG . . . . . 0.452 HH22 ' HE3' ' A' ' 452' ' ' MET . 1.3 mmp_? -112.44 -128.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.861 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 62.52 -170.97 11.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 61.51 -20.97 0.05 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.668 ' H ' ' C ' ' A' ' 450' ' ' GLY . 7.5 mmt -68.92 42.72 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . 0.563 ' H ' ' C ' ' A' ' 451' ' ' GLY . 39.1 p 45.66 90.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.1 t -173.32 -155.66 0.08 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.122 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' HIS . . . . . 0.493 ' O ' HG23 ' A' ' 459' ' ' VAL . 8.5 p-80 -55.24 -41.69 72.46 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.44 50.98 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.366 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.46 -28.41 52.34 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.903 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.51 -54.31 12.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.573 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 455' ' ' HIS . 92.1 t -56.49 -40.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.115 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.64 55.15 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.78 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -65.96 -14.78 62.2 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.814 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.46 -35.61 19.54 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.489 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 7.3 mmt -91.75 -9.72 42.61 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 62.06 24.42 65.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 466' ' ' CYS . 14.3 t -87.7 -166.86 1.7 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' CYS . . . . . 0.46 ' CB ' ' HA3' ' A' ' 401' ' ' GLY . 8.9 t -98.98 123.26 43.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.424 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.759 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.4 t -152.06 139.91 19.97 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 118.018 -1.473 . . . . 0.0 112.708 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.99 161.27 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . 0.55 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 9.0 t -151.46 151.8 32.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.971 -1.491 . . . . 0.0 113.86 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 48.2 90.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.146 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . 0.462 ' SG ' HD11 ' A' ' 446' ' ' LEU . 96.7 m -98.42 -160.53 0.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.834 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.75 -95.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.63 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' GLU . . . . . 0.555 ' N ' ' CD ' ' A' ' 473' ' ' GLU . 1.6 pm0 -142.07 58.94 1.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.1 mt -43.17 102.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.775 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -88.86 113.76 24.75 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 482' ' ' THR . 9.5 mt -88.69 134.37 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 118.602 -1.239 . . . . 0.0 112.38 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.5 123.47 50.29 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.385 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.622 ' C ' ' N ' ' A' ' 480' ' ' ALA . 1.2 tt0 -63.6 -3.43 2.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.442 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -47.71 -16.56 0.07 Allowed 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 118.194 -1.402 . . . . 0.0 108.296 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.622 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -174.8 -100.38 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . 0.57 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.0 OUTLIER -158.05 65.91 0.46 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.848 ' O ' HG23 ' A' ' 476' ' ' ILE . 1.4 p -97.51 178.34 5.22 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' PHE . . . . . 0.542 ' HZ ' HG11 ' A' ' 407' ' ' VAL . 0.2 OUTLIER -151.56 129.69 11.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.471 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -99.61 116.46 31.78 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.665 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 1.016 HD23 ' N ' ' A' ' 486' ' ' GLY . 3.2 tt -136.51 156.25 48.85 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.012 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' GLY . . . . . 1.016 ' N ' HD23 ' A' ' 485' ' ' LEU . . . 44.65 -117.43 2.11 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.283 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -124.42 37.15 2.71 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.532 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' HIS . . . . . 0.506 ' CG ' ' CZ ' ' A' ' 490' ' ' PHE . 0.3 OUTLIER -150.68 129.65 12.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.404 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 83.5 m -102.98 115.07 29.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.59 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.506 ' CZ ' ' CG ' ' A' ' 488' ' ' HIS . 22.8 m-85 -112.43 130.94 55.81 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.751 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -99.18 156.84 16.75 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.484 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.5 tm-20 -65.46 63.67 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.602 -1.239 . . . . 0.0 108.566 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -160.43 25.45 0.29 Allowed Glycine 0 C--N 1.263 -3.512 0 C-N-CA 119.263 -1.446 . . . . 0.0 109.838 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -146.26 -164.62 2.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.046 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -128.23 137.58 52.08 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.215 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 496' ' ' ILE . 2.0 pt -131.93 160.14 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.089 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 506' ' ' TYR . 48.3 m -123.46 110.98 15.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.348 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' LEU . . . . . 0.963 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -105.57 136.92 44.27 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.418 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.963 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.5 OUTLIER -108.6 160.58 15.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.027 0.917 . . . . 0.0 112.244 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' GLY . . . . . 0.612 ' CA ' ' H ' ' A' ' 401' ' ' GLY . . . -142.11 94.2 0.18 Allowed Glycine 0 C--N 1.285 -2.299 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 502' ' ' THR . 4.6 m -171.42 -3.01 0.01 OUTLIER 'General case' 0 C--N 1.244 -3.98 0 CA-C-N 112.577 -1.812 . . . . 0.0 107.398 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 501' ' ' SER . 0.8 OUTLIER -167.09 -16.68 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.555 -2.111 . . . . 0.0 107.276 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.46 40.13 8.58 Favored Glycine 0 N--CA 1.482 1.725 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.371 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -115.37 119.97 38.03 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' ILE . . . . . 0.541 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.5 tt -97.57 160.23 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.425 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' TYR . . . . . 0.716 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 17.8 m-85 -135.15 162.09 33.5 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.178 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.496 ' HD2' ' CE1' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -136.71 142.93 43.12 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.779 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . 0.474 ' N ' ' HD3' ' A' ' 507' ' ' LYS . . . . . . . . 0 N--CA 1.493 2.461 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.758 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.57 142.76 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.539 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 1.9 pt -94.42 -33.53 5.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.757 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 179.67 -167.49 37.39 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.87 -1.633 . . . . 0.0 111.314 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 31.1 t -154.79 120.78 5.21 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.583 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.463 ' HB2' ' SG ' ' A' ' 471' ' ' CYS . . . -93.09 -144.06 0.22 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.076 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 51.2 mt -93.42 128.69 41.48 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . 0.545 ' HG3' ' O ' ' A' ' 502' ' ' THR . 7.7 Cg_endo -68.37 89.35 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.142 1.228 . . . . 0.0 111.565 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -55.37 -54.73 40.06 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.506 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.1 t -150.45 141.85 15.1 Favored Pre-proline 0 C--N 1.307 -1.281 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.177 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -54.34 101.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.121 1.214 . . . . 0.0 110.569 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.584 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -151.46 161.81 29.33 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.544 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.564 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -139.21 114.87 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -138.39 160.73 38.77 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.862 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.17 110.62 6.07 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.709 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.07 167.92 31.24 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.923 -1.608 . . . . 0.0 111.268 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -82.82 137.11 34.43 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.571 ' CG1' ' C ' ' A' ' 491' ' ' ALA . 1.0 OUTLIER -83.37 151.68 3.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 C-N-CA 118.925 -1.11 . . . . 0.0 113.374 -179.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -149.86 -152.79 0.45 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.924 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.481 ' CD2' ' HE2' ' A' ' 481' ' ' LYS . 10.5 m-85 -146.31 -47.71 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.058 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 37.4 p -86.03 143.36 28.15 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.235 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -69.47 -10.91 60.07 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.503 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 412' ' ' ASP . 10.2 m-20 -74.26 -42.55 59.46 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.775 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 413' ' ' GLU . 2.1 mp0 -66.88 -42.47 85.52 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.568 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.7 66.28 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.88 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -73.68 -38.63 64.85 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.396 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.58 -12.2 37.74 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.84 -43.58 9.95 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.837 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' HIS . . . . . 0.463 ' O ' ' CD2' ' A' ' 418' ' ' HIS . 8.8 t60 -69.88 -29.42 66.63 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.219 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.68 -21.89 61.0 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 -5.93 42.86 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.797 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 89.99 45.44 4.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -147.44 131.87 17.63 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.812 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -58.58 157.09 9.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.432 ' N ' ' OE2' ' A' ' 443' ' ' GLU . 2.4 t -148.27 160.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.931 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 426' ' ' LEU . 7.5 mm -130.63 160.97 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.911 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.421 ' N ' HG22 ' A' ' 425' ' ' ILE . 4.3 tp -139.42 144.6 38.16 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.594 -1.242 . . . . 0.0 112.851 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.52 HG23 ' CG2' ' A' ' 407' ' ' VAL . 81.6 t -118.46 130.21 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.557 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ARG . . . . . 0.684 ' H ' HG22 ' A' ' 447' ' ' THR . 0.0 OUTLIER -151.79 135.26 16.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.59 -1.244 . . . . 0.0 112.06 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.11 17.87 0.12 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 428' ' ' ARG . 5.9 pt-20 175.86 147.46 0.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.566 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -87.77 177.39 7.02 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.89 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.2 m -161.6 131.08 3.23 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.712 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.03 -31.61 91.32 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 121.183 1.255 . . . . 0.0 111.807 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -75.46 -16.41 60.32 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.191 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.1 t70 -90.41 -9.24 48.27 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.723 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.679 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -39.3 -52.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.861 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.679 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 26.9 mt-10 -58.23 -35.77 72.18 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.925 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.22 -22.44 73.55 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 2.1 mmt -74.75 -42.02 58.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.433 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.776 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.2 OUTLIER -70.7 -32.98 70.38 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.332 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.776 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -50.09 -29.04 8.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -109.38 92.02 3.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.679 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.641 ' H ' ' CD ' ' A' ' 443' ' ' GLU . 1.4 pm0 -53.0 0.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.949 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -142.01 144.47 14.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.515 HD12 ' SG ' ' A' ' 467' ' ' CYS . 38.8 mt -145.73 135.45 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.459 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.435 ' C ' HD12 ' A' ' 446' ' ' LEU . 5.8 tp -131.05 98.23 4.52 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.004 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 428' ' ' ARG . 1.5 p -107.9 161.49 14.87 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.7 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 474' ' ' ILE . 4.9 t -85.28 -20.11 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.969 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -106.6 -152.05 0.47 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.755 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 81.28 -151.39 31.31 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . 0.629 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 76.78 -50.99 3.03 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.548 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.485 ' O ' ' CB ' ' A' ' 453' ' ' THR . 70.7 mmm -64.45 11.97 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.413 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . 0.62 ' H ' ' C ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.31 108.27 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.019 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 455' ' ' HIS . 30.2 t -158.41 -173.16 4.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.841 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 459' ' ' VAL . 60.4 m80 -50.34 -35.3 27.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.566 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -53.7 -58.71 6.23 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.322 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.63 -52.21 9.37 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.347 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 13.3 t -44.76 -43.42 2.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.675 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 455' ' ' HIS . 97.5 t -69.38 -43.55 80.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.201 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.94 -41.08 87.59 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.84 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -66.35 -27.71 68.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -90.0 -26.7 23.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.671 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 11.2 mmt -94.07 -23.11 18.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.302 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.69 -21.25 30.66 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.966 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 60.2 m -44.22 160.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -87.25 129.1 35.11 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.937 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.8 m -153.3 153.1 31.96 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.434 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -124.38 161.16 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 108.995 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 28.1 t -150.27 155.31 39.46 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.7 -1.2 . . . . 0.0 112.213 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 42.63 82.98 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . 0.667 ' SG ' HD11 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -90.07 -160.4 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.272 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -61.13 -99.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.542 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 474' ' ' ILE . 1.4 mm-40 -145.07 41.25 1.27 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.714 HD12 HG22 ' A' ' 448' ' ' VAL . 0.0 OUTLIER -38.81 107.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.901 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -89.71 123.99 34.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.205 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 3.0 mt -86.41 119.59 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.191 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . 0.452 HD21 ' HG3' ' A' ' 479' ' ' GLU . 53.1 t-20 -89.24 110.83 21.55 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.163 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.725 ' H ' ' CD ' ' A' ' 478' ' ' GLU . 1.4 pm0 -67.67 -9.33 42.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.525 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.452 ' HG3' HD21 ' A' ' 477' ' ' ASN . 11.4 mm-40 -46.3 -19.87 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.342 -1.343 . . . . 0.0 107.661 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.607 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -163.64 -107.21 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.412 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . 0.481 ' HE2' ' CD2' ' A' ' 409' ' ' PHE . 20.2 mmmt -159.47 70.94 0.48 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.881 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 1.2 p -138.63 148.46 44.11 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.867 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' PHE . . . . . 0.814 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 6.2 p90 -104.74 156.53 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.895 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.44 103.57 12.22 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.287 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 486' ' ' GLY . 1.4 tt -126.61 139.72 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' GLY . . . . . 0.827 ' N ' HD23 ' A' ' 485' ' ' LEU . . . 57.06 -110.59 2.28 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.128 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -128.82 36.76 2.36 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.372 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 24.4 m170 -150.35 126.15 10.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.482 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.2 m -99.38 97.36 8.41 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.971 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.565 ' CB ' ' HZ1' ' A' ' 507' ' ' LYS . 35.6 p90 -155.3 158.18 38.37 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.036 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.881 ' HB3' ' HA ' ' A' ' 482' ' ' THR . . . -170.09 -136.08 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.177 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.507 ' HA ' HG13 ' A' ' 407' ' ' VAL . 57.6 tt0 -49.63 94.18 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 117.964 -1.494 . . . . 0.0 109.39 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 152.02 17.7 0.06 OUTLIER Glycine 0 C--N 1.297 -1.611 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -156.25 -152.62 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.435 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -149.71 126.77 11.25 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.284 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.96 161.59 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.49 106.16 11.54 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.3 OUTLIER -92.48 134.77 34.64 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.169 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.513 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.4 OUTLIER -89.48 159.25 17.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.424 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' GLY . . . . . 0.584 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -155.65 95.17 0.15 Allowed Glycine 0 C--N 1.282 -2.453 0 N-CA-C 106.923 -2.471 . . . . 0.0 106.923 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 3.3 t 172.86 7.28 0.0 OUTLIER 'General case' 0 C--N 1.245 -3.956 0 CA-C-N 112.507 -1.846 . . . . 0.0 106.943 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' THR . . . . . 0.545 ' O ' ' HG3' ' A' ' 397' ' ' PRO . 0.0 OUTLIER -171.91 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.385 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.475 ' N ' ' HB3' ' A' ' 397' ' ' PRO . . . 93.11 15.42 51.79 Favored Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.923 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -75.08 172.7 11.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.26 150.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.459 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 7.7 t80 -148.97 161.33 42.12 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.01 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 28.4 tttt -131.78 151.6 51.55 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.865 -1.134 . . . . 0.0 113.701 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.779 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.365 179.645 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 121.395 0.617 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.575 HG22 ' HD1' ' A' ' 506' ' ' TYR . 41.8 t -39.4 139.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.09 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.494 HG13 ' N ' ' A' ' 393' ' ' GLY . 17.7 pt -99.81 -43.22 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.076 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -151.08 -162.9 10.99 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.706 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.8 t -179.21 127.42 0.09 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -117.61 -125.54 0.28 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.461 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 32.5 mt -100.49 139.01 20.3 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.277 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -67.56 93.42 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.274 1.316 . . . . 0.0 110.581 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -64.02 -66.71 0.5 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.107 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 24.2 t -136.97 131.07 17.8 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.848 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.85 92.56 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 121.059 1.173 . . . . 0.0 111.303 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.17 160.18 28.97 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 118.995 -1.574 . . . . 0.0 112.008 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.775 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -126.26 135.89 52.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . 0.697 ' HB1' ' OE2' ' A' ' 443' ' ' GLU . . . -150.42 160.32 43.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . 0.61 ' HB1' ' OH ' ' A' ' 495' ' ' TYR . . . -148.16 109.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.601 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.7 30.83 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.495 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -84.27 133.0 34.58 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.739 -0.785 . . . . 0.0 109.588 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.593 HG11 ' HB1' ' A' ' 491' ' ' ALA . 79.9 t -60.67 154.43 4.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.325 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' A' ' 413' ' ' GLU . 0.5 OUTLIER -162.47 135.75 6.03 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.557 ' CE2' ' NZ ' ' A' ' 481' ' ' LYS . 4.7 m-85 -100.9 28.6 5.12 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.926 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 7.2 p -149.38 143.96 26.09 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.731 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.69 59.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.966 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.8 -43.16 31.47 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . 0.491 ' HG2' ' CE1' ' A' ' 408' ' ' TYR . 0.3 OUTLIER -62.08 -39.31 92.02 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.388 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.69 83.9 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.482 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -65.7 -34.64 78.66 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.77 21.99 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.464 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -82.62 -49.02 10.28 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.982 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -49.28 -27.13 3.53 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -91.57 -28.87 17.26 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -117.48 -35.05 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.111 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -93.19 -45.59 3.51 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.069 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . 0.43 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 1.1 mt-10 66.32 158.13 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.672 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 47.35 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.161 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.91 161.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.382 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 426' ' ' LEU . 47.0 mm -123.31 157.52 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.383 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.481 ' N ' HG22 ' A' ' 425' ' ' ILE . 3.1 tp -128.82 134.52 48.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.255 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 409' ' ' PHE . 48.1 t -119.94 123.5 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.689 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ARG . . . . . 0.663 ' O ' HG22 ' A' ' 447' ' ' THR . 0.6 OUTLIER -151.53 158.31 43.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.957 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 429' ' ' LEU . 7.7 mt -63.14 -49.73 73.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.311 -1.355 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -132.27 177.64 7.43 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -81.41 171.76 14.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.064 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 1.3 m -153.33 142.32 14.54 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.604 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.3 Cg_endo -61.5 -72.92 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.481 1.454 . . . . 0.0 111.919 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.08 -10.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.288 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 433' ' ' PRO . 7.1 t70 -85.94 -8.68 57.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.679 HD12 ' NE2' ' A' ' 440' ' ' HIS . 0.2 OUTLIER -43.34 -58.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.735 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.658 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 46.8 mt-10 -55.92 -31.5 62.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.522 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.04 -23.55 77.58 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 436' ' ' ILE . 2.4 ttm -74.57 -53.99 8.34 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.778 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.679 ' NE2' HD12 ' A' ' 436' ' ' ILE . 85.8 m-70 -58.77 -50.4 74.08 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.755 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 440' ' ' HIS . . . -45.88 -24.88 0.45 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.149 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.679 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -107.15 86.27 2.28 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.488 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.697 ' OE2' ' HB1' ' A' ' 403' ' ' ALA . 0.0 OUTLIER -58.26 14.01 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.955 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.24 133.95 3.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 445' ' ' ILE . 4.5 mp -139.48 150.45 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.135 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.456 HD11 ' CG1' ' A' ' 468' ' ' VAL . 1.2 tp -144.38 128.34 17.47 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.146 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 428' ' ' ARG . 5.7 p -140.61 159.31 42.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.242 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 27.4 t -68.86 -20.85 25.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.452 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -117.0 -151.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.963 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.487 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 84.98 26.17 38.33 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -44.44 161.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.659 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.404 ' C ' HG23 ' A' ' 453' ' ' THR . 25.0 mtt 45.4 -101.52 0.05 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.837 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 452' ' ' MET . 40.3 p -153.91 81.36 1.15 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.831 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.8 m -90.67 -163.02 0.96 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.704 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' HIS . . . . . 0.513 ' O ' HG23 ' A' ' 459' ' ' VAL . 2.9 t60 -47.87 -39.78 19.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.43 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.527 ' H ' HG21 ' A' ' 431' ' ' THR . . . -59.04 -61.88 2.3 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.032 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.78 -55.59 16.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.871 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 459' ' ' VAL . 0.3 OUTLIER -45.65 -49.8 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.694 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.645 ' N ' ' CG1' ' A' ' 458' ' ' VAL . 71.3 t -62.46 -37.15 78.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.34 -46.95 78.2 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -31.14 71.67 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.69 -18.81 69.61 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' MET . . . . . 0.482 ' C ' ' SD ' ' A' ' 463' ' ' MET . 0.0 OUTLIER -94.96 -59.86 1.81 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.955 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . 0.474 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 123.93 20.83 2.47 Favored Glycine 0 N--CA 1.503 3.149 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 466' ' ' CYS . 30.9 m -97.47 166.9 11.31 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.8 m -90.12 128.08 36.24 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.799 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.72 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 13.1 t -151.71 159.07 44.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.801 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 469' ' ' SER . 0.8 OUTLIER -137.08 162.44 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.886 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . 0.487 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 11.7 t -144.27 160.42 41.01 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.894 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 44.17 79.87 0.05 OUTLIER Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.623 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . 0.657 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.0 OUTLIER -78.33 -175.18 4.08 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.107 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.448 ' H ' HD11 ' A' ' 485' ' ' LEU . . . -53.82 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.006 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.9 57.99 1.61 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.611 0.72 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 483' ' ' PHE . 4.5 mt -55.46 114.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.272 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 484' ' ' GLU . 4.4 ttpm? -99.63 122.74 43.1 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 1.7 mt -86.89 127.74 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 117.771 -1.572 . . . . 0.0 112.097 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . 0.489 ' OD1' ' CG2' ' A' ' 489' ' ' THR . 7.8 m120 -96.91 113.38 24.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.123 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.625 ' C ' ' N ' ' A' ' 480' ' ' ALA . 10.5 mt-10 -64.0 -11.88 32.95 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.984 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -46.3 -17.82 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.811 1.291 . . . . 0.0 107.928 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.625 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.32 -97.8 0.01 OUTLIER 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 112.15 -2.296 . . . . 0.0 105.537 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . 0.557 ' NZ ' ' CE2' ' A' ' 409' ' ' PHE . 3.0 mmmt -168.97 70.72 0.08 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.921 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 2.6 p -125.75 147.24 49.45 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.057 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' PHE . . . . . 0.976 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 8.0 p90 -97.68 149.98 21.68 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.572 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 475' ' ' LYS . 7.5 tt0 -110.92 107.14 16.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.129 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.835 HD23 ' H ' ' A' ' 486' ' ' GLY . 0.4 OUTLIER -144.7 156.33 44.03 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.04 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' GLY . . . . . 0.835 ' H ' HD23 ' A' ' 485' ' ' LEU . . . 64.6 -111.4 4.15 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -134.75 26.7 3.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.729 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' HIS . . . . . 0.441 ' CD2' ' H ' ' A' ' 489' ' ' THR . 13.4 t-160 -150.75 152.14 33.41 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 477' ' ' ASN . 77.3 m -115.94 99.38 7.24 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.039 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.547 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 19.6 p90 -153.78 157.55 39.58 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.075 -1.45 . . . . 0.0 114.184 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.976 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . 179.85 -137.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.295 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.591 ' N ' HG11 ' A' ' 407' ' ' VAL . 8.2 tm-20 -34.93 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.654 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 139.68 3.66 1.52 Allowed Glycine 0 C--N 1.29 -2.009 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' ASP . . . . . 0.608 ' CG ' ' H ' ' A' ' 495' ' ' TYR . 36.2 t70 -144.26 -174.16 4.22 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.235 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . 0.61 ' OH ' ' HB1' ' A' ' 404' ' ' ALA . 87.2 t80 -123.91 120.54 32.83 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.029 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.915 HD13 ' O ' ' A' ' 496' ' ' ILE . 0.0 OUTLIER -127.92 161.39 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.577 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 2.4 m -123.34 110.08 14.72 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -95.84 141.18 29.6 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.612 ' N ' HD12 ' A' ' 498' ' ' LEU . 10.3 t70 -99.99 161.41 13.63 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.064 0.935 . . . . 0.0 112.381 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -156.49 95.61 0.15 Allowed Glycine 0 C--N 1.281 -2.508 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 1.4 t 164.66 2.4 0.0 OUTLIER 'General case' 1 C--N 1.238 -4.265 0 CA-C-N 112.749 -1.726 . . . . 0.0 107.47 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 503' ' ' GLY . 6.8 m -161.72 -17.74 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.073 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 73.52 75.8 0.72 Allowed Glycine 0 N--CA 1.485 1.959 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.736 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -165.24 118.95 1.23 Allowed 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.014 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' ILE . . . . . 0.516 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 2.0 tt -99.22 157.84 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.085 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' TYR . . . . . 0.575 ' HD1' HG22 ' A' ' 391' ' ' VAL . 0.1 OUTLIER -151.04 170.49 19.25 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 490' ' ' PHE . 27.2 mtpt -81.41 158.33 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 117.058 -1.857 . . . . 0.0 110.146 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . 0.706 ' H ' ' HA ' ' A' ' 496' ' ' ILE . . . . . . . . 0 N--CA 1.487 2.068 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.582 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 390' ' ' GLU . 1.5 pm0 . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.983 0.421 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.712 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 74.8 t -64.39 137.05 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.018 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.608 ' CG1' ' H ' ' A' ' 393' ' ' GLY . 2.5 pt -103.26 -57.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.757 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . 0.608 ' H ' ' CG1' ' A' ' 392' ' ' ILE . . . -142.18 178.78 20.57 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 12.6 m -156.05 141.31 17.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.814 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.597 ' HB3' HG13 ' A' ' 468' ' ' VAL . . . -124.06 -158.81 0.83 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.835 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.19 126.66 78.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.772 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 101.93 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.033 1.155 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -67.32 -57.75 6.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.589 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 79.3 p -137.19 139.87 29.39 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.713 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.7 95.77 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 121.31 1.34 . . . . 0.0 110.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.82 162.2 30.3 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 118.186 -1.959 . . . . 0.0 112.906 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.56 21.15 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.41 160.87 43.44 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 117.946 -1.502 . . . . 0.0 112.884 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -131.78 102.6 5.94 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.67 166.55 30.81 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.94 156.26 22.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.65 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 492' ' ' GLU . 3.5 m -85.4 138.77 18.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.546 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.61 ' CZ ' ' OE1' ' A' ' 413' ' ' GLU . 0.4 OUTLIER -138.94 159.28 42.53 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.322 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 410' ' ' THR . 9.8 m-85 -122.88 32.81 5.59 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.813 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 409' ' ' PHE . 1.6 p -158.82 143.74 16.02 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.438 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.57 -13.83 61.49 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.591 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -75.17 -43.19 53.65 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.49 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . 0.61 ' OE1' ' CZ ' ' A' ' 408' ' ' TYR . 68.9 mm-40 -62.28 -37.84 87.06 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.411 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 441' ' ' ALA . . . -68.18 -32.32 72.48 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.403 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -68.67 -36.81 79.01 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.518 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.81 23.41 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.837 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -68.12 -54.93 14.54 Favored 'General case' 0 C--N 1.276 -2.621 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' HIS . . . . . 0.639 ' HB2' ' HB1' ' A' ' 441' ' ' ALA . 25.6 t-80 -44.22 -26.55 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.6 OUTLIER -91.48 -22.87 20.18 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.884 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 417' ' ' ALA . 36.2 mmtt -80.64 -59.59 2.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.981 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -155.0 3.87 0.23 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.711 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 54.68 -146.95 0.53 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.094 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . 0.644 ' H ' ' HE ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER 52.37 64.68 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.838 -1.145 . . . . 0.0 107.965 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.842 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 425' ' ' ILE . 6.9 mm -125.33 160.3 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.904 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 5.3 tp -125.57 134.06 52.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.017 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.38 121.57 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.036 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ARG . . . . . 0.675 ' O ' HG22 ' A' ' 447' ' ' THR . 7.3 ttt180 -152.2 148.76 27.97 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.247 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.663 ' H ' HD12 ' A' ' 429' ' ' LEU . 4.3 mp -48.41 -58.01 5.25 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.568 -1.253 . . . . 0.0 109.252 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 431' ' ' THR . 2.2 tm-20 -122.89 175.84 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.436 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.635 ' OG1' ' CD2' ' A' ' 455' ' ' HIS . 1.2 p -112.14 173.37 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.685 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.9 m -154.84 155.14 30.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.998 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 435' ' ' ASP . 3.6 Cg_endo -64.27 -66.58 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 121.758 1.638 . . . . 0.0 112.147 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -38.83 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.269 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 438' ' ' GLY . 1.1 m-20 -74.42 -8.7 57.16 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.829 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.732 HG23 ' N ' ' A' ' 437' ' ' GLU . 9.8 tp -40.4 -50.56 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.827 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.732 ' N ' HG23 ' A' ' 436' ' ' ILE . 69.6 mt-10 -53.85 -38.28 64.52 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.615 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.16 -26.65 70.13 Favored Glycine 0 C--N 1.303 -1.272 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' MET . . . . . 0.514 ' HG2' HD11 ' A' ' 445' ' ' ILE . 40.3 mtt -69.21 -39.11 78.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.988 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.48 ' NE2' HG13 ' A' ' 436' ' ' ILE . 6.8 m-70 -66.68 -57.94 6.14 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.171 -1.411 . . . . 0.0 109.174 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 418' ' ' HIS . . . -46.13 -39.64 9.82 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.073 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.616 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -97.55 85.28 3.57 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.087 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -62.91 35.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.848 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -168.87 143.71 8.25 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . 0.514 HD11 ' HG2' ' A' ' 439' ' ' MET . 1.3 mt -144.63 132.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.17 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.42 ' CD1' ' CG1' ' A' ' 468' ' ' VAL . 7.0 tp -135.79 98.36 3.89 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 428' ' ' ARG . 1.7 p -113.62 161.22 17.7 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.73 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.45 HG13 ' SG ' ' A' ' 471' ' ' CYS . 16.2 t -76.84 -26.34 16.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.796 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' GLY . 6.8 mtt-85 -108.46 -134.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.723 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 70.72 -166.85 51.32 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.948 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . 0.568 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 72.0 -31.85 0.64 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.937 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.505 ' H ' ' C ' ' A' ' 450' ' ' GLY . 15.6 ptm -68.38 42.31 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.946 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 47.22 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.13 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 458' ' ' VAL . 6.8 t -171.32 -166.08 0.44 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' HIS . . . . . 0.635 ' CD2' ' OG1' ' A' ' 431' ' ' THR . 7.2 p-80 -49.66 -48.13 49.58 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.981 -1.087 . . . . 0.0 110.337 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.435 ' CB ' HG21 ' A' ' 431' ' ' THR . . . -38.21 -56.15 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.467 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -81.08 -52.53 7.29 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.487 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 454' ' ' SER . 43.5 t -47.42 -47.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.916 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 455' ' ' HIS . 93.3 t -64.31 -43.78 97.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.782 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.99 -43.75 91.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -69.81 -19.38 63.49 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.57 -36.79 15.56 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 49.8 mmm -93.15 -26.1 17.57 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.24 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.25 42.1 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.63 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 16.7 m -46.83 163.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' CYS . . . . . 0.547 ' HG ' ' C ' ' A' ' 401' ' ' GLY . 48.6 t -85.22 128.59 34.73 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.053 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 13.1 t -151.42 140.49 21.14 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.382 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . 0.597 HG13 ' HB3' ' A' ' 395' ' ' ALA . 0.9 OUTLIER -110.65 161.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.137 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 9.2 t -150.37 148.57 28.96 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.567 -1.253 . . . . 0.0 112.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 61.1 91.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.46 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 448' ' ' VAL . 7.7 p -100.22 176.06 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -59.52 -91.93 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -144.82 59.55 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.632 HG23 ' CB ' ' A' ' 483' ' ' PHE . 10.7 mt -51.6 107.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.839 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -89.16 110.31 21.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 482' ' ' THR . 4.9 mt -87.96 135.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.013 -1.475 . . . . 0.0 113.884 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . 0.511 ' CG ' ' HG1' ' A' ' 482' ' ' THR . 1.3 m120 -113.18 122.04 46.32 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.678 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.65 ' C ' ' H ' ' A' ' 480' ' ' ALA . 7.8 mt-10 -56.4 -5.53 0.21 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.438 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -48.03 -14.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 118.093 -1.443 . . . . 0.0 108.186 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 177.98 -90.88 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . 0.512 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.3 OUTLIER -167.46 54.56 0.07 Allowed 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 123.965 1.841 . . . . 0.0 108.949 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 476' ' ' ILE . 70.0 p -75.57 167.11 22.52 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 111.251 -2.704 . . . . 0.0 112.267 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' PHE . . . . . 0.634 ' CE2' ' CG ' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -153.46 112.83 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.693 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -89.64 120.07 30.61 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.047 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 486' ' ' GLY . 59.3 tp -149.82 157.21 42.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.141 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' GLY . . . . . 0.501 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.39 -117.82 12.54 Favored Glycine 0 N--CA 1.48 1.568 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -127.04 29.1 4.44 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.673 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -151.68 144.3 24.27 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.122 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 45.5 m -95.36 115.19 27.1 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.529 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.634 ' CG ' ' CE2' ' A' ' 483' ' ' PHE . 0.8 OUTLIER -88.49 160.73 17.37 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.747 ' HA ' HG22 ' A' ' 482' ' ' THR . . . -141.0 113.95 8.42 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.856 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.7 tm-20 -48.06 99.68 0.02 OUTLIER 'General case' 0 CA--C 1.481 -1.704 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.887 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 160.24 22.88 0.03 OUTLIER Glycine 0 C--N 1.274 -2.909 0 C-N-CA 118.623 -1.751 . . . . 0.0 109.865 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' ASP . . . . . 0.647 ' CG ' ' N ' ' A' ' 495' ' ' TYR . 16.2 t70 -143.72 -179.91 6.75 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.071 -1.051 . . . . 0.0 112.2 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . 0.647 ' N ' ' CG ' ' A' ' 494' ' ' ASP . 25.1 t80 -101.59 137.91 39.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.667 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.464 HG13 ' N ' ' A' ' 497' ' ' SER . 0.1 OUTLIER -137.15 160.98 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.445 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . 0.464 ' N ' HG13 ' A' ' 496' ' ' ILE . 29.7 t -123.6 104.57 9.11 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.658 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' LEU . . . . . 0.883 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.2 OUTLIER -109.62 134.27 52.14 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.764 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.883 ' N ' HD12 ' A' ' 498' ' ' LEU . 9.1 m-20 -115.36 148.67 39.01 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.821 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -148.45 89.55 0.14 Allowed Glycine 0 C--O 1.188 -2.777 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 22.5 m -162.77 -3.88 0.04 OUTLIER 'General case' 0 C--N 1.255 -3.537 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' THR . . . . . 0.458 ' H ' ' H ' ' A' ' 503' ' ' GLY . 75.8 p -152.77 -14.65 0.16 Allowed 'General case' 0 C--N 1.275 -2.667 0 CA-C-N 111.417 -2.629 . . . . 0.0 105.969 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.458 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 79.04 77.25 0.91 Allowed Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.29 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -156.69 136.13 12.23 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.729 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' ILE . . . . . 0.625 ' C ' ' CD1' ' A' ' 506' ' ' TYR . 10.7 mt -110.54 161.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.807 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' TYR . . . . . 0.712 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 24.6 m-85 -150.33 161.72 41.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 508' ' ' GLY . 13.0 ttmt -134.97 157.47 46.84 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . 0.435 ' N ' ' HG2' ' A' ' 507' ' ' LYS . . . . . . . . 0 N--CA 1.497 2.72 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.648 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 121.012 0.434 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.753 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 67.7 t -93.91 158.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.333 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.477 ' N ' HG12 ' A' ' 391' ' ' VAL . 10.3 pt -102.36 -33.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -178.3 -163.97 30.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 118.899 -1.619 . . . . 0.0 111.279 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 p -165.31 130.44 2.53 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.264 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 471' ' ' CYS . . . -114.65 -147.92 0.42 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.943 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 63.2 mt -81.93 132.31 54.45 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.08 93.61 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.143 1.229 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -58.31 -62.12 2.07 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.47 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -148.61 146.88 23.34 Favored Pre-proline 0 C--N 1.305 -1.333 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.353 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.76 103.05 0.1 Allowed 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.258 1.305 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.06 162.61 29.85 Favored Glycine 0 N--CA 1.509 3.508 0 C-N-CA 118.723 -1.704 . . . . 0.0 112.379 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . 0.49 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -145.65 118.72 8.83 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.01 43.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.776 -1.57 . . . . 0.0 113.765 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -137.84 110.02 7.32 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.437 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.53 169.81 31.68 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.007 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' LYS . . . . . 0.653 ' CD ' ' N ' ' A' ' 406' ' ' LYS . 8.4 mptt -80.2 171.48 15.03 Favored 'General case' 0 C--O 1.201 -1.499 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -120.23 158.98 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.548 -1.261 . . . . 0.0 114.15 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 414' ' ' ALA . 20.0 p90 -156.24 -151.09 0.31 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.716 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 427' ' ' VAL . 28.4 m-85 -148.22 -42.28 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.406 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 36.8 p -94.71 138.55 32.39 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.548 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -56.12 -19.38 13.04 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.262 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -64.5 -49.07 72.78 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 417' ' ' ALA . 40.8 mm-40 -53.22 -50.9 63.77 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.286 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ALA . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 408' ' ' TYR . . . -48.58 -38.46 20.71 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -63.57 -41.19 98.4 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.505 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.3 -9.62 49.88 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.657 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.08 -60.7 1.86 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.401 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -56.23 -21.37 23.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.045 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -27.61 68.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.003 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -73.13 -6.99 49.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.94 71.47 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.16 152.03 3.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.163 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -72.17 153.11 41.83 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.643 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' VAL . . . . . 0.842 ' O ' ' HB1' ' A' ' 442' ' ' ALA . 4.4 t -145.97 160.15 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.446 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ILE . . . . . 0.514 ' O ' ' CE1' ' A' ' 408' ' ' TYR . 5.2 mm -121.85 159.28 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' LEU . . . . . 0.622 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 13.5 tp -115.79 139.16 50.44 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.796 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.545 ' O ' ' CD2' ' A' ' 409' ' ' PHE . 51.9 t -130.57 119.71 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ARG . . . . . 0.762 ' H ' HG22 ' A' ' 447' ' ' THR . 1.0 OUTLIER -151.4 152.75 33.51 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.902 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.417 ' CB ' ' OE2' ' A' ' 430' ' ' GLU . 0.7 OUTLIER -80.31 20.56 0.67 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.393 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.417 ' OE2' ' CB ' ' A' ' 429' ' ' LEU . 1.4 pm0 -179.69 153.08 0.53 Allowed 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 432' ' ' SER . 0.5 OUTLIER -83.14 -175.24 5.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.555 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 431' ' ' THR . 4.2 t -177.07 139.28 0.44 Allowed Pre-proline 0 C--N 1.305 -1.357 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.858 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.5 -69.18 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.367 1.378 . . . . 0.0 111.897 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -46.48 -27.32 1.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.879 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.16 -9.23 45.13 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.477 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' ILE . . . . . 0.722 HG23 ' N ' ' A' ' 437' ' ' GLU . 8.3 tp -60.29 -49.99 82.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.031 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 436' ' ' ILE . 52.3 mm-40 -54.89 -29.96 57.03 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.924 -1.51 . . . . 0.0 108.459 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.66 63.41 Favored Glycine 0 N--CA 1.473 1.143 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 43.8 mtt -69.48 -44.83 70.35 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.893 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.568 ' C ' ' N ' ' A' ' 442' ' ' ALA . 7.0 m170 -61.26 -39.28 89.79 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.408 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -51.63 -18.16 1.08 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' ALA . . . . . 0.842 ' HB1' ' O ' ' A' ' 424' ' ' VAL . . . -122.52 -155.48 0.65 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.283 -1.78 . . . . 0.0 108.077 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -168.62 37.75 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -169.52 143.41 7.93 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.3 mp -142.36 118.45 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.453 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' LEU . . . . . 0.436 HD13 ' CG1' ' A' ' 468' ' ' VAL . 2.5 tp -121.78 98.37 5.92 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.695 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' THR . . . . . 0.762 HG22 ' H ' ' A' ' 428' ' ' ARG . 5.5 p -115.16 160.32 19.84 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.24 -20.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.87 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' ARG . . . . . 0.584 ' CG ' ' H ' ' A' ' 450' ' ' GLY . 2.1 ttt85 -129.26 179.24 5.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' GLY . . . . . 0.584 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 92.59 60.19 1.23 Allowed Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.163 -1.494 . . . . 0.0 109.725 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 453' ' ' THR . . . -141.78 -145.25 4.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 453' ' ' THR . 5.4 ttt 46.52 16.54 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.838 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.53 89.53 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.675 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 455' ' ' HIS . 93.9 p -149.3 -174.58 4.7 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.714 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' HIS . . . . . 0.682 ' O ' HG23 ' A' ' 459' ' ' VAL . 4.6 m170 -40.62 -45.1 2.27 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . 0.41 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -47.49 -61.9 1.7 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.81 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.64 12.66 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.597 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 11.9 t -45.33 -40.18 2.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.393 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 455' ' ' HIS . 72.3 t -71.58 -45.39 67.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.318 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.35 80.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -68.72 -37.27 79.35 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.705 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -74.95 -24.12 72.79 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.528 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' MET . . . . . 0.479 ' HG3' ' N ' ' A' ' 464' ' ' GLY . 8.9 tpt -90.17 -81.92 0.28 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.449 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . 0.479 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 136.12 37.59 0.18 Allowed Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.968 -1.11 . . . . 0.0 110.428 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 10.2 t -108.37 171.43 7.42 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -86.42 126.34 34.32 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.98 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' CYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 0.7 OUTLIER -152.19 155.19 37.3 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.284 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.4 t -135.52 162.66 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.577 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' SER . . . . . 0.568 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 33.5 t -149.98 151.74 33.8 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.028 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.37 83.99 0.01 OUTLIER Glycine 0 N--CA 1.496 2.67 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.087 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 395' ' ' ALA . 7.9 t -85.57 -145.99 0.11 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.023 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -67.94 -101.16 0.03 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -130.18 54.86 1.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.497 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 0.5 OUTLIER -45.63 111.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -105.03 113.91 27.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.22 134.95 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.444 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -105.99 115.32 30.03 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' GLU . . . . . 0.755 ' C ' ' H ' ' A' ' 480' ' ' ALA . 8.3 mp0 -67.76 -8.27 34.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.291 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 480' ' ' ALA . 6.1 mt-10 -59.08 6.77 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.152 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' ALA . . . . . 0.755 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 170.75 -77.72 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 409' ' ' PHE . 4.0 mmtp 158.93 84.07 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.79 1.306 . . . . 0.0 109.482 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . 0.879 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 1.9 p -137.02 142.06 42.49 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' PHE . . . . . 0.968 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 3.8 p90 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.441 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' A' ' 485' ' ' LEU . 5.5 tp10 -109.8 117.45 33.9 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' LEU . . . . . 0.464 ' N ' ' OE2' ' A' ' 484' ' ' GLU . 4.8 mt -150.21 159.85 44.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.789 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 53.98 -104.41 0.23 Allowed Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.575 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -139.96 28.72 2.49 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 119.079 -1.534 . . . . 0.0 111.897 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 23.8 m170 -150.68 142.29 23.58 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.639 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.9 m -106.81 99.04 8.63 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.988 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.559 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 23.3 p90 -154.32 155.13 34.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.302 -1.359 . . . . 0.0 113.948 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' ALA . . . . . 0.968 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . -171.97 -129.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.669 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -47.12 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.187 -1.405 . . . . 0.0 108.94 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 157.69 0.48 0.1 OUTLIER Glycine 0 C--N 1.279 -2.584 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' ASP . . . . . 0.432 ' H ' ' H ' ' A' ' 493' ' ' GLY . 7.9 m-20 -159.81 -163.84 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.948 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' TYR . . . . . 0.484 ' CZ ' ' HA2' ' A' ' 508' ' ' GLY . 4.5 p90 -142.07 144.76 33.73 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.678 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' ILE . . . . . 0.439 HG23 ' CE1' ' A' ' 490' ' ' PHE . 0.0 OUTLIER -123.75 160.6 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.877 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 506' ' ' TYR . 6.7 t -115.31 99.91 7.74 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -98.2 144.44 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.377 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' ASP . . . . . 0.66 ' N ' HD12 ' A' ' 498' ' ' LEU . 6.7 t0 -103.55 157.43 17.05 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.697 0.761 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -145.25 95.47 0.18 Allowed Glycine 0 C--N 1.275 -2.816 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 0.3 OUTLIER 163.21 6.33 0.0 OUTLIER 'General case' 1 C--N 1.24 -4.156 0 CA-C-N 112.014 -2.093 . . . . 0.0 106.617 -179.97 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 504' ' ' LYS . 0.1 OUTLIER -163.56 -21.72 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.203 -2.271 . . . . 0.0 107.592 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.51 -10.35 62.01 Favored Glycine 0 N--CA 1.492 2.42 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.948 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' LYS . . . . . 0.536 ' H ' HG23 ' A' ' 502' ' ' THR . 7.9 mtmt -71.98 120.18 17.21 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.986 -1.086 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' ILE . . . . . 0.667 ' O ' HG13 ' A' ' 391' ' ' VAL . 1.2 tt -96.97 160.65 2.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.867 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' TYR . . . . . 0.753 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 33.0 m-85 -138.18 162.58 33.89 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.128 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' LYS . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 3.1 tmtt? -123.53 151.02 43.28 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.999 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . 0.484 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . . . . . . 0 N--CA 1.489 2.201 0 C-N-CA 118.773 -1.679 . . . . 0.0 109.998 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 387' ' ' LYS . . . 52.15 -159.5 0.11 Allowed 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.792 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 386' ' ' LEU . 71.4 mt 50.37 12.09 0.09 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.977 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 385' ' ' ALA . 0.0 OUTLIER -129.91 -5.27 4.53 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.024 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -171.97 23.94 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 113.814 -1.539 . . . . 0.0 110.03 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.566 ' C ' ' H ' ' A' ' 391' ' ' VAL . . . -63.14 144.04 49.05 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.586 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 391' ' ' VAL . 0.7 OUTLIER -68.12 36.88 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.551 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 505' ' ' ILE . 25.4 t -41.01 143.47 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.326 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.667 HD13 ' CZ ' ' A' ' 490' ' ' PHE . 2.5 pt -87.72 -55.06 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.635 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.619 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -153.98 -157.13 7.97 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.804 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.4 p -164.51 108.47 0.93 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.974 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -84.84 -146.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.724 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 42.0 mt -96.79 139.99 21.89 Favored Pre-proline 0 N--CA 1.484 1.25 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -69.92 93.07 0.53 Allowed 'Trans proline' 0 C--N 1.326 -0.61 0 C-N-CA 121.294 1.329 . . . . 0.0 111.303 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -64.02 -69.85 0.25 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.605 -1.238 . . . . 0.0 109.715 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 57.0 m -133.24 139.25 33.6 Favored Pre-proline 0 N--CA 1.486 1.34 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.756 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.31 100.83 0.07 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.895 1.064 . . . . 0.0 110.406 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.616 ' C ' ' SG ' ' A' ' 466' ' ' CYS . . . -152.03 162.36 29.73 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 118.639 -1.743 . . . . 0.0 112.116 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -141.43 128.44 20.73 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.65 160.58 43.73 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 117.841 -1.544 . . . . 0.0 113.019 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -138.77 107.9 6.06 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.023 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -150.95 166.07 30.35 Favored Glycine 0 N--CA 1.488 2.102 0 C-N-CA 119.051 -1.547 . . . . 0.0 111.307 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.485 ' HE3' ' CD2' ' A' ' 495' ' ' TYR . 3.7 mttp -85.98 137.93 32.36 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.936 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.54 ' O ' ' CG ' ' A' ' 408' ' ' TYR . 49.6 t -55.44 148.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.986 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' A' ' 407' ' ' VAL . 17.8 m-85 -170.98 139.9 1.48 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.724 -1.126 . . . . 0.0 108.653 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.731 ' CD2' ' NZ ' ' A' ' 481' ' ' LYS . 4.1 m-85 -113.79 42.43 2.01 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.313 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 409' ' ' PHE . 1.0 OUTLIER -159.36 145.0 16.03 Favored 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 118.579 -1.248 . . . . 0.0 111.886 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -76.83 -18.23 58.51 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.787 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -74.16 -39.93 62.91 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.69 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.462 ' OE1' ' OG1' ' A' ' 410' ' ' THR . 41.8 mt-10 -66.78 -26.76 67.12 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.6 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -72.5 -38.27 68.17 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.54 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -43.1 86.42 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.175 -1.01 . . . . 0.0 108.876 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.57 -49.58 52.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.842 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -58.77 -62.11 2.11 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.083 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -41.53 -30.58 0.21 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.663 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -89.53 -22.02 22.62 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.575 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . 0.537 ' N ' ' O ' ' A' ' 417' ' ' ALA . 0.0 OUTLIER -94.91 -49.2 5.67 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.521 -0.871 . . . . 0.0 112.842 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 422' ' ' GLU . . . -153.74 -10.64 0.07 OUTLIER Glycine 0 N--CA 1.497 2.737 0 C-N-CA 118.763 -1.684 . . . . 0.0 112.03 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . 0.446 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 3.0 mt-10 64.24 -145.89 0.28 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.567 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 49.87 65.89 1.29 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.614 -1.234 . . . . 0.0 108.352 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.402 HG13 ' HD2' ' A' ' 408' ' ' TYR . 3.3 t -122.47 154.92 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.702 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 426' ' ' LEU . 18.9 mm -118.75 160.9 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.406 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.521 ' N ' HG22 ' A' ' 425' ' ' ILE . 1.4 tp -134.58 125.56 27.47 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 118.953 -1.099 . . . . 0.0 113.183 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 446' ' ' LEU . 38.2 t -114.14 127.16 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.75 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ARG . . . . . 0.613 ' H ' HG22 ' A' ' 447' ' ' THR . 0.0 OUTLIER -152.48 146.69 25.47 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.687 -1.205 . . . . 0.0 112.122 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.49 12.03 2.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.566 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 428' ' ' ARG . 67.2 tt0 -176.4 139.76 0.35 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.168 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.699 HG21 ' HB2' ' A' ' 456' ' ' ALA . 9.1 p -106.14 153.49 22.01 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.271 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.32 158.67 63.39 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.715 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.469 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.9 Cg_endo -65.79 -69.38 0.03 OUTLIER 'Trans proline' 0 C--N 1.322 -0.852 0 C-N-CA 121.903 1.736 . . . . 0.0 112.394 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -35.23 -30.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.568 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.624 ' OD1' ' SD ' ' A' ' 439' ' ' MET . 0.6 OUTLIER -62.83 -8.41 6.88 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.622 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.649 HG22 ' N ' ' A' ' 437' ' ' GLU . 0.3 OUTLIER -32.68 -58.11 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.649 ' N ' HG22 ' A' ' 436' ' ' ILE . 53.2 mt-10 -47.93 -41.19 24.15 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 117.961 -1.496 . . . . 0.0 109.086 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -71.91 -25.85 73.92 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' MET . . . . . 0.632 ' SD ' HG11 ' A' ' 459' ' ' VAL . 40.5 mtp -70.65 -46.93 62.34 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.444 ' CE1' ' SD ' ' A' ' 463' ' ' MET . 85.9 m-70 -58.26 -61.66 2.41 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 118.267 -1.373 . . . . 0.0 109.546 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -49.25 -32.15 10.18 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 118.786 -1.166 . . . . 0.0 109.096 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -98.04 71.45 2.15 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.544 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -56.18 3.83 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.239 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.627 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -144.32 145.17 14.46 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 49.8 mt -148.01 118.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.091 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 427' ' ' VAL . 4.6 tp -115.55 97.96 6.45 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 428' ' ' ARG . 4.4 p -106.16 160.94 14.95 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.785 -0.766 . . . . 0.0 112.901 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 56.6 t -86.47 -20.62 7.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.157 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 470' ' ' GLY . 2.0 tpt85 -99.54 -136.04 0.29 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.615 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.509 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 73.14 -170.47 52.05 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -178.62 -170.34 40.54 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 118.897 -1.62 . . . . 0.0 110.906 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.571 ' O ' HG23 ' A' ' 453' ' ' THR . 13.9 ttt -46.95 -37.97 9.88 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 452' ' ' MET . 0.7 OUTLIER -158.91 129.26 5.91 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.182 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.1 m -174.29 -178.29 1.4 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 459' ' ' VAL . 34.4 m80 -45.63 -38.3 6.52 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.667 -1.213 . . . . 0.0 109.952 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.699 ' HB2' HG21 ' A' ' 431' ' ' THR . . . -59.51 -51.27 70.58 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.694 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -78.19 -52.09 9.22 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.926 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 3.4 t -47.85 -50.49 9.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.284 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 455' ' ' HIS . 65.9 t -63.99 -39.27 84.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.803 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 464' ' ' GLY . . . -65.51 -50.59 64.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.381 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -53.96 -29.07 41.15 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.422 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.15 -35.33 27.4 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' MET . . . . . 0.444 ' SD ' ' CE1' ' A' ' 440' ' ' HIS . 16.2 mmt -97.49 6.43 48.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.727 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 460' ' ' ALA . . . 48.78 24.72 4.4 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.953 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 94.3 m -84.11 146.4 27.91 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.831 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' CYS . . . . . 0.616 ' SG ' ' C ' ' A' ' 401' ' ' GLY . 17.0 t -76.1 129.5 36.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.022 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.702 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 80.0 m -151.54 146.98 26.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.822 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.69 160.41 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.393 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . 0.507 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 7.0 t -151.04 148.15 27.99 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.639 -1.224 . . . . 0.0 112.596 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 52.0 92.39 0.01 OUTLIER Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . 0.553 ' SG ' HD11 ' A' ' 446' ' ' LEU . 7.9 m -100.69 -159.39 0.73 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.643 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.72 -99.0 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.959 -1.591 . . . . 0.0 109.971 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -133.92 43.87 2.8 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.416 0.627 . . . . 0.0 109.34 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.607 HG23 ' CB ' ' A' ' 483' ' ' PHE . 5.0 mt -39.09 110.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.846 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 10.6 tttm -94.3 121.96 36.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 482' ' ' THR . 3.8 mt -87.36 131.13 35.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 117.829 -1.548 . . . . 0.0 112.795 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -104.39 119.45 38.98 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.552 ' C ' ' N ' ' A' ' 480' ' ' ALA . 1.5 mp0 -62.65 -10.69 13.26 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 114.986 -1.006 . . . . 0.0 113.598 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -45.51 -20.18 0.06 Allowed 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 118.236 -1.386 . . . . 0.0 108.518 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.552 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.68 -103.67 0.01 OUTLIER 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . 0.731 ' NZ ' ' CD2' ' A' ' 409' ' ' PHE . 11.2 mmmm -155.96 65.87 0.59 Allowed 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.642 ' O ' HG23 ' A' ' 476' ' ' ILE . 4.8 p -98.43 -179.5 4.36 Favored 'General case' 0 C--O 1.201 -1.475 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.783 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' PHE . . . . . 0.607 ' CB ' HG23 ' A' ' 474' ' ' ILE . 0.5 OUTLIER -150.78 117.23 5.72 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.043 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' GLU . . . . . 0.427 ' CG ' HG23 ' A' ' 489' ' ' THR . 33.8 mt-10 -89.17 118.48 28.9 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.839 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 486' ' ' GLY . 61.6 tp -143.53 154.79 43.98 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.775 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . 0.468 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 56.89 -114.59 5.48 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.484 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -129.62 28.85 3.91 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 119.592 -1.29 . . . . 0.0 110.888 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.11 152.19 33.04 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.791 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.427 HG23 ' CG ' ' A' ' 484' ' ' GLU . 88.3 m -107.79 112.03 24.49 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.946 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.667 ' CZ ' HD13 ' A' ' 392' ' ' ILE . 5.6 m-30 -89.45 110.93 21.71 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.061 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -98.23 149.01 23.02 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.089 -1.044 . . . . 0.0 112.865 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.485 ' O ' ' CG ' ' A' ' 492' ' ' GLU . 1.9 tm-20 -67.29 69.49 0.09 Allowed 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -173.96 22.47 0.06 OUTLIER Glycine 0 C--N 1.269 -3.139 0 C-N-CA 119.206 -1.473 . . . . 0.0 109.765 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 495' ' ' TYR . 2.4 t0 -140.69 -173.94 3.83 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.655 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . 0.485 ' CD2' ' HE3' ' A' ' 406' ' ' LYS . 0.2 OUTLIER -116.41 129.64 56.34 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.879 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.892 HD12 ' N ' ' A' ' 497' ' ' SER . 0.6 OUTLIER -138.37 160.5 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.957 -1.097 . . . . 0.0 112.554 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . 0.892 ' N ' HD12 ' A' ' 496' ' ' ILE . 17.3 m -125.05 112.11 16.15 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.909 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' LEU . . . . . 0.418 HD13 ' CG1' ' A' ' 505' ' ' ILE . 0.0 OUTLIER -108.76 141.25 41.03 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.539 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 498' ' ' LEU . 3.6 m-20 -93.12 161.7 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.037 0.922 . . . . 0.0 112.531 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' GLY . . . . . 0.608 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -150.65 94.73 0.15 Allowed Glycine 0 C--N 1.287 -2.189 0 N-CA-C 106.737 -2.545 . . . . 0.0 106.737 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' SER . . . . . 0.469 ' C ' ' OG1' ' A' ' 502' ' ' THR . 0.3 OUTLIER 174.31 1.55 0.0 OUTLIER 'General case' 1 C--N 1.241 -4.122 0 CA-C-N 112.995 -1.602 . . . . 0.0 108.161 179.797 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' THR . . . . . 0.469 ' OG1' ' C ' ' A' ' 501' ' ' SER . 0.6 OUTLIER -168.66 -21.03 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.019 -1.9 . . . . 0.0 107.844 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.19 72.97 1.28 Allowed Glycine 0 N--CA 1.484 1.865 0 CA-C-N 114.483 -1.235 . . . . 0.0 111.46 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -139.88 112.74 8.06 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.348 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' ILE . . . . . 0.65 ' O ' HG13 ' A' ' 391' ' ' VAL . 5.8 mt -89.46 149.05 4.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 118.974 -1.09 . . . . 0.0 112.286 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' TYR . . . . . 0.412 ' CE2' ' O ' ' A' ' 507' ' ' LYS . 46.4 t80 -147.66 161.44 41.18 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.412 ' O ' ' CE2' ' A' ' 506' ' ' TYR . 15.7 tttt -116.89 160.61 20.61 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.965 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 76.66 128.42 0.31 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.605 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -62.26 115.31 4.05 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.828 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 510' ' ' ILE . 1.5 mt -63.89 165.42 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.718 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.877 179.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.724 0.297 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -138.16 15.85 2.81 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.575 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 75.1 mt -95.94 9.81 39.41 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.611 -0.835 . . . . 0.0 109.198 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -120.62 1.55 10.6 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.271 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -164.26 22.53 0.07 Allowed 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.487 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -77.8 -126.9 0.37 Allowed Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.323 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -147.41 85.87 1.6 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.613 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.572 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 24.3 t -96.59 135.18 31.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.01 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.4 pt -90.75 -31.6 5.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.388 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 164.65 -176.34 40.5 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.075 -1.536 . . . . 0.0 110.92 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 15.8 p -141.5 151.47 43.34 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.184 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -142.46 -152.8 0.43 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.344 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.718 ' N ' ' CD2' ' A' ' 396' ' ' LEU . 0.1 OUTLIER -63.45 115.51 18.77 Favored Pre-proline 0 N--CA 1.481 1.1 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.323 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.79 100.52 0.83 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 121.023 1.149 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -59.89 -76.03 0.05 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.094 -1.043 . . . . 0.0 110.859 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.3 t -137.85 151.38 70.29 Favored Pre-proline 0 N--CA 1.493 1.684 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.732 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.08 104.04 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.447 1.431 . . . . 0.0 110.822 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.605 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -152.62 163.24 30.29 Favored Glycine 0 N--CA 1.503 3.152 0 C-N-CA 118.523 -1.799 . . . . 0.0 112.87 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -137.81 123.41 19.75 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.48 161.16 43.06 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 117.703 -1.599 . . . . 0.0 114.12 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -148.5 107.11 3.79 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.896 -1.502 . . . . 0.0 108.001 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.92 168.47 31.81 Favored Glycine 0 N--CA 1.506 3.318 0 C-N-CA 118.905 -1.617 . . . . 0.0 112.151 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.464 ' NZ ' ' HB2' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -84.5 132.51 34.53 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.522 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . . . . . . . . . 40.8 t -69.49 158.59 5.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.028 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.577 ' CD1' ' CD ' ' A' ' 413' ' ' GLU . 3.8 m-85 -151.8 -170.62 3.7 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.176 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -142.27 6.43 1.71 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.798 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 8.0 p -141.64 142.25 33.41 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.93 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -67.25 -12.17 59.41 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.661 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -73.12 -42.86 62.45 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.058 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.577 ' CD ' ' CD1' ' A' ' 408' ' ' TYR . 49.9 mt-10 -63.92 -37.9 89.12 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.228 -0.989 . . . . 0.0 109.873 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -68.07 -29.42 68.37 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.324 -0.95 . . . . 0.0 109.773 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -69.93 -38.42 76.19 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.271 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.53 -13.29 34.91 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.206 -0.997 . . . . 0.0 111.081 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -90.2 -52.43 4.94 Favored 'General case' 0 C--N 1.28 -2.421 0 C-N-CA 119.361 -0.936 . . . . 0.0 108.83 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' HIS . . . . . 0.583 ' HB2' ' HB1' ' A' ' 441' ' ' ALA . 16.3 t-80 -47.79 -21.58 0.42 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.914 -1.115 . . . . 0.0 109.328 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.9 OUTLIER -83.75 -68.68 0.69 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.205 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -93.2 -24.35 18.24 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.761 -0.776 . . . . 0.0 112.342 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -89.27 -51.87 2.85 Favored Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.519 -1.324 . . . . 0.0 112.027 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 417' ' ' ALA . 3.6 mt-10 62.38 165.65 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.022 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 422' ' ' GLU . 12.6 mpt_? 45.0 80.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.535 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 4.2 t -130.21 161.4 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.984 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 426' ' ' LEU . 7.2 mm -133.42 160.81 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.653 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.478 ' N ' HG22 ' A' ' 425' ' ' ILE . 9.8 tp -131.65 151.69 51.42 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.613 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.455 ' N ' ' HG ' ' A' ' 426' ' ' LEU . 6.2 t -131.45 126.28 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 120.001 -0.679 . . . . 0.0 110.914 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ARG . . . . . 0.67 ' O ' HG22 ' A' ' 447' ' ' THR . 90.4 mtt180 -151.89 150.77 30.44 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.354 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 429' ' ' LEU . 7.0 mt -59.55 -44.09 93.35 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 118.926 -1.11 . . . . 0.0 110.646 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.62 -178.16 4.74 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.405 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -81.81 -178.07 6.83 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.927 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.78 122.42 0.81 Allowed Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.561 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.6 -33.6 93.34 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 121.036 1.157 . . . . 0.0 111.779 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -73.81 -9.4 58.62 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.1 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -87.26 -8.33 56.91 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.565 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.643 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 7.9 tp -39.91 -50.35 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.5 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.643 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 27.3 mt-10 -61.19 -31.53 71.28 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 117.877 -1.529 . . . . 0.0 108.387 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.16 -28.09 60.88 Favored Glycine 0 C--N 1.297 -1.63 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' MET . . . . . 0.552 ' SD ' HG11 ' A' ' 459' ' ' VAL . 75.0 mtp -66.91 -42.65 85.09 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.191 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -67.46 -58.88 3.94 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.198 -1.401 . . . . 0.0 108.924 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.583 ' HB1' ' HB2' ' A' ' 418' ' ' HIS . . . -49.36 -36.07 20.51 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.392 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -94.19 81.59 4.07 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.158 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -59.95 21.34 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.113 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.664 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -165.97 149.57 15.86 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.39 131.56 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.357 -1.337 . . . . 0.0 111.97 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.611 ' CD2' HD22 ' A' ' 498' ' ' LEU . 0.6 OUTLIER -123.72 108.66 12.77 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.06 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 428' ' ' ARG . 3.4 p -121.83 160.23 25.12 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.538 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.578 HG13 HG13 ' A' ' 474' ' ' ILE . 2.6 t -79.09 -25.15 12.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.406 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -121.13 -142.22 0.34 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.197 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 81.13 -143.9 24.36 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.39 -1.386 . . . . 0.0 110.137 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . 0.608 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 55.67 -140.87 40.05 Favored Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.204 -1.474 . . . . 0.0 110.122 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 24.9 mtm 43.82 38.95 2.3 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.487 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 56.2 p 42.43 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.575 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 458' ' ' VAL . 45.5 p -160.06 -164.64 1.33 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.168 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' HIS . . . . . 0.696 ' O ' HG23 ' A' ' 459' ' ' VAL . 69.0 m80 -43.9 -51.36 7.6 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.211 -0.995 . . . . 0.0 110.593 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.405 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -42.34 -55.33 3.42 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.764 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -83.91 -52.48 6.31 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.667 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 454' ' ' SER . 50.3 t -47.02 -40.83 5.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.49 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 455' ' ' HIS . 43.4 t -74.36 -42.13 50.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.26 -35.89 81.57 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.71 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -68.46 -40.34 81.07 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.456 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -61.12 -36.52 92.48 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.388 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 15.5 mmt -90.78 -15.65 29.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.989 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 61.91 57.88 15.4 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.644 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.19 161.24 17.4 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' CYS . . . . . 0.517 ' SG ' ' O ' ' A' ' 401' ' ' GLY . 19.0 t -81.11 91.7 6.16 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.481 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.6 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 4.2 t -129.34 158.8 38.11 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.397 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . 0.466 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -136.62 162.71 34.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.055 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . 0.608 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 32.1 t -143.59 160.17 41.13 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 118.669 -1.213 . . . . 0.0 113.093 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 47.35 75.18 0.2 Allowed Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.434 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . 0.654 ' SG ' HD13 ' A' ' 485' ' ' LEU . 1.8 t -84.75 -171.67 3.76 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.215 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.461 ' H ' HD11 ' A' ' 485' ' ' LEU . . . -50.25 -90.83 0.01 OUTLIER Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.672 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -155.67 66.67 0.62 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.578 HG13 HG13 ' A' ' 448' ' ' VAL . 0.0 OUTLIER -62.79 107.07 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.41 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -89.91 123.28 33.71 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -86.58 126.58 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 118.815 -1.154 . . . . 0.0 112.565 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -97.39 113.63 25.32 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.682 -1.145 . . . . 0.0 110.642 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.702 ' C ' ' H ' ' A' ' 480' ' ' ALA . 0.8 OUTLIER -67.87 -6.12 20.1 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.416 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.428 ' H ' ' HG2' ' A' ' 479' ' ' GLU . 34.8 mm-40 -52.92 -7.43 0.07 Allowed 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.556 -1.258 . . . . 0.0 108.551 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.702 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -179.72 -82.3 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 112.527 -2.124 . . . . 0.0 105.487 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . 0.528 ' HB3' ' CG ' ' A' ' 492' ' ' GLU . 4.5 mttt 169.17 89.18 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.099 0.952 . . . . 0.0 109.772 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 491' ' ' ALA . 1.4 p -151.29 138.78 19.53 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.301 -1.772 . . . . 0.0 111.885 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' PHE . . . . . 0.53 ' HB2' HG22 ' A' ' 474' ' ' ILE . 16.0 p90 -97.83 152.0 19.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.085 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -119.33 116.28 25.9 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.532 -0.867 . . . . 0.0 113.198 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.654 HD13 ' SG ' ' A' ' 471' ' ' CYS . 6.2 tt -150.5 152.87 34.86 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.968 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 69.04 -108.35 2.44 Favored Glycine 0 N--CA 1.486 2.0 0 C-N-CA 118.828 -1.653 . . . . 0.0 110.286 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.614 ' C ' ' CD2' ' A' ' 488' ' ' HIS . . . -137.34 27.21 2.89 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 119.488 -1.339 . . . . 0.0 111.194 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.614 ' CD2' ' C ' ' A' ' 487' ' ' GLY . 26.7 m-70 -150.68 152.51 34.06 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.829 -1.149 . . . . 0.0 111.286 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 12.9 m -119.83 97.12 5.47 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.12 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' A' ' 490' ' ' PHE . 39.0 p90 -155.48 155.31 33.26 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.963 -1.095 . . . . 0.0 112.98 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.716 ' H ' HG22 ' A' ' 482' ' ' THR . . . -152.1 -124.31 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.528 ' CG ' ' HB3' ' A' ' 481' ' ' LYS . 1.1 pt-20 -67.9 49.03 0.05 Allowed 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.281 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -138.51 2.63 2.83 Favored Glycine 0 C--N 1.283 -2.37 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -167.56 -173.97 2.36 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.477 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -122.94 141.94 51.36 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.742 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.598 ' H ' HD12 ' A' ' 496' ' ' ILE . 0.6 OUTLIER -121.47 160.06 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.944 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 506' ' ' TYR . 6.3 m -115.37 99.46 7.4 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' LEU . . . . . 0.611 HD22 ' CD2' ' A' ' 446' ' ' LEU . 0.1 OUTLIER -100.48 140.83 34.18 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.104 -1.038 . . . . 0.0 112.219 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.524 ' N ' HD12 ' A' ' 498' ' ' LEU . 21.7 t70 -93.42 160.64 14.72 Favored 'General case' 0 C--O 1.206 -1.237 0 CA-C-O 122.018 0.913 . . . . 0.0 111.896 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' GLY . . . . . 0.605 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -148.27 95.14 0.16 Allowed Glycine 0 C--N 1.272 -3.026 0 N-CA-C 106.508 -2.637 . . . . 0.0 106.508 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 2.0 t 171.15 4.47 0.0 OUTLIER 'General case' 0 C--N 1.244 -3.981 0 CA-C-N 112.177 -2.012 . . . . 0.0 107.065 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' THR . . . . . 0.413 ' H ' ' H ' ' A' ' 503' ' ' GLY . 0.0 OUTLIER -168.38 -22.79 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 112.516 -2.129 . . . . 0.0 107.496 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 96.93 -7.86 65.08 Favored Glycine 0 N--CA 1.485 1.948 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.882 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.23 154.74 9.8 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.914 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 2.1 mp -135.04 146.79 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.295 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' TYR . . . . . 0.572 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 14.0 m-85 -133.79 161.96 33.3 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.488 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -127.74 153.86 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.209 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 72.78 124.31 0.08 OUTLIER Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.209 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.562 ' N ' ' OD1' ' A' ' 509' ' ' ASP . 13.1 p-10 -42.19 108.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.011 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 510' ' ' ILE . 14.5 pt -74.14 176.14 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.575 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--N 1.303 -1.437 0 CA-C-O 116.3 -1.809 . . . . 0.0 110.818 179.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 120.677 0.275 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 388' ' ' ALA . . . -99.31 119.18 37.51 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.491 ' HG ' HD13 ' A' ' 510' ' ' ILE . 4.7 mt 51.25 46.91 25.77 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.678 ' O ' ' HB3' ' A' ' 388' ' ' ALA . 5.0 tttt 52.62 35.34 17.87 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 387' ' ' LYS . . . 79.72 23.02 0.49 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.616 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 385' ' ' ALA . . . 51.38 55.2 20.64 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 118.882 -1.628 . . . . 0.0 110.411 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -92.37 59.04 3.34 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.709 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.657 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 65.1 t -46.3 156.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.289 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.47 ' N ' HG12 ' A' ' 391' ' ' VAL . 34.3 pt -128.29 -11.8 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.363 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -175.25 -167.41 34.37 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.896 -1.621 . . . . 0.0 111.481 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 1.2 p 177.12 122.18 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.327 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.36 -151.69 0.49 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.952 -0.699 . . . . 0.0 111.194 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 396' ' ' LEU . 8.9 mt -80.74 127.16 76.12 Favored Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.601 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.08 97.32 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.072 1.181 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -60.39 -59.37 5.51 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.146 -1.021 . . . . 0.0 109.946 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.01 133.72 12.44 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.428 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.91 98.06 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 120.791 0.994 . . . . 0.0 110.935 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.592 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -153.43 159.58 28.7 Favored Glycine 0 N--CA 1.504 3.169 0 C-N-CA 118.876 -1.63 . . . . 0.0 111.882 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.756 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -133.13 132.05 41.2 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.198 -0.601 . . . . 0.0 109.711 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.421 ' HB2' ' SG ' ' A' ' 466' ' ' CYS . . . -150.39 161.38 42.6 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.324 -1.35 . . . . 0.0 113.184 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.14 110.94 6.21 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.231 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -153.16 167.69 31.83 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 118.812 -1.661 . . . . 0.0 111.774 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -83.89 156.46 22.39 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.179 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.71 ' HB ' ' H ' ' A' ' 492' ' ' GLU . 0.0 OUTLIER -78.79 165.23 3.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 119.639 -0.825 . . . . 0.0 113.072 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.59 ' CE1' ' OE1' ' A' ' 413' ' ' GLU . 3.6 m-85 -170.37 170.0 7.29 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.993 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.505 ' CG ' ' HD2' ' A' ' 481' ' ' LYS . 14.2 m-85 -137.36 23.21 2.97 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.805 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 12.6 p -146.95 142.0 27.09 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.087 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -71.25 -12.28 61.37 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.455 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -78.22 -36.47 47.12 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.451 -0.899 . . . . 0.0 109.718 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.59 ' OE1' ' CE1' ' A' ' 408' ' ' TYR . 62.0 mm-40 -65.58 -40.38 92.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.114 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ALA . . . . . 0.589 ' HB1' ' CB ' ' A' ' 441' ' ' ALA . . . -67.5 -39.63 85.19 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.811 -1.156 . . . . 0.0 109.345 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -56.48 -34.25 66.74 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.065 -1.054 . . . . 0.0 109.762 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.62 -50.82 5.71 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 119.146 -1.022 . . . . 0.0 110.717 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -55.17 -48.02 74.35 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.28 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' HIS . . . . . 0.594 ' ND1' ' OE1' ' A' ' 419' ' ' GLU . 17.9 t-80 -43.76 -41.01 4.66 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.045 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.594 ' OE1' ' ND1' ' A' ' 418' ' ' HIS . 0.6 OUTLIER -91.92 -25.6 18.83 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.457 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 420' ' ' LYS . 7.6 mtpm? -92.69 -52.8 4.45 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.63 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -101.3 -31.6 5.52 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.148 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . 0.461 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 0.9 OUTLIER 65.96 148.6 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.396 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 55.89 95.01 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.879 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.8 t -134.54 162.45 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.484 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 426' ' ' LEU . 16.8 mm -121.69 159.93 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.93 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.445 ' N ' HG22 ' A' ' 425' ' ' ILE . 6.6 tp -136.15 134.52 38.34 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.345 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.556 HG21 ' CE2' ' A' ' 483' ' ' PHE . 8.7 t -117.72 121.73 68.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.714 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ARG . . . . . 0.911 ' O ' HG22 ' A' ' 447' ' ' THR . 47.8 mtt180 -151.29 161.64 42.34 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.44 -66.5 0.53 Allowed 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.62 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -109.3 -165.53 1.02 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.721 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.678 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -99.0 -163.97 1.09 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.32 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.517 ' N ' ' OG1' ' A' ' 431' ' ' THR . 1.4 t -175.61 137.16 0.51 Allowed Pre-proline 0 N--CA 1.489 1.519 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.557 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.5 Cg_endo -62.27 -77.59 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.388 1.392 . . . . 0.0 112.126 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -44.01 -18.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.705 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 439' ' ' MET . 11.0 m-20 -82.53 -9.0 59.6 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.39 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.967 HG23 ' H ' ' A' ' 437' ' ' GLU . 6.1 tp -46.78 -63.54 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.579 -0.849 . . . . 0.0 111.145 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.967 ' H ' HG23 ' A' ' 436' ' ' ILE . 5.4 mt-10 -52.27 -26.98 13.34 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.414 -1.315 . . . . 0.0 108.59 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -81.17 -24.67 56.9 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' MET . . . . . 0.534 ' N ' ' O ' ' A' ' 435' ' ' ASP . 53.3 mtt -77.64 -41.97 36.47 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.861 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.852 ' NE2' HD11 ' A' ' 436' ' ' ILE . 28.1 m170 -65.14 -49.04 71.41 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 118.363 -1.335 . . . . 0.0 108.813 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.589 ' CB ' ' HB1' ' A' ' 414' ' ' ALA . . . -48.38 -20.83 0.45 Allowed 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.536 ' N ' ' C ' ' A' ' 440' ' ' HIS . . . -116.57 61.77 0.72 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.94 -1.482 . . . . 0.0 108.53 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.718 ' H ' ' CD ' ' A' ' 443' ' ' GLU . 1.4 pm0 -26.03 -58.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.875 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' A' ' 425' ' ' ILE . . . -81.48 145.2 25.01 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 118.494 -1.812 . . . . 0.0 109.009 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 41.0 mt -147.81 112.66 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 118.449 -1.301 . . . . 0.0 112.202 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.461 ' HA ' HD13 ' A' ' 446' ' ' LEU . 1.3 mm? -100.35 137.63 38.51 Favored 'General case' 0 C--O 1.187 -2.217 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.911 HG22 ' O ' ' A' ' 428' ' ' ARG . 0.3 OUTLIER -149.64 151.44 33.76 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 118.019 -1.473 . . . . 0.0 111.896 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.703 HG22 ' HB ' ' A' ' 474' ' ' ILE . 18.8 t -77.02 -24.29 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.805 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 10.7 ttt-85 -108.13 -143.66 0.38 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.225 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.508 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 73.93 -162.69 54.44 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . 0.672 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 77.21 -41.92 1.85 Allowed Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.159 -1.496 . . . . 0.0 110.392 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.683 ' C ' HG23 ' A' ' 453' ' ' THR . 53.7 mtt -64.86 19.09 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.239 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . 0.683 HG23 ' C ' ' A' ' 452' ' ' MET . 1.0 OUTLIER 62.84 114.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.874 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.7 t -173.28 -155.54 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.154 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 459' ' ' VAL . 45.8 t60 -57.67 -36.8 72.4 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.281 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.678 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -63.23 -44.67 94.59 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.816 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.0 -57.43 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.648 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 34.3 t -45.67 -41.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.7 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 455' ' ' HIS . 51.5 t -65.95 -53.66 35.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.056 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.11 73.48 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.693 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -69.33 -24.0 63.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.252 -0.979 . . . . 0.0 110.606 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.05 -48.3 5.8 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.419 -1.372 . . . . 0.0 110.642 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 56.7 mmm -78.41 -40.81 34.88 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.982 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.35 22.0 30.68 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.574 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' THR . . . . . 0.831 HG22 ' H ' ' A' ' 466' ' ' CYS . 7.3 m -76.03 -170.51 1.41 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' CYS . . . . . 0.831 ' H ' HG22 ' A' ' 465' ' ' THR . 0.0 OUTLIER -99.1 120.32 39.29 Favored 'General case' 0 C--O 1.202 -1.414 0 C-N-CA 119.604 -0.839 . . . . 0.0 109.667 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 23.4 t -151.29 147.24 26.72 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.055 -1.458 . . . . 0.0 112.005 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.89 162.71 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.747 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . 0.508 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 28.8 t -147.79 160.58 42.58 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.995 -1.082 . . . . 0.0 112.62 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 46.94 72.92 0.35 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.695 -1.241 . . . . 0.0 111.184 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . 0.618 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.5 OUTLIER -83.43 -158.82 0.32 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.878 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 471' ' ' CYS . . . -67.69 -101.71 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.989 -1.577 . . . . 0.0 110.31 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -135.33 54.57 1.92 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.861 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.812 HG23 ' CB ' ' A' ' 483' ' ' PHE . 5.1 mt -45.67 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.921 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -89.37 121.39 31.58 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 1.8 mt -87.01 122.44 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.929 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -99.46 111.97 24.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.788 ' C ' ' H ' ' A' ' 480' ' ' ALA . 35.9 mt-10 -60.54 0.29 0.21 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.286 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.647 ' O ' ' HB2' ' A' ' 480' ' ' ALA . 47.4 mt-10 -64.24 17.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.254 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.788 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 155.2 -71.65 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . 0.505 ' HD2' ' CG ' ' A' ' 409' ' ' PHE . 2.1 mmtt 158.51 79.3 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.492 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 1.005 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 6.7 p -132.28 143.76 50.12 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.681 -0.807 . . . . 0.0 112.325 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' PHE . . . . . 1.015 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 10.8 p90 -98.96 143.51 29.17 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.848 -0.741 . . . . 0.0 111.201 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' GLU . . . . . 0.517 ' OE1' ' N ' ' A' ' 485' ' ' LEU . 5.1 tp10 -101.54 111.24 23.42 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.196 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 487' ' ' GLY . 0.8 OUTLIER -134.6 117.83 16.55 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.002 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 485' ' ' LEU . . . 21.3 -74.15 0.0 OUTLIER Glycine 0 N--CA 1.51 3.593 0 O-C-N 124.486 1.116 . . . . 0.0 114.439 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 485' ' ' LEU . . . -51.76 -67.92 1.78 Allowed Glycine 0 N--CA 1.485 1.917 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.543 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 26.6 m80 -154.44 163.53 40.03 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 118.156 -1.418 . . . . 0.0 112.869 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 484' ' ' GLU . 9.2 m -93.6 99.29 11.76 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.438 ' CE1' ' HE3' ' A' ' 507' ' ' LYS . 40.3 p90 -153.22 154.13 34.07 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 118.455 -1.298 . . . . 0.0 113.825 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 1.015 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . 170.94 172.52 0.07 Allowed 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 113.767 -1.561 . . . . 0.0 108.678 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.71 ' H ' ' HB ' ' A' ' 407' ' ' VAL . 19.7 tt0 26.06 41.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.28 0 O-C-N 124.266 0.979 . . . . 0.0 109.978 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -167.61 1.43 0.04 OUTLIER Glycine 0 C--N 1.281 -2.505 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' ASP . . . . . 0.425 ' O ' HG22 ' A' ' 407' ' ' VAL . 2.9 m-20 -156.96 -152.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.513 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . 0.448 ' HE2' ' H ' ' A' ' 509' ' ' ASP . 1.5 p90 -154.32 140.52 18.51 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.433 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.842 ' H ' HD12 ' A' ' 496' ' ' ILE . 0.2 OUTLIER -122.99 160.6 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.569 -0.852 . . . . 0.0 113.073 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 506' ' ' TYR . 1.8 p -115.29 98.37 6.72 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -93.39 142.31 27.47 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 118.893 -1.123 . . . . 0.0 113.012 -179.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.733 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.9 OUTLIER -106.52 161.54 14.52 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.479 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' GLY . . . . . 0.592 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -156.28 95.41 0.15 Allowed Glycine 0 C--N 1.277 -2.707 0 N-CA-C 106.836 -2.505 . . . . 0.0 106.836 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 502' ' ' THR . 77.7 p -178.03 6.68 0.01 OUTLIER 'General case' 1 C--N 1.241 -4.142 0 CA-C-N 112.358 -1.921 . . . . 0.0 107.33 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 501' ' ' SER . 0.0 OUTLIER -175.35 -19.3 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 112.822 -1.99 . . . . 0.0 107.72 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 86.77 74.73 1.27 Allowed Glycine 0 N--CA 1.489 2.221 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.558 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 499' ' ' ASP . 19.8 mttp -155.45 115.16 3.68 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.258 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' ILE . . . . . 0.548 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.1 tt -93.91 160.45 2.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.659 -1.216 . . . . 0.0 112.687 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' TYR . . . . . 0.657 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 18.8 m-85 -141.82 161.44 37.95 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.771 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.438 ' HE3' ' CE1' ' A' ' 490' ' ' PHE . 47.6 tttt -107.67 154.36 21.57 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.695 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 77.27 144.7 1.98 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.224 -1.465 . . . . 0.0 110.567 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.448 ' H ' ' HE2' ' A' ' 495' ' ' TYR . 2.9 p-10 -61.41 157.31 17.09 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.519 -0.872 . . . . 0.0 110.701 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' ILE . . . . . 1.11 HD12 ' H ' ' A' ' 511' ' ' GLU . 0.2 OUTLIER -103.28 164.99 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.907 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 1.11 ' H ' HD12 ' A' ' 510' ' ' ILE . 6.4 tm-20 . . . . . 0 C--N 1.298 -1.656 0 CA-C-O 116.381 -1.771 . . . . 0.0 110.82 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.866 0.365 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -99.39 33.75 2.37 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.881 -0.728 . . . . 0.0 110.733 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 386' ' ' LEU . 2.4 pp -103.3 13.67 33.27 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.23 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.0 -5.99 7.32 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.942 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -169.15 19.54 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -75.26 -109.71 0.1 OUTLIER Glycine 0 N--CA 1.489 2.192 0 C-N-CA 118.889 -1.624 . . . . 0.0 110.425 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -154.31 90.41 1.34 Allowed 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.485 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.72 HG23 ' CE1' ' A' ' 506' ' ' TYR . 0.4 OUTLIER -83.79 137.63 20.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.707 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.771 HD12 HD21 ' A' ' 485' ' ' LEU . 28.2 pt -77.48 -39.38 27.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.571 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.52 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -178.56 -162.33 27.97 Favored Glycine 0 N--CA 1.489 2.194 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.499 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 121.11 0.88 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.615 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.434 ' HB2' ' SG ' ' A' ' 471' ' ' CYS . . . -94.86 -142.69 0.25 Allowed 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.913 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.77 128.34 48.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.328 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -62.73 98.2 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 121.076 1.184 . . . . 0.0 111.756 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -62.93 -74.36 0.09 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.611 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.26 146.24 60.07 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.946 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -52.27 100.4 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 121.762 1.642 . . . . 0.0 111.078 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.65 161.22 29.74 Favored Glycine 0 N--CA 1.499 2.884 0 C-N-CA 117.9 -2.095 . . . . 0.0 112.989 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -150.48 117.23 5.83 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 114.732 -0.734 . . . . 0.0 109.135 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.49 161.57 42.46 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 118.048 -1.461 . . . . 0.0 112.652 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -125.56 120.35 30.63 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.504 -1.225 . . . . 0.0 107.746 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.16 166.64 31.09 Favored Glycine 0 N--CA 1.494 2.535 0 C-N-CA 118.337 -1.887 . . . . 0.0 112.338 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -85.24 134.29 34.14 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.567 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 483' ' ' PHE . 2.2 p -66.21 138.24 23.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.431 -0.908 . . . . 0.0 112.998 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.658 ' CE1' ' OE2' ' A' ' 413' ' ' GLU . 1.5 m-85 -153.08 146.16 24.63 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.131 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.623 ' O ' HG23 ' A' ' 410' ' ' THR . 4.2 m-85 -110.94 41.53 1.8 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.789 -0.765 . . . . 0.0 112.531 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 409' ' ' PHE . 0.8 OUTLIER -160.95 143.65 12.72 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 118.65 -1.22 . . . . 0.0 111.189 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -78.11 -13.36 59.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.831 -1.148 . . . . 0.0 108.606 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.61 -41.04 24.61 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.06 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.658 ' OE2' ' CE1' ' A' ' 408' ' ' TYR . 6.0 mm-40 -64.38 -40.6 96.14 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.966 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.07 97.99 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.348 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.46 -38.28 90.54 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.296 -0.961 . . . . 0.0 110.232 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -82.01 -16.96 48.52 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.112 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.56 -52.4 4.91 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.183 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.51 -19.06 55.78 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.563 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.579 ' C ' ' H ' ' A' ' 421' ' ' GLY . 0.7 OUTLIER -64.6 -48.24 75.67 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 119.182 -1.007 . . . . 0.0 109.877 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -1.07 0.08 Allowed 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 77.82 64.86 1.98 Allowed Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.682 -1.247 . . . . 0.0 110.08 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . 0.701 ' C ' ' HE ' ' A' ' 423' ' ' ARG . 7.2 mt-10 -146.43 -166.53 2.5 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.414 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . 0.753 ' N ' ' HE ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER -115.69 148.36 39.82 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.632 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.419 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 1.7 t -148.97 162.1 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.075 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . . . . . . . . . 6.2 mm -123.81 160.74 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.252 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 4.5 tp -127.24 121.14 30.39 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.432 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 409' ' ' PHE . 24.8 t -111.31 117.27 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.246 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ARG . . . . . 0.61 ' O ' HG22 ' A' ' 447' ' ' THR . 17.0 mtp85 -152.43 155.52 37.7 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.941 HD23 ' H ' ' A' ' 429' ' ' LEU . 0.7 OUTLIER -106.32 28.71 7.48 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.571 1.177 . . . . 0.0 109.649 179.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.39 121.17 2.96 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 113.622 -1.626 . . . . 0.0 110.965 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.721 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.8 OUTLIER -76.08 179.56 5.57 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.97 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 2.9 t -177.24 139.5 0.44 Allowed Pre-proline 0 N--CA 1.488 1.47 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.068 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -66.91 -72.9 0.02 OUTLIER 'Trans proline' 0 C--O 1.213 -0.769 0 C-N-CA 121.617 1.545 . . . . 0.0 111.871 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' A' ' 435' ' ' ASP . 7.4 pt-20 -39.48 -32.41 0.12 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.659 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 438' ' ' GLY . 4.0 m-20 -62.14 -8.6 5.75 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.727 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.624 HG23 ' N ' ' A' ' 437' ' ' GLU . 6.7 tp -48.54 -43.4 13.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.878 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.624 ' N ' HG23 ' A' ' 436' ' ' ILE . 23.2 mt-10 -62.66 -27.19 69.06 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 117.769 -1.572 . . . . 0.0 107.957 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -78.88 -26.93 57.58 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 108.639 -1.784 . . . . 0.0 108.639 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 27.8 mtt -66.49 -39.22 88.62 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 118.75 -1.18 . . . . 0.0 109.604 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.756 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -74.54 -39.72 62.16 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.336 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.756 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -55.76 -28.77 57.71 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 118.782 -1.167 . . . . 0.0 107.91 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -112.84 89.47 3.09 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.118 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 443' ' ' GLU . 7.0 pt-20 -64.36 37.23 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.775 -0.77 . . . . 0.0 111.862 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -171.58 140.52 5.9 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.9 mm -139.24 132.17 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 118.808 -1.157 . . . . 0.0 110.913 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 427' ' ' VAL . 1.4 tp -135.96 95.98 3.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.2 p -109.14 161.44 15.21 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.804 -0.758 . . . . 0.0 112.768 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 474' ' ' ILE . 37.0 t -85.23 -21.0 8.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.971 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 470' ' ' GLY . 19.1 mmm-85 -105.97 -148.11 0.41 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.597 -0.841 . . . . 0.0 112.626 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 89.08 -136.58 13.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . 0.578 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 82.59 163.69 33.76 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 16.8 tpp 46.64 13.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.482 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.3 OUTLIER 66.97 131.51 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.592 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.654 ' H ' ' HB3' ' A' ' 457' ' ' ALA . 9.0 t -163.58 -169.97 2.08 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.662 -0.815 . . . . 0.0 109.957 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' HIS . . . . . 0.603 ' O ' HG23 ' A' ' 459' ' ' VAL . 4.6 m80 -43.41 -46.04 6.47 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.231 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.721 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -61.39 -48.12 82.68 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.663 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.654 ' HB3' ' H ' ' A' ' 454' ' ' SER . . . -74.66 -55.02 6.33 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.534 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 459' ' ' VAL . 2.2 t -50.25 -53.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.548 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 455' ' ' HIS . 88.6 t -54.08 -44.1 61.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.527 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.696 ' HB1' ' SG ' ' A' ' 467' ' ' CYS . . . -61.22 -55.17 35.15 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.083 -1.047 . . . . 0.0 110.368 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -55.38 -28.69 55.64 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.534 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -72.61 -29.11 66.14 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.602 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 463' ' ' MET . 1.1 tpt -91.46 -41.66 10.72 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.863 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.03 83.94 1.64 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.523 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' THR . . . . . 0.643 HG22 ' N ' ' A' ' 466' ' ' CYS . 1.9 m -162.36 171.93 16.42 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.8 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' CYS . . . . . 0.643 ' N ' HG22 ' A' ' 465' ' ' THR . 12.8 t -78.1 126.47 30.87 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.958 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.696 ' SG ' ' HB1' ' A' ' 460' ' ' ALA . 0.5 OUTLIER -151.2 148.36 28.15 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.795 -1.162 . . . . 0.0 111.89 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 469' ' ' SER . 1.2 t -127.01 160.78 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.67 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . 0.578 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 6.9 t -150.85 152.6 33.95 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.443 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 44.16 87.28 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.986 -1.102 . . . . 0.0 111.431 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -99.63 -174.78 2.8 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.45 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -47.22 -84.29 0.02 OUTLIER Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.363 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -158.15 66.91 0.46 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.95 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.3 mt -61.96 102.71 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.604 -0.839 . . . . 0.0 112.45 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.69 120.29 29.95 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.851 HG23 ' O ' ' A' ' 482' ' ' THR . 52.9 mt -88.76 137.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 118.173 -1.411 . . . . 0.0 112.327 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.529 ' CB ' ' OG1' ' A' ' 482' ' ' THR . 0.3 OUTLIER -107.42 123.15 47.96 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.682 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.604 ' C ' ' N ' ' A' ' 480' ' ' ALA . 20.3 mm-40 -54.58 -7.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.656 -1.156 . . . . 0.0 113.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 478' ' ' GLU . 0.1 OUTLIER -46.46 -18.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 118.239 -1.384 . . . . 0.0 108.311 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.604 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . 177.56 -97.37 0.0 OUTLIER 'General case' 0 C--N 1.272 -2.776 0 CA-C-N 112.283 -2.235 . . . . 0.0 105.43 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . 0.584 ' CD ' ' CD2' ' A' ' 409' ' ' PHE . 3.6 mmpp? -148.55 40.49 0.92 Allowed 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.851 ' O ' HG23 ' A' ' 476' ' ' ILE . 44.5 p -68.94 172.94 5.88 Favored 'General case' 0 C--O 1.197 -1.708 0 CA-C-N 113.975 -1.466 . . . . 0.0 114.384 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' PHE . . . . . 0.732 ' CE1' HG21 ' A' ' 407' ' ' VAL . 0.1 OUTLIER -151.5 147.94 27.45 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.812 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' GLU . . . . . 0.495 ' C ' ' CD ' ' A' ' 484' ' ' GLU . 3.1 tp10 -131.72 113.89 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.372 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.889 HD23 ' O ' ' A' ' 485' ' ' LEU . 0.3 OUTLIER -151.08 161.73 42.18 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.786 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.21 -115.41 7.97 Favored Glycine 0 N--CA 1.483 1.831 0 C-N-CA 119.036 -1.554 . . . . 0.0 109.974 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.454 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -130.17 29.53 3.67 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.38 -1.391 . . . . 0.0 110.804 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.454 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 15.3 m170 -151.21 148.77 28.63 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.68 -1.208 . . . . 0.0 111.41 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.427 ' OG1' ' OE1' ' A' ' 484' ' ' GLU . 3.3 m -116.71 99.14 6.92 Favored 'General case' 0 N--CA 1.485 1.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.169 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.568 ' HE2' HG21 ' A' ' 392' ' ' ILE . 38.3 m-85 -90.06 160.6 16.23 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.562 ' CA ' HG22 ' A' ' 482' ' ' THR . . . -126.5 126.27 43.45 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.116 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.478 ' CB ' ' HB2' ' A' ' 481' ' ' LYS . 2.6 tm-20 -45.05 103.12 0.03 OUTLIER 'General case' 0 CA--C 1.478 -1.794 0 C-N-CA 118.477 -1.289 . . . . 0.0 109.402 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 159.01 14.26 0.04 OUTLIER Glycine 0 C--N 1.261 -3.613 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' ASP . . . . . 0.594 ' CG ' ' N ' ' A' ' 495' ' ' TYR . 0.4 OUTLIER -138.44 -153.31 0.47 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.139 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . 0.594 ' N ' ' CG ' ' A' ' 494' ' ' ASP . 2.5 p90 -152.55 139.79 19.39 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.597 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 496' ' ' ILE . 0.0 OUTLIER -127.38 161.34 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.528 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 506' ' ' TYR . 3.3 t -104.61 102.88 12.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' LEU . . . . . 0.824 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -102.28 134.29 45.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.642 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.824 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.1 OUTLIER -121.03 142.38 49.86 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.481 179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -147.8 90.4 0.15 Allowed Glycine 0 C--O 1.197 -2.188 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 502' ' ' THR . 7.4 p -160.74 8.34 0.08 Allowed 'General case' 0 C--N 1.252 -3.642 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' THR . . . . . 0.462 ' H ' ' H ' ' A' ' 503' ' ' GLY . 0.0 OUTLIER -172.41 -16.48 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 111.67 -2.514 . . . . 0.0 106.863 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.462 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 86.3 85.45 1.06 Allowed Glycine 0 N--CA 1.484 1.835 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.194 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -158.04 102.82 1.82 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' ILE . . . . . 0.611 HG12 HD13 ' A' ' 498' ' ' LEU . 3.5 mt -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.391 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' TYR . . . . . 0.72 ' CE1' HG23 ' A' ' 391' ' ' VAL . 75.5 m-85 -123.01 161.81 23.55 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.902 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 10.7 tmtt? -108.76 152.82 24.34 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.634 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . 67.99 141.39 0.08 OUTLIER Glycine 0 N--CA 1.484 1.84 0 C-N-CA 119.057 -1.545 . . . . 0.0 110.243 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.424 ' H ' ' HE2' ' A' ' 495' ' ' TYR . 1.9 p30 -57.93 146.02 33.7 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.6 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' ILE . . . . . . . . . . . . . 1.7 mt -140.69 165.58 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.46 ' OXT' ' CG ' ' A' ' 511' ' ' GLU . 2.2 tt0 . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.638 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.434 ' O ' ' HB3' ' A' ' 385' ' ' ALA . . . . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.95 0.405 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.56 ' C ' ' N ' ' A' ' 387' ' ' LYS . . . 60.78 172.97 0.1 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.008 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 12.1 mt 46.79 15.05 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.791 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.56 ' N ' ' C ' ' A' ' 385' ' ' ALA . 47.9 mttm -136.98 -1.6 2.17 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.354 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -153.72 15.31 0.5 Allowed 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 113.907 -1.497 . . . . 0.0 109.96 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -85.93 139.2 16.82 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.028 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -80.91 59.36 3.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.794 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 2.3 t -50.13 132.21 9.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 505' ' ' ILE . 3.4 pt -78.03 -52.49 15.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.564 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . 170.84 -170.92 43.54 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.024 -1.56 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.7 p -143.2 142.11 31.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.769 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -114.09 -145.75 0.4 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.782 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 396' ' ' LEU . 6.8 mt -77.17 125.28 86.8 Favored Pre-proline 0 N--CA 1.488 1.449 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.768 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -66.82 102.36 0.63 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.982 1.122 . . . . 0.0 111.26 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -70.77 -62.15 1.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.356 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.8 t -146.73 140.88 15.54 Favored Pre-proline 0 C--N 1.304 -1.389 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.975 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.29 103.36 0.15 Allowed 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 121.078 1.185 . . . . 0.0 111.072 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -151.25 161.68 29.22 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 118.772 -1.68 . . . . 0.0 112.28 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -134.93 124.6 25.2 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -149.76 160.89 43.18 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.143 -1.423 . . . . 0.0 112.595 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.698 ' HB1' ' OH ' ' A' ' 495' ' ' TYR . . . -142.16 110.11 5.87 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.017 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.12 165.92 30.89 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.957 -1.592 . . . . 0.0 111.292 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.502 ' N ' ' HD2' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -85.18 147.14 26.75 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.688 HG11 ' HZ ' ' A' ' 483' ' ' PHE . 2.0 m -78.72 142.7 13.7 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 118.473 -1.291 . . . . 0.0 113.228 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -146.87 146.47 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.892 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 427' ' ' VAL . 4.9 m-85 -105.84 37.41 2.25 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.439 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 409' ' ' PHE . 21.5 p -155.85 141.45 17.84 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.028 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -79.42 -12.8 59.89 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.278 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -73.47 -43.62 59.81 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.384 -0.926 . . . . 0.0 109.672 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.15 -42.62 86.29 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.674 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ALA . . . . . 0.786 ' HB1' ' HB1' ' A' ' 441' ' ' ALA . . . -61.29 -39.67 91.31 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.089 -1.044 . . . . 0.0 109.523 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -58.86 -30.15 67.51 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.985 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -88.6 -38.74 14.62 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.537 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -69.04 -61.01 1.97 Allowed 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.041 -0.982 . . . . 0.0 109.114 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' HIS . . . . . 0.409 ' C ' ' O ' ' A' ' 417' ' ' ALA . 19.5 t-80 -43.4 -26.52 0.2 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.811 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.435 ' N ' ' C ' ' A' ' 417' ' ' ALA . 30.1 tt0 -91.17 -33.92 15.22 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.375 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 417' ' ' ALA . 29.4 mtmt -131.74 49.9 2.28 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.813 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -178.38 -48.24 0.07 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . 0.523 ' O ' ' NE ' ' A' ' 423' ' ' ARG . 2.5 mt-10 48.96 71.23 0.39 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.167 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . 0.523 ' NE ' ' O ' ' A' ' 422' ' ' GLU . 6.3 mtm180 164.04 84.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.432 ' CG2' ' C ' ' A' ' 423' ' ' ARG . 0.2 OUTLIER -147.51 160.34 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.698 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 426' ' ' LEU . 43.2 mm -121.25 160.66 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.102 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.48 ' N ' HG22 ' A' ' 425' ' ' ILE . 13.1 tp -127.31 118.55 24.4 Favored 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.83 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.596 HG11 ' CZ ' ' A' ' 409' ' ' PHE . 1.5 t -104.66 130.82 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.038 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ARG . . . . . 0.726 ' O ' HG22 ' A' ' 447' ' ' THR . 1.6 mtp85 -153.01 145.94 24.51 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.825 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.696 ' H ' HD12 ' A' ' 429' ' ' LEU . 5.8 mp -56.61 -60.72 3.13 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 117.816 -1.553 . . . . 0.0 109.698 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.9 -175.09 2.59 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.611 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.662 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -94.17 176.61 6.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.183 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 16.2 t -173.09 128.35 0.52 Allowed Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.357 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 435' ' ' ASP . 2.0 Cg_endo -61.41 -56.37 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.107 1.205 . . . . 0.0 111.501 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 434' ' ' GLU . 8.1 mt-10 -45.71 -13.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 433' ' ' PRO . 13.4 t70 -90.31 -8.3 51.2 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.576 -0.85 . . . . 0.0 111.557 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.944 HG23 ' H ' ' A' ' 437' ' ' GLU . 4.9 tp -41.85 -60.57 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 119.896 -0.721 . . . . 0.0 111.174 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.944 ' H ' HG23 ' A' ' 436' ' ' ILE . 19.3 mm-40 -49.11 -33.75 12.51 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.419 -1.312 . . . . 0.0 109.189 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.46 -24.18 68.66 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 436' ' ' ILE . 26.8 mtt -72.71 -34.37 67.08 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 118.907 -1.117 . . . . 0.0 110.71 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 441' ' ' ALA . 0.0 OUTLIER -75.74 -45.6 35.65 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 118.113 -1.435 . . . . 0.0 109.622 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.786 ' HB1' ' HB1' ' A' ' 414' ' ' ALA . . . -47.41 -36.39 9.73 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.426 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.666 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -106.86 93.07 4.36 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.501 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.79 28.22 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.597 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.666 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -160.28 132.01 2.82 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.2 mm -127.97 142.26 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.001 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 427' ' ' VAL . 4.7 tp -150.1 97.32 2.55 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.261 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 428' ' ' ARG . 0.9 OUTLIER -108.72 160.33 16.04 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.874 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.557 HG22 ' HB ' ' A' ' 474' ' ' ILE . 34.0 t -75.76 -45.05 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.829 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -94.08 -150.15 0.29 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.458 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 77.46 128.29 0.39 Allowed Glycine 0 N--CA 1.482 1.759 0 C-N-CA 119.145 -1.502 . . . . 0.0 109.4 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 453' ' ' THR . . . 175.62 -163.43 33.19 Favored Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.095 -1.526 . . . . 0.0 110.331 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . . . . . . . . . 53.9 mtp 44.04 19.58 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.084 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 67.16 122.87 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.66 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 458' ' ' VAL . 69.9 p -166.64 -156.2 0.23 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.318 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' HIS . . . . . 0.684 ' O ' HG23 ' A' ' 459' ' ' VAL . 26.3 m80 -51.88 -51.1 59.16 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.971 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.662 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -52.55 -42.4 64.4 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.533 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -84.55 -51.02 7.2 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.174 -1.011 . . . . 0.0 110.519 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 454' ' ' SER . 79.0 t -55.28 -44.82 76.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.748 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 455' ' ' HIS . 47.2 t -67.16 -55.2 18.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.003 -1.079 . . . . 0.0 110.066 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.27 -28.96 65.43 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.289 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -65.35 -45.62 83.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -67.15 -24.29 73.28 Favored Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.147 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.3 -21.31 31.07 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.815 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 63.02 21.12 63.32 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.59 -1.29 . . . . 0.0 110.675 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' THR . . . . . 0.889 HG22 ' H ' ' A' ' 466' ' ' CYS . 14.4 m -93.08 -168.89 2.03 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.773 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' CYS . . . . . 0.889 ' H ' HG22 ' A' ' 465' ' ' THR . 8.9 t -97.44 122.6 40.68 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.222 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.645 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.7 t -151.18 149.2 29.18 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.729 -1.188 . . . . 0.0 111.351 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -127.37 160.89 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.393 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . 0.482 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 6.2 t -150.43 155.68 40.01 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.34 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 450' ' ' GLY . . . 53.72 75.46 0.23 Allowed Glycine 0 N--CA 1.497 2.747 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.999 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . 0.734 ' SG ' HD22 ' A' ' 485' ' ' LEU . 0.6 OUTLIER -82.93 -179.58 7.48 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.919 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -57.82 -96.78 0.01 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -140.38 58.52 1.57 Allowed 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.439 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.65 HG23 ' CB ' ' A' ' 483' ' ' PHE . 11.3 mt -53.36 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.637 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -89.26 115.3 26.65 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 482' ' ' THR . 11.1 mt -88.18 136.6 22.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 C-N-CA 118.273 -1.371 . . . . 0.0 113.129 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.416 HD22 ' C ' ' A' ' 476' ' ' ILE . 4.9 m120 -114.63 127.2 55.64 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.18 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' A' ' 480' ' ' ALA . 10.3 pt-20 -62.85 -5.44 2.83 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.048 -0.978 . . . . 0.0 113.227 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 478' ' ' GLU . 5.2 mm-40 -46.13 -19.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.437 -1.305 . . . . 0.0 108.45 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.562 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . -175.14 -101.68 0.0 OUTLIER 'General case' 0 C--N 1.269 -2.933 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . 0.536 ' HD2' ' CD2' ' A' ' 409' ' ' PHE . 0.8 OUTLIER -153.5 56.78 0.75 Allowed 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.874 ' O ' HG23 ' A' ' 476' ' ' ILE . 1.6 p -86.6 175.37 8.34 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' PHE . . . . . 0.688 ' HZ ' HG11 ' A' ' 407' ' ' VAL . 0.3 OUTLIER -151.93 120.86 6.61 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.701 -2.045 . . . . 0.0 107.762 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -91.95 114.42 26.95 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.533 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.734 HD22 ' SG ' ' A' ' 471' ' ' CYS . 63.6 tp -138.3 155.69 48.35 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.843 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . 0.473 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.66 -107.92 1.86 Allowed Glycine 0 N--CA 1.488 2.132 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.186 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -139.11 28.87 2.58 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.065 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.24 160.56 43.6 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.781 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 3.4 m -113.82 107.96 16.42 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.19 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.52 ' HB2' ' CE2' ' A' ' 483' ' ' PHE . 10.0 m-30 -89.55 119.44 29.99 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.505 -0.878 . . . . 0.0 108.859 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -100.24 136.78 39.6 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.427 -0.909 . . . . 0.0 112.155 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.508 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.9 tm-20 -50.05 95.12 0.01 OUTLIER 'General case' 0 CA--C 1.474 -1.949 0 C-N-CA 118.438 -1.305 . . . . 0.0 108.742 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 161.44 17.87 0.03 OUTLIER Glycine 0 C--N 1.267 -3.3 0 C-N-CA 118.313 -1.899 . . . . 0.0 109.624 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -128.69 -161.33 1.1 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.08 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . 0.698 ' OH ' ' HB1' ' A' ' 404' ' ' ALA . 1.8 t80 -137.64 132.7 33.37 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.864 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.491 HG22 ' CG ' ' A' ' 507' ' ' LYS . 0.6 OUTLIER -136.81 162.35 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.818 -179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 28.9 p -130.17 113.21 14.18 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.684 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -109.13 152.61 24.87 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 118.981 -1.088 . . . . 0.0 112.716 -179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.491 ' O ' HD12 ' A' ' 498' ' ' LEU . 4.4 t70 -99.42 160.39 14.32 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.027 0.918 . . . . 0.0 112.847 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' GLY . . . . . 0.641 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -155.64 96.46 0.16 Allowed Glycine 0 C--N 1.289 -2.032 0 N-CA-C 107.043 -2.423 . . . . 0.0 107.043 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' SER . . . . . 0.814 ' O ' HG23 ' A' ' 502' ' ' THR . 3.6 t 175.06 5.38 0.0 OUTLIER 'General case' 1 C--N 1.242 -4.071 0 CA-C-N 112.911 -1.644 . . . . 0.0 107.779 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 501' ' ' SER . 0.4 OUTLIER -175.0 -23.26 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 112.842 -1.981 . . . . 0.0 107.542 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 96.26 85.52 1.74 Allowed Glycine 0 N--CA 1.479 1.506 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -151.38 101.78 2.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.465 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' ILE . . . . . 0.642 HG21 HD11 ' A' ' 392' ' ' ILE . 4.7 mt -89.05 146.61 5.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.286 -0.965 . . . . 0.0 110.749 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 12.2 t80 -148.96 161.7 41.38 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.441 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.59 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 1.8 ttpt -125.74 156.36 39.53 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.598 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 84.72 142.51 5.73 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.249 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.93 154.65 2.07 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.296 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' ILE . . . . . 0.705 HG22 ' H ' ' A' ' 511' ' ' GLU . 12.4 mm -88.68 175.61 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.589 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.705 ' H ' HG22 ' A' ' 510' ' ' ILE . 35.6 mt-10 . . . . . 0 C--N 1.304 -1.372 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.799 0.333 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.53 ' HA ' ' CA ' ' A' ' 389' ' ' GLY . . . -84.3 33.46 0.5 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.82 -1.152 . . . . 0.0 110.118 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.798 ' H ' ' CD1' ' A' ' 386' ' ' LEU . 0.0 OUTLIER -94.0 17.84 11.64 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.831 -1.148 . . . . 0.0 111.874 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 388' ' ' ALA . 3.4 tptp -152.8 22.9 0.59 Allowed 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 387' ' ' LYS . . . 85.31 19.87 0.11 Allowed 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.059 -1.882 . . . . 0.0 107.022 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 385' ' ' ALA . . . 37.82 -161.26 0.01 OUTLIER Glycine 0 N--CA 1.512 3.733 0 CA-C-N 114.176 -1.375 . . . . 0.0 112.218 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 46.62 93.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.277 -0.462 . . . . 0.0 112.243 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.686 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 19.9 t -112.66 140.41 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.388 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.863 HD12 HD21 ' A' ' 485' ' ' LEU . 0.7 OUTLIER -92.06 -25.32 5.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.215 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 162.78 -172.65 38.87 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.236 -1.459 . . . . 0.0 111.04 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.95 129.76 19.34 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.764 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.48 -146.22 0.24 Allowed 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.274 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 60.6 mt -86.7 140.79 33.51 Favored Pre-proline 0 N--CA 1.484 1.249 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.94 96.94 0.46 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.227 1.285 . . . . 0.0 111.65 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -75.14 -73.14 0.26 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.643 -1.223 . . . . 0.0 110.351 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.9 p -136.88 144.16 45.46 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.347 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.89 101.66 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.983 1.122 . . . . 0.0 110.344 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.605 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.54 162.45 29.93 Favored Glycine 0 N--CA 1.51 3.624 0 C-N-CA 117.685 -2.198 . . . . 0.0 113.658 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.752 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -136.53 119.76 16.71 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.71 161.77 41.99 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 117.936 -1.506 . . . . 0.0 113.802 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -144.92 112.59 6.25 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 113.904 -1.498 . . . . 0.0 107.708 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.85 168.03 31.7 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 118.848 -1.644 . . . . 0.0 112.124 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.41 142.67 29.96 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.149 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.417 HG12 ' H ' ' A' ' 407' ' ' VAL . 0.2 OUTLIER -78.46 148.15 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.7 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.506 ' C ' ' H ' ' A' ' 410' ' ' THR . 0.4 OUTLIER -159.97 99.61 1.38 Allowed 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.769 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CE1' ' O ' ' A' ' 481' ' ' LYS . 7.8 m-85 -57.12 -0.32 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.846 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . 0.506 ' H ' ' C ' ' A' ' 408' ' ' TYR . 3.2 p -106.39 140.91 38.57 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.99 26.12 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.515 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -70.7 -38.09 73.63 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.167 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 417' ' ' ALA . 68.9 mm-40 -62.81 -51.42 67.14 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.361 -0.935 . . . . 0.0 109.211 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' A' ' 441' ' ' ALA . . . -54.67 -31.71 58.13 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.982 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -71.27 -47.36 57.48 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.59 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -86.19 -9.35 56.75 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.116 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.03 -55.11 3.75 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.536 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -56.8 -28.03 60.77 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.863 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 421' ' ' GLY . 1.6 tt0 -55.58 -45.48 77.35 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.189 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . 0.459 ' HD2' ' N ' ' A' ' 420' ' ' LYS . 0.8 OUTLIER -59.33 -6.12 0.92 Allowed 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.493 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 82.92 49.02 5.23 Favored Glycine 0 N--CA 1.488 2.106 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.467 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -133.33 154.21 50.91 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.679 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . 0.519 ' H ' ' HD2' ' A' ' 423' ' ' ARG . 0.4 OUTLIER -79.12 146.46 33.19 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.775 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -144.21 160.84 15.37 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.637 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 426' ' ' LEU . 41.5 mm -125.83 160.55 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 C-N-CA 120.214 -0.595 . . . . 0.0 109.731 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.546 ' N ' HG22 ' A' ' 425' ' ' ILE . 3.4 tp -132.17 121.19 23.32 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.042 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.484 ' CG1' ' CZ ' ' A' ' 409' ' ' PHE . 7.2 t -110.57 121.03 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.36 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ARG . . . . . 0.664 ' O ' HG22 ' A' ' 447' ' ' THR . 0.1 OUTLIER -150.9 148.67 28.72 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.02 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 429' ' ' LEU . 5.7 mt -53.43 -49.64 66.91 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 118.199 -1.401 . . . . 0.0 109.107 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -135.82 167.82 20.46 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.651 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.863 HG21 ' HB2' ' A' ' 456' ' ' ALA . 0.5 OUTLIER -107.65 161.66 14.67 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.317 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.94 160.92 32.71 Favored Pre-proline 0 N--CA 1.488 1.44 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.64 -31.51 94.45 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.99 1.793 . . . . 0.0 112.329 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -71.46 -12.91 61.64 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 439' ' ' MET . 15.0 m-20 -90.85 -9.05 47.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.919 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.644 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -35.78 -56.12 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.694 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.644 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 32.9 mt-10 -61.07 -38.69 87.12 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 118.341 -1.344 . . . . 0.0 109.052 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -72.83 -21.77 79.52 Favored Glycine 0 C--N 1.3 -1.45 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' MET . . . . . 0.543 ' N ' ' O ' ' A' ' 435' ' ' ASP . 70.9 mtp -79.22 -46.41 17.92 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.336 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.773 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.1 OUTLIER -71.84 -34.79 69.58 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 117.921 -1.512 . . . . 0.0 109.398 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.773 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -56.45 -23.74 40.88 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 118.647 -1.221 . . . . 0.0 107.979 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.624 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -117.11 85.4 2.32 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.969 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.437 ' HA ' ' CG2' ' A' ' 465' ' ' THR . 11.8 pt-20 -52.41 -0.49 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.864 -0.734 . . . . 0.0 111.591 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -136.24 139.66 10.87 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.538 HD12 ' SG ' ' A' ' 467' ' ' CYS . 67.8 mt -141.36 142.8 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 118.886 -1.126 . . . . 0.0 111.689 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.406 HD11 ' SG ' ' A' ' 471' ' ' CYS . 4.6 tp -140.24 98.95 3.55 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.306 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.6 p -111.53 161.27 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.42 -24.45 12.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.621 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' A' ' 470' ' ' GLY . 14.0 mmt180 -100.87 -121.88 0.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.315 -0.954 . . . . 0.0 112.324 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.497 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 68.43 144.6 0.13 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -131.16 179.87 16.68 Favored Glycine 0 N--CA 1.502 3.053 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.22 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.437 ' H ' ' HG3' ' A' ' 452' ' ' MET . 86.9 mtp -43.72 -28.83 0.45 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.853 -0.739 . . . . 0.0 111.091 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . 0.416 ' O ' ' CG2' ' A' ' 453' ' ' THR . 6.7 t -160.59 132.28 5.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.998 -1.081 . . . . 0.0 111.325 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 2.3 p 179.05 -176.85 0.26 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.53 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' HIS . . . . . 0.704 ' O ' HG23 ' A' ' 459' ' ' VAL . 68.0 m80 -42.98 -49.52 5.98 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.336 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.863 ' HB2' HG21 ' A' ' 431' ' ' THR . . . -48.44 -48.64 37.28 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.636 -0.826 . . . . 0.0 111.819 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -80.85 -58.73 2.96 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.567 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 2.6 t -45.13 -45.58 3.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.734 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 455' ' ' HIS . 24.2 t -70.42 -40.27 77.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.575 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -68.66 -32.77 72.85 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.595 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -67.7 -36.95 81.59 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.791 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -75.28 -33.67 53.09 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.534 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 6.7 mmt -94.27 0.32 55.56 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 53.41 39.96 60.53 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' THR . . . . . 0.437 ' CG2' ' HA ' ' A' ' 443' ' ' GLU . 0.2 OUTLIER -95.31 156.1 16.46 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.718 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' CYS . . . . . 0.752 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.0 OUTLIER -89.43 129.88 35.87 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.692 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.753 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 99.5 m -152.86 157.42 40.68 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 117.988 -1.485 . . . . 0.0 112.062 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -126.15 162.28 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.263 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . 0.517 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 7.9 t -150.3 147.71 27.97 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.73 -1.188 . . . . 0.0 112.278 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 57.23 90.45 0.01 OUTLIER Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.349 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . 0.406 ' SG ' HD11 ' A' ' 446' ' ' LEU . 0.1 OUTLIER -99.85 170.18 8.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.744 -0.783 . . . . 0.0 110.569 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -44.77 -82.02 0.03 OUTLIER Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.614 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -156.06 68.06 0.62 Allowed 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.037 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.644 HG23 ' CB ' ' A' ' 483' ' ' PHE . 17.4 mt -66.47 102.64 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.081 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 13.7 mmmt -88.72 120.03 29.74 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.841 HG23 ' O ' ' A' ' 482' ' ' THR . 3.8 mt -87.68 132.32 33.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 117.995 -1.482 . . . . 0.0 112.77 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.22 122.13 45.92 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.609 ' C ' ' N ' ' A' ' 480' ' ' ALA . 0.4 OUTLIER -53.06 -9.65 0.15 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.105 -1.407 . . . . 0.0 113.338 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -44.92 -18.45 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.276 -1.37 . . . . 0.0 108.401 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.609 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -177.88 -102.29 0.0 OUTLIER 'General case' 0 C--N 1.263 -3.176 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . 0.545 ' O ' ' CE1' ' A' ' 409' ' ' PHE . 10.9 mmmt -150.61 43.39 0.83 Allowed 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.841 ' O ' HG23 ' A' ' 476' ' ' ILE . 52.1 p -69.06 174.35 4.64 Favored 'General case' 0 C--O 1.194 -1.857 0 CA-C-N 113.23 -1.805 . . . . 0.0 114.41 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' PHE . . . . . 0.644 ' CB ' HG23 ' A' ' 474' ' ' ILE . 0.7 OUTLIER -152.04 132.18 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.809 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -112.59 116.53 30.34 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.031 -0.667 . . . . 0.0 111.146 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.866 HD23 ' O ' ' A' ' 485' ' ' LEU . 0.3 OUTLIER -150.63 161.89 41.72 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.971 -1.091 . . . . 0.0 110.903 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.55 -113.01 5.47 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -132.21 26.15 3.77 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.378 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 2.7 m-70 -150.16 153.23 35.95 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.721 -1.192 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 58.4 m -115.06 100.23 8.02 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.481 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.517 ' CZ ' ' HG2' ' A' ' 507' ' ' LYS . 7.6 m-85 -89.78 158.37 17.53 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.582 ' CB ' HG22 ' A' ' 482' ' ' THR . . . -126.43 128.21 46.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.325 -0.95 . . . . 0.0 112.323 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.47 ' CB ' ' HB2' ' A' ' 481' ' ' LYS . 0.0 OUTLIER -47.4 95.36 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.472 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 168.53 14.32 0.02 OUTLIER Glycine 0 C--N 1.266 -3.311 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -142.64 -153.57 0.47 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.887 -0.657 . . . . 0.0 109.76 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . 0.445 ' CD1' ' N ' ' A' ' 495' ' ' TYR . 4.0 p90 -147.99 155.39 41.47 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.849 -1.141 . . . . 0.0 111.841 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.4 ' CG2' ' HG3' ' A' ' 507' ' ' LYS . 39.9 pt -136.99 162.31 34.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.833 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 30.7 t -127.76 108.84 11.08 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' LEU . . . . . 1.087 HD23 ' H ' ' A' ' 498' ' ' LEU . 1.7 pt? -117.03 159.35 22.66 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.746 -1.182 . . . . 0.0 113.723 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 500' ' ' GLY . 50.5 t0 -94.95 161.44 14.14 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.661 -1.609 . . . . 0.0 111.272 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -144.73 93.69 0.17 Allowed Glycine 0 C--N 1.283 -2.369 0 N-CA-C 106.327 -2.709 . . . . 0.0 106.327 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 53.6 p 175.22 -7.32 0.0 OUTLIER 'General case' 0 C--N 1.25 -3.754 0 CA-C-N 111.66 -2.27 . . . . 0.0 106.08 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.8 -28.02 0.13 Allowed 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.045 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 100.52 -11.44 59.67 Favored Glycine 0 N--CA 1.49 2.271 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.638 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -50.38 125.81 13.56 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.67 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' ILE . . . . . 0.626 HG23 ' HB3' ' A' ' 498' ' ' LEU . 6.9 mt -113.88 135.04 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.397 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' TYR . . . . . 0.686 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 0.5 OUTLIER -128.21 159.89 33.8 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.631 ' HE3' ' H ' ' A' ' 507' ' ' LYS . 0.0 OUTLIER -119.29 161.01 21.14 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.186 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 73.19 133.44 0.2 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.376 -1.392 . . . . 0.0 110.991 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 509' ' ' ASP . 6.6 p30 -48.31 153.15 0.76 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.58 -0.848 . . . . 0.0 111.047 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 511' ' ' GLU . 0.1 OUTLIER -96.89 161.42 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.421 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.516 ' N ' HG13 ' A' ' 510' ' ' ILE . 46.6 tt0 . . . . . 0 C--N 1.305 -1.34 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.854 0.359 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.811 ' O ' HD12 ' A' ' 386' ' ' LEU . . . -90.21 -163.73 1.06 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.889 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.811 HD12 ' O ' ' A' ' 385' ' ' ALA . 0.6 OUTLIER 33.47 26.4 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 124.109 0.881 . . . . 0.0 110.915 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.623 ' N ' ' O ' ' A' ' 385' ' ' ALA . 17.0 ttpp -140.94 -10.35 1.0 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.519 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -139.29 14.07 2.59 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.01 -1.45 . . . . 0.0 110.152 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -74.87 -142.06 0.81 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.407 -1.377 . . . . 0.0 110.285 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -119.91 73.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.709 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.716 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 45.5 t -66.57 150.18 11.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.645 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.504 ' CG1' ' N ' ' A' ' 393' ' ' GLY . 5.2 pt -117.22 -48.46 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.694 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 392' ' ' ILE . . . -159.14 -157.54 8.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.554 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 13.5 p -171.41 116.1 0.41 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -93.78 -145.87 0.24 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.196 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 396' ' ' LEU . 96.4 mt -87.44 134.3 36.46 Favored Pre-proline 0 C--N 1.308 -1.2 0 C-N-CA 119.461 -0.895 . . . . 0.0 110.674 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.51 86.44 0.44 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.016 1.144 . . . . 0.0 110.807 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -60.89 -60.83 3.17 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.084 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 78.3 p -143.77 145.87 32.58 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.217 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.35 119.36 6.24 Favored 'Trans proline' 0 C--N 1.326 -0.642 0 C-N-CA 121.085 1.19 . . . . 0.0 109.916 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.612 ' H ' ' CA ' ' A' ' 500' ' ' GLY . . . -152.48 162.88 30.11 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.524 -2.274 . . . . 0.0 114.556 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -151.85 107.17 3.3 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.4 161.39 42.58 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 117.968 -1.493 . . . . 0.0 113.472 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.23 5.36 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.013 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.97 167.58 31.15 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.649 -1.262 . . . . 0.0 111.134 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.443 ' HG3' HG13 ' A' ' 424' ' ' VAL . 9.5 ptpt -82.72 161.76 21.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 118.987 -1.085 . . . . 0.0 108.305 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.542 HG11 ' HZ ' ' A' ' 483' ' ' PHE . 1.5 m -97.79 149.96 4.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.757 ' CZ ' ' HB2' ' A' ' 414' ' ' ALA . 33.1 p90 -153.44 174.75 13.98 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.035 -1.438 . . . . 0.0 107.536 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.57 ' CE1' ' HB3' ' A' ' 481' ' ' LYS . 2.7 m-85 -129.76 -19.32 3.33 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.841 -1.144 . . . . 0.0 113.203 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 38.8 p -100.51 135.6 41.7 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.47 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -62.82 -23.1 67.11 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.856 -1.138 . . . . 0.0 108.837 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -68.68 -41.36 79.34 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.269 -0.972 . . . . 0.0 109.098 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.92 -40.91 90.51 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.076 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ALA . . . . . 0.757 ' HB2' ' CZ ' ' A' ' 408' ' ' TYR . . . -57.69 -37.55 73.67 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.394 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.19 -35.45 80.83 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.433 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.53 -13.52 37.17 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.468 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.59 -55.51 3.55 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.74 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' HIS . . . . . 0.516 ' ND1' ' O ' ' A' ' 418' ' ' HIS . 0.3 OUTLIER -61.21 -21.1 63.53 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.846 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.486 ' CA ' ' OE1' ' A' ' 419' ' ' GLU . 0.6 OUTLIER -69.65 -38.08 76.98 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.588 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -64.53 -1.87 2.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.488 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 419' ' ' GLU . . . 73.12 44.14 36.89 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.665 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -137.12 136.37 38.24 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . 0.41 ' C ' ' CG2' ' A' ' 424' ' ' VAL . 11.4 mmt180 -56.23 155.62 6.55 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.311 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.443 HG13 ' HG3' ' A' ' 406' ' ' LYS . 2.0 t -147.64 158.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.988 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.434 ' O ' ' CD1' ' A' ' 408' ' ' TYR . 6.3 mm -126.24 158.58 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.618 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 5.3 tp -127.61 142.97 51.21 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.511 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.445 ' N ' ' HG ' ' A' ' 426' ' ' LEU . 25.1 t -128.04 120.13 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.268 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ARG . . . . . 0.667 ' O ' HG22 ' A' ' 447' ' ' THR . 0.1 OUTLIER -151.37 149.42 29.3 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.093 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.48 ' H ' HD12 ' A' ' 429' ' ' LEU . 3.5 mp -48.04 -57.04 6.32 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.366 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 431' ' ' THR . 1.0 OUTLIER -130.4 165.18 23.11 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.467 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.442 ' H ' ' HG3' ' A' ' 430' ' ' GLU . 0.4 OUTLIER -101.17 -179.63 4.1 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.383 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 27.2 p -163.98 151.73 10.81 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.564 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.8 Cg_endo -61.59 -53.07 2.51 Favored 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 121.467 1.445 . . . . 0.0 112.036 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 434' ' ' GLU . 8.4 mm-40 -45.08 -18.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.8 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.544 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.8 m-20 -87.2 -6.35 58.63 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.656 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.736 HG23 ' N ' ' A' ' 437' ' ' GLU . 10.4 tp -33.63 -51.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.736 ' N ' HG23 ' A' ' 436' ' ' ILE . 3.0 pm0 -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 118.074 -1.45 . . . . 0.0 108.448 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.656 ' H ' ' CD ' ' A' ' 437' ' ' GLU . . . -66.49 -30.82 77.15 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -62.4 -44.01 97.45 Favored 'General case' 0 C--O 1.215 -0.749 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.959 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -62.29 -56.88 14.16 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.42 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -46.73 -33.2 4.14 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.56 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.682 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -96.2 81.01 3.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.069 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -59.76 17.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.755 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.72 143.93 9.15 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.418 HG22 ' SG ' ' A' ' 467' ' ' CYS . 0.6 OUTLIER -135.3 133.95 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.316 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.462 HD11 ' SG ' ' A' ' 471' ' ' CYS . 3.5 tp -135.8 98.12 3.82 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.105 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 428' ' ' ARG . 2.1 p -116.24 161.84 18.37 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 7.2 t -75.67 -23.18 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.72 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' ARG . . . . . 0.452 HH22 ' HE3' ' A' ' 452' ' ' MET . 1.3 mmp_? -112.44 -128.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.861 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 62.52 -170.97 11.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.25 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 453' ' ' THR . . . 61.51 -20.97 0.05 OUTLIER Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.545 -1.312 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.668 ' H ' ' C ' ' A' ' 450' ' ' GLY . 7.5 mmt -68.92 42.72 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.041 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . 0.563 ' H ' ' C ' ' A' ' 451' ' ' GLY . 39.1 p 45.66 90.0 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.1 t -173.32 -155.66 0.08 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.122 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' HIS . . . . . 0.493 ' O ' HG23 ' A' ' 459' ' ' VAL . 8.5 p-80 -55.24 -41.69 72.46 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.954 -1.098 . . . . 0.0 110.632 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -53.34 -53.44 50.98 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.366 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.46 -28.41 52.34 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.903 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.51 -54.31 12.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.573 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 455' ' ' HIS . 92.1 t -56.49 -40.22 66.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.115 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.64 55.15 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.78 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -65.96 -14.78 62.2 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.225 -0.99 . . . . 0.0 110.814 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.46 -35.61 19.54 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.424 -1.37 . . . . 0.0 110.489 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 7.3 mmt -91.75 -9.72 42.61 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 62.06 24.42 65.01 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 466' ' ' CYS . 14.3 t -87.7 -166.86 1.7 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.889 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' CYS . . . . . 0.46 ' CB ' ' HA3' ' A' ' 401' ' ' GLY . 8.9 t -98.98 123.26 43.15 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.424 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.759 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.4 t -152.06 139.91 19.97 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 118.018 -1.473 . . . . 0.0 112.708 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.0 OUTLIER -117.99 161.27 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . 0.55 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 9.0 t -151.46 151.8 32.14 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.971 -1.491 . . . . 0.0 113.86 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 48.2 90.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.146 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . 0.462 ' SG ' HD11 ' A' ' 446' ' ' LEU . 96.7 m -98.42 -160.53 0.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.728 -0.789 . . . . 0.0 109.834 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -66.75 -95.72 0.03 OUTLIER Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.63 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . 0.555 ' N ' ' CD ' ' A' ' 473' ' ' GLU . 1.6 pm0 -142.07 58.94 1.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 1.1 mt -43.17 102.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.775 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -88.86 113.76 24.75 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 482' ' ' THR . 9.5 mt -88.69 134.37 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 118.602 -1.239 . . . . 0.0 112.38 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.5 123.47 50.29 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.385 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.622 ' C ' ' N ' ' A' ' 480' ' ' ALA . 1.2 tt0 -63.6 -3.43 2.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.977 -1.01 . . . . 0.0 113.442 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -47.71 -16.56 0.07 Allowed 'General case' 0 N--CA 1.506 2.334 0 C-N-CA 118.194 -1.402 . . . . 0.0 108.296 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.622 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -174.8 -100.38 0.0 OUTLIER 'General case' 0 C--N 1.265 -3.096 0 N-CA-C 103.586 -2.746 . . . . 0.0 103.586 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . 0.57 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.0 OUTLIER -158.05 65.91 0.46 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.848 ' O ' HG23 ' A' ' 476' ' ' ILE . 1.4 p -97.51 178.34 5.22 Favored 'General case' 0 C--O 1.2 -1.545 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' PHE . . . . . 0.542 ' HZ ' HG11 ' A' ' 407' ' ' VAL . 0.2 OUTLIER -151.56 129.69 11.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.068 -1.878 . . . . 0.0 108.471 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -99.61 116.46 31.78 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.665 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 1.016 HD23 ' N ' ' A' ' 486' ' ' GLY . 3.2 tt -136.51 156.25 48.85 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.012 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . 1.016 ' N ' HD23 ' A' ' 485' ' ' LEU . . . 44.65 -117.43 2.11 Favored Glycine 0 N--CA 1.487 2.043 0 C-N-CA 119.598 -1.287 . . . . 0.0 110.283 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -124.42 37.15 2.71 Favored Glycine 0 N--CA 1.498 2.833 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.532 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.506 ' CG ' ' CZ ' ' A' ' 490' ' ' PHE . 0.3 OUTLIER -150.68 129.65 12.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.404 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 83.5 m -102.98 115.07 29.89 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.59 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.506 ' CZ ' ' CG ' ' A' ' 488' ' ' HIS . 22.8 m-85 -112.43 130.94 55.81 Favored 'General case' 0 N--CA 1.504 2.245 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.751 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.634 ' O ' ' N ' ' A' ' 493' ' ' GLY . . . -99.18 156.84 16.75 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.343 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.484 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.5 tm-20 -65.46 63.67 0.03 OUTLIER 'General case' 0 CA--C 1.482 -1.635 0 C-N-CA 118.602 -1.239 . . . . 0.0 108.566 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . -160.43 25.45 0.29 Allowed Glycine 0 C--N 1.263 -3.512 0 C-N-CA 119.263 -1.446 . . . . 0.0 109.838 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -146.26 -164.62 2.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.046 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -128.23 137.58 52.08 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.215 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 496' ' ' ILE . 2.0 pt -131.93 160.14 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.089 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 506' ' ' TYR . 48.3 m -123.46 110.98 15.78 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.348 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' LEU . . . . . 0.963 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -105.57 136.92 44.27 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.418 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.963 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.5 OUTLIER -108.6 160.58 15.81 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 122.027 0.917 . . . . 0.0 112.244 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' GLY . . . . . 0.612 ' CA ' ' H ' ' A' ' 401' ' ' GLY . . . -142.11 94.2 0.18 Allowed Glycine 0 C--N 1.285 -2.299 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' SER . . . . . 0.71 ' O ' HG23 ' A' ' 502' ' ' THR . 4.6 m -171.42 -3.01 0.01 OUTLIER 'General case' 0 C--N 1.244 -3.98 0 CA-C-N 112.577 -1.812 . . . . 0.0 107.398 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 501' ' ' SER . 0.8 OUTLIER -167.09 -16.68 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.483 0 CA-C-N 112.555 -2.111 . . . . 0.0 107.276 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.46 40.13 8.58 Favored Glycine 0 N--CA 1.482 1.725 0 CA-C-N 114.022 -1.445 . . . . 0.0 111.371 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -115.37 119.97 38.03 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' ILE . . . . . 0.541 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 1.5 tt -97.57 160.23 3.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 119.021 -1.072 . . . . 0.0 112.425 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' TYR . . . . . 0.716 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 17.8 m-85 -135.15 162.09 33.5 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.178 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.496 ' HD2' ' CE1' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -136.71 142.93 43.12 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.779 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 510' ' ' ILE . . . 94.81 141.55 11.72 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.758 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -50.43 89.52 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.683 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' ILE . . . . . 1.103 HD12 ' H ' ' A' ' 511' ' ' GLU . 0.2 OUTLIER -51.93 165.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.713 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 1.103 ' H ' HD12 ' A' ' 510' ' ' ILE . 22.9 tt0 . . . . . 0 C--N 1.297 -1.703 0 CA-C-O 116.309 -1.805 . . . . 0.0 110.744 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.649 ' O ' ' HB3' ' A' ' 385' ' ' ALA . . . . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 120.928 0.394 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 384' ' ' ALA . . . 71.7 165.95 0.3 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.82 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 49.41 11.04 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.717 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.605 ' H ' ' C ' ' A' ' 385' ' ' ALA . 10.8 tptm -134.63 0.09 2.95 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.299 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -153.35 12.24 0.47 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.115 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -81.98 -125.03 0.8 Allowed Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.247 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -168.2 83.28 0.18 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.115 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.57 142.76 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.539 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 1.9 pt -94.42 -33.53 5.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.757 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . 179.67 -167.49 37.39 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.87 -1.633 . . . . 0.0 111.314 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 31.1 t -154.79 120.78 5.21 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.583 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.463 ' HB2' ' SG ' ' A' ' 471' ' ' CYS . . . -93.09 -144.06 0.22 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.076 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 51.2 mt -93.42 128.69 41.48 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.888 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . 0.545 ' HG3' ' O ' ' A' ' 502' ' ' THR . 7.7 Cg_endo -68.37 89.35 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 121.142 1.228 . . . . 0.0 111.565 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -55.37 -54.73 40.06 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.414 -1.314 . . . . 0.0 109.506 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.1 t -150.45 141.85 15.1 Favored Pre-proline 0 C--N 1.307 -1.281 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.177 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -54.34 101.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 121.121 1.214 . . . . 0.0 110.569 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.584 ' H ' ' HA3' ' A' ' 500' ' ' GLY . . . -151.46 161.81 29.33 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.544 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.564 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -139.21 114.87 9.96 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -138.39 160.73 38.77 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.862 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -142.17 110.62 6.07 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.709 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.07 167.92 31.24 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.923 -1.608 . . . . 0.0 111.268 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -82.82 137.11 34.43 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.571 ' CG1' ' C ' ' A' ' 491' ' ' ALA . 1.0 OUTLIER -83.37 151.68 3.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 C-N-CA 118.925 -1.11 . . . . 0.0 113.374 -179.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -149.86 -152.79 0.45 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.924 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.481 ' CD2' ' HE2' ' A' ' 481' ' ' LYS . 10.5 m-85 -146.31 -47.71 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.996 -1.081 . . . . 0.0 112.058 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 37.4 p -86.03 143.36 28.15 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.296 -0.962 . . . . 0.0 111.235 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -69.47 -10.91 60.07 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.503 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . 0.411 ' N ' ' OD1' ' A' ' 412' ' ' ASP . 10.2 m-20 -74.26 -42.55 59.46 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.395 -0.922 . . . . 0.0 109.775 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 413' ' ' GLU . 2.1 mp0 -66.88 -42.47 85.52 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.568 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.7 66.28 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.88 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -73.68 -38.63 64.85 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.396 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -90.58 -12.2 37.74 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . . . . . . . . . . . -90.84 -43.58 9.95 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.837 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' HIS . . . . . 0.463 ' O ' ' CD2' ' A' ' 418' ' ' HIS . 8.8 t60 -69.88 -29.42 66.63 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.219 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.68 -21.89 61.0 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.223 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.34 -5.93 42.86 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.797 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 89.99 45.44 4.49 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -147.44 131.87 17.63 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.812 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtm-85 -58.58 157.09 9.61 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.31 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.432 ' N ' ' OE2' ' A' ' 443' ' ' GLU . 2.4 t -148.27 160.23 6.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.931 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.421 HG22 ' N ' ' A' ' 426' ' ' LEU . 7.5 mm -130.63 160.97 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.911 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.421 ' N ' HG22 ' A' ' 425' ' ' ILE . 4.3 tp -139.42 144.6 38.16 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 118.594 -1.242 . . . . 0.0 112.851 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.52 HG23 ' CG2' ' A' ' 407' ' ' VAL . 81.6 t -118.46 130.21 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.557 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ARG . . . . . 0.684 ' H ' HG22 ' A' ' 447' ' ' THR . 0.0 OUTLIER -151.79 135.26 16.1 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.59 -1.244 . . . . 0.0 112.06 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.11 17.87 0.12 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 428' ' ' ARG . 5.9 pt-20 175.86 147.46 0.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.566 ' CG2' ' HB2' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -87.77 177.39 7.02 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.89 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.2 m -161.6 131.08 3.23 Favored Pre-proline 0 N--CA 1.484 1.258 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.712 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -61.03 -31.61 91.32 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 121.183 1.255 . . . . 0.0 111.807 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -75.46 -16.41 60.32 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.191 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 438' ' ' GLY . 3.1 t70 -90.41 -9.24 48.27 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.723 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.679 ' CG2' ' N ' ' A' ' 437' ' ' GLU . 0.2 OUTLIER -39.3 -52.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.994 -0.683 . . . . 0.0 111.861 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.679 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 26.9 mt-10 -58.23 -35.77 72.18 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 118.025 -1.47 . . . . 0.0 108.925 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -76.22 -22.44 73.55 Favored Glycine 0 C--N 1.299 -1.519 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 2.1 mmt -74.75 -42.02 58.99 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.433 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.776 ' ND1' ' N ' ' A' ' 441' ' ' ALA . 0.2 OUTLIER -70.7 -32.98 70.38 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.332 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.776 ' N ' ' ND1' ' A' ' 440' ' ' HIS . . . -50.09 -29.04 8.15 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -109.38 92.02 3.88 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.201 -1.363 . . . . 0.0 108.679 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.641 ' H ' ' CD ' ' A' ' 443' ' ' GLU . 1.4 pm0 -53.0 0.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.949 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -142.01 144.47 14.28 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.515 HD12 ' SG ' ' A' ' 467' ' ' CYS . 38.8 mt -145.73 135.45 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 118.512 -1.275 . . . . 0.0 111.459 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.435 ' C ' HD12 ' A' ' 446' ' ' LEU . 5.8 tp -131.05 98.23 4.52 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.004 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.684 HG22 ' H ' ' A' ' 428' ' ' ARG . 1.5 p -107.9 161.49 14.87 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 119.758 -0.777 . . . . 0.0 112.7 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 474' ' ' ILE . 4.9 t -85.28 -20.11 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.969 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -106.6 -152.05 0.47 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.755 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . . . . . . . . . . . 81.28 -151.39 31.31 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . 0.629 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 76.78 -50.99 3.03 Favored Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.235 -1.459 . . . . 0.0 110.548 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.485 ' O ' ' CB ' ' A' ' 453' ' ' THR . 70.7 mmm -64.45 11.97 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.195 -1.002 . . . . 0.0 110.413 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . 0.62 ' H ' ' C ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.31 108.27 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.019 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 455' ' ' HIS . 30.2 t -158.41 -173.16 4.17 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.841 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 459' ' ' VAL . 60.4 m80 -50.34 -35.3 27.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.692 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.566 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -53.7 -58.71 6.23 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.322 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.63 -52.21 9.37 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.347 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 13.3 t -44.76 -43.42 2.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.675 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 455' ' ' HIS . 97.5 t -69.38 -43.55 80.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.201 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.94 -41.08 87.59 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.84 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -66.35 -27.71 68.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 119.259 -0.976 . . . . 0.0 110.82 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -90.0 -26.7 23.45 Favored Glycine 0 N--CA 1.489 2.182 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.671 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 11.2 mmt -94.07 -23.11 18.11 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.38 -0.928 . . . . 0.0 111.302 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.69 -21.25 30.66 Favored Glycine 0 N--CA 1.497 2.725 0 C-N-CA 119.498 -1.334 . . . . 0.0 110.966 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 60.2 m -44.22 160.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.749 -0.781 . . . . 0.0 111.407 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -87.25 129.1 35.11 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.937 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 1.8 m -153.3 153.1 31.96 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.434 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 469' ' ' SER . 0.9 OUTLIER -124.38 161.16 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-N 115.536 -0.756 . . . . 0.0 108.995 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . 0.629 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 28.1 t -150.27 155.31 39.46 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 118.7 -1.2 . . . . 0.0 112.213 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 42.63 82.98 0.02 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.483 -1.341 . . . . 0.0 111.023 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . 0.667 ' SG ' HD11 ' A' ' 485' ' ' LEU . 0.1 OUTLIER -90.07 -160.4 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.272 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -61.13 -99.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.213 -1.47 . . . . 0.0 109.542 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 474' ' ' ILE . 1.4 mm-40 -145.07 41.25 1.27 Allowed 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.714 HD12 HG22 ' A' ' 448' ' ' VAL . 0.0 OUTLIER -38.81 107.53 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.901 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 5.6 ttmm -89.71 123.99 34.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.205 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 3.0 mt -86.41 119.59 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 118.992 -1.083 . . . . 0.0 112.191 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.452 HD21 ' HG3' ' A' ' 479' ' ' GLU . 53.1 t-20 -89.24 110.83 21.55 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.871 -1.058 . . . . 0.0 110.163 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.725 ' H ' ' CD ' ' A' ' 478' ' ' GLU . 1.4 pm0 -67.67 -9.33 42.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.525 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.452 ' HG3' HD21 ' A' ' 477' ' ' ASN . 11.4 mm-40 -46.3 -19.87 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.342 -1.343 . . . . 0.0 107.661 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.607 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -163.64 -107.21 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.412 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . 0.481 ' HE2' ' CD2' ' A' ' 409' ' ' PHE . 20.2 mmmt -159.47 70.94 0.48 Allowed 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.881 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 1.2 p -138.63 148.46 44.11 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.867 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' PHE . . . . . 0.814 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 6.2 p90 -104.74 156.53 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.895 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.44 103.57 12.22 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.287 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 486' ' ' GLY . 1.4 tt -126.61 139.72 52.97 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . 0.827 ' N ' HD23 ' A' ' 485' ' ' LEU . . . 57.06 -110.59 2.28 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.216 -1.469 . . . . 0.0 111.128 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.515 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -128.82 36.76 2.36 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.372 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.515 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 24.4 m170 -150.35 126.15 10.39 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.482 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 15.2 m -99.38 97.36 8.41 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.971 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.565 ' CB ' ' HZ1' ' A' ' 507' ' ' LYS . 35.6 p90 -155.3 158.18 38.37 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.521 -1.272 . . . . 0.0 114.036 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.881 ' HB3' ' HA ' ' A' ' 482' ' ' THR . . . -170.09 -136.08 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 114.19 -1.368 . . . . 0.0 108.177 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.507 ' HA ' HG13 ' A' ' 407' ' ' VAL . 57.6 tt0 -49.63 94.18 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 117.964 -1.494 . . . . 0.0 109.39 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 152.02 17.7 0.06 OUTLIER Glycine 0 C--N 1.297 -1.611 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -156.25 -152.62 0.39 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.435 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -149.71 126.77 11.25 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.284 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.96 161.59 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.49 106.16 11.54 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.3 OUTLIER -92.48 134.77 34.64 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.169 -179.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.513 ' N ' HD12 ' A' ' 498' ' ' LEU . 0.4 OUTLIER -89.48 159.25 17.35 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.424 179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' GLY . . . . . 0.584 ' HA3' ' H ' ' A' ' 401' ' ' GLY . . . -155.65 95.17 0.15 Allowed Glycine 0 C--N 1.282 -2.453 0 N-CA-C 106.923 -2.471 . . . . 0.0 106.923 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 3.3 t 172.86 7.28 0.0 OUTLIER 'General case' 0 C--N 1.245 -3.956 0 CA-C-N 112.507 -1.846 . . . . 0.0 106.943 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' THR . . . . . 0.545 ' O ' ' HG3' ' A' ' 397' ' ' PRO . 0.0 OUTLIER -171.91 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.385 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.475 ' N ' ' HB3' ' A' ' 397' ' ' PRO . . . 93.11 15.42 51.79 Favored Glycine 0 N--CA 1.487 2.067 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.923 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -75.08 172.7 11.88 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -148.26 150.89 13.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.459 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 507' ' ' LYS . 7.7 t80 -148.97 161.33 42.12 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.01 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.624 ' N ' ' CD1' ' A' ' 506' ' ' TYR . 28.4 tttt -131.78 151.6 51.55 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.865 -1.134 . . . . 0.0 113.701 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 85.35 133.43 2.97 Favored Glycine 0 N--CA 1.498 2.779 0 C-N-CA 119.558 -1.306 . . . . 0.0 113.365 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 31.6 -153.83 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' ILE . . . . . 0.905 HG23 ' N ' ' A' ' 511' ' ' GLU . 1.0 OUTLIER 55.28 -163.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.875 -179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.905 ' N ' HG23 ' A' ' 510' ' ' ILE . 4.9 tt0 . . . . . 0 C--N 1.295 -1.803 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.75 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 385' ' ' ALA . . . . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.576 ' C ' ' N ' ' A' ' 387' ' ' LYS . . . 62.0 -157.34 0.33 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.051 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 386' ' ' LEU . 5.6 mt 46.91 15.87 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.309 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.576 ' N ' ' C ' ' A' ' 385' ' ' ALA . 1.7 ttmp? -129.78 -5.31 4.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.608 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -140.78 15.05 2.31 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.564 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -93.13 120.59 6.26 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.088 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -84.93 63.3 8.0 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.797 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.575 HG22 ' HD1' ' A' ' 506' ' ' TYR . 41.8 t -39.4 139.45 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.09 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.494 HG13 ' N ' ' A' ' 393' ' ' GLY . 17.7 pt -99.81 -43.22 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.076 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 392' ' ' ILE . . . -151.08 -162.9 10.99 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.917 -1.611 . . . . 0.0 110.706 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 9.8 t -179.21 127.42 0.09 Allowed 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.74 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -117.61 -125.54 0.28 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.461 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 32.5 mt -100.49 139.01 20.3 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.277 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -67.56 93.42 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.274 1.316 . . . . 0.0 110.581 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -64.02 -66.71 0.5 Allowed 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.107 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 24.2 t -136.97 131.07 17.8 Favored Pre-proline 0 N--CA 1.486 1.327 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.848 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.85 92.56 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 121.059 1.173 . . . . 0.0 111.303 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.17 160.18 28.97 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 118.995 -1.574 . . . . 0.0 112.008 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.775 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -126.26 135.89 52.12 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . 0.697 ' HB1' ' OE2' ' A' ' 443' ' ' GLU . . . -150.42 160.32 43.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.723 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . 0.61 ' HB1' ' OH ' ' A' ' 495' ' ' TYR . . . -148.16 109.71 4.42 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.601 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.7 30.83 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.324 -1.417 . . . . 0.0 111.495 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 406' ' ' LYS . 0.0 OUTLIER -84.27 133.0 34.58 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 119.739 -0.785 . . . . 0.0 109.588 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.593 HG11 ' HB1' ' A' ' 491' ' ' ALA . 79.9 t -60.67 154.43 4.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 115.263 -0.881 . . . . 0.0 113.325 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' A' ' 413' ' ' GLU . 0.5 OUTLIER -162.47 135.75 6.03 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.557 ' CE2' ' NZ ' ' A' ' 481' ' ' LYS . 4.7 m-85 -100.9 28.6 5.12 Favored 'General case' 0 N--CA 1.503 2.207 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.926 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 7.2 p -149.38 143.96 26.09 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.731 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -77.33 -12.69 59.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.966 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.8 -43.16 31.47 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.3 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.491 ' HG2' ' CE1' ' A' ' 408' ' ' TYR . 0.3 OUTLIER -62.08 -39.31 92.02 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.388 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ALA . . . . . . . . . . . . . . . -67.26 -37.69 83.9 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.202 -0.999 . . . . 0.0 109.482 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -65.7 -34.64 78.66 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.431 -0.907 . . . . 0.0 110.223 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.48 -23.77 21.99 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.464 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 421' ' ' GLY . . . -82.62 -49.02 10.28 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.982 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -49.28 -27.13 3.53 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -91.57 -28.87 17.26 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.35 -0.94 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -117.48 -35.05 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.111 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 417' ' ' ALA . . . -93.19 -45.59 3.51 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.069 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . 0.43 ' CG ' ' C ' ' A' ' 421' ' ' GLY . 1.1 mt-10 66.32 158.13 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.672 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 43.4 mtp180 47.35 83.99 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.161 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.91 161.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.382 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 426' ' ' LEU . 47.0 mm -123.31 157.52 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.383 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.481 ' N ' HG22 ' A' ' 425' ' ' ILE . 3.1 tp -128.82 134.52 48.37 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.255 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 409' ' ' PHE . 48.1 t -119.94 123.5 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.689 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ARG . . . . . 0.663 ' O ' HG22 ' A' ' 447' ' ' THR . 0.6 OUTLIER -151.53 158.31 43.42 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.957 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 429' ' ' LEU . 7.7 mt -63.14 -49.73 73.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 118.311 -1.355 . . . . 0.0 109.799 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -132.27 177.64 7.43 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.434 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.527 HG21 ' H ' ' A' ' 456' ' ' ALA . 0.1 OUTLIER -81.41 171.76 14.37 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.415 -0.812 . . . . 0.0 111.064 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 1.3 m -153.33 142.32 14.54 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.604 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.502 ' O ' ' N ' ' A' ' 435' ' ' ASP . 1.3 Cg_endo -61.5 -72.92 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 121.481 1.454 . . . . 0.0 111.919 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -49.08 -10.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.288 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 433' ' ' PRO . 7.1 t70 -85.94 -8.68 57.84 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.322 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.679 HD12 ' NE2' ' A' ' 440' ' ' HIS . 0.2 OUTLIER -43.34 -58.51 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.735 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.658 ' N ' ' CG2' ' A' ' 436' ' ' ILE . 46.8 mt-10 -55.92 -31.5 62.94 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.522 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.04 -23.55 77.58 Favored Glycine 0 C--N 1.3 -1.458 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' MET . . . . . 0.425 ' N ' ' O ' ' A' ' 436' ' ' ILE . 2.4 ttm -74.57 -53.99 8.34 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.778 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.679 ' NE2' HD12 ' A' ' 436' ' ' ILE . 85.8 m-70 -58.77 -50.4 74.08 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.755 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 440' ' ' HIS . . . -45.88 -24.88 0.45 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.149 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.679 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -107.15 86.27 2.28 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.488 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.697 ' OE2' ' HB1' ' A' ' 403' ' ' ALA . 0.0 OUTLIER -58.26 14.01 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.955 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -162.24 133.95 3.3 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 445' ' ' ILE . 4.5 mp -139.48 150.45 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 118.647 -1.221 . . . . 0.0 112.135 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.456 HD11 ' CG1' ' A' ' 468' ' ' VAL . 1.2 tp -144.38 128.34 17.47 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.146 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.663 HG22 ' O ' ' A' ' 428' ' ' ARG . 5.7 p -140.61 159.31 42.48 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.492 -1.283 . . . . 0.0 113.242 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 27.4 t -68.86 -20.85 25.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 114.517 -1.22 . . . . 0.0 111.452 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' ARG . . . . . . . . . . . . . 20.5 mmt85 -117.0 -151.3 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.963 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.487 ' C ' ' OG ' ' A' ' 469' ' ' SER . . . 84.98 26.17 38.33 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -44.44 161.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.66 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.659 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.404 ' C ' HG23 ' A' ' 453' ' ' THR . 25.0 mtt 45.4 -101.52 0.05 Allowed 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.837 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . 0.404 HG23 ' C ' ' A' ' 452' ' ' MET . 40.3 p -153.91 81.36 1.15 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.831 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 3.8 m -90.67 -163.02 0.96 Allowed 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.704 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' HIS . . . . . 0.513 ' O ' HG23 ' A' ' 459' ' ' VAL . 2.9 t60 -47.87 -39.78 19.69 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.43 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.527 ' H ' HG21 ' A' ' 431' ' ' THR . . . -59.04 -61.88 2.3 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.558 -0.857 . . . . 0.0 112.032 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -65.78 -55.59 16.41 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.871 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.645 ' CG1' ' N ' ' A' ' 459' ' ' VAL . 0.3 OUTLIER -45.65 -49.8 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.694 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.645 ' N ' ' CG1' ' A' ' 458' ' ' VAL . 71.3 t -62.46 -37.15 78.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.408 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.34 -46.95 78.2 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.859 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -31.14 71.67 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -80.69 -18.81 69.61 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.49 -1.338 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' MET . . . . . 0.482 ' C ' ' SD ' ' A' ' 463' ' ' MET . 0.0 OUTLIER -94.96 -59.86 1.81 Allowed 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.955 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . 0.474 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 123.93 20.83 2.47 Favored Glycine 0 N--CA 1.503 3.149 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.616 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 466' ' ' CYS . 30.9 m -97.47 166.9 11.31 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.994 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 1.8 m -90.12 128.08 36.24 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.799 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.72 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 13.1 t -151.71 159.07 44.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.176 -1.41 . . . . 0.0 112.801 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . 0.474 HG13 ' N ' ' A' ' 469' ' ' SER . 0.8 OUTLIER -137.08 162.44 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.886 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . 0.487 ' OG ' ' C ' ' A' ' 450' ' ' GLY . 11.7 t -144.27 160.42 41.01 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.762 -1.175 . . . . 0.0 112.894 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 44.17 79.87 0.05 OUTLIER Glycine 0 N--CA 1.489 2.231 0 C-N-CA 120.174 -1.012 . . . . 0.0 111.623 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . 0.657 ' SG ' HD12 ' A' ' 474' ' ' ILE . 0.0 OUTLIER -78.33 -175.18 4.08 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.107 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.448 ' H ' HD11 ' A' ' 485' ' ' LEU . . . -53.82 -94.21 0.01 OUTLIER Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.453 -1.356 . . . . 0.0 111.006 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.9 57.99 1.61 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.611 0.72 . . . . 0.0 109.204 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 483' ' ' PHE . 4.5 mt -55.46 114.3 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.272 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . 0.488 ' NZ ' ' OE2' ' A' ' 484' ' ' GLU . 4.4 ttpm? -99.63 122.74 43.1 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 1.7 mt -86.89 127.74 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 117.771 -1.572 . . . . 0.0 112.097 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.489 ' OD1' ' CG2' ' A' ' 489' ' ' THR . 7.8 m120 -96.91 113.38 24.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.123 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.625 ' C ' ' N ' ' A' ' 480' ' ' ALA . 10.5 mt-10 -64.0 -11.88 32.95 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.984 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -46.3 -17.82 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 122.811 1.291 . . . . 0.0 107.928 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.625 ' N ' ' C ' ' A' ' 478' ' ' GLU . . . -171.32 -97.8 0.01 OUTLIER 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 112.15 -2.296 . . . . 0.0 105.537 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . 0.557 ' NZ ' ' CE2' ' A' ' 409' ' ' PHE . 3.0 mmmt -168.97 70.72 0.08 Allowed 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.921 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 2.6 p -125.75 147.24 49.45 Favored 'General case' 0 N--CA 1.512 2.664 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.057 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' PHE . . . . . 0.976 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 8.0 p90 -97.68 149.98 21.68 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.572 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' GLU . . . . . 0.488 ' OE2' ' NZ ' ' A' ' 475' ' ' LYS . 7.5 tt0 -110.92 107.14 16.49 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.88 -0.728 . . . . 0.0 112.129 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.835 HD23 ' H ' ' A' ' 486' ' ' GLY . 0.4 OUTLIER -144.7 156.33 44.03 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.04 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . 0.835 ' H ' HD23 ' A' ' 485' ' ' LEU . . . 64.6 -111.4 4.15 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.077 -1.535 . . . . 0.0 110.289 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -134.75 26.7 3.28 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.729 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.441 ' CD2' ' H ' ' A' ' 489' ' ' THR . 13.4 t-160 -150.75 152.14 33.41 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 119.053 -1.059 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . 0.489 ' CG2' ' OD1' ' A' ' 477' ' ' ASN . 77.3 m -115.94 99.38 7.24 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.924 -0.71 . . . . 0.0 111.039 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.547 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 19.6 p90 -153.78 157.55 39.58 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.075 -1.45 . . . . 0.0 114.184 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.976 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . 179.85 -137.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 113.959 -1.473 . . . . 0.0 109.295 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.591 ' N ' HG11 ' A' ' 407' ' ' VAL . 8.2 tm-20 -34.93 94.03 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.654 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 139.68 3.66 1.52 Allowed Glycine 0 C--N 1.29 -2.009 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' ASP . . . . . 0.608 ' CG ' ' H ' ' A' ' 495' ' ' TYR . 36.2 t70 -144.26 -174.16 4.22 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 118.972 -1.091 . . . . 0.0 112.235 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . 0.61 ' OH ' ' HB1' ' A' ' 404' ' ' ALA . 87.2 t80 -123.91 120.54 32.83 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.029 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.915 HD13 ' O ' ' A' ' 496' ' ' ILE . 0.0 OUTLIER -127.92 161.39 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 C-N-CA 119.171 -1.012 . . . . 0.0 112.577 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . . . . . . . . . 2.4 m -123.34 110.08 14.72 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.559 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -95.84 141.18 29.6 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.612 ' N ' HD12 ' A' ' 498' ' ' LEU . 10.3 t70 -99.99 161.41 13.63 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 122.064 0.935 . . . . 0.0 112.381 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' GLY . . . . . 0.626 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -156.49 95.61 0.15 Allowed Glycine 0 C--N 1.281 -2.508 0 N-CA-C 106.286 -2.725 . . . . 0.0 106.286 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 1.4 t 164.66 2.4 0.0 OUTLIER 'General case' 1 C--N 1.238 -4.265 0 CA-C-N 112.749 -1.726 . . . . 0.0 107.47 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 503' ' ' GLY . 6.8 m -161.72 -17.74 0.04 OUTLIER 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 112.823 -1.99 . . . . 0.0 108.073 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 73.52 75.8 0.72 Allowed Glycine 0 N--CA 1.485 1.959 0 CA-C-N 114.636 -1.166 . . . . 0.0 110.736 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -165.24 118.95 1.23 Allowed 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.014 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' ILE . . . . . 0.516 ' CG1' ' N ' ' A' ' 506' ' ' TYR . 2.0 tt -99.22 157.84 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.085 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' TYR . . . . . 0.575 ' HD1' HG22 ' A' ' 391' ' ' VAL . 0.1 OUTLIER -151.04 170.49 19.25 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.448 ' HD2' ' CE2' ' A' ' 490' ' ' PHE . 27.2 mtpt -81.41 158.33 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 117.058 -1.857 . . . . 0.0 110.146 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . 0.706 ' H ' ' HA ' ' A' ' 496' ' ' ILE . . . -69.08 -169.38 6.1 Favored Glycine 0 N--CA 1.487 2.068 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.582 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 508' ' ' GLY . 0.9 OUTLIER 75.14 33.78 0.69 Allowed 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.456 -0.872 . . . . 0.0 111.117 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.21 -162.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.811 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 116.366 -1.778 . . . . 0.0 110.617 179.925 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.215 0 CA-C-O 120.792 0.329 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -142.11 18.96 2.1 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.736 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 76.1 mt -96.91 10.03 40.23 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.608 -0.837 . . . . 0.0 109.645 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -120.44 -0.46 10.34 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.323 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -149.83 16.88 0.88 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.434 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -73.18 -145.35 0.71 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.239 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 390' ' ' GLU . 1.5 pm0 -147.64 65.28 1.12 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.649 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.712 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 74.8 t -64.39 137.05 25.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.018 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.608 ' CG1' ' H ' ' A' ' 393' ' ' GLY . 2.5 pt -103.26 -57.84 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.757 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . 0.608 ' H ' ' CG1' ' A' ' 392' ' ' ILE . . . -142.18 178.78 20.57 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.545 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 12.6 m -156.05 141.31 17.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.814 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.597 ' HB3' HG13 ' A' ' 468' ' ' VAL . . . -124.06 -158.81 0.83 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.835 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.19 126.66 78.78 Favored Pre-proline 0 N--CA 1.489 1.498 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.772 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.28 101.93 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 121.033 1.155 . . . . 0.0 110.397 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -67.32 -57.75 6.06 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.589 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 79.3 p -137.19 139.87 29.39 Favored Pre-proline 0 N--CA 1.49 1.534 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.713 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.7 95.77 0.04 OUTLIER 'Trans proline' 0 C--O 1.217 -0.525 0 C-N-CA 121.31 1.34 . . . . 0.0 110.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 500' ' ' GLY . . . -153.82 162.2 30.3 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 118.186 -1.959 . . . . 0.0 112.906 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -144.8 132.56 21.15 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -150.41 160.87 43.44 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 117.946 -1.502 . . . . 0.0 112.884 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -131.78 102.6 5.94 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.719 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -151.67 166.55 30.81 Favored Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.134 -1.508 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.94 156.26 22.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.65 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.452 ' CG2' ' HA ' ' A' ' 492' ' ' GLU . 3.5 m -85.4 138.77 18.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 118.92 -1.112 . . . . 0.0 113.546 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.61 ' CZ ' ' OE1' ' A' ' 413' ' ' GLU . 0.4 OUTLIER -138.94 159.28 42.53 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.322 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.557 ' O ' HG23 ' A' ' 410' ' ' THR . 9.8 m-85 -122.88 32.81 5.59 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 119.672 -0.811 . . . . 0.0 112.813 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 409' ' ' PHE . 1.6 p -158.82 143.74 16.02 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.438 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -72.57 -13.83 61.49 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.591 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -75.17 -43.19 53.65 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.49 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.61 ' OE1' ' CZ ' ' A' ' 408' ' ' TYR . 68.9 mm-40 -62.28 -37.84 87.06 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.411 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' A' ' 441' ' ' ALA . . . -68.18 -32.32 72.48 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.403 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -68.67 -36.81 79.01 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.518 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -83.71 -36.81 23.41 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.837 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 420' ' ' LYS . . . -68.12 -54.93 14.54 Favored 'General case' 0 C--N 1.276 -2.621 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.987 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' HIS . . . . . 0.639 ' HB2' ' HB1' ' A' ' 441' ' ' ALA . 25.6 t-80 -44.22 -26.55 0.32 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.054 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . 0.413 ' N ' ' C ' ' A' ' 417' ' ' ALA . 0.6 OUTLIER -91.48 -22.87 20.18 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.884 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 417' ' ' ALA . 36.2 mmtt -80.64 -59.59 2.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.603 -0.839 . . . . 0.0 111.981 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . -155.0 3.87 0.23 Allowed Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.711 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 54.68 -146.95 0.53 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.656 -0.818 . . . . 0.0 112.094 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . 0.644 ' H ' ' HE ' ' A' ' 423' ' ' ARG . 0.0 OUTLIER 52.37 64.68 1.76 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.838 -1.145 . . . . 0.0 107.965 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.75 157.6 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.842 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 425' ' ' ILE . 6.9 mm -125.33 160.3 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.904 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . . . . . . . . . 5.3 tp -125.57 134.06 52.09 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.38 -0.928 . . . . 0.0 112.017 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.38 121.57 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.036 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ARG . . . . . 0.675 ' O ' HG22 ' A' ' 447' ' ' THR . 7.3 ttt180 -152.2 148.76 27.97 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.247 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.663 ' H ' HD12 ' A' ' 429' ' ' LEU . 4.3 mp -48.41 -58.01 5.25 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.568 -1.253 . . . . 0.0 109.252 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 431' ' ' THR . 2.2 tm-20 -122.89 175.84 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.436 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.635 ' OG1' ' CD2' ' A' ' 455' ' ' HIS . 1.2 p -112.14 173.37 6.39 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.685 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 3.9 m -154.84 155.14 30.06 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 119.424 -0.911 . . . . 0.0 110.998 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 435' ' ' ASP . 3.6 Cg_endo -64.27 -66.58 0.05 OUTLIER 'Trans proline' 0 C--O 1.212 -0.808 0 C-N-CA 121.758 1.638 . . . . 0.0 112.147 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -38.83 -26.78 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.269 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 438' ' ' GLY . 1.1 m-20 -74.42 -8.7 57.16 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.419 -0.913 . . . . 0.0 111.829 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.732 HG23 ' N ' ' A' ' 437' ' ' GLU . 9.8 tp -40.4 -50.56 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.827 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.732 ' N ' HG23 ' A' ' 436' ' ' ILE . 69.6 mt-10 -53.85 -38.28 64.52 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.035 -1.466 . . . . 0.0 108.615 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 435' ' ' ASP . . . -73.16 -26.65 70.13 Favored Glycine 0 C--N 1.303 -1.272 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' MET . . . . . 0.514 ' HG2' HD11 ' A' ' 445' ' ' ILE . 40.3 mtt -69.21 -39.11 78.79 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.988 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.48 ' NE2' HG13 ' A' ' 436' ' ' ILE . 6.8 m-70 -66.68 -57.94 6.14 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 118.171 -1.411 . . . . 0.0 109.174 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 418' ' ' HIS . . . -46.13 -39.64 9.82 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.073 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.616 ' C ' ' H ' ' A' ' 444' ' ' GLY . . . -97.55 85.28 3.57 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.087 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -62.91 35.77 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.848 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 442' ' ' ALA . . . -168.87 143.71 8.25 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . 0.514 HD11 ' HG2' ' A' ' 439' ' ' MET . 1.3 mt -144.63 132.01 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.17 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.42 ' CD1' ' CG1' ' A' ' 468' ' ' VAL . 7.0 tp -135.79 98.36 3.89 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.053 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 428' ' ' ARG . 1.7 p -113.62 161.22 17.7 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.73 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.45 HG13 ' SG ' ' A' ' 471' ' ' CYS . 16.2 t -76.84 -26.34 16.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.796 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' GLY . 6.8 mtt-85 -108.46 -134.46 0.34 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.723 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 452' ' ' MET . . . 70.72 -166.85 51.32 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.61 -1.281 . . . . 0.0 109.948 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . 0.568 ' N ' ' OG ' ' A' ' 469' ' ' SER . . . 72.0 -31.85 0.64 Allowed Glycine 0 N--CA 1.495 2.6 0 C-N-CA 119.332 -1.413 . . . . 0.0 110.937 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.505 ' H ' ' C ' ' A' ' 450' ' ' GLY . 15.6 ptm -68.38 42.31 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.946 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.8 OUTLIER 47.22 97.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.13 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 458' ' ' VAL . 6.8 t -171.32 -166.08 0.44 Allowed 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.294 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' HIS . . . . . 0.635 ' CD2' ' OG1' ' A' ' 431' ' ' THR . 7.2 p-80 -49.66 -48.13 49.58 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 118.981 -1.087 . . . . 0.0 110.337 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.435 ' CB ' HG21 ' A' ' 431' ' ' THR . . . -38.21 -56.15 1.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.956 -0.698 . . . . 0.0 112.467 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -81.08 -52.53 7.29 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.487 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 454' ' ' SER . 43.5 t -47.42 -47.32 10.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 C-N-CA 119.235 -0.986 . . . . 0.0 109.916 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 455' ' ' HIS . 93.3 t -64.31 -43.78 97.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 119.252 -0.979 . . . . 0.0 109.782 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.99 -43.75 91.52 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.946 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 70.1 mtm180 -69.81 -19.38 63.49 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.83 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -82.57 -36.79 15.56 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.414 -1.374 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' MET . . . . . . . . . . . . . 49.8 mmm -93.15 -26.1 17.57 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.24 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.87 -17.25 42.1 Favored Glycine 0 N--CA 1.494 2.523 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.63 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 16.7 m -46.83 163.86 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.108 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' CYS . . . . . 0.547 ' HG ' ' C ' ' A' ' 401' ' ' GLY . 48.6 t -85.22 128.59 34.73 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.053 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.661 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 13.1 t -151.42 140.49 21.14 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.382 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . 0.597 HG13 ' HB3' ' A' ' 395' ' ' ALA . 0.9 OUTLIER -110.65 161.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.137 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . 0.568 ' OG ' ' N ' ' A' ' 451' ' ' GLY . 9.2 t -150.37 148.57 28.96 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.567 -1.253 . . . . 0.0 112.61 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 449' ' ' ARG . . . 61.1 91.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.491 -1.338 . . . . 0.0 111.46 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 448' ' ' VAL . 7.7 p -100.22 176.06 5.51 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.326 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -59.52 -91.93 0.01 OUTLIER Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.291 -1.433 . . . . 0.0 110.381 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -144.82 59.55 1.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.632 HG23 ' CB ' ' A' ' 483' ' ' PHE . 10.7 mt -51.6 107.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.839 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -89.16 110.31 21.07 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 482' ' ' THR . 4.9 mt -87.96 135.49 25.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.013 -1.475 . . . . 0.0 113.884 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . 0.511 ' CG ' ' HG1' ' A' ' 482' ' ' THR . 1.3 m120 -113.18 122.04 46.32 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.678 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.65 ' C ' ' H ' ' A' ' 480' ' ' ALA . 7.8 mt-10 -56.4 -5.53 0.21 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.867 -1.06 . . . . 0.0 113.438 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -48.03 -14.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 118.093 -1.443 . . . . 0.0 108.186 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.65 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 177.98 -90.88 0.0 OUTLIER 'General case' 0 C--N 1.27 -2.849 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . 0.512 ' HB3' ' CE1' ' A' ' 409' ' ' PHE . 0.3 OUTLIER -167.46 54.56 0.07 Allowed 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 123.965 1.841 . . . . 0.0 108.949 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 476' ' ' ILE . 70.0 p -75.57 167.11 22.52 Favored 'General case' 0 C--N 1.255 -3.54 0 CA-C-N 111.251 -2.704 . . . . 0.0 112.267 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' PHE . . . . . 0.634 ' CE2' ' CG ' ' A' ' 490' ' ' PHE . 0.7 OUTLIER -153.46 112.83 3.8 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.693 179.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -89.64 120.07 30.61 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.047 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 486' ' ' GLY . 59.3 tp -149.82 157.21 42.97 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.885 -1.126 . . . . 0.0 111.141 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . 0.501 ' N ' ' HG ' ' A' ' 485' ' ' LEU . . . 62.39 -117.82 12.54 Favored Glycine 0 N--CA 1.48 1.568 0 C-N-CA 119.318 -1.42 . . . . 0.0 110.16 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . . . . . . . . . . . -127.04 29.1 4.44 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.673 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -151.68 144.3 24.27 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.122 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 45.5 m -95.36 115.19 27.1 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.529 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.634 ' CG ' ' CE2' ' A' ' 483' ' ' PHE . 0.8 OUTLIER -88.49 160.73 17.37 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.832 -0.747 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.747 ' HA ' HG22 ' A' ' 482' ' ' THR . . . -141.0 113.95 8.42 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.856 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . 0.452 ' HA ' ' CG2' ' A' ' 407' ' ' VAL . 1.7 tm-20 -48.06 99.68 0.02 OUTLIER 'General case' 0 CA--C 1.481 -1.704 0 C-N-CA 117.69 -1.604 . . . . 0.0 108.887 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 160.24 22.88 0.03 OUTLIER Glycine 0 C--N 1.274 -2.909 0 C-N-CA 118.623 -1.751 . . . . 0.0 109.865 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' ASP . . . . . 0.647 ' CG ' ' N ' ' A' ' 495' ' ' TYR . 16.2 t70 -143.72 -179.91 6.75 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.071 -1.051 . . . . 0.0 112.2 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . 0.647 ' N ' ' CG ' ' A' ' 494' ' ' ASP . 25.1 t80 -101.59 137.91 39.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.667 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.464 HG13 ' N ' ' A' ' 497' ' ' SER . 0.1 OUTLIER -137.15 160.98 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.445 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . 0.464 ' N ' HG13 ' A' ' 496' ' ' ILE . 29.7 t -123.6 104.57 9.11 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.658 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' LEU . . . . . 0.883 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.2 OUTLIER -109.62 134.27 52.14 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.764 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.883 ' N ' HD12 ' A' ' 498' ' ' LEU . 9.1 m-20 -115.36 148.67 39.01 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.821 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 401' ' ' GLY . . . -148.45 89.55 0.14 Allowed Glycine 0 C--O 1.188 -2.777 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' SER . . . . . . . . . . . . . 22.5 m -162.77 -3.88 0.04 OUTLIER 'General case' 0 C--N 1.255 -3.537 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' THR . . . . . 0.458 ' H ' ' H ' ' A' ' 503' ' ' GLY . 75.8 p -152.77 -14.65 0.16 Allowed 'General case' 0 C--N 1.275 -2.667 0 CA-C-N 111.417 -2.629 . . . . 0.0 105.969 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.458 ' H ' ' H ' ' A' ' 502' ' ' THR . . . 79.04 77.25 0.91 Allowed Glycine 0 N--CA 1.478 1.477 0 CA-C-N 113.525 -1.67 . . . . 0.0 111.29 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' LYS . . . . . . . . . . . . . 37.8 mttm -156.69 136.13 12.23 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.729 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' ILE . . . . . 0.625 ' C ' ' CD1' ' A' ' 506' ' ' TYR . 10.7 mt -110.54 161.15 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.807 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' TYR . . . . . 0.712 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 24.6 m-85 -150.33 161.72 41.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.435 ' HG2' ' N ' ' A' ' 508' ' ' GLY . 13.0 ttmt -134.97 157.47 46.84 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . 0.435 ' N ' ' HG2' ' A' ' 507' ' ' LYS . . . 101.6 -179.32 27.88 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.338 -1.41 . . . . 0.0 110.648 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 510' ' ' ILE . 11.4 t0 -90.52 142.54 27.64 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.531 -0.867 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' ILE . . . . . 0.591 HG22 ' H ' ' A' ' 511' ' ' GLU . 7.7 mt -148.45 171.73 2.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.619 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.591 ' H ' HG22 ' A' ' 510' ' ' ILE . 2.9 mp0 . . . . . 0 C--N 1.303 -1.423 0 CA-C-O 116.305 -1.807 . . . . 0.0 110.846 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.916 0.389 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . 0.589 ' C ' ' H ' ' A' ' 387' ' ' LYS . . . -162.94 -152.44 0.22 Allowed 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.575 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 57.6 mt 49.45 10.94 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.969 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.589 ' H ' ' C ' ' A' ' 385' ' ' ALA . 26.6 ttpp -122.43 -11.29 8.34 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.653 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ALA . . . . . . . . . . . . . . . -147.29 21.34 1.21 Allowed 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.35 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -79.93 -130.24 0.82 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.279 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -158.03 92.83 1.2 Allowed 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.622 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.753 ' CG2' ' CE2' ' A' ' 506' ' ' TYR . 67.7 t -93.91 158.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.333 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.477 ' N ' HG12 ' A' ' 391' ' ' VAL . 10.3 pt -102.36 -33.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.808 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' GLY . . . . . . . . . . . . . . . -178.3 -163.97 30.62 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 118.899 -1.619 . . . . 0.0 111.279 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' SER . . . . . . . . . . . . . 49.0 p -165.31 130.44 2.53 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.016 -0.673 . . . . 0.0 110.264 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.506 ' HB2' ' HA ' ' A' ' 471' ' ' CYS . . . -114.65 -147.92 0.42 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.943 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . . . . . . . . . 63.2 mt -81.93 132.31 54.45 Favored Pre-proline 0 C--N 1.31 -1.137 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.08 93.61 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 121.143 1.229 . . . . 0.0 110.806 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 467' ' ' CYS . . . -58.31 -62.12 2.07 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.47 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' SER . . . . . . . . . . . . . 1.4 t -148.61 146.88 23.34 Favored Pre-proline 0 C--N 1.305 -1.333 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.353 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -55.76 103.05 0.1 Allowed 'Trans proline' 0 C--N 1.325 -0.664 0 C-N-CA 121.258 1.305 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLY . . . . . 0.658 ' O ' ' N ' ' A' ' 500' ' ' GLY . . . -152.06 162.61 29.85 Favored Glycine 0 N--CA 1.509 3.508 0 C-N-CA 118.723 -1.704 . . . . 0.0 112.379 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . 0.49 ' N ' ' SG ' ' A' ' 466' ' ' CYS . . . -145.65 118.72 8.83 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ALA . . . . . . . . . . . . . . . -151.0 161.01 43.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 117.776 -1.57 . . . . 0.0 113.765 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' ALA . . . . . . . . . . . . . . . -137.84 110.02 7.32 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.056 -1.429 . . . . 0.0 107.437 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -152.53 169.81 31.68 Favored Glycine 0 N--CA 1.497 2.721 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.007 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' LYS . . . . . 0.653 ' CD ' ' N ' ' A' ' 406' ' ' LYS . 8.4 mptt -80.2 171.48 15.03 Favored 'General case' 0 C--O 1.201 -1.499 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 408' ' ' TYR . 0.2 OUTLIER -120.23 158.98 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 118.548 -1.261 . . . . 0.0 114.15 -179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' TYR . . . . . 0.623 ' CZ ' ' HB2' ' A' ' 414' ' ' ALA . 20.0 p90 -156.24 -151.09 0.31 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.716 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 427' ' ' VAL . 28.4 m-85 -148.22 -42.28 0.16 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 118.416 -1.314 . . . . 0.0 112.406 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' THR . . . . . . . . . . . . . 36.8 p -94.71 138.55 32.39 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.548 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' ALA . . . . . . . . . . . . . . . -56.12 -19.38 13.04 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.262 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -64.5 -49.07 72.78 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 417' ' ' ALA . 40.8 mm-40 -53.22 -50.9 63.77 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.286 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ALA . . . . . 0.623 ' HB2' ' CZ ' ' A' ' 408' ' ' TYR . . . -48.58 -38.46 20.71 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -63.57 -41.19 98.4 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.505 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -89.3 -9.62 49.88 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.657 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 413' ' ' GLU . . . -90.08 -60.7 1.86 Allowed 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.401 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -56.23 -21.37 23.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.045 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -27.61 68.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.003 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -73.13 -6.99 49.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.633 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' GLY . . . . . . . . . . . . . . . 80.94 71.47 1.28 Allowed Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.16 152.03 3.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.163 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -72.17 153.11 41.83 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.643 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' VAL . . . . . 0.842 ' O ' ' HB1' ' A' ' 442' ' ' ALA . 4.4 t -145.97 160.15 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.446 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ILE . . . . . 0.514 ' O ' ' CE1' ' A' ' 408' ' ' TYR . 5.2 mm -121.85 159.28 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.732 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' LEU . . . . . 0.622 ' CD1' ' CE2' ' A' ' 408' ' ' TYR . 13.5 tp -115.79 139.16 50.44 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.796 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.545 ' O ' ' CD2' ' A' ' 409' ' ' PHE . 51.9 t -130.57 119.71 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ARG . . . . . 0.762 ' H ' HG22 ' A' ' 447' ' ' THR . 1.0 OUTLIER -151.4 152.75 33.51 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 118.739 -1.184 . . . . 0.0 111.902 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.417 ' CB ' ' OE2' ' A' ' 430' ' ' GLU . 0.7 OUTLIER -80.31 20.56 0.67 Allowed 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.393 179.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.417 ' OE2' ' CB ' ' A' ' 429' ' ' LEU . 1.4 pm0 -179.69 153.08 0.53 Allowed 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 432' ' ' SER . 0.5 OUTLIER -83.14 -175.24 5.74 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.555 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 431' ' ' THR . 4.2 t -177.07 139.28 0.44 Allowed Pre-proline 0 C--N 1.305 -1.357 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.858 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -64.5 -69.18 0.03 OUTLIER 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 121.367 1.378 . . . . 0.0 111.897 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -46.48 -27.32 1.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.879 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.16 -9.23 45.13 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.163 -1.015 . . . . 0.0 111.477 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' ILE . . . . . 0.722 HG23 ' N ' ' A' ' 437' ' ' GLU . 8.3 tp -60.29 -49.99 82.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.031 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . 0.722 ' N ' HG23 ' A' ' 436' ' ' ILE . 52.3 mm-40 -54.89 -29.96 57.03 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.924 -1.51 . . . . 0.0 108.459 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . . . . . . . . . . . -75.3 -27.66 63.41 Favored Glycine 0 N--CA 1.473 1.143 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' MET . . . . . . . . . . . . . 43.8 mtt -69.48 -44.83 70.35 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.893 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.568 ' C ' ' N ' ' A' ' 442' ' ' ALA . 7.0 m170 -61.26 -39.28 89.79 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 118.437 -1.305 . . . . 0.0 109.408 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' ALA . . . . . . . . . . . . . . . -51.63 -18.16 1.08 Allowed 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' ALA . . . . . 0.842 ' HB1' ' O ' ' A' ' 424' ' ' VAL . . . -122.52 -155.48 0.65 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.283 -1.78 . . . . 0.0 108.077 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -168.62 37.75 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.175 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' GLY . . . . . . . . . . . . . . . -169.52 143.41 7.93 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' ILE . . . . . . . . . . . . . 1.3 mp -142.36 118.45 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 118.703 -1.199 . . . . 0.0 111.453 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' LEU . . . . . 0.436 HD13 ' CG1' ' A' ' 468' ' ' VAL . 2.5 tp -121.78 98.37 5.92 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.695 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' THR . . . . . 0.762 HG22 ' H ' ' A' ' 428' ' ' ARG . 5.5 p -115.16 160.32 19.84 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 21.2 t -81.24 -20.82 10.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.87 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' ARG . . . . . 0.584 ' CG ' ' H ' ' A' ' 450' ' ' GLY . 2.1 ttt85 -129.26 179.24 5.89 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.952 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' GLY . . . . . 0.584 ' H ' ' CG ' ' A' ' 449' ' ' ARG . . . 92.59 60.19 1.23 Allowed Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.163 -1.494 . . . . 0.0 109.725 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 453' ' ' THR . . . -141.78 -145.25 4.5 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 453' ' ' THR . 5.4 ttt 46.52 16.54 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.903 -1.119 . . . . 0.0 109.838 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . 0.524 ' N ' ' O ' ' A' ' 451' ' ' GLY . 0.2 OUTLIER 75.53 89.53 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.675 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 455' ' ' HIS . 93.9 p -149.3 -174.58 4.7 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.714 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' HIS . . . . . 0.682 ' O ' HG23 ' A' ' 459' ' ' VAL . 4.6 m170 -40.62 -45.1 2.27 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.895 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . 0.41 ' HB2' ' CG2' ' A' ' 431' ' ' THR . . . -47.49 -61.9 1.7 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.81 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -77.04 -50.64 12.66 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.597 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' VAL . . . . . . . . . . . . . 11.9 t -45.33 -40.18 2.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.393 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 455' ' ' HIS . 72.3 t -71.58 -45.39 67.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.318 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.35 80.6 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.826 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' ARG . . . . . . . . . . . . . 34.1 mtp180 -68.72 -37.27 79.35 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.705 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . -74.95 -24.12 72.79 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.528 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' MET . . . . . 0.479 ' HG3' ' N ' ' A' ' 464' ' ' GLY . 8.9 tpt -90.17 -81.92 0.28 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.449 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . 0.479 ' N ' ' HG3' ' A' ' 463' ' ' MET . . . 136.12 37.59 0.18 Allowed Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.968 -1.11 . . . . 0.0 110.428 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' THR . . . . . . . . . . . . . 10.2 t -108.37 171.43 7.42 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.935 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 402' ' ' ALA . 0.0 OUTLIER -86.42 126.34 34.32 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.98 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' CYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 398' ' ' ALA . 0.7 OUTLIER -152.19 155.19 37.3 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.341 -1.344 . . . . 0.0 112.284 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' VAL . . . . . 0.568 ' CG1' ' N ' ' A' ' 469' ' ' SER . 1.4 t -135.52 162.66 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.577 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' SER . . . . . 0.568 ' N ' ' CG1' ' A' ' 468' ' ' VAL . 33.5 t -149.98 151.74 33.8 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.028 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 38.37 83.99 0.01 OUTLIER Glycine 0 N--CA 1.496 2.67 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.087 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 395' ' ' ALA . 7.9 t -85.57 -145.99 0.11 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.023 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . -67.94 -101.16 0.03 OUTLIER Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.054 -1.546 . . . . 0.0 110.04 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -130.18 54.86 1.83 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.497 ' CG2' ' HB2' ' A' ' 483' ' ' PHE . 0.5 OUTLIER -45.63 111.7 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -105.03 113.91 27.8 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' ILE . . . . . . . . . . . . . 4.6 mt -88.22 134.95 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 118.573 -1.251 . . . . 0.0 112.444 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -105.99 115.32 30.03 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' GLU . . . . . 0.755 ' C ' ' H ' ' A' ' 480' ' ' ALA . 8.3 mp0 -67.76 -8.27 34.27 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.291 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 480' ' ' ALA . 6.1 mt-10 -59.08 6.77 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.152 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ALA . . . . . 0.755 ' H ' ' C ' ' A' ' 478' ' ' GLU . . . 170.75 -77.72 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 409' ' ' PHE . 4.0 mmtp 158.93 84.07 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 O-C-N 124.79 1.306 . . . . 0.0 109.482 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . 0.879 ' HA ' ' HB3' ' A' ' 491' ' ' ALA . 1.9 p -137.02 142.06 42.49 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.978 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' PHE . . . . . 0.968 ' CD2' ' HB2' ' A' ' 491' ' ' ALA . 3.8 p90 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.441 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' GLU . . . . . 0.464 ' OE2' ' N ' ' A' ' 485' ' ' LEU . 5.5 tp10 -109.8 117.45 33.9 Favored 'General case' 0 C--N 1.309 -1.152 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.702 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' LEU . . . . . 0.464 ' N ' ' OE2' ' A' ' 484' ' ' GLU . 4.8 mt -150.21 159.85 44.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.789 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 53.98 -104.41 0.23 Allowed Glycine 0 N--CA 1.487 2.064 0 C-N-CA 118.963 -1.589 . . . . 0.0 110.575 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' GLY . . . . . 0.527 ' O ' ' CD2' ' A' ' 488' ' ' HIS . . . -139.96 28.72 2.49 Favored Glycine 0 N--CA 1.503 3.111 0 C-N-CA 119.079 -1.534 . . . . 0.0 111.897 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' A' ' 487' ' ' GLY . 23.8 m170 -150.68 142.29 23.58 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.639 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' THR . . . . . . . . . . . . . 11.9 m -106.81 99.04 8.63 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.988 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.559 ' O ' ' CE1' ' A' ' 483' ' ' PHE . 23.3 p90 -154.32 155.13 34.55 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.302 -1.359 . . . . 0.0 113.948 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' ALA . . . . . 0.968 ' HB2' ' CD2' ' A' ' 483' ' ' PHE . . . -171.97 -129.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.669 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -47.12 90.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 118.187 -1.405 . . . . 0.0 108.94 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 491' ' ' ALA . . . 157.69 0.48 0.1 OUTLIER Glycine 0 C--N 1.279 -2.584 0 N-CA-C 107.637 -2.185 . . . . 0.0 107.637 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' ASP . . . . . 0.432 ' H ' ' H ' ' A' ' 493' ' ' GLY . 7.9 m-20 -159.81 -163.84 1.22 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.63 -0.785 . . . . 0.0 109.948 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' TYR . . . . . 0.484 ' CZ ' ' HA2' ' A' ' 508' ' ' GLY . 4.5 p90 -142.07 144.76 33.73 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.678 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' ILE . . . . . 0.439 HG23 ' CE1' ' A' ' 490' ' ' PHE . 0.0 OUTLIER -123.75 160.6 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.877 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 506' ' ' TYR . 6.7 t -115.31 99.91 7.74 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 499' ' ' ASP . 0.1 OUTLIER -98.2 144.44 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.377 -179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' ASP . . . . . 0.66 ' N ' HD12 ' A' ' 498' ' ' LEU . 6.7 t0 -103.55 157.43 17.05 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.697 0.761 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' GLY . . . . . 0.658 ' N ' ' O ' ' A' ' 401' ' ' GLY . . . -145.25 95.47 0.18 Allowed Glycine 0 C--N 1.275 -2.816 0 N-CA-C 107.156 -2.378 . . . . 0.0 107.156 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 500' ' ' GLY . 0.3 OUTLIER 163.21 6.33 0.0 OUTLIER 'General case' 1 C--N 1.24 -4.156 0 CA-C-N 112.014 -2.093 . . . . 0.0 106.617 -179.97 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 504' ' ' LYS . 0.1 OUTLIER -163.56 -21.72 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.203 -2.271 . . . . 0.0 107.592 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 84.51 -10.35 62.01 Favored Glycine 0 N--CA 1.492 2.42 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.948 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' LYS . . . . . 0.536 ' H ' HG23 ' A' ' 502' ' ' THR . 7.9 mtmt -71.98 120.18 17.21 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.986 -1.086 . . . . 0.0 110.774 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' ILE . . . . . 0.667 ' O ' HG13 ' A' ' 391' ' ' VAL . 1.2 tt -96.97 160.65 2.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.867 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' TYR . . . . . 0.753 ' CE2' ' CG2' ' A' ' 391' ' ' VAL . 33.0 m-85 -138.18 162.58 33.89 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.128 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' LYS . . . . . 0.493 ' HG3' ' CZ ' ' A' ' 490' ' ' PHE . 3.1 tmtt? -123.53 151.02 43.28 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.999 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . 0.484 ' HA2' ' CZ ' ' A' ' 495' ' ' TYR . . . 60.89 99.2 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 C-N-CA 118.773 -1.679 . . . . 0.0 109.998 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 508' ' ' GLY . 36.2 m-20 -35.9 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 120.099 -0.64 . . . . 0.0 111.795 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.49 -26.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.224 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 511' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.271 -2.822 0 CA-C-O 116.378 -1.772 . . . . 0.0 110.847 -179.995 . . . . . . . . 2 2 . 1 stop_ save_